# ID	Inflected form	Lemmatised form	Frequency	DDW	Head	Modifier	MainHead
8215	pylori infection	pylori infection	21	13.423911236263	274	501	274	
3975	triple therapy	triple therapy	11	9.37984182133483	464	3976	464	
3123	fatty acid	fatty acid	11	8.51316550354199	4	3124	4	
2902	Φ st1	Φ st1	10	9.87403161140781	120	2903	120	
13426	negative bacteria	negative bacteria	10	6.39233868393476	1999	238	1999	
942	T cells	T cell	10	6.74662043085299	113	58	113	
14636	nov .	nov .	10	7.18022624556461	4472	13361	4472	
3626	Mycobacterium tuberculosis	Mycobacterium tuberculosis	10	6.09279773497527	491	261	491	
499	Helicobacter pylori	Helicobacter pylori	10	6.09279773497527	501	500	501	
2317	Pseudomonas aeruginosa	Pseudomonas aeruginosa	9	5.75310481554128	2319	2318	2319	
385	gastric cancer	gastric cancer	8	7.89922528912625	387	190	387	
559	chain reaction	chain reaction	8	4.87423818798021	561	320	561	
2110	drug resistance	drug resistance	8	5.74418099645169	1830	162	1830	
4834	important role	important role	7	4.47463707875433	233	118	233	
2518	burnetii infection	burnetii infection	7	6.91182212798547	274	2519	274	
4471	. pylori	. pylori	7	5.02615837189523	501	4472	501	
11671	bile resistance	bile resistance	7	6.91182212798547	1830	1024	1830	
2363	gel electrophoresis	gel electrophoresis	7	4.26495841448269	2365	2364	2365	
1288	alkaline phosphatase	alkaline phosphatase	7	5.41746895679945	1290	1289	1290	
2922	virulence factors	virulence factor	7	4.47463707875433	2924	383	2924	
557	polymerase chain reaction	polymerase chain reaction	7	4.26495841448269	559	558	561	
4469	H . pylori	H . pylori	7	5.02615837189523	4471	764	501	
2361	field gel electrophoresis	field gel electrophoresis	6	3.83540321036086	2363	2362	2365	
4585	Mycoplasma otitis	Mycoplasma otitis	6	5.92441896684469	4587	4341	4587	
8007	clinical isolates	clinical isolate	6	3.83540321036086	334	323	334	
4556	effector proteins	effector protein	6	4.64354482011382	27	4557	27	
7288	enzyme activity	enzyme activity	6	4.64354482011382	393	4250	393	
189	gastric pH	gastric pH	6	5.92441896684469	191	190	191	
9182	Ure antibody	Ure antibody	6	5.92441896684469	1299	9183	1299	
15658	resistant isolates	resistant isolate	6	4.30813574733877	334	123	334	
2079	growth medium	growth medium	6	4.04797225851179	1926	217	1926	
1270	amino acid	amino acid	6	4.30813574733877	4	1271	4	
13347	resistant strains	resistant strain	6	4.64354482011382	551	123	551	
7852	quinolone resistance	quinolone resistance	6	5.92441896684469	1830	7853	1830	
1911	gene transfer	gene transfer	5	3.86962068342818	1913	18	1913	
4213	abiotic surface	abiotic surface	5	4.93701580570391	339	4214	339	
5441	virulence plasmid	virulence plasmid	5	4.93701580570391	3040	383	3040	
5587	heat stress	heat stress	5	4.93701580570391	780	1986	780	
5156	professional phagocytes	professional phagocyte	5	4.93701580570391	5158	5157	5158	
3395	gene expression	gene expression	5	3.59011312278231	373	18	373	
12106	time PCR	time PCR	5	4.93701580570391	2264	1403	2264	
11519	years of age	year of age	5	4.26356446424311	7377	912	7377	
8896	resistant strain	resistant strain	5	3.86962068342818	76	123	76	
7309	carriage rate	carriage rate	5	4.93701580570391	154	7310	154	
16261	log₁₀ CFU	log₁₀ CFU	5	4.93701580570391	3295	2480	3295	
2857	delta T cells	delta T cell	5	4.93701580570391	942	56	113	
11828	coli strains	coli strain	5	3.86962068342818	551	696	551	
5345	Lyme arthritis	Lyme arthritis	5	4.93701580570391	2776	5346	2776	
9003	fatty acids	fatty acid	5	3.59011312278231	3060	3124	3060	
14434	octadecenoic acid	octadecenoic acid	5	4.93701580570391	4	14435	4	
1088	cell line	cell line	5	3.86962068342818	1090	235	1090	
2855	gamma delta T cells	gamma delta T cell	5	4.93701580570391	2857	54	113	
3110	amino acids	amino acid	5	3.37331021542649	3060	1271	3060	
10304	O157 strains	O157 strain	5	4.93701580570391	551	5537	551	
4939	lipid A	lipid A	5	4.93701580570391	1379	3526	1379	
1883	strain L	strain L	5	4.26356446424311	1885	76	1885	
266	meningococcal disease	meningococcal disease	5	4.93701580570391	268	267	268	
1252	cord injury	cord injury	4	3.94961264456312	909	1253	909	
1250	spinal cord injury	spinal cord injury	4	3.94961264456312	1252	1251	909	
5582	Staphylococcus aureus	Staphylococcus aureus	4	3.09569654674254	5584	3099	5584	
13086	cystic fibrosis	cystic fibrosis	4	3.41085157139449	13088	13087	13088	
4781	Chlorobaculum tepidum	Chlorobaculum tepidum	4	3.41085157139449	4783	4782	4783	
2774	destructive arthritis	destructive arthritis	4	3.94961264456312	2776	2775	2776	
3168	positive bacteria	positive bacteria	4	3.09569654674254	1999	953	1999	
3898	TTS system	TTS system	4	3.94961264456312	1501	3899	1501	
4116	Chlamydia trachomatis	Chlamydia trachomatis	4	3.09569654674254	4118	4117	4118	
1546	necrotic enteritis	necrotic enteritis	4	3.94961264456312	1548	1547	1548	
8668	minced meat	minced meat	4	3.94961264456312	8670	8669	8670	
6914	general strategy	general strategy	4	3.41085157139449	6916	5391	6916	
3771	expression of MyD88	expression of MyD88	4	3.94961264456312	373	3773	373	
14897	FIGE REA	FIGE REA	4	3.94961264456312	2278	14898	2278	
8844	like THP -1 cells	like THP -1 cell	4	3.94961264456312	8846	829	113	
10427	Helicobacter pylori	Helicobacter pylorus	4	3.41085157139449	10429	500	10429	
279	cell death	cell death	4	3.94961264456312	281	235	281	
15573	capsule production	capsule production	4	3.94961264456312	93	4156	93	
284	granulomatous response	granulomatous response	4	3.94961264456312	286	285	286	
12195	cyclopropane fatty acid	cyclopropane fatty acid	4	3.94961264456312	3123	12196	4	
5580	resistant Staphylococcus aureus	resistant Staphylococcus aureus	4	3.09569654674254	5582	123	5584	
490	tuberculosis isolates	tuberculosis isolate	4	3.41085157139449	334	491	334	
7594	n-hexane extract	n-hexane extract	4	3.94961264456312	3075	7595	3075	
1186	shock proteins	shock protein	4	3.94961264456312	27	1187	27	
5013	gastric mucosa	gastric mucosa	4	3.41085157139449	247	190	247	
4800	incubation conditions	incubation condition	4	3.94961264456312	2285	4801	2285	
498	Helicobacter pylori infection	Helicobacter pylori infection	4	3.09569654674254	274	499	274	
8846	THP -1 cells	THP -1 cell	4	3.94961264456312	8848	8847	113	
15526	prevalence of H	prevalence of H	4	3.09569654674254	1786	764	1786	
5685	adhesive factor	adhesive factor	4	3.94961264456312	72	5686	72	
15881	diagnosis of H	diagnosis of H	4	3.94961264456312	5010	764	5010	
2056	T cell	T cell	4	3.09569654674254	235	58	235	
2143	host cells	host cell	4	3.41085157139449	113	271	113	
8848	-1 cells	-1 cell	4	3.94961264456312	113	145	113	
9225	duodenal ulcer	duodenal ulcer	4	3.94961264456312	6180	1306	6180	
294	Japanese flounder	Japanese flounder	4	3.94961264456312	296	295	296	
900	protein array	protein array	4	3.94961264456312	902	406	902	
2341	surface protein	surface protein	4	3.09569654674254	406	339	406	
152	eradication rate	eradication rate	4	3.41085157139449	154	153	154	
5115	bacterial surface	bacterial surface	4	2.87209049822585	339	185	339	
8704	substrate specificity	substrate specificity	4	3.41085157139449	3352	3652	3352	
4421	antibody detection	antibody detection	4	3.94961264456312	2459	1299	2459	
4298	resistant Enterococcus	resistant Enterococcus	4	3.41085157139449	4300	123	4300	
466	duplex DNA	duplex DNA	4	3.94961264456312	468	467	468	
1489	antibody response	antibody response	4	3.41085157139449	286	1299	286	
7155	ICP monitor	ICP monitor	3	2.96220948342234	7157	315	7157	
184	bacterial pathogens	bacterial pathogen	3	2.32177241005691	186	185	186	
16015	annua leaves	annua leaf	3	2.96220948342234	7578	5403	7578	
3722	membrane proteins	membrane protein	3	2.32177241005691	27	3723	27	
1314	catalytic activities	catalytic activity	3	2.55813867854586	1316	1315	1316	
8402	strain PTJT	strain PTJT	3	2.96220948342234	5123	76	5123	
3242	amino acids	amino acid	3	2.32177241005691	3060	3243	3060	
204	riboflavin synthase	riboflavin synthase	3	2.96220948342234	206	205	206	
759	jejunal tissue	jejunal tissue	3	2.96220948342234	569	760	569	
2733	Wap65 genes	Wap65 gene	3	2.96220948342234	444	2734	444	
5387	signaling pathways	signaling pathway	3	2.96220948342234	5389	731	5389	
1535	aim of this study	aim of this study	3	2.32177241005691	1536	1514	1536	
11760	Israeli travelers	Israeli traveler	3	2.96220948342234	3076	5953	3076	
2120	metabolic engineering	metabolic engineering	3	2.96220948342234	2122	2121	2122	
2105	lactic acid bacteria	lactic acid bacteria	3	2.55813867854586	2107	2106	1999	
5509	diffusion method	diffusion method	3	2.32177241005691	596	5510	596	
3377	risk factors	risk factor	3	2.32177241005691	2924	3378	2924	
3670	sialic acid	sialic acid	3	2.96220948342234	4	3671	4	
1105	asymmetric unit	asymmetric unit	3	2.55813867854586	1107	1106	1107	
2097	genetic diversity	genetic diversity	3	2.55813867854586	2099	880	2099	
7565	Ah lexA	Ah lexA	3	2.96220948342234	7567	5461	7567	
1761	inclusion bodies	inclusion body	3	2.55813867854586	1763	1762	1763	
1712	structural disorder	structural disorder	3	2.96220948342234	291	156	291	
10876	chronic active gastritis	chronic active gastritis	3	2.96220948342234	10878	363	4245	
3066	sequence analysis	sequence analysis	3	2.32177241005691	203	1657	203	
14292	coli O157 strains	coli O157 strain	3	2.96220948342234	10304	696	551	
1569	mRNA levels	mRNA level	3	2.55813867854586	495	1570	495	
1335	large yellow croaker	large yellow croaker	3	2.96220948342234	1337	288	1339	
10133	fatty acid composition	fatty acid composition	3	2.96220948342234	10137	3123	10137	
5631	tuberculosis infection	tuberculosis infection	3	2.96220948342234	274	491	274	
6313	infantile diarrhea	infantile diarrhea	3	2.55813867854586	982	6314	982	
13650	PRO group	PRO group	3	2.96220948342234	351	13651	351	
842	infectious complications	infectious complication	3	2.96220948342234	844	843	844	
8061	actin polymerization	actin polymerization	3	2.96220948342234	8063	932	8063	
3262	cultural method	cultural method	3	2.96220948342234	596	3263	596	
234	cell toxicity	cell toxicity	3	2.96220948342234	236	235	236	
2333	adhesion of E	adhesion of E	3	2.55813867854586	336	79	336	
4211	adhesion to the abiotic surface	adhesion to the abiotic surface	3	2.96220948342234	336	4213	336	
4456	primer sets	primer set	3	2.96220948342234	4458	4457	4458	
1411	bacterial flora	bacterial flora	3	2.55813867854586	1413	185	1413	
13708	surface proteins	surface protein	3	2.55813867854586	27	339	27	
3207	duration of follow-up	duration of follow-up	3	2.96220948342234	3208	3209	3208	
7490	monoclonal antibodies	monoclonal antibody	3	2.55813867854586	517	1298	517	
257	MALT lymphoma	MALT lymphoma	3	2.96220948342234	259	258	259	
3122	fatty acid compositions	fatty acid composition	3	2.55813867854586	3126	3123	3126	
1008	amyloidogenic peptides	amyloidogenic peptide	3	2.96220948342234	1010	1009	1010	
10724	LM17 medium	LM17 medium	3	2.96220948342234	1926	10725	1926	
1828	antibiotic resistance	antibiotic resistance	3	2.32177241005691	1830	31	1830	
9345	yolk sacs	yolk sac	3	2.96220948342234	9347	9346	9347	
1974	antimicrobial susceptibility	antimicrobial susceptibility	3	2.32177241005691	273	1753	273	
4493	immune system	immune system	3	2.32177241005691	1501	2357	1501	
9308	milk beverage	milk beverage	3	2.96220948342234	9310	6945	9310	
10264	structural studies	structural study	3	2.32177241005691	2918	156	2918	
8031	crystal formation	crystal formation	3	2.96220948342234	4488	8032	4488	
2526	rabbit serum	rabbit serum	3	2.96220948342234	1798	2247	1798	
1201	LVS binding	LVS binding	3	2.96220948342234	159	1202	159	
8243	PMN ROS production	PMN ROS production	3	2.96220948342234	8245	278	93	
4092	serum pepsinogen	serum pepsinogen	3	2.96220948342234	4094	1798	4094	
13436	ulcerative colitis	ulcerative colitis	3	2.55813867854586	4287	13437	4287	
10546	presence of urea	presence of urea	3	2.96220948342234	139	3833	139	
5910	bacillary load	bacillary load	3	2.96220948342234	5912	5911	5912	
1337	yellow croaker	yellow croaker	3	2.96220948342234	1339	1338	1339	
10454	breath test	breath test	3	2.55813867854586	85	10455	85	
1787	clonal strains	clonal strain	3	2.96220948342234	551	1788	551	
10600	cytoplasmic membrane	cytoplasmic membrane	3	2.55813867854586	3723	10601	3723	
12304	intracellular bacteria	intracellular bacteria	3	2.55813867854586	1999	859	1999	
12271	like receptor	like receptor	3	2.55813867854586	345	829	345	
1809	environmental surfaces	environmental surface	3	2.96220948342234	1811	1810	1811	
3193	bacterial species	bacterial specie	3	2.32177241005691	73	185	73	
3325	deficient individuals	deficient individual	3	2.96220948342234	134	1064	134	
10780	GM17 medium	GM17 medium	3	2.96220948342234	1926	10781	1926	
6347	susceptible counterparts	susceptible counterpart	3	2.96220948342234	6349	2970	6349	
6288	hexadecanoic acid	hexadecanoic acid	3	2.96220948342234	4	6289	4	
2544	soft stools	soft stool	3	2.96220948342234	2546	2545	2546	
5952	Israeli isolates	Israeli isolate	3	2.96220948342234	334	5953	334	
2260	cell counts	cell count	3	2.55813867854586	2262	235	2262	
122	resistant E	resistant E	3	2.96220948342234	79	123	79	
6174	NAP intensity	NAP intensity	3	2.96220948342234	4874	1466	4874	
3710	causative agent	causative agent	3	2.32177241005691	1357	229	1357	
4505	gopher tortoises	gopher tortoise	3	2.96220948342234	1769	4506	1769	
8458	present study	present study	3	2.32177241005691	1514	8459	1514	
1038	food industry	food industry	3	2.55813867854586	1040	43	1040	
228	causative pathogens	causative pathogen	3	2.96220948342234	186	229	186	
2750	recurrence rate	recurrence rate	3	2.96220948342234	154	2751	154	
544	chemokine receptors	chemokine receptor	3	2.96220948342234	546	545	546	
8245	ROS production	ROS production	3	2.96220948342234	93	3478	93	
2772	severe destructive arthritis	severe destructive arthritis	3	2.96220948342234	2774	2773	2776	
3130	anthrax toxins	anthrax toxin	3	2.96220948342234	3132	2492	3132	
1035	positive samples	positive sample	3	2.55813867854586	225	953	225	
8906	concentration of E	concentration of E	3	2.96220948342234	2012	79	2012	
10413	outpatient clinic	outpatient clinic	3	2.96220948342234	5334	10414	5334	
2505	cell surface	cell surface	3	2.55813867854586	339	235	339	
2356	immune response	immune response	3	2.55813867854586	286	2357	286	
143	PGL -1	PGL -1	3	2.96220948342234	145	144	145	
57	T lymphocytes	T lymphocyte	3	2.55813867854586	59	58	59	
14571	agarases A	agaras A	3	2.96220948342234	1379	14572	1379	
8640	atrophic gastritis	atrophic gastritis	3	2.55813867854586	4245	8641	4245	
10272	pumilus MTCC	pumilus MTCC	3	2.96220948342234	10274	6326	10274	
337	biotic surface	biotic surface	3	2.96220948342234	339	338	339	
2107	acid bacteria	acid bacteria	3	2.55813867854586	1999	4	1999	
910	median age	median age	3	2.55813867854586	912	911	912	
3848	high numbers	high number	3	2.55813867854586	46	264	46	
3494	respiratory tract	respiratory tract	3	2.55813867854586	3496	735	3496	
1297	monoclonal antibody	monoclonal antibody	3	2.55813867854586	1299	1298	1299	
957	gold criterion	gold criterion	3	2.96220948342234	959	958	959	
15340	CagA antibody	CagA antibody	3	2.96220948342234	1299	6682	1299	
12664	host cell	host cell	3	2.32177241005691	235	271	235	
8435	bacterial infections	bacterial infection	3	2.32177241005691	736	185	736	
2005	campestris pv	campestris pv	3	2.96220948342234	2007	2006	2007	
1426	tortoise populations	tortoise population	3	2.96220948342234	1428	1427	1428	
6560	fever group	fever group	3	2.96220948342234	351	2841	351	
16801	H pylori infection	H pylori infection	3	2.96220948342234	8215	764	274	
15734	cell disruption	cell disruption	3	2.96220948342234	3307	235	3307	
5132	electron microscopy	electron microscopy	3	2.32177241005691	2816	5133	2816	
4869	dyspeptic patients	dyspeptic patient	3	2.55813867854586	226	4870	226	
10024	quinolone resistance levels	quinolone resistance level	3	2.96220948342234	495	7852	495	
10878	active gastritis	active gastritis	3	2.96220948342234	4245	1	4245	
1305	duodenal ulcers	duodenal ulcer	3	2.96220948342234	1307	1306	1307	
7647	pregnancy loss	pregnancy loss	3	2.96220948342234	4308	7648	4308	
15981	horizontal gene transfer	horizontal gene transfer	3	2.55813867854586	1911	15982	1913	
132	healthy individuals	healthy individual	3	2.96220948342234	134	133	134	
1574	antibacterial activity	antibacterial activity	3	2.55813867854586	393	1575	393	
7438	atrophy of the gastric mucosa	atrophy of the gastric mucosa	2	1.97480632228156	1396	5013	1396	
9562	strontium chloride M broth	strontium chloride M broth	2	1.97480632228156	9564	1619	1622	
9849	routine microbiological surveillance	routine microbiological surveillance	2	1.97480632228156	9851	9850	3820	
8934	pestis strain KIM6	pestis strain KIM6	2	1.97480632228156	8936	8935	8938	
5624	20% sucrose	20% sucrose	2	1.97480632228156	2232	5625	2232	
2762	cell line J774	cell line J774	2	1.97480632228156	2766	1088	2766	
4788	day-care center	day-care center	2	1.97480632228156	4790	4789	4790	
6373	iron uptake	iron uptake	2	1.70542578569724	4481	1953	4481	
130	environment of healthy individuals	environment of healthy individual	2	1.97480632228156	131	132	131	
12798	non-duplicated subjects	non-duplicated subject	2	1.97480632228156	2625	12799	2625	
1120	natural ecosystems	natural ecosystem	2	1.97480632228156	1122	1029	1122	
9104	active compounds	active compound	2	1.97480632228156	2878	1	2878	
8281	cell types	cell type	2	1.97480632228156	769	235	769	
8559	lytic bacteriophage	lytic bacteriophage	2	1.97480632228156	8561	7799	8561	
16032	low activities	low activity	2	1.97480632228156	1316	1109	1316	
1391	respiratory illness	respiratory illness	2	1.97480632228156	637	735	637	
7827	ICU days	ICU day	2	1.97480632228156	316	7828	316	
1591	monoclonal B cells	monoclonal B cell	2	1.97480632228156	1593	1298	113	
2845	Groups B	Group B	2	1.97480632228156	977	1378	977	
1266	N-terminal fragment	N-terminal fragment	2	1.97480632228156	1268	1267	1268	
10238	innate immune system	innate immune system	2	1.70542578569724	4493	2355	1501	
14535	description of Flavihumibacter petaseus	description of Flavihumibacter petaseus	2	1.97480632228156	14536	14537	14536	
11697	strains of C	strain of C	2	1.97480632228156	551	243	551	
1799	Mycobacterium leprae	Mycobacterium leprae	2	1.70542578569724	1801	261	1801	
2301	exogenous ones	exogenous one	2	1.97480632228156	2303	2302	2303	
6929	Group A	Group A	2	1.70542578569724	1379	1640	1379	
1377	Groups A	Group A	2	1.97480632228156	1379	1378	1379	
11841	nosocomial infection	nosocomial infection	2	1.97480632228156	274	11842	274	
4483	fluorescence polarization	fluorescence polarization	2	1.97480632228156	4485	930	4485	
3277	Shigella spp	Shigella spp	2	1.97480632228156	708	3278	708	
7958	tryptic soy broth	tryptic soy broth	2	1.97480632228156	7960	7959	1622	
13573	exchangeable effector loci	exchangeable effector locus	2	1.97480632228156	13575	13574	1078	
11996	LD distributions	LD distribution	2	1.97480632228156	4442	1980	4442	
327	ARS site	ARS site	2	1.97480632228156	3	328	3	
1764	objective of this study	objective of this study	2	1.70542578569724	1765	1514	1765	
10058	crystal structure	crystal structure	2	1.70542578569724	201	4195	201	
1312	new catalytic activities	new catalytic activity	2	1.97480632228156	1314	1171	1316	
9384	variable fragment	variable fragment	2	1.97480632228156	1268	6069	1268	
9660	surface nucleolin	surface nucleolin	2	1.97480632228156	254	339	254	
14502	MDR pathogens	MDR pathogen	2	1.97480632228156	186	6925	186	
10508	negative bacterium	negative bacterium	2	1.70542578569724	1136	238	1136	
5243	positive H . pylori serology	positive H . pylori serology	2	1.97480632228156	5245	953	5251	
4448	resistance to antibiotics	resistance to antibiotic	2	1.70542578569724	1830	3547	1830	
3545	prophylactic antibiotics	prophylactic antibiotic	2	1.97480632228156	3547	3546	3547	
9115	lethal toxin	lethal toxin	2	1.97480632228156	1598	9116	1598	
4926	course of therapy	course of therapy	2	1.70542578569724	2939	464	2939	
2667	energy of maintenance	energy of maintenance	2	1.97480632228156	1624	216	1624	
10066	real time	real time	2	1.97480632228156	1403	10067	1403	
670	screening agar	screening agar	2	1.70542578569724	672	671	672	
9448	study groups	study group	2	1.70542578569724	4420	1514	4420	
11490	otitis media	otitis medium	2	1.97480632228156	4763	4587	4763	
3481	high affinity	high affinity	2	1.70542578569724	2311	264	2311	
2328	urine of leprosy patients	urine of leprosy patient	2	1.97480632228156	892	2330	892	
4479	bacterial uptake	bacterial uptake	2	1.97480632228156	4481	185	4481	
16313	pathogen recognition	pathogen recognition	2	1.97480632228156	1126	1905	1126	
13617	aromatic monoacylglycerols	aromatic monoacylglycerol	2	1.97480632228156	13619	3835	13619	
1778	Mtb infection	Mtb infection	2	1.97480632228156	274	654	274	
9893	throat cultures	throat culture	2	1.97480632228156	4706	3328	4706	
6443	plant cell	plant cell	2	1.97480632228156	235	5726	235	
5966	bacterial strains	bacterial strain	2	1.70542578569724	551	185	551	
9343	infected yolk sacs	infected yolk sac	2	1.97480632228156	9345	1838	9347	
6143	non-O1 V	non-O1 V	2	1.97480632228156	2022	6144	2022	
673	microbiological safety	microbiological safety	2	1.97480632228156	675	674	675	
1857	gene clusters	gene cluster	2	1.97480632228156	1859	18	1859	
11381	bilateral septic embolism	bilateral septic embolism	2	1.97480632228156	11383	11382	11385	
2642	inflammatory bowel disease	inflammatory bowel disease	2	1.97480632228156	2644	2643	268	
2310	affinity chromatography	affinity chromatography	2	1.70542578569724	2312	2311	2312	
7847	native siderophores	native siderophore	2	1.97480632228156	6892	7848	6892	
3280	lymphocytic infiltrates	lymphocytic infiltrate	2	1.97480632228156	3282	3281	3282	
67	secondary acylation	secondary acylation	2	1.97480632228156	69	68	69	
11298	active HOX	active HOX	2	1.97480632228156	11300	1	11300	
11195	cell wall	cell wall	2	1.97480632228156	1918	235	1918	
2746	culture medium	culture medium	2	1.70542578569724	1926	2092	1926	
4769	elongation factor Tu	elongation factor Tu	2	1.97480632228156	4771	4770	3221	
9427	natural infection	natural infection	2	1.97480632228156	274	1029	274	
5926	median time	median time	2	1.97480632228156	1403	5927	1403	
2649	human pathogens	human pathogen	2	1.70542578569724	186	834	186	
9425	burnetii natural infection	burnetii natural infection	2	1.97480632228156	9427	9426	274	
4634	nervous system	nervous system	2	1.70542578569724	1501	1499	1501	
8116	Mycoplasma pneumoniae	Mycoplasma pneumoniae	2	1.70542578569724	8118	4341	8118	
13478	retail poultry	retail poultry	2	1.97480632228156	9654	7021	9654	
15267	cephem compounds	cephem compound	2	1.97480632228156	2878	15268	2878	
8991	ICP monitor insertion	ICP monitor insertion	2	1.97480632228156	8995	7155	8995	
4713	HCN production	HCN production	2	1.97480632228156	93	4714	93	
5414	bacterium Chlorobaculum tepidum	bacterium Chlorobaculum tepidum	2	1.70542578569724	4781	1136	4783	
10149	infection control	infection control	2	1.70542578569724	575	274	575	
8762	processing plant	processing plant	2	1.97480632228156	5726	8763	5726	
13322	-1 receptor	-1 receptor	2	1.70542578569724	345	145	345	
16071	dalfopristin therapy	dalfopristin therapy	2	1.97480632228156	464	14490	464	
1103	crystallographic asymmetric unit	crystallographic asymmetric unit	2	1.97480632228156	1105	1104	1107	
12639	regression models	regression model	2	1.97480632228156	7459	6309	7459	
840	subsequent infectious complications	subsequent infectious complication	2	1.97480632228156	842	841	844	
5885	reference strains	reference strain	2	1.70542578569724	551	1447	551	
5871	adaptor protein	adaptor protein	2	1.70542578569724	406	1003	406	
7965	hexadecenoic acid	hexadecenoic acid	2	1.97480632228156	4	7966	4	
13921	mucosal inflammation	mucosal inflammation	2	1.97480632228156	1772	9417	1772	
5732	lactis subsp	lactis subsp	2	1.97480632228156	5734	1984	5734	
9773	N-linked C14	N-linked C14	2	1.97480632228156	4565	9774	4565	
1226	Clostridium difficile infection	Clostridium difficile infection	2	1.70542578569724	1228	1227	274	
7457	animal models	animal model	2	1.70542578569724	7459	4461	7459	
4283	chronic catarrhal colitis	chronic catarrhal colitis	2	1.97480632228156	4285	363	4287	
13320	interleukin -1 receptor	interleukin -1 receptor	2	1.70542578569724	13322	7918	345	
5401	Artemisia annua	Artemisia annua	2	1.97480632228156	5403	5402	5403	
16170	biofilm formation	biofilm formation	2	1.70542578569724	4488	8662	4488	
11080	Additional research	Additional research	2	1.70542578569724	11082	11081	11082	
5245	H . pylori serology	H . pylori serology	2	1.97480632228156	5251	4469	5251	
542	CC chemokine receptors	CC chemokine receptor	2	1.97480632228156	544	543	546	
8159	addition of nisin	addition of nisin	2	1.97480632228156	2743	8161	2743	
6359	HUC -1	HUC -1	2	1.97480632228156	145	6360	145	
13575	effector loci	effector locus	2	1.97480632228156	1078	4557	1078	
1303	healing of duodenal ulcers	healing of duodenal ulcer	2	1.97480632228156	1304	1305	1304	
3940	cytokine modulation	cytokine modulation	2	1.97480632228156	193	1568	193	
8540	infective endocarditis model	infective endocarditis model	2	1.97480632228156	8542	536	361	
5574	Escherichia coli strain	Escherichia coli strain	2	1.97480632228156	5576	1840	76	
11488	acute otitis media	acute otitis medium	2	1.97480632228156	11490	6312	4763	
212	E λ	E λ	2	1.97480632228156	214	79	214	
6155	Bacillus intermedius	Bacillus intermedius	2	1.97480632228156	6157	3924	6157	
1832	antimicrobial agents	antimicrobial agent	2	1.70542578569724	1834	1753	1834	
4624	antibiotic sensitivity	antibiotic sensitivity	2	1.70542578569724	1818	31	1818	
9827	bacterial virulence	bacterial virulence	2	1.70542578569724	383	185	383	
15783	binding activity	binding activity	2	1.97480632228156	393	159	393	
6699	various infections	various infection	2	1.97480632228156	736	3269	736	
9460	LL patients	LL patient	2	1.97480632228156	226	9461	226	
7083	human cells	human cell	2	1.70542578569724	113	834	113	
6871	conversion ratio	conversion ratio	2	1.97480632228156	3302	6872	3302	
1855	carotenoid gene clusters	carotenoid gene cluster	2	1.97480632228156	1857	514	1859	
241	treatment of C	treatment of C	2	1.97480632228156	61	243	61	
3657	airway infection	airway infection	2	1.97480632228156	274	3658	274	
7411	sensitive strains	sensitive strain	2	1.97480632228156	551	3589	551	
9422	living conditions	living condition	2	1.97480632228156	2285	9423	2285	
9566	M broth	M broth	2	1.97480632228156	1622	1921	1622	
5753	C3 deposition	C3 deposition	2	1.97480632228156	5755	528	5755	
15289	. pylori	. pylorus	2	1.70542578569724	10429	4472	10429	
7078	casei strain Shirota	casei strain Shirota	2	1.97480632228156	7080	7079	7082	
10312	negative phenotype	negative phenotype	2	1.97480632228156	5168	238	5168	
12978	polypeptide gene	polypeptide gene	2	1.97480632228156	18	1854	18	
9955	strain 96-OK	strain 96-OK	2	1.97480632228156	9957	76	9957	
9791	care clinic	care clinic	2	1.97480632228156	5334	3025	5334	
1096	early stages	early stage	2	1.97480632228156	1098	1097	1098	
5706	submerged fermentation	submerged fermentation	2	1.97480632228156	5708	5707	5708	
1488	antibody response to R	antibody response to R	2	1.97480632228156	1489	1492	286	
2354	innate immune response	innate immune response	2	1.97480632228156	2356	2355	286	
10641	pseudomallei isolates	pseudomallei isolate	2	1.97480632228156	334	2600	334	
10501	absence of TLR2 activation	absence of TLR2 activation	2	1.97480632228156	5502	10503	5502	
5067	time monitoring of hydrogen cyanide	time monitoring of hydrogen cyanide	2	1.97480632228156	5069	1403	2523	
7012	strain typing	strain typing	2	1.97480632228156	1658	76	1658	
11169	bladder patients	bladder patient	2	1.97480632228156	226	11170	226	
5071	hydrogen cyanide	hydrogen cyanide	2	1.97480632228156	968	5072	968	
5735	marcescens MG1	marcescen MG1	2	1.97480632228156	5737	2349	5737	
8310	major surface antigen	major surface antigen	2	1.97480632228156	8312	71	655	
12601	tularensis infection	tularensis infection	2	1.70542578569724	274	5453	274	
1092	probiotic treatment	probiotic treatment	2	1.97480632228156	61	1093	61	
4202	respiratory tract disease	respiratory tract disease	2	1.97480632228156	268	3494	268	
5052	nasopharyngeal cultures	nasopharyngeal culture	2	1.97480632228156	4706	5053	4706	
12628	methanotroph Methylomonas sp	methanotroph Methylomonas sp	2	1.97480632228156	12630	12629	3950	
1983	lactis strains	lactis strain	2	1.97480632228156	551	1984	551	
15728	human sera	human serum	2	1.97480632228156	3345	834	3345	
10433	range of incubation conditions	range of incubation condition	2	1.97480632228156	928	4800	928	
14584	resistant lineages	resistant lineage	2	1.97480632228156	14337	123	14337	
15789	mean age	mean age	2	1.70542578569724	912	3232	912	
1841	coli cells	coli cell	2	1.70542578569724	113	1842	113	
7080	strain Shirota	strain Shirota	2	1.97480632228156	7082	76	7082	
9382	chain variable fragment	chain variable fragment	2	1.97480632228156	9384	320	1268	
13070	coli adhesion	coli adhesion	2	1.97480632228156	336	696	336	
13080	deficient patients	deficient patient	2	1.97480632228156	226	1064	226	
15355	Scophthalmus maximus	Scophthalmus maximus	2	1.97480632228156	15357	15356	15357	
9729	high levels	high level	2	1.70542578569724	495	264	495	
12920	human blood monocytes	human blood monocyte	2	1.97480632228156	12922	834	2934	
8268	hind paws	hind paw	2	1.97480632228156	8270	8269	8270	
10807	important implications	important implication	2	1.70542578569724	1783	118	1783	
4047	acquisition of antimicrobial resistance	acquisition of antimicrobial resistance	2	1.97480632228156	4048	4049	4048	
1562	apoptotic cells	apoptotic cell	2	1.70542578569724	113	1563	113	
2760	like cell line J774	like cell line J774	2	1.97480632228156	2762	829	2766	
4234	virulence factor	virulence factor	2	1.70542578569724	72	383	72	
10581	clinical syndrome	clinical syndrome	2	1.97480632228156	356	323	356	
11564	immunodeficiency virus	immunodeficiency virus	2	1.97480632228156	768	11565	768	
10774	narcotic medications	narcotic medication	2	1.97480632228156	10776	10775	10776	
10503	TLR2 activation	TLR2 activation	2	1.97480632228156	2118	115	2118	
8162	rice seedlings	rice seedling	2	1.97480632228156	8164	34	8164	
16133	host origin	host origin	2	1.97480632228156	13639	271	13639	
2414	level organization	level organization	2	1.97480632228156	2416	1113	2416	
12509	urinary tract infections	urinary tract infection	2	1.97480632228156	12511	6278	736	
8605	mechanism of action	mechanism of action	2	1.70542578569724	525	8607	525	
1510	murine tuberculosis	murine tuberculosis	2	1.97480632228156	491	1511	491	
3867	dilution method	dilution method	2	1.70542578569724	596	3868	596	
9246	glycopeptide resistance	glycopeptide resistance	2	1.97480632228156	1830	9247	1830	
6316	disease activity	disease activity	2	1.97480632228156	393	268	393	
8238	n-hexane extract	n-hexane extract	2	1.97480632228156	3075	4879	3075	
9458	urine of LL patients	urine of LL patient	2	1.97480632228156	892	9460	892	
14263	expression of vvhA	expression of vvhA	2	1.97480632228156	373	2778	373	
2913	Helicobacter pullorum	Helicobacter pullorum	2	1.97480632228156	2915	500	2915	
5466	probable number	probable number	2	1.97480632228156	1034	5467	1034	
6024	French isolates	French isolate	2	1.97480632228156	334	6025	334	
3094	Perdix perdix	Perdix perdix	2	1.97480632228156	3096	3095	3096	
619	C3 position	C3 position	2	1.97480632228156	621	528	621	
2417	pathogenic bacteria	pathogenic bacteria	2	1.70542578569724	1999	2418	1999	
11600	PCR products	PCR product	2	1.97480632228156	1031	2264	1031	
5069	monitoring of hydrogen cyanide	monitoring of hydrogen cyanide	2	1.97480632228156	2523	5071	2523	
8278	urease test	urease test	2	1.70542578569724	85	809	85	
3140	CD4 cell counts	CD4 cell count	2	1.97480632228156	2260	3141	2262	
3303	Bile resistance	Bile resistance	2	1.97480632228156	1830	3304	1830	
6177	perianal ulcer disease	perianal ulcer disease	2	1.97480632228156	6179	1180	268	
2961	HSV -1	HSV -1	2	1.97480632228156	145	2962	145	
7161	prevention measures	prevention measure	2	1.97480632228156	489	7162	489	
3803	outer membrane protein	outer membrane protein	2	1.70542578569724	3805	2374	406	
14537	Flavihumibacter petaseus	Flavihumibacter petaseus	2	1.97480632228156	14539	14538	14539	
8241	inhibition of PMN ROS production	inhibition of PMN ROS production	2	1.97480632228156	2510	8243	2510	
3022	intensive care unit	intensive care unit	2	1.70542578569724	3024	3023	1107	
6719	detection rate	detection rate	2	1.97480632228156	154	2459	154	
10310	dominant negative phenotype	dominant negative phenotype	2	1.97480632228156	10312	1533	5168	
5714	farm level	farm level	2	1.97480632228156	1113	3592	1113	
2020	planktonic V	planktonic V	2	1.97480632228156	2022	2021	2022	
1249	spinal cord injury patients	spinal cord injury patient	2	1.97480632228156	226	1250	226	
3780	influenzae b	influenzae b	2	1.97480632228156	3779	3781	3779	
13682	RAPD profiles	RAPD profile	2	1.97480632228156	3564	12492	3564	
1228	difficile infection	difficile infection	2	1.70542578569724	274	1229	274	
4049	antimicrobial resistance	antimicrobial resistance	2	1.97480632228156	1830	1753	1830	
12386	green alga	green alga	2	1.97480632228156	12388	7717	12388	
12184	gasseri K	gasseri K	2	1.97480632228156	548	12185	548	
3901	role of TLR2	role of TLR2	2	1.97480632228156	233	115	233	
6617	necrotic enteritis disease model	necrotic enteritis disease model	2	1.97480632228156	6621	1546	361	
7245	rolBTR protein	rolBTR protein	2	1.97480632228156	406	16	406	
2338	strains of E	strain of E	2	1.97480632228156	551	79	551	
4577	bacterial groups	bacterial group	2	1.70542578569724	4420	185	4420	
9131	packs of minced meat	pack of minced meat	2	1.97480632228156	3529	8668	3529	
7516	epithelial autografts	epithelial autograft	2	1.97480632228156	7518	5102	7518	
513	carotenoid synthesis	carotenoid synthesis	2	1.97480632228156	515	514	515	
8859	human blood	human blood	2	1.70542578569724	2208	834	2208	
10703	mucin expression	mucin expression	2	1.97480632228156	373	677	373	
2075	virulence genes	virulence gene	2	1.70542578569724	444	383	444	
13778	indirect enzyme	indirect enzyme	2	1.70542578569724	4250	4332	4250	
1238	light organ	light organ	2	1.97480632228156	1240	1239	1240	
5535	serogroup O157	serogroup O157	2	1.97480632228156	5537	5536	5537	
1902	fish pathogen Vibrio salmonicida	fish pathogen Vibrio salmonicida	2	1.97480632228156	1904	1903	1908	
10466	CNS infection	CNS infection	2	1.97480632228156	274	2273	274	
8748	pdhA expression	pdhA expression	2	1.97480632228156	373	6389	373	
11709	human monocyte	human monocyte	2	1.70542578569724	1204	834	1204	
15932	new genus	new genus	2	1.70542578569724	8152	1171	8152	
128	intestinal environment of healthy individuals	intestinal environment of healthy individual	2	1.97480632228156	130	129	131	
8363	gastric MALT lymphoma	gastric MALT lymphoma	2	1.97480632228156	257	190	259	
2908	LuxS quorum	LuxS quorum	2	1.97480632228156	2910	2909	2910	
4771	factor Tu	factor Tu	2	1.97480632228156	3221	72	3221	
1429	glycosylation pathway	glycosylation pathway	2	1.97480632228156	661	1430	661	
2644	bowel disease	bowel disease	2	1.97480632228156	268	2645	268	
4798	extreme incubation conditions	extreme incubation condition	2	1.97480632228156	4800	4799	2285	
954	predictive value	predictive value	2	1.97480632228156	211	955	211	
9472	ion-exchange chromatography	ion-exchange chromatography	2	1.70542578569724	2312	9473	2312	
7076	Lactobacillus casei strain Shirota	Lactobacillus casei strain Shirota	2	1.97480632228156	7078	6761	7082	
7071	healthy children	healthy child	2	1.70542578569724	1560	133	1560	
16060	exchange column	exchange column	2	1.97480632228156	16062	9212	16062	
5101	epithelial cells	epithelial cell	2	1.70542578569724	113	5102	113	
15397	maltosa J288	maltosa J288	2	1.97480632228156	15399	3206	15399	
9851	microbiological surveillance	microbiological surveillance	2	1.97480632228156	3820	674	3820	
8545	negative flora	negative flora	2	1.97480632228156	1413	238	1413	
7017	dendritic cells	dendritic cell	2	1.70542578569724	113	7018	113	
7158	environmental sources	environmental source	2	1.97480632228156	5235	1810	5235	
7711	environmental isolates	environmental isolate	2	1.70542578569724	334	1810	334	
2003	Xanthomonas campestris pv	Xanthomonas campestris pv	2	1.97480632228156	2005	2004	2007	
1464	increase of NAP	increase of NAP	2	1.97480632228156	1465	1466	1465	
11167	neurogenic bladder patients	neurogenic bladder patient	2	1.97480632228156	11169	11168	226	
8483	antisense transcription	antisense transcription	2	1.97480632228156	1075	8484	1075	
10118	clinical signs	clinical sign	2	1.97480632228156	7841	323	7841	
12922	blood monocytes	blood monocyte	2	1.97480632228156	2934	2208	2934	
8341	number of colonies	number of colony	2	1.97480632228156	1034	8343	1034	
2313	multidrug resistant Pseudomonas aeruginosa	multidrug resistant Pseudomonas aeruginosa	2	1.97480632228156	2315	2314	2319	
14664	free alkaline xylanase	free alkaline xylanase	2	1.97480632228156	14666	112	7233	
14903	recombinant EF	recombinant EF	2	1.97480632228156	1019	2986	1019	
12860	linear dichroism	linear dichroism	2	1.97480632228156	12862	12861	12862	
5356	comorbid conditions	comorbid condition	2	1.97480632228156	2285	5357	2285	
10270	Bacillus pumilus MTCC	Bacillus pumilus MTCC	2	1.97480632228156	10272	3924	10274	
3358	rolB protein	rolB protein	2	1.97480632228156	406	3359	406	
6355	marine bacteria	marine bacteria	2	1.70542578569724	1999	1135	1999	
8207	observational studies	observational study	2	1.97480632228156	2918	8208	2918	
6621	disease model	disease model	2	1.97480632228156	361	268	361	
5969	synthetic duplex DNA	synthetic duplex DNA	2	1.97480632228156	466	3339	468	
8872	food handlers	food handler	2	1.97480632228156	8874	43	8874	
4932	ligand complex	ligand complex	2	1.97480632228156	1524	1993	1524	
5021	body gastritis	body gastritis	2	1.97480632228156	4245	367	4245	
8301	DC efferocytosis	DC efferocytosis	2	1.97480632228156	8303	6154	8303	
3161	history of colonization	history of colonization	2	1.97480632228156	3162	2703	3162	
5572	enterotoxigenic Escherichia coli strain	enterotoxigenic Escherichia coli strain	2	1.97480632228156	5574	5573	76	
12630	Methylomonas sp	Methylomonas sp	2	1.97480632228156	3950	12631	3950	
105	tandem repeats	tandem repeat	2	1.70542578569724	107	106	107	
12946	blot analysis	blot analysis	2	1.70542578569724	203	12947	203	
12338	liquid chromatography	liquid chromatography	2	1.97480632228156	2312	6433	2312	
2550	intestinal microbiota	intestinal microbiota	2	1.70542578569724	2226	129	2226	
5159	nutrient broth	nutrient broth	2	1.97480632228156	1622	5160	1622	
4285	catarrhal colitis	catarrhal colitis	2	1.97480632228156	4287	4286	4287	
15287	H . pylori	H . pylorus	2	1.70542578569724	15289	764	10429	
14437	quality of life	quality of life	2	1.97480632228156	10457	3227	10457	
3777	influenzae b	influenzae b	2	1.97480632228156	3779	3778	3779	
4559	sensitive cohorts	sensitive cohort	2	1.97480632228156	4561	3589	4561	
8141	effect of omeprazole	effect of omeprazole	2	1.97480632228156	2937	5767	2937	
1710	inner structural disorder	inner structural disorder	2	1.97480632228156	1712	1711	291	
7630	stone formation	stone formation	2	1.97480632228156	4488	7631	4488	
13336	additive effect	additive effect	2	1.97480632228156	2937	13337	2937	
16535	chromosomal resistance	chromosomal resistance	2	1.97480632228156	1830	9066	1830	
11142	feed intake	feed intake	2	1.97480632228156	2477	6870	2477	
6883	level of creatinine	level of creatinine	2	1.97480632228156	1113	6885	1113	
3986	domain of UreR	domain of UreR	2	1.97480632228156	253	90	253	
8412	blood stream infections	blood stream infection	2	1.97480632228156	8414	2208	736	
7028	human infection	human infection	2	1.70542578569724	274	834	274	
8029	intracellular crystal formation	intracellular crystal formation	2	1.97480632228156	8031	859	4488	
4133	strain 16a	strain 16a	2	1.97480632228156	4135	76	4135	
7868	recent years	recent year	2	1.70542578569724	7377	1540	7377	
1389	lower respiratory illness	low respiratory illness	2	1.97480632228156	1391	1390	637	
6737	tract infection	tract infection	2	1.97480632228156	274	3496	274	
1906	Vibrio salmonicida	Vibrio salmonicida	2	1.97480632228156	1908	1907	1908	
12	meningococci W135	meningococci W135	2	1.97480632228156	14	13	14	
9885	presence of lysozyme	presence of lysozyme	2	1.97480632228156	139	136	139	
1073	reverse transcription	reverse transcription	2	1.70542578569724	1075	1074	1075	
3795	eastern strains	eastern strain	2	1.97480632228156	551	3796	551	
16388	broiler performance	broiler performance	2	1.97480632228156	16390	680	16390	
7845	utilization of native siderophores	utilization of native siderophore	2	1.97480632228156	2300	7847	2300	
11750	VacA antibody	VacA antibody	2	1.97480632228156	1299	11130	1299	
431	BChl molecules	BChl molecule	2	1.97480632228156	433	432	433	
3296	Thalidomide treatment	Thalidomide treatment	2	1.97480632228156	61	886	61	
4297	resistant Enterococcus faecium	resistant Enterococcus faecium	2	1.97480632228156	1675	4298	1675	
745	intestinal microbiocenosis	intestinal microbiocenosis	2	1.97480632228156	747	129	747	
4194	crystal forms	crystal form	2	1.97480632228156	2616	4195	2616	
8414	stream infections	stream infection	2	1.97480632228156	736	8415	736	
5933	growth conditions	growth condition	2	1.70542578569724	2285	217	2285	
12511	tract infections	tract infection	2	1.97480632228156	736	3496	736	
14742	staphylococcus aureus	staphylococcus aureus	2	1.97480632228156	5584	14743	5584	
4655	elbow abscess	elbow abscess	2	1.97480632228156	4657	4656	4657	
12835	endogenous proteases	endogenous protease	2	1.97480632228156	10464	6292	10464	
3024	care unit	care unit	2	1.70542578569724	1107	3025	1107	
4718	areas of the state	area of the state	2	1.97480632228156	4719	788	4719	
8758	chicken nugget processing plant	chicken nugget processing plant	2	1.97480632228156	8760	8759	5726	
975	mosquitocidal B	mosquitocidal B	2	1.97480632228156	977	976	977	
4062	H pylori	H pylori	2	1.97480632228156	501	764	501	
6179	ulcer disease	ulcer disease	2	1.97480632228156	268	6180	268	
11442	eligible studies	eligible study	2	1.97480632228156	2918	11443	2918	
4721	SNF patients	SNF patient	2	1.97480632228156	226	4216	226	
15257	Recent studies	Recent study	2	1.70542578569724	2918	14533	2918	
574	control group	control group	2	1.70542578569724	351	575	351	
11587	agarase A	agarase A	2	1.97480632228156	1379	9590	1379	
9760	farm sediments	farm sediment	2	1.97480632228156	7741	3592	7741	
12904	molecular epidemiology	molecular epidemiology	2	1.70542578569724	5717	376	5717	
2617	detection limit	detection limit	2	1.70542578569724	2619	2459	2619	
1948	bacterial survival	bacterial survival	2	1.70542578569724	1950	185	1950	
852	BCG granulomas	BCG granuloma	2	1.97480632228156	854	853	854	
16492	product samples	product sample	2	1.97480632228156	225	19	225	
12626	obligate methanotroph Methylomonas sp	obligate methanotroph Methylomonas sp	2	1.97480632228156	12628	3322	3950	
277	PMN cell death	PMN cell death	2	1.97480632228156	279	278	281	
5377	clinical trial	clinical trial	2	1.70542578569724	4199	323	4199	
1654	multilocus sequence typing	multilocus sequence typing	2	1.70542578569724	1656	1655	1658	
11562	human immunodeficiency virus	human immunodeficiency virus	2	1.97480632228156	11564	834	768	
3198	Acinetobacter baumannii	Acinetobacter baumannii	2	1.97480632228156	3200	707	3200	
6068	variable fragments	variable fragment	2	1.97480632228156	6070	6069	6070	
6220	prevalence of antibodies	prevalence of antibody	2	1.97480632228156	1786	517	1786	
7536	frequency of sampling	frequency of sampling	2	1.97480632228156	265	1345	265	
2164	gastric hypoacidity	gastric hypoacidity	2	1.97480632228156	1460	190	1460	
6735	urinary tract infection	urinary tract infection	2	1.97480632228156	6737	6278	274	
9564	chloride M broth	chloride M broth	2	1.97480632228156	9566	9565	1622	
734	respiratory infections	respiratory infection	2	1.70542578569724	736	735	736	
12771	type b	type b	2	1.97480632228156	3779	1698	3779	
2387	VNTR genotypes	VNTR genotype	2	1.97480632228156	2389	1323	2389	
7940	high throughput	high throughput	2	1.97480632228156	7942	264	7942	
9936	egg products	egg product	2	1.97480632228156	1031	4842	1031	
6166	genital tissues	genital tissue	2	1.97480632228156	1485	6167	1485	
5576	coli strain	coli strain	2	1.97480632228156	76	1842	76	
6219	prevalence of antibodies to M	prevalence of antibody to M	2	1.97480632228156	6220	1921	1786	
6300	time of initial colonization	time of initial colonization	2	1.97480632228156	1403	6302	1403	
1286	neutrophil alkaline phosphatase	neutrophil alkaline phosphatase	2	1.97480632228156	1288	1287	1290	
11941	stool quality	stool quality	2	1.97480632228156	10457	1259	10457	
10587	vvhA expression	vvhA expression	2	1.97480632228156	373	2778	373	
3270	protease inhibitors	protease inhibitor	2	1.97480632228156	3272	1184	3272	
11153	chromosomal locations	chromosomal location	2	1.97480632228156	11155	9066	11155	
11426	6P hydrolase	6P hydrolase	2	1.97480632228156	8572	11427	8572	
6881	serum level of creatinine	serum level of creatinine	2	1.97480632228156	6883	1798	1113	
3805	membrane protein	membrane protein	2	1.70542578569724	406	3723	406	
314	ICP days	ICP day	2	1.97480632228156	316	315	316	
14643	phorbol ester	phorbol ester	2	1.97480632228156	3579	14644	3579	
12963	psittaci strains	psittaci strain	2	1.97480632228156	551	12964	551	
12229	oligomeric proteins	oligomeric protein	2	1.97480632228156	27	12230	27	
8574	Ec lexA	Ec lexA	2	1.97480632228156	7567	6649	7567	
16925	nalidixic acid	nalidixic acid	2	1.70542578569724	4	16926	4	
6092	constitutive expression	constitutive expression	2	1.70542578569724	373	6093	373	
8760	nugget processing plant	nugget processing plant	2	1.97480632228156	8762	8761	5726	
5193	aryl ring	aryl ring	2	1.97480632228156	5195	5194	5195	
6685	effector genes	effector gene	2	1.97480632228156	444	4557	444	
10021	VAN q12h	VAN q12h	2	1.97480632228156	2036	8805	2036	
9758	fish farm sediments	fish farm sediment	2	1.97480632228156	9760	1903	7741	
161	drug concentrations	drug concentration	2	1.70542578569724	163	162	163	
8276	rapid urease test	rapid urease test	2	1.70542578569724	8278	4185	85	
5922	essential role	essential role	2	1.70542578569724	233	1607	233	
7116	parvum oocysts	parvum oocyst	2	1.97480632228156	482	5174	482	
1706	peptidoglycan layer	peptidoglycan layer	2	1.70542578569724	1708	1707	1708	
1231	discriminatory index	discriminatory index	2	1.70542578569724	1233	1232	1233	
4829	amino acid protein	amino acid protein	2	1.97480632228156	406	1270	406	
13540	paraffin sections	paraffin section	2	1.97480632228156	7183	10418	7183	
9801	type strain	type strain	2	1.70542578569724	76	1698	76	
3762	substrate analogue	substrate analogue	2	1.97480632228156	3764	3652	3764	
13703	molecular mechanisms	molecular mechanism	2	1.97480632228156	519	376	519	
11273	membrane polarization	membrane polarization	2	1.97480632228156	4485	3723	4485	
2174	subtilisin variants	subtilisin variant	2	1.97480632228156	2176	2175	2176	
14486	influenzae cell	influenzae cell	2	1.97480632228156	235	3778	235	
8936	strain KIM6	strain KIM6	2	1.97480632228156	8938	76	8938	
8312	surface antigen	surface antigen	2	1.97480632228156	655	339	655	
10861	recipients of macrophages	recipient of macrophage	2	1.97480632228156	10862	394	10862	
250	RGG domain of nucleolin	RGG domain of nucleolin	2	1.97480632228156	252	251	253	
252	domain of nucleolin	domain of nucleolin	2	1.97480632228156	253	254	253	
2330	leprosy patients	leprosy patient	2	1.97480632228156	226	2331	226	
3635	DNA molecules	DNA molecule	2	1.97480632228156	433	468	433	
1593	B cells	B cell	2	1.97480632228156	113	977	113	
9872	pediatric practice	pediatric practice	2	1.97480632228156	8599	9873	8599	
5658	strains of P	strain of P	2	1.70542578569724	551	160	551	
14104	3.8-kb fragment	3.8-kb fragment	2	1.97480632228156	1268	14105	1268	
483	metabolome quantification	metabolome quantification	2	1.97480632228156	485	484	485	
8542	endocarditis model	endocarditis model	2	1.97480632228156	361	3878	361	
435	severity of the disease	severity of the disease	2	1.97480632228156	436	268	436	
10344	human neutrophils	human neutrophil	2	1.97480632228156	2439	834	2439	
7742	bacterial meningitis	bacterial meningitis	2	1.97480632228156	1362	185	1362	
6918	secondary analysis	secondary analysis	2	1.70542578569724	203	68	203	
7842	ratio of MDRP	ratio of MDRP	2	1.97480632228156	3302	541	3302	
14166	treatment of duodenal ulcer	treatment of duodenal ulcer	2	1.97480632228156	61	9225	61	
3633	hybrid DNA molecules	hybrid DNA molecule	2	1.97480632228156	3635	3634	433	
16344	genetic approaches	genetic approach	2	1.70542578569724	15636	880	15636	
14666	alkaline xylanase	alkaline xylanase	2	1.97480632228156	7233	1289	7233	
2315	resistant Pseudomonas aeruginosa	resistant Pseudomonas aeruginosa	2	1.97480632228156	2317	123	2319	
16204	plant material	plant material	2	1.97480632228156	7239	5726	7239	
10852	VRE colonization	VRE colonization	2	1.97480632228156	2703	3192	2703	
1264	ActA N-terminal fragment	ActA N-terminal fragment	2	1.97480632228156	1266	1265	1268	
1839	Escherichia coli cells	Escherichia coli cell	2	1.70542578569724	1841	1840	113	
3933	human disease	human disease	2	1.70542578569724	268	834	268	
10750	host tissues	host tissue	2	1.70542578569724	1485	271	1485	
1656	sequence typing	sequence typing	2	1.70542578569724	1658	1657	1658	
8672	time polymerase chain reaction	time polymerase chain reaction	2	1.70542578569724	557	1403	561	
12506	limit of detection	limit of detection	2	1.70542578569724	2619	2459	2619	
3414	better state	good state	2	1.97480632228156	788	3415	788	
12394	study population	study population	2	1.70542578569724	1248	1514	1248	
1486	predominant antibody response to R	predominant antibody response to R	2	1.97480632228156	1488	1487	286	
7664	odds ratio	odd ratio	2	1.70542578569724	3302	7665	3302	
3009	Antimicrobial resistance	Antimicrobial resistance	2	1.97480632228156	1830	3010	1830	
7718	photosynthetic bacteria	photosynthetic bacteria	2	1.97480632228156	1999	7719	1999	
6596	enteropathogenic E	enteropathogenic E	2	1.70542578569724	79	6597	79	
1693	toxicity spectrum	toxicity spectrum	2	1.97480632228156	1695	236	1695	
1904	pathogen Vibrio salmonicida	pathogen Vibrio salmonicida	2	1.97480632228156	1906	1905	1908	
3501	thermal injury	thermal injury	2	1.70542578569724	909	962	909	
8624	SecA protein	SecA protein	2	1.97480632228156	406	2245	406	
15520	ventilator days	ventilator day	2	1.97480632228156	316	7213	316	
10371	Staphylococcus epidermidis	Staphylococcus epidermidis	2	1.70542578569724	7831	3099	7831	
1063	deficient mice	deficient mouse	2	1.70542578569724	1065	1064	1065	
12838	Gambian children	Gambian child	2	1.97480632228156	1560	12839	1560	
1718	defecation frequency	defecation frequency	2	1.97480632228156	265	1719	265	
14402	lung function	lung function	2	1.70542578569724	778	936	778	
8570	6-phosphate hydrolase	6-phosphate hydrolase	2	1.97480632228156	8572	8571	8572	
4252	Sequence analysis	Sequence analysis	2	1.70542578569724	203	4253	203	
5720	percentage of neutrophils	percentage of neutrophil	2	1.97480632228156	3374	2439	3374	
5868	susceptibility testing	susceptibility testing	2	1.97480632228156	5870	273	5870	
9205	phase HPLC	phase HPLC	2	1.97480632228156	9207	1218	9207	
9438	vector system	vector system	2	1.97480632228156	1501	2218	1501	
9580	healthy controls	healthy control	2	1.70542578569724	7682	133	7682	
7960	soy broth	soy broth	2	1.97480632228156	1622	7961	1622	
8568	MurNAc 6-phosphate hydrolase	MurNAc 6-phosphate hydrolase	2	1.97480632228156	8570	8569	8572	
6302	initial colonization	initial colonization	2	1.97480632228156	2703	2838	2703	
5281	active enzyme	active enzyme	2	1.70542578569724	4250	1	4250	
10018	parasuis neuraminidase	parasuis neuraminidase	2	1.97480632228156	227	4886	227	
1585	parC genes	parC gene	2	1.97480632228156	444	1586	444	
8713	Rapid detection	Rapid detection	2	1.70542578569724	2459	8714	2459	
6636	mutation patterns	mutation pattern	2	1.97480632228156	2366	4259	2366	
11383	septic embolism	septic embolism	2	1.97480632228156	11385	1409	11385	
15025	adaptive colitis	adaptive colitis	2	1.97480632228156	4287	15026	4287	
4392	NMR spectroscopy	NMR spectroscopy	2	1.97480632228156	1117	2611	1117	
8070	degrees C	degree C	2	1.70542578569724	243	818	243	
9710	mutation sites	mutation site	2	1.97480632228156	1139	4259	1139	
8913	cell type	cell type	2	1.97480632228156	1698	235	1698	
9203	reverse phase HPLC	reverse phase HPLC	2	1.97480632228156	9205	1074	9207	
2978	gyrA genes	gyrA gene	2	1.97480632228156	444	2979	444	
6869	feed conversion ratio	feed conversion ratio	2	1.97480632228156	6871	6870	3302	
2883	prevalence of K	prevalence of K	2	1.97480632228156	1786	548	1786	
10452	urea breath test	urea breath test	2	1.97480632228156	10454	3833	85	
1879	Hispanic populations	Hispanic population	1	0.987403161140781	1428	1880	1428	
4256	jail setting	jail setting	1	0.987403161140781	4258	4257	4258	
16094	fluorescens strain	fluorescen strain	1	0.987403161140781	76	6821	76	
15033	entry process	entry process	1	0.987403161140781	2489	526	2489	
520	microbial inactivation	microbial inactivation	1	0.987403161140781	522	521	522	
4089	pylori therapy	pylori therapy	1	0.987403161140781	464	501	464	
53	gamma delta T lymphocytes	gamma delta T lymphocyte	1	0.987403161140781	55	54	59	
945	longer chain alkanes	long chain alkane	1	0.987403161140781	947	946	949	
7036	class specific antibodies	class specific antibody	1	0.987403161140781	7038	2435	517	
9224	duodenal ulcer disease	duodenal ulcer disease	1	0.987403161140781	268	9225	268	
13938	organic acid	organic acid	1	0.987403161140781	4	8308	4	
9487	pathogenesis of Lyme arthritis	pathogenesis of Lyme arthritis	1	0.987403161140781	3055	5345	3055	
8420	selection of polypeptides	selection of polypeptide	1	0.987403161140781	1647	8422	1647	
1216	stationary phase	stationary phase	1	0.987403161140781	1218	1217	1218	
4618	endophytic member of the family	endophytic member of the family	1	0.987403161140781	4620	4619	4621	
8829	rates of multiresistance	rate of multiresistance	1	0.987403161140781	450	2995	450	
7385	pdhA genes	pdhA gene	1	0.987403161140781	444	6389	444	
10183	minimum inhibitory concentration breakpoints	minimum inhibitory concentration breakpoint	1	0.987403161140781	10185	7126	10189	
13145	super family motif CX5R	super family motif CX5R	1	0.987403161140781	13147	13146	13151	
3527	consumers packs	consumer pack	1	0.987403161140781	3529	3528	3529	
15018	major cellular fatty acids	major cellular fatty acid	1	0.987403161140781	15020	71	3060	
755	regulator Mga	regulator Mga	1	0.987403161140781	757	756	757	
16954	dermaseptin S4 derivatives	dermaseptin S4 derivative	1	0.987403161140781	16956	4640	3424	
11217	history of H	history of H	1	0.987403161140781	3162	764	3162	
9213	protective vaccine	protective vaccine	1	0.987403161140781	9215	4387	9215	
5991	aggregate excitonic properties	aggregate excitonic property	1	0.987403161140781	5993	5992	3103	
3536	interpretation of pooled estimates of time to clearance	interpretation of pooled estimate of time to clearance	1	0.987403161140781	3537	3538	3537	
6683	putative effector genes	putative effector gene	1	0.987403161140781	6685	2074	444	
8090	swarming differentiation of V	swarming differentiation of V	1	0.987403161140781	8092	8091	884	
14233	percent of necropsied calves	percent of necropsied calf	1	0.987403161140781	7188	14235	7188	
3870	hydrophobic residues	hydrophobic residue	1	0.987403161140781	50	3871	50	
5343	destructive Lyme arthritis	destructive Lyme arthritis	1	0.987403161140781	5345	2775	2776	
13488	respiratory disease outbreaks	respiratory disease outbreak	1	0.987403161140781	13490	735	3550	
9958	lysophosphatidic acid	lysophosphatidic acid	1	0.987403161140781	4	9959	4	
10475	total body surface area burns	total body surface area burn	1	0.987403161140781	10477	1402	10483	
12110	activity of the LuxS quorum	activity of the LuxS quorum	1	0.987403161140781	393	2908	393	
15418	diffraction data	diffraction datum	1	0.987403161140781	609	9286	609	
11026	N-terminal amino acid sequences of parasporal inclusion proteins	N-terminal amino acid sequence of parasporal inclusion protein	1	0.987403161140781	11027	11034	534	
4058	eradication rate of H pylori	eradication rate of H pylori	1	0.987403161140781	152	4062	154	
5741	genomic analysis	genomic analysis	1	0.987403161140781	203	3065	203	
16408	protein of this bacterial species	protein of this bacterial specie	1	0.987403161140781	406	3193	406	
4511	intestinal tracts of healthy fish	intestinal tract of healthy fish	1	0.987403161140781	4513	129	1795	
8653	standard triple therapy	standard triple therapy	1	0.987403161140781	3975	8654	464	
7862	diversity of seed	diversity of seed	1	0.987403161140781	2099	5478	2099	
1752	antimicrobial agent	antimicrobial agent	1	0.987403161140781	1357	1753	1357	
5331	aeruginosa isolates	aeruginosa isolate	1	0.987403161140781	334	2319	334	
10798	MBD monomer	MBD monomer	1	0.987403161140781	9929	1931	9929	
1108	low educational level of parents	low educational level of parent	1	0.987403161140781	1110	1109	1113	
10481	area burns	area burn	1	0.987403161140781	10483	3774	10483	
4569	outer protein YopJ	outer protein YopJ	1	0.987403161140781	4142	4570	4142	
4819	sucrose lethality	sucrose lethality	1	0.987403161140781	4821	2232	4821	
8455	GEN resistance	GEN resistance	1	0.987403161140781	1830	849	1830	
9056	acid amplification tests	acid amplification test	1	0.987403161140781	9058	4	2025	
2071	regulon of putative virulence genes	regulon of putative virulence gene	1	0.987403161140781	2072	2073	2072	
7633	perfringens numbers	perfringen number	1	0.987403161140781	46	7634	46	
13403	cell biotic surface	cell biotic surface	1	0.987403161140781	337	235	339	
13953	in vitro assay of tuberculin hypersensitivity	in_vitro assay of tuberculin hypersensitivity	1	0.987403161140781	13955	6428	562	
10157	root disease	root disease	1	0.987403161140781	268	4487	268	
1068	value of fidaxomicin	value of fidaxomicin	1	0.987403161140781	211	1070	211	
6864	preliminary picture of diarrhea	preliminary picture of diarrhea	1	0.987403161140781	6866	6865	6867	
11707	infection of human monocyte	infection of human monocyte	1	0.987403161140781	274	11709	274	
4738	large plasmids	large plasmid	1	0.987403161140781	1400	288	1400	
11938	application of this method	application of this method	1	0.987403161140781	1507	596	1507	
1730	endocytosis of Ser349	endocytosis of Ser349	1	0.987403161140781	1731	1732	1731	
8171	adsorption rates	adsorption rate	1	0.987403161140781	450	8172	450	
16478	cell viability analysis	cell viability analysis	1	0.987403161140781	16480	235	203	
1328	Hexose oxidase	Hexose oxidase	1	0.987403161140781	1330	1329	1330	
3020	admission to the intensive care unit	admission to the intensive care unit	1	0.987403161140781	3021	3022	3021	
11915	enzyme production	enzyme production	1	0.987403161140781	93	4250	93	
15828	unusual N-linked C14	unusual N-linked C14	1	0.987403161140781	9773	1692	4565	
6071	tuberculosis control	tuberculosis control	1	0.987403161140781	575	491	575	
202	analysis of riboflavin synthase	analysis of riboflavin synthase	1	0.987403161140781	203	204	203	
10141	~10¹⁰ CFU	~10¹⁰ CFU	1	0.987403161140781	3295	10142	3295	
2269	term data	term datum	1	0.987403161140781	609	2270	609	
5512	loss of membrane integrity	loss of membrane integrity	1	0.987403161140781	4308	5514	4308	
16662	statistical methods aid	statistical method aid	1	0.987403161140781	16664	14802	16666	
402	monomeric lumazine protein	monomeric lumazine protein	1	0.987403161140781	404	403	406	
9629	cellular response	cellular response	1	0.987403161140781	286	3121	286	
16467	overproduced proteins	overproduced protein	1	0.987403161140781	27	16468	27	
7138	Deinococcus radiodurans	Deinococcus radioduran	1	0.987403161140781	7140	7139	7140	
15677	different morphogenetic activity	different morphogenetic activity	1	0.987403161140781	15679	816	393	
3259	% of the samples	% of the sample	1	0.987403161140781	1209	225	1209	
397	analysis of the kinetic network	analysis of the kinetic network	1	0.987403161140781	203	399	203	
16880	Preinfection percentage of neutrophils	Preinfection percentage of neutrophil	1	0.987403161140781	5720	16881	3374	
787	state levels of RNAIII	state level of RNAIII	1	0.987403161140781	789	788	495	
6932	cellophane membrane disks	cellophane membrane disk	1	0.987403161140781	6934	6933	6936	
14801	statistical testing	statistical testing	1	0.987403161140781	5870	14802	5870	
14140	rolBTR protein activity	rolBTR protein activity	1	0.987403161140781	393	7245	393	
11277	bacterial flora of rice varieties	bacterial flora of rice variety	1	0.987403161140781	1411	11281	1413	
5170	Detection of Cryptosporidium parvum	Detection of Cryptosporidium parvum	1	0.987403161140781	598	5172	598	
1211	definite serotypes of E	definite serotype of E	1	0.987403161140781	1213	1212	1214	
10830	atypical lymphoid infiltrates	atypical lymphoid infiltrate	1	0.987403161140781	10832	10831	3282	
1962	milligram quantities	milligram quantity	1	0.987403161140781	1964	1963	1964	
12696	catalytic cycle	catalytic cycle	1	0.987403161140781	12698	1315	12698	
10128	new treatments	new treatment	1	0.987403161140781	963	1171	963	
13344	pro-inflammatory cytokines	pro-inflammatory cytokine	1	0.987403161140781	13346	13345	13346	
7327	genital infections	genital infection	1	0.987403161140781	736	6167	736	
2565	specific MAb	specific MAb	1	0.987403161140781	2567	504	2567	
10195	bacteriological effect	bacteriological effect	1	0.987403161140781	2937	10196	2937	
10832	lymphoid infiltrates	lymphoid infiltrate	1	0.987403161140781	3282	4361	3282	
9026	fusion proteins	fusion protein	1	0.987403161140781	27	8418	27	
11935	metabolic adaptability	metabolic adaptability	1	0.987403161140781	11937	2121	11937	
4535	Cloacal swabs of partridges	Cloacal swab of partridge	1	0.987403161140781	4537	4536	3050	
2865	strong reduction	strong reduction	1	0.987403161140781	276	1751	276	
13895	de novo protein synthesis	de_novo protein synthesis	1	0.987403161140781	13897	13896	515	
12187	membrane mucin expression	membrane mucin expression	1	0.987403161140781	10703	3723	373	
4395	single isolate	single isolate	1	0.987403161140781	4397	1933	4397	
2749	recurrence rate of infection	recurrence rate of infection	1	0.987403161140781	2750	274	154	
11814	Paraffin sections	Paraffin section	1	0.987403161140781	7183	11815	7183	
14674	household contacts of the patients	household contact of the patient	1	0.987403161140781	14676	14675	14677	
13392	LTQ Obitrap	LTQ Obitrap	1	0.987403161140781	13394	5943	13394	
2162	demographics of gastric hypoacidity	demographic of gastric hypoacidity	1	0.987403161140781	2163	2164	2163	
1742	peak positions	peak position	1	0.987403161140781	1744	1743	1744	
9237	development of microorganisms	development of microorganism	1	0.987403161140781	1679	1629	1679	
3919	symbiotic relationship	symbiotic relationship	1	0.987403161140781	2156	3920	2156	
10225	competitive inhibitors	competitive inhibitor	1	0.987403161140781	3272	10226	3272	
10472	state of knowledge	state of knowledge	1	0.987403161140781	788	7278	788	
11931	aeruginosa PAO1	aeruginosa PAO1	1	0.987403161140781	11933	2319	11933	
14414	frequent isolate	frequent isolate	1	0.987403161140781	4397	7629	4397	
1189	similar molecular mass	similar molecular mass	1	0.987403161140781	1191	1190	1193	
3666	bacterial neuraminidases	bacterial neuraminidas	1	0.987403161140781	3668	185	3668	
9613	log(10) CFU	log(10) CFU	1	0.987403161140781	3295	9614	3295	
10235	filarial nematodes	filarial nematode	1	0.987403161140781	10237	103	10237	
2479	log₁₀ PFU	log₁₀ PFU	1	0.987403161140781	2481	2480	2481	
7672	plant pathogen	plant pathogen	1	0.987403161140781	1905	5726	1905	
415	characterization of a set	characterization of a set	1	0.987403161140781	416	417	416	
3516	usual dose	usual dose	1	0.987403161140781	1894	595	1894	
88	residues of UreR	residue of UreR	1	0.987403161140781	50	90	50	
6291	endogenous metabolism of Escherichia coli cells	endogenous metabolism of Escherichia coli cell	1	0.987403161140781	6293	6292	1955	
6625	cDNA library of P	cDNA library of P	1	0.987403161140781	6627	6626	6628	
14213	inhibition of autolysins	inhibition of autolysin	1	0.987403161140781	2510	14215	2510	
3329	transmission of certain viruses	transmission of certain virus	1	0.987403161140781	1849	3331	1849	
14900	infected cattle	infected cattle	1	0.987403161140781	1058	1838	1058	
10478	body surface	body surface	1	0.987403161140781	339	367	339	
2441	lineage clusters	lineage cluster	1	0.987403161140781	1859	2442	1859	
3210	unexpected protein	unexpected protein	1	0.987403161140781	406	2594	406	
10714	resistance to evolutionary escape	resistance to evolutionary escape	1	0.987403161140781	1830	10716	1830	
980	morbidity of diarrhea	morbidity of diarrhea	1	0.987403161140781	981	982	981	
3256	determinants of virulence	determinant of virulence	1	0.987403161140781	1717	383	1717	
456	point of spoilage	point of spoilage	1	0.987403161140781	457	458	457	
556	polymerase chain reaction assay	polymerase chain reaction assay	1	0.987403161140781	562	557	562	
9300	theoretical models of frequency	theoretical model of frequency	1	0.987403161140781	9302	9301	7459	
9578	age-matched healthy controls	age-matched healthy control	1	0.987403161140781	9580	9579	7682	
13719	serum PGI	serum PGI	1	0.987403161140781	5677	1798	5677	
15624	rate of bacterial elimination	rate of bacterial elimination	1	0.987403161140781	154	15626	154	
166	Two-week proton pump inhibitor	Two-week proton pump inhibitor	1	0.987403161140781	168	167	172	
4030	physiological state of the culture	physiological state of the culture	1	0.987403161140781	4032	4031	788	
7716	green photosynthetic bacteria	green photosynthetic bacteria	1	0.987403161140781	7718	7717	1999	
4052	weeks of storage	week of storage	1	0.987403161140781	4053	4054	4053	
3001	Wap65 protein	Wap65 protein	1	0.987403161140781	406	2734	406	
505	metal binding	metal binding	1	0.987403161140781	159	506	159	
15110	different groups	different group	1	0.987403161140781	4420	816	4420	
8696	electron micrograph	electron micrograph	1	0.987403161140781	8698	5133	8698	
3171	presence of H	presence of H	1	0.987403161140781	139	764	139	
11883	TRA region	TRA region	1	0.987403161140781	3464	11884	3464	
10319	eradication rates	eradication rate	1	0.987403161140781	450	153	450	
14258	exaggerated influx of neutrophils	exaggerated influx of neutrophil	1	0.987403161140781	14260	14259	14261	
3190	indigenous VRE	indigenous VRE	1	0.987403161140781	3192	3191	3192	
16012	Youden's index	Youden' index	1	0.987403161140781	1233	16013	1233	
11176	addition of valine to medium	addition of valine to medium	1	0.987403161140781	2743	11178	2743	
10431	variable range of incubation conditions	variable range of incubation condition	1	0.987403161140781	10433	6069	928	
7615	mutant strains	mutant strain	1	0.987403161140781	551	7616	551	
9493	host enzyme activity	host enzyme activity	1	0.987403161140781	7288	271	393	
9733	positive cells	positive cell	1	0.987403161140781	113	953	113	
3454	protease subtilisin	protease subtilisin	1	0.987403161140781	2175	1184	2175	
4529	Phylogenetic analysis	Phylogenetic analysis	1	0.987403161140781	203	4530	203	
2891	large scales	large scale	1	0.987403161140781	2893	288	2893	
2726	prime T lymphocytes	prime T lymphocyte	1	0.987403161140781	57	2727	59	
721	major complication	major complication	1	0.987403161140781	723	71	723	
10489	Fibrin clots	Fibrin clot	1	0.987403161140781	127	10490	127	
6767	product surface	product surface	1	0.987403161140781	339	19	339	
11483	intracellular growth of F	intracellular growth of F	1	0.987403161140781	11485	859	217	
8113	phloem tissues	phloem tissue	1	0.987403161140781	1485	8114	1485	
992	pesticide residues	pesticide residue	1	0.987403161140781	50	993	50	
14858	leprosy bacteria	leprosy bacteria	1	0.987403161140781	1999	2331	1999	
10342	interaction of human neutrophils	interaction of human neutrophil	1	0.987403161140781	1709	10344	1709	
7214	Phosphoinositide binding to the N-terminal region of ActA	Phosphoinositide binding to the N-terminal region of ActA	1	0.987403161140781	7216	7215	159	
12481	benign florid lymphoid hyperplasia	benign florid lymphoid hyperplasia	1	0.987403161140781	12483	12482	12487	
8959	replacement solutions	replacement solution	1	0.987403161140781	8961	8843	8961	
15127	past year	past year	1	0.987403161140781	2400	15128	2400	
3389	transcriptional regulator of urease gene expression	transcriptional regulator of urease gene expression	1	0.987403161140781	3391	2780	756	
5222	ladder patterns	ladder pattern	1	0.987403161140781	2366	5223	2366	
6574	open communities	open community	1	0.987403161140781	990	6575	990	
4416	antibiotic treatments	antibiotic treatment	1	0.987403161140781	963	31	963	
2862	log cfu	log cfu	1	0.987403161140781	2864	1996	2864	
5874	sensitivity of the MPN	sensitivity of the MPN	1	0.987403161140781	1818	5876	1818	
890	artificial urine	artificial urine	1	0.987403161140781	892	891	892	
15345	aspartic proteinases pepsinogen	aspartic proteinas pepsinogen	1	0.987403161140781	15347	6723	4094	
10765	green sulfur bacterium Chlorobaculum tepidum	green sulfur bacterium Chlorobaculum tepidum	1	0.987403161140781	10767	7717	4783	
7301	chronic antral gastritis	chronic antral gastritis	1	0.987403161140781	7303	363	4245	
14516	clinical practice	clinical practice	1	0.987403161140781	8599	323	8599	
10620	differentiation of vibrio vulnificus	differentiation of vibrio vulnificus	1	0.987403161140781	884	10622	884	
5027	Adoratopsylla antiquorum antiquorum	Adoratopsylla antiquorum antiquorum	1	0.987403161140781	5029	5028	5030	
6267	different B	different B	1	0.987403161140781	977	816	977	
15264	site channel	site channel	1	0.987403161140781	15266	3	15266	
14702	analysis of caspase	analysis of caspase	1	0.987403161140781	203	14704	203	
14653	obvious Shine	obvious Shine	1	0.987403161140781	14655	14654	14655	
13090	single medical center	single medical center	1	0.987403161140781	13092	1933	4790	
6658	Listeria monocytogenes ActA protein	Listeria monocytogene ActA protein	1	0.987403161140781	6660	6659	406	
14766	medical chart abstraction	medical chart abstraction	1	0.987403161140781	14768	13093	14770	
13295	ligand pathway	ligand pathway	1	0.987403161140781	661	1993	661	
6606	polyacrylamide gel electrophoresis silver	polyacrylamide gel electrophoresis silver	1	0.987403161140781	6608	6607	6612	
10985	Mycobacterium tuberculosis infection	Mycobacterium tuberculosis infection	1	0.987403161140781	274	3626	274	
11912	symbiotic bacteria	symbiotic bacteria	1	0.987403161140781	1999	3920	1999	
6653	small intestinal lesions	small intestinal lesion	1	0.987403161140781	6655	566	2399	
14552	granulomatous immune response	granulomatous immune response	1	0.987403161140781	2356	285	286	
11620	DPH fluorescence polarization	DPH fluorescence polarization	1	0.987403161140781	4483	9390	4485	
2714	types of opsonin receptors	type of opsonin receptor	1	0.987403161140781	769	2716	769	
13678	bactericidal kinetics	bactericidal kinetic	1	0.987403161140781	13680	9620	13680	
2938	course of fidaxomicin	course of fidaxomicin	1	0.987403161140781	2939	1070	2939	
12174	process of regeneration	process of regeneration	1	0.987403161140781	2489	1684	2489	
475	C-UBT value	C-UBT value	1	0.987403161140781	211	476	211	
1813	Order of fusions	Order of fusion	1	0.987403161140781	1814	1815	1814	
16237	cell wall layers	cell wall layer	1	0.987403161140781	16241	11195	16241	
6577	host cytoplasm	host cytoplasm	1	0.987403161140781	1387	271	1387	
623	fructose -1	fructose -1	1	0.987403161140781	145	624	145	
11060	overall case	overall case	1	0.987403161140781	618	5154	618	
2237	N-acetylmuramic acid	N-acetylmuramic acid	1	0.987403161140781	4	2238	4	
14464	infection control policy	infection control policy	1	0.987403161140781	14468	10149	14468	
16999	different food handlers	different food handler	1	0.987403161140781	8872	816	8874	
16650	halophilic marine bacteria	halophilic marine bacteria	1	0.987403161140781	6355	14996	1999	
3548	problematic outbreaks	problematic outbreak	1	0.987403161140781	3550	3549	3550	
14281	major allergen	major allergen	1	0.987403161140781	8703	71	8703	
2576	  ×  10(9) CFU)	_ × _10(9)_CFU)	1	0.987403161140781	2578	2577	2580	
6966	region of ompA	region of ompA	1	0.987403161140781	3464	6968	3464	
9704	cells of H	cell of H	1	0.987403161140781	113	764	113	
6481	functional homologs of effectors	functional homolog of effector	1	0.987403161140781	6483	3355	6484	
8344	inflammatory role	inflammatory role	1	0.987403161140781	233	2643	233	
6743	health status	health status	1	0.987403161140781	4668	6744	4668	
3660	Citrobacter freundii Gentamicin	Citrobacter freundii Gentamicin	1	0.987403161140781	3662	3661	3664	
13924	Impact of intracranial pressure monitor prophylaxis	Impact of intracranial pressure monitor prophylaxis	1	0.987403161140781	13925	13926	13925	
15805	clearance of MRSA	clearance of MRSA	1	0.987403161140781	449	369	449	
12436	skin wounds	skin wound	1	0.987403161140781	12438	12437	12438	
11136	community SNF	community SNF	1	0.987403161140781	4216	11137	4216	
1125	recognition complexes	recognition complex	1	0.987403161140781	1127	1126	1127	
16920	antennae of photosynthetic bacteria	antenna of photosynthetic bacteria	1	0.987403161140781	16921	7718	16921	
12310	Injury Severity Score	Injury Severity Score	1	0.987403161140781	12312	3736	3737	
423	respect to the surface of the two-dimensional aggregate of BChl molecules	respect to the surface of the two-dimensional aggregate of BChl molecule	1	0.987403161140781	424	425	424	
4735	immune cells	immune cell	1	0.987403161140781	113	2357	113	
8079	evidence of clustering of resistance phenotypes	evidence of clustering of resistance phenotype	1	0.987403161140781	2412	8081	2412	
9337	novel glycoprotein	novel glycoprotein	1	0.987403161140781	140	82	140	
6435	quarters of all genes	quarter of all gene	1	0.987403161140781	6436	444	6436	
15699	lymphocyte populations	lymphocyte population	1	0.987403161140781	1428	15700	1428	
12355	minor portion of the label	minor portion of the label	1	0.987403161140781	12357	8702	9160	
4749	ether bond	ether bond	1	0.987403161140781	4751	4750	4751	
12931	reports of clonal strains of Pseudomonas aeruginosa	report of clonal strain of Pseudomonas aeruginosa	1	0.987403161140781	4876	12933	4876	
13663	bacterial infection	bacterial infection	1	0.987403161140781	274	185	274	
14210	peptides' hydrophobicity	peptides' hydrophobicity	1	0.987403161140781	3063	14211	3063	
15350	phosphate buffer saline	phosphate buffer saline	1	0.987403161140781	15352	350	1923	
4904	blood culture	blood culture	1	0.987403161140781	2092	2208	2092	
12169	members of the bacterial flora	member of the bacterial flora	1	0.987403161140781	2171	1411	2171	
4390	19F NMR spectroscopy	19F NMR spectroscopy	1	0.987403161140781	4392	1060	1117	
5148	individual amino acids	individual amino acid	1	0.987403161140781	3242	3288	3060	
13702	molecular mechanisms of bacterial surface proteins	molecular mechanism of bacterial surface protein	1	0.987403161140781	13703	13706	519	
14936	C2 atom	C2 atom	1	0.987403161140781	14938	14937	14938	
16221	resistant staphylococcal endocarditis	resistant staphylococcal endocarditis	1	0.987403161140781	16223	123	3878	
12286	necrosis factor	necrosis factor	1	0.987403161140781	72	422	72	
5144	effects of omission of individual amino acids	effect of omission of individual amino acid	1	0.987403161140781	1055	5146	1055	
9289	animal infections	animal infection	1	0.987403161140781	736	6832	736	
12620	cells types	cell type	1	0.987403161140781	769	113	769	
1170	new purification method	new purification method	1	0.987403161140781	1172	1171	596	
6192	secretion system	secretion system	1	0.987403161140781	1501	2586	1501	
3182	guinea pig erythrocytes	guinea pig erythrocyte	1	0.987403161140781	3184	3183	3186	
6689	antagonism of fungal pathogens	antagonism of fungal pathogen	1	0.987403161140781	6690	6691	6690	
2825	dairy breeds	dairy breed	1	0.987403161140781	2827	2826	2827	
4012	PCR method	PCR method	1	0.987403161140781	596	2264	596	
12160	humanized MAb	humanized MAb	1	0.987403161140781	2567	5770	2567	
15322	lung cytokine levels	lung cytokine level	1	0.987403161140781	495	15323	495	
5864	Antimicrobial agent susceptibility testing	Antimicrobial agent susceptibility testing	1	0.987403161140781	5866	3010	5870	
15622	excellent rate of bacterial elimination	excellent rate of bacterial elimination	1	0.987403161140781	15624	4009	154	
12137	patient care	patient care	1	0.987403161140781	3025	3504	3025	
7320	metalloregulator of the bacterial mercury resistance	metalloregulator of the bacterial mercury resistance	1	0.987403161140781	7321	7322	7321	
2283	operating conditions	operating condition	1	0.987403161140781	2285	2284	2285	
15871	native hapten	native hapten	1	0.987403161140781	15873	7848	15873	
2777	vvhA transcriptional reporter assay	vvhA transcriptional reporter assay	1	0.987403161140781	2779	2778	562	
1325	transcriptome analysis	transcriptome analysis	1	0.987403161140781	203	1326	203	
11194	cell wall of Pseudomonas aeruginosa	cell wall of Pseudomonas aeruginosa	1	0.987403161140781	11195	2317	1918	
16057	marine organisms	marine organism	1	0.987403161140781	3385	1135	3385	
5308	Live LcS	Live LcS	1	0.987403161140781	5310	5309	5310	
478	recovery efficiency of the oocysts	recovery efficiency of the oocyst	1	0.987403161140781	480	479	481	
3237	time of the system	time of the system	1	0.987403161140781	1403	1501	1403	
7525	fix LJ regulatory cascade	fix LJ regulatory cascade	1	0.987403161140781	7527	7526	7531	
3004	antibody techniques	antibody technique	1	0.987403161140781	3006	1299	3006	
7645	Early pregnancy loss	Early pregnancy loss	1	0.987403161140781	7647	7646	4308	
11034	parasporal inclusion proteins	parasporal inclusion protein	1	0.987403161140781	11036	11035	27	
10332	functional properties	functional property	1	0.987403161140781	3103	3355	3103	
11095	serum bactericidal activity	serum bactericidal activity	1	0.987403161140781	11097	1798	393	
2887	single site	single site	1	0.987403161140781	3	1933	3	
11715	dipole moment	dipole moment	1	0.987403161140781	11717	11716	11717	
9952	McCoy cells	McCoy cell	1	0.987403161140781	113	9953	113	
16820	poor families	poor family	1	0.987403161140781	8110	16821	8110	
14051	duration of total follow-up	duration of total follow-up	1	0.987403161140781	3208	14053	3208	
16633	health of tortoise populations	health of tortoise population	1	0.987403161140781	6744	1426	6744	
7944	incidence of gastric cancer	incidence of gastric cancer	1	0.987403161140781	3432	385	3432	
10909	economic analysis	economic analysis	1	0.987403161140781	203	1067	203	
1208	% of isolates	% of isolate	1	0.987403161140781	1209	334	1209	
10698	maximal levels	maximal level	1	0.987403161140781	495	10699	495	
828	like organism test	like organism test	1	0.987403161140781	830	829	85	
9812	acid sequencing of regions of the katG	acid sequencing of region of the katG	1	0.987403161140781	9814	4	1583	
4119	resistant Mycobacterium tuberculosis isolates	resistant Mycobacterium tuberculosis isolate	1	0.987403161140781	4121	123	334	
8041	majority of functional effector genes	majority of functional effector gene	1	0.987403161140781	5215	8043	5215	
6319	VHSV infection	VHSV infection	1	0.987403161140781	274	6320	274	
1160	carotenoid transposons	carotenoid transposon	1	0.987403161140781	1162	514	1162	
6099	inflammatory response	inflammatory response	1	0.987403161140781	286	2643	286	
3013	inhibitory effect	inhibitory effect	1	0.987403161140781	2937	3014	2937	
11184	step ultrafiltration procedure	step ultrafiltration procedure	1	0.987403161140781	11186	4671	650	
11423	IpgB family	IpgB family	1	0.987403161140781	2170	11424	2170	
13960	body fluids	body fluid	1	0.987403161140781	13962	367	13962	
7757	bacterial membrane proteins	bacterial membrane protein	1	0.987403161140781	3722	185	27	
6640	development of resistance to antibiotics	development of resistance to antibiotic	1	0.987403161140781	1679	4448	1679	
14049	median duration of total follow-up	median duration of total follow-up	1	0.987403161140781	14051	911	3208	
12493	use of narcotic medications	use of narcotic medication	1	0.987403161140781	32	10774	32	
8550	state of IBD	state of IBD	1	0.987403161140781	788	8552	788	
14725	time readout of eukaryotic cell toxicity	time readout of eukaryotic cell toxicity	1	0.987403161140781	14727	1403	14728	
10712	unprecedented resistance to evolutionary escape	unprecedented resistance to evolutionary escape	1	0.987403161140781	10714	10713	1830	
8254	recipient cells	recipient cell	1	0.987403161140781	113	8255	113	
16772	specific cleavage reaction	specific cleavage reaction	1	0.987403161140781	16774	504	561	
7208	bromide cleavage	bromide cleavage	1	0.987403161140781	4898	7209	4898	
5475	degradation products	degradation product	1	0.987403161140781	1031	5476	1031	
2023	API tests	API test	1	0.987403161140781	2025	2024	2025	
3862	enzymatic activity	enzymatic activity	1	0.987403161140781	393	3863	393	
2719	dependent manner	dependent manner	1	0.987403161140781	2721	807	2721	
8304	in vivo study	in_vivo study	1	0.987403161140781	1514	8305	1514	
4314	effects of a regular 4-week intake of probiotics	effect of a regular 4-week intake of probiotic	1	0.987403161140781	1055	4316	1055	
11669	characteristics of bile resistance	characteristic of bile resistance	1	0.987403161140781	3758	11671	3758	
3914	acid suppression	acid suppression	1	0.987403161140781	3916	4	3916	
11573	subcutaneous injections of thalidomide	subcutaneous injection of thalidomide	1	0.987403161140781	11575	11574	11576	
3563	profiles of the LPSs	profile of the LPS	1	0.987403161140781	3564	39	3564	
5564	strains of Chlamydia trachomatis	strain of Chlamydia trachomatis	1	0.987403161140781	551	4116	551	
6229	gene of Escherichia coli heat	gene of Escherichia coli heat	1	0.987403161140781	18	6231	18	
11405	composition of the transcriptomes	composition of the transcriptome	1	0.987403161140781	10137	11407	10137	
1401	total time	total time	1	0.987403161140781	1403	1402	1403	
13567	gene sequencing	gene sequencing	1	0.987403161140781	1583	18	1583	
9008	24-h transfusions	24-h transfusion	1	0.987403161140781	2707	9009	2707	
549	untypable strains	untypable strain	1	0.987403161140781	551	550	551	
1234	juvenile squid's light organ	juvenile squid' light organ	1	0.987403161140781	1236	1235	1240	
1030	products chemistry	product chemistry	1	0.987403161140781	1032	1031	1032	
7105	wide maps of transcriptional start sites	wide map of transcriptional start site	1	0.987403161140781	7107	2070	7108	
3673	mesenteric lymph nodes	mesenteric lymph node	1	0.987403161140781	3675	3674	3677	
9041	Poisson distribution	Poisson distribution	1	0.987403161140781	895	9042	895	
2657	burst size	burst size	1	0.987403161140781	2659	2658	2659	
2296	transposon promoter	transposon promoter	1	0.987403161140781	2298	2297	2298	
5177	restriction endonuclease fragment length polymorphism	restriction endonuclease fragment length polymorphism	1	0.987403161140781	5179	5178	5185	
1219	patients residual bulbitis	patient residual bulbitis	1	0.987403161140781	1221	226	1223	
7628	frequent stone formation	frequent stone formation	1	0.987403161140781	7630	7629	4488	
10400	turbot serum	turbot serum	1	0.987403161140781	1798	10401	1798	
8034	immunophenotype pattern	immunophenotype pattern	1	0.987403161140781	4145	8035	4145	
8616	secondary effluents	secondary effluent	1	0.987403161140781	8618	68	8618	
364	foreign body MRSA infection	foreign body MRSA infection	1	0.987403161140781	366	365	274	
13580	index of suspicion	index of suspicion	1	0.987403161140781	1233	13582	1233	
14893	HOX activity	HOX activity	1	0.987403161140781	393	11300	393	
7483	testing grounds	testing ground	1	0.987403161140781	7485	5870	7485	
12047	main virulence factors of the bacterium	main virulence factor of the bacterium	1	0.987403161140781	12049	232	2924	
1300	TCR delta	TCR delta	1	0.987403161140781	56	1301	56	
7671	plant pathogen Xanthomonas campestris pv	plant pathogen Xanthomonas campestris pv	1	0.987403161140781	2003	7672	2007	
16728	study of acute lower respiratory illness	study of acute low respiratory illness	1	0.987403161140781	1514	16730	1514	
14941	mirabilis infection	mirabilis infection	1	0.987403161140781	274	7654	274	
16603	DNA phage	DNA phage	1	0.987403161140781	2407	468	2407	
10971	marinum infection	marinum infection	1	0.987403161140781	274	10972	274	
12895	protein translation	protein translation	1	0.987403161140781	3708	406	3708	
9684	putative aminoglycoside phosphotransferase	putative aminoglycoside phosphotransferase	1	0.987403161140781	9686	2074	9688	
1100	Homology searches	Homology search	1	0.987403161140781	1102	1101	1102	
347	C6 phosphate group	C6 phosphate group	1	0.987403161140781	349	348	351	
12204	humanized variable fragments of an LPS	humanized variable fragment of an LPS	1	0.987403161140781	12206	5770	6070	
4363	optimum multiplicity of infection	optimum multiplicity of infection	1	0.987403161140781	4365	4364	4366	
10253	adhesive factors	adhesive factor	1	0.987403161140781	2924	5686	2924	
13373	non-random distribution	non-random distribution	1	0.987403161140781	895	13374	895	
2504	cell surface adhesins	cell surface adhesin	1	0.987403161140781	2508	2505	2508	
11880	mucosal surfaces	mucosal surface	1	0.987403161140781	1811	9417	1811	
10755	cattle sera	cattle serum	1	0.987403161140781	3345	1058	3345	
13759	available antibiotics	available antibiotic	1	0.987403161140781	3547	3319	3547	
16600	Atypical mycobacteria	Atypical mycobacterium	1	0.987403161140781	11100	16601	11100	
3688	bacterial pathogenesis	bacterial pathogenesis	1	0.987403161140781	3055	185	3055	
7907	similarity to the respective N	similarity to the respective N	1	0.987403161140781	7908	7909	7908	
11445	innate immune responses	innate immune response	1	0.987403161140781	11447	2355	2627	
16686	. influenzae	. influenzae	1	0.987403161140781	717	4472	717	
12658	control of antimicrobial susceptibility	control of antimicrobial susceptibility	1	0.987403161140781	575	1974	575	
2953	synthesis of heat	synthesis of heat	1	0.987403161140781	515	1986	515	
3811	specific cell	specific cell	1	0.987403161140781	235	504	235	
2141	rate of host cells	rate of host cell	1	0.987403161140781	154	2143	154	
381	aureus virulence	aureus virulence	1	0.987403161140781	383	382	383	
4340	Mycoplasma testudineum	Mycoplasma testudineum	1	0.987403161140781	4342	4341	4342	
1886	nerve injury	nerve injury	1	0.987403161140781	909	1774	909	
1620	selenite broth	selenite broth	1	0.987403161140781	1622	1621	1622	
16180	AvrBs3 effector domain	AvrBs3 effector domain	1	0.987403161140781	16182	16181	253	
15920	insertional inactivation of vvhA	insertional inactivation of vvhA	1	0.987403161140781	15922	15921	522	
2455	beef calves	beef calf	1	0.987403161140781	2101	2456	2101	
5009	diagnosis of early gastric mucosa	diagnosis of early gastric mucosa	1	0.987403161140781	5010	5011	5010	
16972	PCR unit	PCR unit	1	0.987403161140781	1107	2264	1107	
15761	time reverse transcription PCR analysis	time reverse transcription PCR analysis	1	0.987403161140781	203	15762	203	
9554	monthly prevalence of K	monthly prevalence of K	1	0.987403161140781	2883	9555	1786	
5996	EPEC adherence factor sequences	EPEC adherence factor sequence	1	0.987403161140781	5998	4490	534	
7559	residues Glu	residue Glu	1	0.987403161140781	4970	50	4970	
15207	P-induced apoptosis	P-induced apoptosis	1	0.987403161140781	4126	15208	4126	
7504	cases of trachoma	case of trachoma	1	0.987403161140781	2770	7506	2770	
14827	Quantitative analysis of the NOESY spectra	Quantitative analysis of the NOESY spectrum	1	0.987403161140781	14829	1072	203	
6342	role of Carnobacterium piscicola	role of Carnobacterium piscicola	1	0.987403161140781	233	6344	233	
15051	susceptible parent	susceptible parent	1	0.987403161140781	4478	2970	4478	
16365	range of environments	range of environment	1	0.987403161140781	928	752	928	
13012	BCG granulomatous lesion	BCG granulomatous lesion	1	0.987403161140781	13014	853	13016	
11886	author's transl)	author' transl)	1	0.987403161140781	11888	11887	11888	
14300	cytotoxic effector molecule expression	cytotoxic effector molecule expression	1	0.987403161140781	14302	7897	373	
16480	viability analysis	viability analysis	1	0.987403161140781	203	4309	203	
16227	attachment to host tissues	attachment to host tissue	1	0.987403161140781	938	10750	938	
3631	classes of hybrid DNA molecules	class of hybrid DNA molecule	1	0.987403161140781	3632	3633	3632	
16849	high clinical efficacy rate	high clinical efficacy rate	1	0.987403161140781	16851	264	154	
14933	libraries of mutants	library of mutant	1	0.987403161140781	9378	1936	9378	
10350	selective pressure	selective pressure	1	0.987403161140781	8058	5410	8058	
6594	phenotype of enteropathogenic E	phenotype of enteropathogenic E	1	0.987403161140781	5168	6596	5168	
6367	non-glycosylated proteins	non-glycosylated protein	1	0.987403161140781	27	6368	27	
10682	standard antibiotics	standard antibiotic	1	0.987403161140781	3547	8654	3547	
6473	transcription factor sigma B	transcription factor sigma B	1	0.987403161140781	6475	1075	977	
3363	oligonucleotide primers	oligonucleotide primer	1	0.987403161140781	3365	3364	3365	
8055	intracranial pressure monitor	intracranial pressure monitor	1	0.987403161140781	8057	8056	7157	
14838	scavenger receptors	scavenger receptor	1	0.987403161140781	546	14839	546	
13570	scale surveillance	scale surveillance	1	0.987403161140781	3820	11128	3820	
7926	enterotoxigenic Bacteroides fragilis	enterotoxigenic Bacteroide fragili	1	0.987403161140781	7928	5573	7930	
8417	fusion to a polypeptide	fusion to a polypeptide	1	0.987403161140781	8418	1854	8418	
10259	viable methicillin	viable methicillin	1	0.987403161140781	1650	1966	1650	
12637	Logistic regression models	Logistic regression model	1	0.987403161140781	12639	12638	7459	
2822	retailed fish	retailed fish	1	0.987403161140781	2824	2823	2824	
12588	roughness of paper carton fibres	roughness of paper carton fibre	1	0.987403161140781	12589	12590	12589	
11472	Salmonella antigens	Salmonella antigen	1	0.987403161140781	4100	3520	4100	
5183	length polymorphism	length polymorphism	1	0.987403161140781	5185	2539	5185	
4755	inoculum age	inoculum age	1	0.987403161140781	912	4756	912	
12377	mammalian proteins	mammalian protein	1	0.987403161140781	27	411	27	
12431	Mycobacterium tuberculosis isolates	Mycobacterium tuberculosis isolate	1	0.987403161140781	334	3626	334	
2547	NCCLS recommendations	NCCLS recommendation	1	0.987403161140781	2549	2548	2549	
11351	eaten arselle	eaten arselle	1	0.987403161140781	176	11352	176	
14134	pattern of recovery of these agents	pattern of recovery of these agent	1	0.987403161140781	4145	14136	4145	
16182	effector domain	effector domain	1	0.987403161140781	253	4557	253	
1282	cytometric measurement of neutrophil alkaline phosphatase	cytometric measurement of neutrophil alkaline phosphatase	1	0.987403161140781	1284	1283	1285	
5295	little demographic change	little demographic change	1	0.987403161140781	5297	628	3734	
11189	reduction rate of S	reduction rate of S	1	0.987403161140781	11191	276	154	
7512	single runs	single run	1	0.987403161140781	7514	1933	7514	
11105	extracellular signal	extracellular signal	1	0.987403161140781	11107	6	11107	
8443	N-terminal domain of UreR	N-terminal domain of UreR	1	0.987403161140781	3986	1267	253	
14546	selective broths	selective broth	1	0.987403161140781	14548	5410	14548	
9241	wastewater particles	wastewater particle	1	0.987403161140781	9243	5036	9243	
9292	CT6919 seeds	CT6919 seed	1	0.987403161140781	35	9293	35	
879	genetic group designation	genetic group designation	1	0.987403161140781	881	880	883	
4166	mucin adhesion	mucin adhesion	1	0.987403161140781	336	677	336	
8377	pleiotropic changes	pleiotropic change	1	0.987403161140781	1846	8378	1846	
16489	leaf discs	leaf disc	1	0.987403161140781	16491	16490	16491	
282	progressive granulomatous response	progressive granulomatous response	1	0.987403161140781	284	283	286	
9861	rural areas	rural area	1	0.987403161140781	4719	9862	4719	
1549	different antibiograms	different antibiogram	1	0.987403161140781	1551	816	1551	
16419	Staphylococcus aureus	Staphylococcus aureus	1	0.987403161140781	5584	16420	5584	
7211	percent of the ventilator	percent of the ventilator	1	0.987403161140781	7188	7213	7188	
8603	unique mechanism of action	unique mechanism of action	1	0.987403161140781	8605	3347	525	
2483	DNA extraction	DNA extraction	1	0.987403161140781	2173	468	2173	
5055	lungs of thalidomide	lung of thalidomide	1	0.987403161140781	3027	5057	3027	
9748	specific polyclonal murine antibody	specific polyclonal murine antibody	1	0.987403161140781	9750	504	1299	
14485	influenzae cell to penicillins	influenzae cell to penicillin	1	0.987403161140781	14486	633	235	
15913	members of the Map	member of the Map	1	0.987403161140781	2171	15915	2171	
13210	response to S	response to S	1	0.987403161140781	286	1898	286	
1194	Hb-binding proteins	Hb-binding protein	1	0.987403161140781	27	1195	27	
3754	heterogeneity of study characteristics	heterogeneity of study characteristic	1	0.987403161140781	3593	3756	3593	
487	outcomes of these measures	outcome of these measure	1	0.987403161140781	488	489	488	
2194	bony involvement	bony involvement	1	0.987403161140781	2061	2195	2061	
6378	greater improvements	great improvement	1	0.987403161140781	6380	4501	6380	
14931	combinatorial libraries of mutants	combinatorial library of mutant	1	0.987403161140781	14933	14932	9378	
5907	bacterial peritonitis	bacterial peritonitis	1	0.987403161140781	5909	185	5909	
14329	diagnosis of atrophic gastritis	diagnosis of atrophic gastritis	1	0.987403161140781	5010	8640	5010	
16570	production of outer membrane proteins	production of outer membrane protein	1	0.987403161140781	93	16572	93	
2187	direct physical contact	direct physical contact	1	0.987403161140781	2189	2188	2191	
8218	Clostridium perfringens Type A	Clostridium perfringen Type A	1	0.987403161140781	8220	1227	1379	
1532	dominant pulsotype	dominant pulsotype	1	0.987403161140781	1534	1533	1534	
2008	evolution of group	evolution of group	1	0.987403161140781	2009	351	2009	
17	gene product	gene product	1	0.987403161140781	19	18	19	
11344	strontium selenite A broth	strontium selenite A broth	1	0.987403161140781	11346	1619	1622	
6730	entry sites	entry site	1	0.987403161140781	1139	526	1139	
13253	aliphatic chain	aliphatic chain	1	0.987403161140781	320	13254	320	
6031	costimulatory molecule CD252	costimulatory molecule CD252	1	0.987403161140781	6033	6032	6035	
12732	pseudomallei biotypes	pseudomallei biotype	1	0.987403161140781	10534	2600	10534	
11110	C-terminal domain of P28	C-terminal domain of P28	1	0.987403161140781	11112	3985	253	
2690	bearing C12	bearing C12	1	0.987403161140781	2692	2691	2692	
11777	pneumococcal vaccination	pneumococcal vaccination	1	0.987403161140781	11779	4647	11779	
8119	Mycoplasma pneumoniae	Mycoplasma pneumoniae	1	0.987403161140781	8121	4341	8121	
6899	therapeutic significance of cellular invasion	therapeutic significance of cellular invasion	1	0.987403161140781	6901	2756	4435	
12240	gastric cancer development	gastric cancer development	1	0.987403161140781	1679	385	1679	
4476	MRSA parent	MRSA parent	1	0.987403161140781	4478	369	4478	
13185	inocula of either species	inocula of either species	1	0.987403161140781	13186	74	13186	
292	Vaccination of Japanese flounder	Vaccination of Japanese flounder	1	0.987403161140781	293	294	293	
6984	free FlgF	free FlgF	1	0.987403161140781	6986	112	6986	
10936	CDI diagnosis	CDI diagnosis	1	0.987403161140781	5010	979	5010	
10827	pdhB genes	pdhB gene	1	0.987403161140781	444	10828	444	
9569	higher hole	high hole	1	0.987403161140781	9571	151	9571	
13505	NONE group	NONE group	1	0.987403161140781	351	13506	351	
7793	human corneal	human corneal	1	0.987403161140781	7795	834	7795	
14186	study follow-up	study follow-up	1	0.987403161140781	3209	1514	3209	
94	contribution to thermotolerance of the nitrogen	contribution to thermotolerance of the nitrogen	1	0.987403161140781	95	96	95	
8646	divalent metal ions	divalent metal ion	1	0.987403161140781	8648	2723	8650	
13046	nonvirulent Ara+ Burkholderia pseudomallei isolates	nonvirulent Ara+ Burkholderia pseudomallei isolate	1	0.987403161140781	13048	13047	334	
8368	goodness of fit	goodness of fit	1	0.987403161140781	8369	8370	8369	
2078	growth medium of H	growth medium of H	1	0.987403161140781	2079	764	1926	
13897	protein synthesis	protein synthesis	1	0.987403161140781	515	406	515	
7527	LJ regulatory cascade	LJ regulatory cascade	1	0.987403161140781	7529	7528	7531	
16114	residues Glu120	residue Glu120	1	0.987403161140781	16116	50	16116	
16500	recording of any side	recording of any side	1	0.987403161140781	16501	3859	16501	
3692	PFGE results	PFGE result	1	0.987403161140781	2870	3693	2870	
2532	Immune response to infection	Immune response to infection	1	0.987403161140781	2534	2533	286	
6963	multienzyme complex	multienzyme complex	1	0.987403161140781	1524	6964	1524	
16577	recombinant interferon gamma	recombinant interferon gamma	1	0.987403161140781	16579	2986	54	
1627	Susceptibility of microorganisms	Susceptibility of microorganism	1	0.987403161140781	1628	1629	1628	
12976	190-kDa polypeptide gene	190-kDa polypeptide gene	1	0.987403161140781	12978	8506	18	
16532	number of cells	number of cell	1	0.987403161140781	1034	113	1034	
13978	sediment sample	sediment sample	1	0.987403161140781	2222	1960	2222	
14906	Lyme spirochete	Lyme spirochete	1	0.987403161140781	14908	5346	14908	
14302	effector molecule expression	effector molecule expression	1	0.987403161140781	14304	4557	373	
5977	mass spectrometry (MS(n))	mass spectrometry (MS(n))	1	0.987403161140781	5979	1193	5981	
8726	major signaling kinases	major signaling kinase	1	0.987403161140781	8728	71	8730	
7726	maltosa genome	maltosa genome	1	0.987403161140781	1581	3206	1581	
14124	nonfimbrial bacterial surface protein	nonfimbrial bacterial surface protein	1	0.987403161140781	14126	5684	406	
5562	requirements of strains of Chlamydia trachomatis	requirement of strain of Chlamydia trachomatis	1	0.987403161140781	658	5564	658	
896	disease melioidosis	disease melioidosis	1	0.987403161140781	898	268	898	
1932	single band	single band	1	0.987403161140781	1934	1933	1934	
6413	urban areas	urban area	1	0.987403161140781	4719	6414	4719	
10285	properties of cells	property of cell	1	0.987403161140781	3103	113	3103	
11044	surface hydrophobicity	surface hydrophobicity	1	0.987403161140781	3063	339	3063	
16722	confidence interval	confidence interval	1	0.987403161140781	16724	16723	16724	
10949	PA therapies	PA therapy	1	0.987403161140781	10951	3422	10951	
10324	expression of virulence factors	expression of virulence factor	1	0.987403161140781	373	2922	373	
14808	length polymorphism analysis	length polymorphism analysis	1	0.987403161140781	14810	2539	203	
5089	catalytic cleft	catalytic cleft	1	0.987403161140781	5091	1315	5091	
146	resistant N	resistant N	1	0.987403161140781	148	123	148	
9637	use of proton pump inhibitors	use of proton pump inhibitor	1	0.987403161140781	32	9639	32	
15105	HCl secretion	HCl secretion	1	0.987403161140781	2586	741	2586	
13965	radiotelemetry device	radiotelemetry device	1	0.987403161140781	6282	13966	6282	
2704	wide survey	wide survey	1	0.987403161140781	2706	2070	2706	
3485	O-linked glycosylation processes	O-linked glycosylation process	1	0.987403161140781	3487	3486	3489	
14659	variety of marine environments	variety of marine environment	1	0.987403161140781	1261	14661	1261	
15002	electron microscopy experiments	electron microscopy experiment	1	0.987403161140781	1434	5132	1434	
1167	staphylococcal infections	staphylococcal infection	1	0.987403161140781	736	823	736	
3064	genomic sequence analysis	genomic sequence analysis	1	0.987403161140781	3066	3065	203	
10961	red algal galactans	red algal galactan	1	0.987403161140781	10963	1022	10965	
795	broad understanding of the causes	broad understanding of the cause	1	0.987403161140781	797	796	729	
11115	routine use of prophylactic antibiotics	routine use of prophylactic antibiotic	1	0.987403161140781	11117	9850	32	
3624	virulent Mycobacterium tuberculosis	virulent Mycobacterium tuberculosis	1	0.987403161140781	3626	3625	491	
13229	Rickettsia infection	Rickettsia infection	1	0.987403161140781	274	1449	274	
15060	leaderless translation	leaderless translation	1	0.987403161140781	3708	15061	3708	
13879	detection of drug resistance	detection of drug resistance	1	0.987403161140781	2459	2110	2459	
9933	de-differentiated state	de-differentiated state	1	0.987403161140781	788	9934	788	
2837	initial reduction of fever	initial reduction of fever	1	0.987403161140781	2839	2838	276	
12722	relative contents of hexadecenoic acid	relative content of hexadecenoic acid	1	0.987403161140781	12724	6285	6287	
2628	further evidence	further evidence	1	0.987403161140781	2412	2629	2412	
1641	C therapy	C therapy	1	0.987403161140781	464	243	464	
15473	C2 position	C2 position	1	0.987403161140781	621	14937	621	
2224	gut microbiota	gut microbiota	1	0.987403161140781	2226	2225	2226	
5938	polymorphic FcgammaRIIa	polymorphic FcgammaRIIa	1	0.987403161140781	686	5939	686	
7453	higher potency	high potency	1	0.987403161140781	927	151	927	
718	phagosomal escape	phagosomal escape	1	0.987403161140781	720	719	720	
77	enterohemorrhagic E	enterohemorrhagic E	1	0.987403161140781	79	78	79	
3310	Child B	Child B	1	0.987403161140781	977	3311	977	
16046	isolation of N	isolation of N	1	0.987403161140781	326	148	326	
13218	Involvement of CD252	Involvement of CD252	1	0.987403161140781	13219	6035	13219	
15764	reverse transcription PCR	reverse transcription PCR	1	0.987403161140781	2264	1073	2264	
2831	NMR analysis of site	NMR analysis of site	1	0.987403161140781	2833	2611	203	
3847	high numbers of leukocytes	high number of leukocyte	1	0.987403161140781	3848	3851	46	
14974	discovery initiatives	discovery initiative	1	0.987403161140781	14976	9600	14976	
3443	iron supplementation	iron supplementation	1	0.987403161140781	3445	1953	3445	
5918	significant reduction	significant reduction	1	0.987403161140781	276	24	276	
2688	GroP bearing C12	GroP bearing C12	1	0.987403161140781	2690	2689	2692	
11149	sp .	sp .	1	0.987403161140781	4472	3950	4472	
16992	fish farming	fish farming	1	0.987403161140781	16994	1903	16994	
9909	contaminant microflora	contaminant microflora	1	0.987403161140781	960	9910	960	
75	strain of enterohemorrhagic E	strain of enterohemorrhagic E	1	0.987403161140781	76	77	76	
16232	prone peptides	prone peptide	1	0.987403161140781	1010	16233	1010	
2395	BCG granulomatous lesions	BCG granulomatous lesion	1	0.987403161140781	2397	853	2399	
16928	critical mechanism	critical mechanism	1	0.987403161140781	525	8801	525	
2209	cell count	cell count	1	0.987403161140781	2211	235	2211	
14182	estimate to length of study follow-up	estimate to length of study follow-up	1	0.987403161140781	14183	14184	14183	
16903	wall active antibiotics	wall active antibiotic	1	0.987403161140781	16905	1918	3547	
4217	Salmonella enterica	Salmonella enterica	1	0.987403161140781	4219	3520	4219	
14559	analysis of phytoplasma genes	analysis of phytoplasma gene	1	0.987403161140781	203	14561	203	
9647	digestive system symptoms	digestive system symptom	1	0.987403161140781	9649	9648	2641	
11864	spontaneous aging of proteins	spontaneous aging of protein	1	0.987403161140781	11866	5906	8086	
6666	occurrence of phenotypes	occurrence of phenotype	1	0.987403161140781	871	6668	871	
7478	DNA types	DNA type	1	0.987403161140781	769	468	769	
11301	purification of peptides	purification of peptide	1	0.987403161140781	1173	1010	1173	
7291	colonization properties	colonization property	1	0.987403161140781	3103	2703	3103	
7446	initial swelling	initial swelling	1	0.987403161140781	7448	2838	7448	
10004	level of diversity	level of diversity	1	0.987403161140781	1113	2099	1113	
1436	Dalgarno motif	Dalgarno motif	1	0.987403161140781	1438	1437	1438	
1115	photoacoustic spectroscopy	photoacoustic spectroscopy	1	0.987403161140781	1117	1116	1117	
4333	immunofluorescence assay	immunofluorescence assay	1	0.987403161140781	562	4334	562	
4744	key procedures	key procedure	1	0.987403161140781	4746	1002	4746	
5835	analysis of the N-terminal domain of UreR	analysis of the N-terminal domain of UreR	1	0.987403161140781	203	5837	203	
14024	nature of non-coding transcripts	nature of non-coding transcript	1	0.987403161140781	3765	14026	3765	
16911	RAPD profile combination	RAPD profile combination	1	0.987403161140781	1027	16912	1027	
7199	m Mg(2+)	m Mg(2+)	1	0.987403161140781	7201	7200	7201	
7889	certain FcgammaR allotypes	certain FcgammaR allotype	1	0.987403161140781	7891	3332	687	
13417	Eco HD	Eco HD	1	0.987403161140781	13419	13418	13419	
10211	Clonal strains of Pseudomonas aeruginosa	Clonal strain of Pseudomonas aeruginosa	1	0.987403161140781	10213	10212	551	
16969	clearance of colonization	clearance of colonization	1	0.987403161140781	449	2703	449	
11523	Microbial systems	Microbial system	1	0.987403161140781	4029	11524	4029	
4173	Chlamydia muridarum respiratory infections	Chlamydia muridarum respiratory infection	1	0.987403161140781	4175	4117	736	
13695	phagocytosis of the W135 meningococci	phagocytosis of the W135 meningococci	1	0.987403161140781	8836	13697	8836	
9819	infection Y	infection Y	1	0.987403161140781	4774	274	4774	
13950	meliloti cells	meliloti cell	1	0.987403161140781	113	13951	113	
360	model of chronic foreign body MRSA infection	model of chronic foreign body MRSA infection	1	0.987403161140781	361	362	361	
16572	outer membrane proteins	outer membrane protein	1	0.987403161140781	3722	2374	27	
9162	inhalation solution	inhalation solution	1	0.987403161140781	5423	9163	5423	
5837	N-terminal domain of UreR	N-terminal domain of UreR	1	0.987403161140781	5838	90	253	
7660	potential pathogens	potential pathogen	1	0.987403161140781	186	2154	186	
1920	M Tris	M Tris	1	0.987403161140781	1922	1921	1922	
12323	IgE epitopes	IgE epitope	1	0.987403161140781	12325	12324	12325	
16358	acute aerosol M	acute aerosol M	1	0.987403161140781	16360	6312	1921	
3938	effect of cytokine modulation	effect of cytokine modulation	1	0.987403161140781	2937	3940	2937	
762	st-positive H	st-positive H	1	0.987403161140781	764	763	764	
7820	stronger NAP intensity increase	strong NAP intensity increase	1	0.987403161140781	7822	7797	1465	
83	noninvasive test	noninvasive test	1	0.987403161140781	85	84	85	
2571	presence of 15% NaCl	presence of 15% NaCl	1	0.987403161140781	139	2573	139	
5473	analysis of the degradation products	analysis of the degradation product	1	0.987403161140781	203	5475	203	
5348	parkeri infected animals	parkeri infected animal	1	0.987403161140781	5350	5349	1634	
6364	model system	model system	1	0.987403161140781	1501	361	1501	
503	specific metal binding	specific metal binding	1	0.987403161140781	505	504	159	
691	Genotypic characterization of drug	Genotypic characterization of drug	1	0.987403161140781	693	692	416	
15409	X-ray crystallographic structural studies	X-ray crystallographic structural study	1	0.987403161140781	15411	199	2918	
14173	types of drug resistance	type of drug resistance	1	0.987403161140781	769	2110	769	
195	Adult partridges	Adult partridge	1	0.987403161140781	197	196	197	
1942	universal modification of proteins	universal modification of protein	1	0.987403161140781	1944	1000	1945	
16368	Lack of a consistent definition of clearance	Lack of a consistent definition of clearance	1	0.987403161140781	16369	16370	16369	
4408	discriminatory indices	discriminatory index	1	0.987403161140781	4410	1232	4410	
7424	LD parameter distributions	LD parameter distribution	1	0.987403161140781	7426	1980	4442	
1369	microbial work	microbial work	1	0.987403161140781	1371	521	1371	
15723	Mycobacterium tuberculosis H37Rv	Mycobacterium tuberculosis H37Rv	1	0.987403161140781	15727	3626	15727	
15513	Ability of Lactobacillus gasseri K	Ability of Lactobacillus gasseri K	1	0.987403161140781	15514	15515	15514	
13246	stasis survival	stasis survival	1	0.987403161140781	1950	6813	1950	
1639	Group C therapy	Group C therapy	1	0.987403161140781	1641	1640	464	
11861	flora of children	flora of child	1	0.987403161140781	1413	1560	1413	
13667	detection of a specific Mycobacterium leprae antigen	detection of a specific Mycobacterium leprae antigen	1	0.987403161140781	2459	13669	2459	
7808	colon perforation	colon perforation	1	0.987403161140781	7810	7809	7810	
2458	detection performances	detection performance	1	0.987403161140781	2460	2459	2460	
8841	molecular replacement	molecular replacement	1	0.987403161140781	8843	376	8843	
14325	positive reactions	positive reaction	1	0.987403161140781	14327	953	14327	
995	central necrosis	central necrosis	1	0.987403161140781	422	863	422	
4605	Clostridium difficile infection	Clostridium difficile infection	1	0.987403161140781	4607	1227	274	
5198	molecular mechanism	molecular mechanism	1	0.987403161140781	525	376	525	
13706	bacterial surface proteins	bacterial surface protein	1	0.987403161140781	13708	185	27	
5612	surface of meningococci	surface of meningococci	1	0.987403161140781	339	13	339	
14568	significant morbidity	significant morbidity	1	0.987403161140781	981	24	981	
14822	similar biological roles	similar biological role	1	0.987403161140781	14824	1190	8900	
11494	prevalence of Helicobacter pylori infection	prevalence of Helicobacter pylori infection	1	0.987403161140781	1786	11496	1786	
14727	readout of eukaryotic cell toxicity	readout of eukaryotic cell toxicity	1	0.987403161140781	14728	14729	14728	
14405	equal frequency	equal frequency	1	0.987403161140781	265	2183	265	
14147	exposure questionnaire	exposure questionnaire	1	0.987403161140781	14149	5191	14149	
15515	Lactobacillus gasseri K	Lactobacillus gasseri K	1	0.987403161140781	12184	6761	548	
8168	healthy carriers	healthy carrier	1	0.987403161140781	8170	133	8170	
418	chlorosome structure	chlorosome structure	1	0.987403161140781	201	419	201	
10849	certain groups	certain group	1	0.987403161140781	4420	3332	4420	
15086	third pathogroup	third pathogroup	1	0.987403161140781	15088	1527	15088	
14314	sequence of the DNA	sequence of the DNA	1	0.987403161140781	1657	468	1657	
6370	Å(3) Da	Å(3) Da	1	0.987403161140781	6372	6371	6372	
11478	K digestion method	K digestion method	1	0.987403161140781	11480	548	596	
2672	enlarged irregular mantle zone	enlarged irregular mantle zone	1	0.987403161140781	2674	2673	2678	
15809	chronic dyspepsia	chronic dyspepsia	1	0.987403161140781	15811	363	15811	
7796	stronger lytic activity	strong lytic activity	1	0.987403161140781	7798	7797	393	
7696	gastric pH of 39%	gastric pH of 39%	1	0.987403161140781	189	7700	191	
11056	game bird	game bird	1	0.987403161140781	11058	10330	11058	
2288	virulence determinants	virulence determinant	1	0.987403161140781	1717	383	1717	
16885	ABK q24h	ABK q24h	1	0.987403161140781	9848	11558	9848	
7432	Tissue dispersion	Tissue dispersion	1	0.987403161140781	7434	7433	7434	
13983	Construction of a cloning vector	Construction of a cloning vector	1	0.987403161140781	1364	13985	1364	
9667	Siderophore production	Siderophore production	1	0.987403161140781	93	9668	93	
1112	level of parents	level of parent	1	0.987403161140781	1113	1114	1113	
13746	total counts of LAB	total count of LAB	1	0.987403161140781	13748	1402	2262	
8862	neonatal deaths	neonatal death	1	0.987403161140781	5429	8863	5429	
971	report of the occurrence of a mosquitocidal B	report of the occurrence of a mosquitocidal B	1	0.987403161140781	972	973	972	
12148	ml of the phage	ml of the phage	1	0.987403161140781	1183	2407	1183	
937	attachment ability	attachment ability	1	0.987403161140781	939	938	939	
3038	smaller plasmid	small plasmid	1	0.987403161140781	3040	1198	3040	
2085	attachment to hydrophilic tissue culture plates	attachment to hydrophilic tissue culture plate	1	0.987403161140781	938	2087	938	
4446	prevalence of resistance to antibiotics	prevalence of resistance to antibiotic	1	0.987403161140781	1786	4448	1786	
6387	vicinity of pdhA	vicinity of pdhA	1	0.987403161140781	6388	6389	6388	
2964	metal affinity chromatography	metal affinity chromatography	1	0.987403161140781	2310	506	2312	
16672	GroEL proteins	GroEL protein	1	0.987403161140781	27	16673	27	
8565	features of the disease	feature of the disease	1	0.987403161140781	157	268	157	
16806	geographic areas	geographic area	1	0.987403161140781	4719	16807	4719	
12694	half of the catalytic cycle	half of the catalytic cycle	1	0.987403161140781	12695	12696	12695	
14007	novel mosquitocidal Cry protein	novel mosquitocidal Cry protein	1	0.987403161140781	14009	82	406	
7955	report of the sequence	report of the sequence	1	0.987403161140781	972	1657	972	
3511	levels of resistance to penicillins	level of resistance to penicillin	1	0.987403161140781	495	3513	495	
11014	autolytic changes	autolytic change	1	0.987403161140781	1846	7287	1846	
3980	passage levels	passage level	1	0.987403161140781	495	3981	495	
16714	transition dipole moment orientations	transition dipole moment orientation	1	0.987403161140781	16716	16715	16720	
10007	treatment of infection	treatment of infection	1	0.987403161140781	61	274	61	
6524	higher level of functional activity	high level of functional activity	1	0.987403161140781	6525	6528	1113	
4441	distributions of LD observables	distribution of LD observable	1	0.987403161140781	4442	4443	4442	
7467	recycling of peptidoglycan	recycling of peptidoglycan	1	0.987403161140781	7468	1707	7468	
13030	procathepsin D	procathepsin D	1	0.987403161140781	13032	13031	13032	
15532	pH of the medium	pH of the medium	1	0.987403161140781	191	1926	191	
15070	tolerance to the lethal action of bactericidal agents	tolerance to the lethal action of bactericidal agent	1	0.987403161140781	1278	15072	1278	
3609	pseudopeptide HB	pseudopeptide HB	1	0.987403161140781	3611	1324	3611	
12824	Physical mapping of the 9-kb plasmid	Physical mapping of the 9-kb plasmid	1	0.987403161140781	12826	12825	12827	
1224	treatment of Clostridium difficile infection	treatment of Clostridium difficile infection	1	0.987403161140781	61	1226	61	
10379	outskirts of the city	outskirt of the city	1	0.987403161140781	10380	10381	10380	
15775	addition of tryptophan to the medium	addition of tryptophan to the medium	1	0.987403161140781	2743	15777	2743	
9311	strains of Vibro parahaemolyticus	strain of Vibro parahaemolyticus	1	0.987403161140781	551	9313	551	
12992	properdin deficiency	properdin deficiency	1	0.987403161140781	5340	12993	5340	
7993	respiration gene expression	respiration gene expression	1	0.987403161140781	3395	7994	373	
6504	Ser315Thr amino acid change	Ser315Thr amino acid change	1	0.987403161140781	6506	6505	3734	
10788	molar excess of Zn(II)	molar excess of Zn(II)	1	0.987403161140781	10790	10789	10204	
7122	populations of mosquitoes	population of mosquito	1	0.987403161140781	1428	7124	1428	
14929	random combinatorial libraries of mutants	random combinatorial library of mutant	1	0.987403161140781	14931	6159	9378	
11392	human leprosy	human leprosy	1	0.987403161140781	11394	834	11394	
11146	higher symmetry	high symmetry	1	0.987403161140781	11148	151	11148	
8102	pooled analyses	pooled analysis	1	0.987403161140781	8104	3539	8104	
12743	group P2(1)2(1)2(1)	group P2(1)2(1)2(1)	1	0.987403161140781	12745	351	12745	
1648	resistant methicillin	resistant methicillin	1	0.987403161140781	1650	123	1650	
6627	library of P	library of P	1	0.987403161140781	6628	160	6628	
3959	peak wavelength	peak wavelength	1	0.987403161140781	3961	1743	3961	
13819	gene V protein	gene V protein	1	0.987403161140781	13821	18	406	
8882	cytotoxic properties of screening compounds	cytotoxic property of screening compound	1	0.987403161140781	8884	7897	3103	
8470	group A rotavirus	group A rotavirus	1	0.987403161140781	8472	351	8474	
5322	morphology of Φ st1	morphology of Φ st1	1	0.987403161140781	5323	2902	5323	
5202	naladixic acid	naladixic acid	1	0.987403161140781	4	5203	4	
14661	marine environments	marine environment	1	0.987403161140781	752	1135	752	
14457	molecular mechanisms of virulence factors	molecular mechanism of virulence factor	1	0.987403161140781	13703	2922	519	
16305	presence of H . pylori	presence of H . pylori	1	0.987403161140781	139	4469	139	
13048	Ara+ Burkholderia pseudomallei isolates	Ara+ Burkholderia pseudomallei isolate	1	0.987403161140781	13050	38	334	
13957	tuberculin hypersensitivity	tuberculin hypersensitivity	1	0.987403161140781	13959	13958	13959	
7735	pigs' jejunal tissue	pigs' jejunal tissue	1	0.987403161140781	759	564	569	
2661	correct species identification	correct species identification	1	0.987403161140781	2663	923	644	
16774	cleavage reaction	cleavage reaction	1	0.987403161140781	561	4898	561	
3391	regulator of urease gene expression	regulator of urease gene expression	1	0.987403161140781	756	3393	756	
10521	length polypeptide chain	length polypeptide chain	1	0.987403161140781	10523	2539	320	
10678	S4 pocket	S4 pocket	1	0.987403161140781	10680	4641	10680	
1835	am5 infected Escherichia coli cells	am5 infected Escherichia coli cell	1	0.987403161140781	1837	1836	113	
8965	therapeutic optimalization of antibiotic treatment	therapeutic optimalization of antibiotic treatment	1	0.987403161140781	8967	2756	8968	
8742	unique strain	unique strain	1	0.987403161140781	76	3347	76	
12850	available studies	available study	1	0.987403161140781	2918	3319	2918	
12416	mean serum concentration of PGI	mean serum concentration of PGI	1	0.987403161140781	12418	3232	2012	
8048	correct interpretation of clonality	correct interpretation of clonality	1	0.987403161140781	8050	923	3537	
7146	aqueous phases	aqueous phase	1	0.987403161140781	7148	7147	7148	
3572	H monovalent serum	H monovalent serum	1	0.987403161140781	3574	764	1798	
8663	lack of health information	lack of health information	1	0.987403161140781	1151	8665	1151	
9999	early stage	early stage	1	0.987403161140781	10001	1097	10001	
926	potency range	potency range	1	0.987403161140781	928	927	928	
11543	specificities of the monoclonal antibodies	specificity of the monoclonal antibody	1	0.987403161140781	11544	7490	11544	
3912	gastric acid suppression	gastric acid suppression	1	0.987403161140781	3914	190	3916	
3769	broad expression of MyD88	broad expression of MyD88	1	0.987403161140781	3771	796	373	
15159	proliferation of GMOs	proliferation of GMO	1	0.987403161140781	7985	3697	7985	
3538	pooled estimates of time to clearance	pooled estimate of time to clearance	1	0.987403161140781	3540	3539	3541	
1553	handling of the peptides	handling of the peptide	1	0.987403161140781	1554	1010	1554	
6311	acute infantile diarrhea	acute infantile diarrhea	1	0.987403161140781	6313	6312	982	
6839	dot-blot technique	dot-blot technique	1	0.987403161140781	1245	6840	1245	
2945	adult CF units	adult CF unit	1	0.987403161140781	2947	2946	1085	
11259	recent study	recent study	1	0.987403161140781	1514	1540	1514	
5751	insufficient C3 deposition	insufficient C3 deposition	1	0.987403161140781	5753	5752	5755	
1415	common biosynthetic precursors	common biosynthetic precursor	1	0.987403161140781	1417	870	1419	
330	exception of4 isolates	exception of4 isolate	1	0.987403161140781	332	331	334	
14317	last outbreak of cholera	last outbreak of cholera	1	0.987403161140781	14319	14318	986	
16824	intrinsic bifidobacteria	intrinsic bifidobacteria	1	0.987403161140781	7443	15746	7443	
1110	educational level of parents	educational level of parent	1	0.987403161140781	1112	1111	1113	
10614	fnbB transcripts	fnbB transcript	1	0.987403161140781	10616	10615	10616	
141	micrograms of PGL -1	microgram of PGL -1	1	0.987403161140781	142	143	142	
1973	antimicrobial susceptibility of isolates	antimicrobial susceptibility of isolate	1	0.987403161140781	1974	334	273	
14349	magnesium sulphate	magnesium sulphate	1	0.987403161140781	14351	14350	14351	
11231	ribosomal P1 protein	ribosomal P1 protein	1	0.987403161140781	11233	5662	406	
12425	extracellular compartment	extracellular compartment	1	0.987403161140781	12427	6	12427	
16962	distinct biotypes	distinct biotype	1	0.987403161140781	10534	2607	10534	
16834	=KCTC 12089(T)=CCUG 47092(T))	=KCTC 12089(T)=CCUG 47092(T))	1	0.987403161140781	16836	16835	16838	
7937	Interpretation of high throughput screening	Interpretation of high throughput screening	1	0.987403161140781	7938	7939	7938	
14060	spirochetal growth medium	spirochetal growth medium	1	0.987403161140781	2079	14061	1926	
1669	location differences	location difference	1	0.987403161140781	1671	1670	1671	
14222	h of infection	h of infection	1	0.987403161140781	4754	274	4754	
8983	environmental cleaning	environmental cleaning	1	0.987403161140781	8985	1810	8985	
12880	complex glycans	complex glycan	1	0.987403161140781	12882	2220	12882	
5861	intervention study	intervention study	1	0.987403161140781	1514	5862	1514	
12597	dot-blot assay	dot-blot assay	1	0.987403161140781	562	6840	562	
10622	vibrio vulnificus	vibrio vulnificus	1	0.987403161140781	5974	10623	5974	
8043	functional effector genes	functional effector gene	1	0.987403161140781	6685	3355	444	
4686	positive subjects	positive subject	1	0.987403161140781	2625	953	2625	
5652	selenomethionine structure	selenomethionine structure	1	0.987403161140781	201	5653	201	
7655	stool swab cultures	stool swab culture	1	0.987403161140781	7657	1259	4706	
14067	BID group	BID group	1	0.987403161140781	351	12886	351	
16401	third of the human population	third of the human population	1	0.987403161140781	16402	16403	16402	
9359	plant pathogens	plant pathogen	1	0.987403161140781	186	5726	186	
16293	small derivative	small derivative	1	0.987403161140781	9722	566	9722	
8942	low-grade gastric mucosal	low-grade gastric mucosal	1	0.987403161140781	8944	256	8946	
15145	culture surveillance	culture surveillance	1	0.987403161140781	3820	2092	3820	
9899	faecium strains	faecium strain	1	0.987403161140781	551	1675	551	
8075	content of chickens	content of chicken	1	0.987403161140781	4526	5114	4526	
14471	strains of Escherichia coli exploit type	strain of Escherichia coli exploit type	1	0.987403161140781	551	14473	551	
16782	correctional facilities	correctional facility	1	0.987403161140781	9381	16783	9381	
7026	source of human infection	source of human infection	1	0.987403161140781	3893	7028	3893	
8433	multiple bacterial infections	multiple bacterial infection	1	0.987403161140781	8435	6040	736	
1455	use of this agent	use of this agent	1	0.987403161140781	32	1357	32	
12549	pharyngeal carriage	pharyngeal carriage	1	0.987403161140781	7310	12550	7310	
6580	transposon mutagenesis	transposon mutagenesis	1	0.987403161140781	5829	2297	5829	
16007	outbreak cases	outbreak case	1	0.987403161140781	2770	11215	2770	
4350	antibacterial spectrum	antibacterial spectrum	1	0.987403161140781	1695	1575	1695	
1618	strontium selenite broth	strontium selenite broth	1	0.987403161140781	1620	1619	1622	
8187	different purification	different purification	1	0.987403161140781	1173	816	1173	
5761	dosing frequency	dosing frequency	1	0.987403161140781	265	5762	265	
14913	expansion of these lineages	expansion of these lineage	1	0.987403161140781	7695	14337	7695	
11848	new insights	new insight	1	0.987403161140781	1541	1171	1541	
6487	respiratory quinone	respiratory quinone	1	0.987403161140781	6489	735	6489	
5931	specific growth conditions	specific growth condition	1	0.987403161140781	5933	504	2285	
13132	human innate immune system	human innate immune system	1	0.987403161140781	10238	834	1501	
7557	nucleophilic residues Glu	nucleophilic residue Glu	1	0.987403161140781	7559	7558	4970	
4465	Intervention Trial of H . pylori	Intervention Trial of H . pylori	1	0.987403161140781	4467	4466	4468	
4955	short report	short report	1	0.987403161140781	972	4956	972	
6569	xopC locus	xopC locus	1	0.987403161140781	6571	4056	6571	
7254	Sequence Typing	Sequence Typing	1	0.987403161140781	7256	4253	7256	
4872	enzyme intensity	enzyme intensity	1	0.987403161140781	4874	4250	4874	
6534	cellulose acetate electrophoresis	cellulose acetate electrophoresis	1	0.987403161140781	6536	6535	2365	
45	numbers of F praunsitzii	number of F praunsitzii	1	0.987403161140781	46	47	46	
6459	hospital environments	hospital environment	1	0.987403161140781	752	6460	752	
10644	numerous cell types	numerous cell type	1	0.987403161140781	8281	10645	769	
10199	presence of a large excess of ligand	presence of a large excess of ligand	1	0.987403161140781	139	10201	139	
13055	host blood	host blood	1	0.987403161140781	2208	271	2208	
12485	lymphoid hyperplasia	lymphoid hyperplasia	1	0.987403161140781	12487	4361	12487	
7114	Cryptosporidium parvum oocysts	Cryptosporidium parvum oocyst	1	0.987403161140781	7116	5173	482	
16699	numbers of E coli	number of E coli	1	0.987403161140781	696	16700	696	
13635	strains of oculogenital origin	strain of oculogenital origin	1	0.987403161140781	551	13637	551	
1860	prevalence of URTD	prevalence of URTD	1	0.987403161140781	1786	1862	1786	
676	mucin colocalization	mucin colocalization	1	0.987403161140781	678	677	678	
2405	Selection of phage	Selection of phage	1	0.987403161140781	2406	2407	2406	
15884	relevant cyanobacteria	relevant cyanobacteria	1	0.987403161140781	9700	15885	9700	
16947	hydrophila infection	hydrophila infection	1	0.987403161140781	274	4797	274	
4945	application of this combination	application of this combination	1	0.987403161140781	1507	1027	1507	
12192	surface of xylanase	surface of xylanase	1	0.987403161140781	339	7233	339	
11410	adult PNS	adult PNS	1	0.987403161140781	11412	2946	11412	
11726	chloramphenicol treatment	chloramphenicol treatment	1	0.987403161140781	61	463	61	
10171	atopic sera	atopic serum	1	0.987403161140781	3345	10172	3345	
14287	absence of antibiotic selection	absence of antibiotic selection	1	0.987403161140781	5502	14289	5502	
2324	coli mastitis	coli mastitis	1	0.987403161140781	2326	696	2326	
11763	power of DC efferocytosis	power of DC efferocytosis	1	0.987403161140781	11764	8301	11764	
9531	tissue architecture	tissue architecture	1	0.987403161140781	5034	569	5034	
14004	slower process	slow process	1	0.987403161140781	2489	14005	2489	
10403	infectious human bacterial pathogens	infectious human bacterial pathogen	1	0.987403161140781	10405	843	186	
15427	standard culture conditions	standard culture condition	1	0.987403161140781	15429	8654	2285	
16936	novel species of a new genus	novel specie of a new genus	1	0.987403161140781	16938	82	73	
4592	eaeA gene	eaeA gene	1	0.987403161140781	18	4593	18	
776	mechanisms of function	mechanism of function	1	0.987403161140781	519	778	519	
12381	one-base mechanism of action	one-base mechanism of action	1	0.987403161140781	8605	12382	525	
15237	ml of S	ml of S	1	0.987403161140781	1183	1898	1183	
6430	culture liquid of the streptomycin	culture liquid of the streptomycin	1	0.987403161140781	6432	2092	6433	
10835	species of Mycoplasma	specie of Mycoplasma	1	0.987403161140781	73	4341	73	
5452	tularensis ssp tularensis	tularensis ssp tularensis	1	0.987403161140781	5454	5453	5453	
6261	Iron transport	Iron transport	1	0.987403161140781	6263	6262	6263	
9396	swine pathogen	swine pathogen	1	0.987403161140781	1905	9397	1905	
13889	resistance to quinupristin	resistance to quinupristin	1	0.987403161140781	1830	10162	1830	
6323	cytokine production	cytokine production	1	0.987403161140781	93	1568	93	
16588	isotope dilution method	isotope dilution method	1	0.987403161140781	3867	16589	596	
8016	dihydrolipoamide acetyltransferase	dihydrolipoamide acetyltransferase	1	0.987403161140781	8018	8017	8018	
13830	mean episodes of stools	mean episode of stool	1	0.987403161140781	13832	3232	1666	
14722	analysis of Rv3168	analysis of Rv3168	1	0.987403161140781	203	9039	203	
6081	lithium acetate methods	lithium acetate method	1	0.987403161140781	6083	6082	2371	
1513	study of inmates' nasal specimens	study of inmates' nasal specimen	1	0.987403161140781	1514	1515	1514	
9523	cytosolic multiplication of LVS	cytosolic multiplication of LVS	1	0.987403161140781	9525	9524	4113	
5517	enzyme yield	enzyme yield	1	0.987403161140781	5519	4250	5519	
4130	importance of H	importance of H	1	0.987403161140781	684	764	684	
9387	Dynamic studies	Dynamic study	1	0.987403161140781	2918	9388	2918	
4491	host immune system	host immune system	1	0.987403161140781	4493	271	1501	
14131	Antimicrobial therapy	Antimicrobial therapy	1	0.987403161140781	464	3010	464	
8930	protein domains	protein domain	1	0.987403161140781	8932	406	8932	
8092	differentiation of V	differentiation of V	1	0.987403161140781	884	2022	884	
5830	cerebrospinal fluid	cerebrospinal fluid	1	0.987403161140781	5371	5831	5371	
8496	strain HA	strain HA	1	0.987403161140781	8498	76	8498	
8986	older age	old age	1	0.987403161140781	912	6741	912	
15798	shock response	shock response	1	0.987403161140781	286	1187	286	
9649	system symptoms	system symptom	1	0.987403161140781	2641	1501	2641	
6710	younger ones	young one	1	0.987403161140781	2303	6711	2303	
2742	addition of pyruvate to the culture medium	addition of pyruvate to the culture medium	1	0.987403161140781	2743	2744	2743	
1397	IS6110 fingerprinting	IS6110 fingerprinting	1	0.987403161140781	1399	1398	1399	
12463	overall eradication rate	overall eradication rate	1	0.987403161140781	152	5154	154	
1385	coli cytoplasm	coli cytoplasm	1	0.987403161140781	1387	696	1387	
15565	glucose extract	glucose extract	1	0.987403161140781	3075	607	3075	
9054	nucleic acid amplification tests	nucleic acid amplification test	1	0.987403161140781	9056	3791	2025	
3675	lymph nodes	lymph node	1	0.987403161140781	3677	3216	3677	
659	non-canonical pathway	non-canonical pathway	1	0.987403161140781	661	660	661	
187	predictor of gastric pH	predictor of gastric pH	1	0.987403161140781	188	189	188	
8803	alternative to VAN	alternative to VAN	1	0.987403161140781	1941	8805	1941	
11653	wild strain	wild strain	1	0.987403161140781	76	11654	76	
2996	mechanism of metal	mechanism of metal	1	0.987403161140781	525	506	525	
11284	symbiotic partner	symbiotic partner	1	0.987403161140781	11286	3920	11286	
3984	C-terminal domain of UreR	C-terminal domain of UreR	1	0.987403161140781	3986	3985	253	
2360	field gel electrophoresis patterns	field gel electrophoresis pattern	1	0.987403161140781	2366	2361	2366	
10250	host defense	host defense	1	0.987403161140781	1340	271	1340	
319	chain product	chain product	1	0.987403161140781	19	320	19	
2277	REA DNA type	REA DNA type	1	0.987403161140781	2279	2278	1698	
15916	therapeutic regime	therapeutic regime	1	0.987403161140781	15918	2756	15918	
7151	cage infection	cage infection	1	0.987403161140781	274	7152	274	
10100	polymorphonuclear cells	polymorphonuclear cell	1	0.987403161140781	113	10101	113	
2294	Use of transposon promoter	Use of transposon promoter	1	0.987403161140781	2295	2296	2295	
16173	pigs' jejunum	pigs' jejunum	1	0.987403161140781	16175	564	16175	
1496	central nervous system infections	central nervous system infection	1	0.987403161140781	1498	863	736	
6083	acetate methods	acetate method	1	0.987403161140781	2371	6084	2371	
16518	endogenous M	endogenous M	1	0.987403161140781	1921	6292	1921	
8273	human enteritis	human enteritis	1	0.987403161140781	1548	834	1548	
14601	length HOX polypeptide	length HOX polypeptide	1	0.987403161140781	14603	2539	1854	
8006	clinical isolates of patients	clinical isolate of patient	1	0.987403161140781	8007	226	334	
10566	J774 cell line	J774 cell line	1	0.987403161140781	1088	2766	1090	
7899	natural history of MRSA	natural history of MRSA	1	0.987403161140781	7901	1029	3162	
16967	Time to clearance of colonization	Time to clearance of colonization	1	0.987403161140781	9407	16969	9407	
13858	host cell surface	host cell surface	1	0.987403161140781	339	12664	339	
14343	hematological malignancies	hematological malignancy	1	0.987403161140781	14345	4266	14345	
13075	atrophic body gastritis	atrophic body gastritis	1	0.987403161140781	5021	8641	4245	
11055	game bird farm	game bird farm	1	0.987403161140781	3592	11056	3592	
8899	roles of active site residues	role of active site residue	1	0.987403161140781	8900	8901	8900	
16449	available O antisera	available O antiserum	1	0.987403161140781	16451	3319	16453	
7050	dynamics of the HCN production	dynamic of the HCN production	1	0.987403161140781	592	4713	592	
7774	intrauterine secretions	intrauterine secretion	1	0.987403161140781	7776	7775	7776	
9713	resistant Mycobacterium tuberculosis	resistant Mycobacterium tuberculosis	1	0.987403161140781	3626	123	491	
679	broiler weight	broiler weight	1	0.987403161140781	681	680	681	
15201	biofilm maturation	biofilm maturation	1	0.987403161140781	9881	8662	9881	
10934	days of CDI diagnosis	day of CDI diagnosis	1	0.987403161140781	316	10936	316	
11659	Clostridium perfringens	Clostridium perfringen	1	0.987403161140781	7634	1227	7634	
2172	extraction of subtilisin variants	extraction of subtilisin variant	1	0.987403161140781	2173	2174	2173	
15901	new target	new target	1	0.987403161140781	6812	1171	6812	
9691	carbonic anhydrase psCA3	carbonic anhydrase psCA3	1	0.987403161140781	9693	7266	441	
6973	release of LDH	release of LDH	1	0.987403161140781	4192	6975	4192	
4318	4-week intake of probiotics	4-week intake of probiotic	1	0.987403161140781	4320	2475	2477	
11206	strontium chloride	strontium chloride	1	0.987403161140781	9565	1619	9565	
13141	tyrosine phosphatase super family motif CX5R	tyrosine phosphatase super family motif CX5R	1	0.987403161140781	13143	12689	13151	
1014	nontoxinogenic E	nontoxinogenic E	1	0.987403161140781	79	1015	79	
6702	sulfur bacteria	sulfur bacteria	1	0.987403161140781	1999	6703	1999	
7426	parameter distributions	parameter distribution	1	0.987403161140781	4442	7427	4442	
13240	strain EDL	strain EDL	1	0.987403161140781	13242	76	13242	
2272	CNS infections	CNS infection	1	0.987403161140781	736	2273	736	
5043	third type	third type	1	0.987403161140781	1698	1527	1698	
4938	lipid A species	lipid A specie	1	0.987403161140781	73	4939	73	
14794	small G protein Rac1	small G protein Rac1	1	0.987403161140781	14800	14795	14800	
6128	variable states of acylation	variable state of acylation	1	0.987403161140781	6130	6069	1909	
16484	crucial role	crucial role	1	0.987403161140781	233	13811	233	
8145	different host	different host	1	0.987403161140781	271	816	271	
5975	multistage mass spectrometry (MS(n))	multistage mass spectrometry (MS(n))	1	0.987403161140781	5977	5976	5981	
12562	deep vein occlusion of the left ileofemoral vein	deep vein occlusion of the left ileofemoral vein	1	0.987403161140781	12564	12563	12567	
11966	different stages of processing	different stage of processing	1	0.987403161140781	11968	816	1098	
3738	urethral smears	urethral smear	1	0.987403161140781	3740	3739	3740	
11090	positive bacterium	positive bacterium	1	0.987403161140781	1136	953	1136	
5238	amino acids of UreR	amino acid of UreR	1	0.987403161140781	3110	90	3060	
16320	initial fructose	initial fructose	1	0.987403161140781	624	2838	624	
16323	further reverse phase HPLC	further reverse phase HPLC	1	0.987403161140781	9203	2629	9207	
6907	phenotypic differences	phenotypic difference	1	0.987403161140781	1671	6382	1671	
9616	productive patients	productive patient	1	0.987403161140781	226	9617	226	
9918	nonclonal strains	nonclonal strain	1	0.987403161140781	551	9919	551	
3133	severity of the severe destructive arthritis	severity of the severe destructive arthritis	1	0.987403161140781	436	2772	436	
12360	pathogenicity of B	pathogenicity of B	1	0.987403161140781	3092	977	3092	
4878	n-hexane extracts	n-hexane extract	1	0.987403161140781	3189	4879	3189	
6500	successful treatment	successful treatment	1	0.987403161140781	61	5435	61	
15718	intracellular bacterial pathogen	intracellular bacterial pathogen	1	0.987403161140781	15720	859	1905	
1601	bacterial neutral protease	bacterial neutral protease	1	0.987403161140781	1603	185	1184	
358	rat model of chronic foreign body MRSA infection	rat model of chronic foreign body MRSA infection	1	0.987403161140781	360	359	361	
9187	salt solution	salt solution	1	0.987403161140781	5423	1479	5423	
1011	major RTKs	major RTK	1	0.987403161140781	1013	71	1013	
8821	regulation of adhesion	regulation of adhesion	1	0.987403161140781	378	336	378	
4964	11-month follow-up	11-month follow-up	1	0.987403161140781	3209	4965	3209	
8307	organic acids	organic acid	1	0.987403161140781	3060	8308	3060	
7330	petroleum reservoir production fluid	petroleum reservoir production fluid	1	0.987403161140781	7332	7331	5371	
12365	DC antigen	DC antigen	1	0.987403161140781	655	6154	655	
16786	elective surgery	elective surgery	1	0.987403161140781	16788	16787	16788	
830	organism test	organism test	1	0.987403161140781	85	308	85	
5361	pure compounds	pure compound	1	0.987403161140781	2878	5362	2878	
16890	synthesis of the C(40) carotenoids canthaxanthin	synthesis of the C(40) carotenoid canthaxanthin	1	0.987403161140781	515	16892	515	
4615	count SUP15 × 10(9)	count SUP15 × 10(9)	1	0.987403161140781	4617	2211	4617	
6749	second gene of the locus	second gene of the locus	1	0.987403161140781	6751	3410	18	
3553	mannitol salts	mannitol salt	1	0.987403161140781	3555	3554	3555	
6831	animal pathogenic bacteria	animal pathogenic bacteria	1	0.987403161140781	2417	6832	1999	
10293	gastrointestinal pathogen	gastrointestinal pathogen	1	0.987403161140781	1905	10294	1905	
9979	thuringiensis serovar sotto strain	thuringiensis serovar sotto strain	1	0.987403161140781	9981	1321	76	
6923	genetics of MDR	genetic of MDR	1	0.987403161140781	6924	6925	6924	
15358	normal yolk sacs	normal yolk sac	1	0.987403161140781	9345	1349	9347	
6613	metal stoichiometries	metal stoichiometry	1	0.987403161140781	6615	506	6615	
9019	effect of the dietary addition	effect of the dietary addition	1	0.987403161140781	2937	9021	2937	
2219	complex sample matrices	complex sample matrix	1	0.987403161140781	2221	2220	2223	
12845	cloning system	cloning system	1	0.987403161140781	1501	8928	1501	
2680	sarA P3 promoter	sarA P3 promoter	1	0.987403161140781	2682	2681	2298	
4822	mol% G+C	mol% G+C	1	0.987403161140781	4824	4823	4824	
8198	MDRP outbreak	MDRP outbreak	1	0.987403161140781	986	541	986	
15438	length product	length product	1	0.987403161140781	19	2539	19	
3602	efficiency of transformation	efficiency of transformation	1	0.987403161140781	481	3604	481	
4825	disease of grave	disease of grave	1	0.987403161140781	268	4827	268	
15671	Chronic airway infection	Chronic airway infection	1	0.987403161140781	3657	4244	274	
771	Surface mutations	Surface mutation	1	0.987403161140781	773	772	773	
3283	times reduction	time reduction	1	0.987403161140781	276	3284	276	
10716	evolutionary escape	evolutionary escape	1	0.987403161140781	720	10717	720	
11978	folding of the mammalian partner protein to the native state	folding of the mammalian partner protein to the native state	1	0.987403161140781	10269	11980	10269	
16905	active antibiotics	active antibiotic	1	0.987403161140781	3547	1	3547	
9752	murine antibody	murine antibody	1	0.987403161140781	1299	1511	1299	
4695	eukaryotic cell biology to the bacterium's advantage	eukaryotic cell biology to the bacterium' advantage	1	0.987403161140781	4697	4696	1725	
2731	fish Wap65 genes	fish Wap65 gene	1	0.987403161140781	2733	1903	444	
1626	Susceptibility of microorganisms to ozone	Susceptibility of microorganism to ozone	1	0.987403161140781	1627	1630	1628	
13389	mannose receptor	mannose receptor	1	0.987403161140781	345	13390	345	
10939	Histopathologic examination	Histopathologic examination	1	0.987403161140781	10941	10940	10941	
9854	susceptibility to growth inhibition	susceptibility to growth inhibition	1	0.987403161140781	273	9856	273	
13376	end of the intake period	end of the intake period	1	0.987403161140781	4425	13378	4425	
6446	destabilized samples	destabilized sample	1	0.987403161140781	225	6447	225	
7179	Immunohistochemical thin sections	Immunohistochemical thin section	1	0.987403161140781	7181	7180	7183	
13689	blood monocyte	blood monocyte	1	0.987403161140781	1204	2208	1204	
4032	state of the culture	state of the culture	1	0.987403161140781	788	2092	788	
874	cloacae IPM	cloaca IPM	1	0.987403161140781	876	875	876	
13358	mg AZLI	mg AZLI	1	0.987403161140781	8720	1420	8720	
7904	bipartite proteins	bipartite protein	1	0.987403161140781	27	7905	27	
6874	microbiological safety of food products	microbiological safety of food product	1	0.987403161140781	673	6878	675	
12907	burnetii infectivity	burnetii infectivity	1	0.987403161140781	10956	2519	10956	
10084	hemolysin gene	hemolysin gene	1	0.987403161140781	18	4170	18	
765	parainfluenza virus types	parainfluenza virus type	1	0.987403161140781	767	766	769	
12686	receptor tyrosine kinase	receptor tyrosine kinase	1	0.987403161140781	12688	345	11364	
3574	monovalent serum	monovalent serum	1	0.987403161140781	1798	3575	1798	
14774	fluorescence experiments	fluorescence experiment	1	0.987403161140781	1434	930	1434	
2502	potential cell surface adhesins	potential cell surface adhesin	1	0.987403161140781	2504	2154	2508	
7553	cytotoxin genes	cytotoxin gene	1	0.987403161140781	444	7554	444	
6740	older children	old child	1	0.987403161140781	1560	6741	1560	
3459	marine bacterium of the family	marine bacterium of the family	1	0.987403161140781	3461	1135	1136	
11431	network to the bacterial advantage	network to the bacterial advantage	1	0.987403161140781	401	11433	401	
379	Staphylococcus aureus virulence	Staphylococcus aureus virulence	1	0.987403161140781	381	380	383	
14836	A scavenger receptors	A scavenger receptor	1	0.987403161140781	14838	1379	546	
12423	HOX to the extracellular compartment	HOX to the extracellular compartment	1	0.987403161140781	11300	12425	11300	
1733	reflux oesophagitis	reflux oesophagitis	1	0.987403161140781	1735	1734	1735	
15801	Azithromycin therapy	Azithromycin therapy	1	0.987403161140781	464	15802	464	
16917	diverse clades	diverse clade	1	0.987403161140781	16919	4082	16919	
2308	agarose affinity chromatography	agarose affinity chromatography	1	0.987403161140781	2310	2309	2312	
7055	head kidney	head kidney	1	0.987403161140781	7057	5525	7057	
404	lumazine protein	lumazine protein	1	0.987403161140781	406	405	406	
4098	NH antigens	NH antigen	1	0.987403161140781	4100	2852	4100	
12554	evolutionary pressure	evolutionary pressure	1	0.987403161140781	8058	10717	8058	
16710	Different values of the transition dipole moment orientations	Different value of the transition dipole moment orientation	1	0.987403161140781	16712	2409	7423	
16643	bacterial elongation factor Tu	bacterial elongation factor Tu	1	0.987403161140781	4769	185	3221	
13514	protein translocation genes	protein translocation gene	1	0.987403161140781	13516	406	444	
553	H131 donors	H131 donor	1	0.987403161140781	555	554	555	
10275	Relative resistance to cotrimoxazole	Relative resistance to cotrimoxazole	1	0.987403161140781	10277	10276	1830	
14101	pyruvate kinase	pyruvate kinase	1	0.987403161140781	11364	2745	11364	
210	value of E λ	value of E λ	1	0.987403161140781	211	212	211	
16547	quantities of material	quantity of material	1	0.987403161140781	1964	7239	1964	
10658	DNA binding	DNA binding	1	0.987403161140781	159	468	159	
4574	Form B	Form B	1	0.987403161140781	977	4575	977	
8613	food applications	food application	1	0.987403161140781	2931	43	2931	
11112	domain of P28	domain of P28	1	0.987403161140781	253	2788	253	
12582	epidemiologic spectrum of bronchiolitis	epidemiologic spectrum of bronchiolitis	1	0.987403161140781	12584	7177	1695	
8751	neutrophil fate	neutrophil fate	1	0.987403161140781	8753	1287	8753	
10425	prevalence of Helicobacter pylori	prevalence of Helicobacter pylorus	1	0.987403161140781	1786	10427	1786	
13178	rice cultivars CT6919	rice cultivar CT6919	1	0.987403161140781	13180	34	9293	
13597	two-dimensional electronic spectra	two-dimensional electronic spectrum	1	0.987403161140781	13599	428	10533	
7851	quinolone resistance strains	quinolone resistance strain	1	0.987403161140781	551	7852	551	
11837	main cause of nosocomial infection	main cause of nosocomial infection	1	0.987403161140781	11839	232	8326	
13139	characteristic tyrosine phosphatase super family motif CX5R	characteristic tyrosine phosphatase super family motif CX5R	1	0.987403161140781	13141	13140	13151	
9867	infection stone model	infection stone model	1	0.987403161140781	9869	274	361	
11201	essential enzymes	essential enzyme	1	0.987403161140781	8183	1607	8183	
9794	increase of cardiac failure markers	increase of cardiac failure marker	1	0.987403161140781	1465	9796	1465	
10727	distinct patterns of amino acid requirements	distinct pattern of amino acid requirement	1	0.987403161140781	10729	2607	2366	
2985	recombinant LVS EF	recombinant LVS EF	1	0.987403161140781	2987	2986	1019	
16868	4th quarter	4th quarter	1	0.987403161140781	4339	16869	4339	
12758	sequence similarity	sequence similarity	1	0.987403161140781	7908	1657	7908	
11721	algae gen	algae gen	1	0.987403161140781	1344	11722	1344	
3766	bacterial growth	bacterial growth	1	0.987403161140781	217	185	217	
4302	MIC90S of ciprofloxacin	MIC90S of ciprofloxacin	1	0.987403161140781	4303	1989	4303	
7939	high throughput screening	high throughput screening	1	0.987403161140781	671	7940	671	
15731	term carriage	term carriage	1	0.987403161140781	7310	2270	7310	
12158	use of a humanized MAb	use of a humanized MAb	1	0.987403161140781	32	12160	32	
16529	pneumonia infections	pneumonia infection	1	0.987403161140781	736	665	736	
9173	median length	median length	1	0.987403161140781	2539	911	2539	
15406	detergent LAS	detergent LAS	1	0.987403161140781	15408	15407	15408	
12042	lambdoid phages	lambdoid phage	1	0.987403161140781	12044	6714	12044	
16207	epidemiology of diarrhea	epidemiology of diarrhea	1	0.987403161140781	5717	982	5717	
9512	adverse events	adverse event	1	0.987403161140781	9514	9513	9514	
14145	standardized exposure questionnaire	standardized exposure questionnaire	1	0.987403161140781	14147	14146	14149	
14450	Biochemical characterizations of the sucrose	Biochemical characterization of the sucrose	1	0.987403161140781	14452	14451	14453	
13306	alkaline phosphatase of B	alkaline phosphatase of B	1	0.987403161140781	1288	977	1290	
11224	16S rRNA sequence analysis	16S rRNA sequence analysis	1	0.987403161140781	11226	4019	203	
2336	enterotoxic strains of E	enterotoxic strain of E	1	0.987403161140781	2338	2337	551	
1406	unhygienic septic tank	unhygienic septic tank	1	0.987403161140781	1408	1407	1410	
4707	spectral shifts	spectral shift	1	0.987403161140781	4709	4708	4709	
12674	routine vaccinations	routine vaccination	1	0.987403161140781	12676	9850	12676	
2200	culicine mosquito	culicine mosquito	1	0.987403161140781	2202	2201	2202	
13877	rapid detection of drug resistance	rapid detection of drug resistance	1	0.987403161140781	13879	4185	2459	
9406	Time to defervescence	Time to defervescence	1	0.987403161140781	9407	8709	9407	
16476	endpoint cell viability analysis	endpoint cell viability analysis	1	0.987403161140781	16478	16477	203	
11634	different rate constants	different rate constant	1	0.987403161140781	11636	816	11638	
14219	M17 medium	M17 medium	1	0.987403161140781	1926	14220	1926	
12944	Western blot analysis	Western blot analysis	1	0.987403161140781	12946	12945	203	
297	displacement of E	displacement of E	1	0.987403161140781	298	79	298	
12801	management of MSM	management of MSM	1	0.987403161140781	5807	7637	5807	
16117	Myeloid differentiation factor	Myeloid differentiation factor	1	0.987403161140781	16119	16118	72	
693	characterization of drug	characterization of drug	1	0.987403161140781	416	162	416	
10082	vvhBA hemolysin gene	vvhBA hemolysin gene	1	0.987403161140781	10084	10083	18	
1026	combination of natural products chemistry	combination of natural product chemistry	1	0.987403161140781	1027	1028	1027	
14577	healing rate	healing rate	1	0.987403161140781	154	1304	154	
9435	Form A	Form A	1	0.987403161140781	1379	4575	1379	
6810	interesting target	interesting target	1	0.987403161140781	6812	460	6812	
11851	effector sequences	effector sequence	1	0.987403161140781	534	4557	534	
70	major factor	major factor	1	0.987403161140781	72	71	72	
6454	wastewater samples	wastewater sample	1	0.987403161140781	225	5036	225	
2258	blood cell counts	blood cell count	1	0.987403161140781	2260	2208	2262	
10080	expression of the vvhBA hemolysin gene	expression of the vvhBA hemolysin gene	1	0.987403161140781	373	10082	373	
2779	transcriptional reporter assay	transcriptional reporter assay	1	0.987403161140781	2781	2780	562	
8728	signaling kinases	signaling kinase	1	0.987403161140781	8730	731	8730	
5220	identical ladder patterns	identical ladder pattern	1	0.987403161140781	5222	4144	2366	
13326	Spanish hospitals	Spanish hospital	1	0.987403161140781	6146	13327	6146	
30	antibiotic use	antibiotic use	1	0.987403161140781	32	31	32	
14639	selective binding	selective binding	1	0.987403161140781	159	5410	159	
7276	basis of the knowledge	basis of the knowledge	1	0.987403161140781	6748	7278	6748	
3220	Tu proteins	Tu protein	1	0.987403161140781	27	3221	27	
3896	vesicatoria TTS system	vesicatoria TTS system	1	0.987403161140781	3898	3897	1501	
6141	isolates of non-O1 V	isolate of non-O1 V	1	0.987403161140781	334	6143	334	
613	growth of Gram	growth of Gram	1	0.987403161140781	217	615	217	
3354	functional homologue of the rolB protein	functional homologue of the rolB protein	1	0.987403161140781	3356	3355	3357	
6399	genetic code	genetic code	1	0.987403161140781	6401	880	6401	
7747	autologous dendritic cells	autologous dendritic cell	1	0.987403161140781	7017	7748	113	
3497	Serotyping of E	Serotyping of E	1	0.987403161140781	3498	79	3498	
2062	cardiovascular system	cardiovascular system	1	0.987403161140781	1501	2063	1501	
14452	characterizations of the sucrose	characterization of the sucrose	1	0.987403161140781	14453	2232	14453	
9127	Characterization of a lipopolysaccharide	Characterization of a lipopolysaccharide	1	0.987403161140781	2897	3623	2897	
8746	Induction of pdhA expression	Induction of pdhA expression	1	0.987403161140781	2451	8748	2451	
3187	burnetii extracts	burnetii extract	1	0.987403161140781	3189	2519	3189	
9073	xylanase action	xylanase action	1	0.987403161140781	8607	7233	8607	
12618	number of all cells types	number of all cell type	1	0.987403161140781	1034	12620	1034	
64	mature biofilms	mature biofilm	1	0.987403161140781	66	65	66	
567	intestinal tissue	intestinal tissue	1	0.987403161140781	569	129	569	
8201	grain colonization	grain colonization	1	0.987403161140781	2703	8202	2703	
5764	corpus of the stomach	corpus of the stomach	1	0.987403161140781	1395	5766	1395	
15864	tick species	tick specie	1	0.987403161140781	73	15865	73	
16742	symbiotic stage	symbiotic stage	1	0.987403161140781	10001	3920	10001	
7896	cytotoxic proteins	cytotoxic protein	1	0.987403161140781	27	7897	27	
2266	subset of these inpatients	subset of these inpatient	1	0.987403161140781	2267	2268	2267	
2169	family members	family member	1	0.987403161140781	2171	2170	2171	
4537	swabs of partridges	swab of partridge	1	0.987403161140781	3050	197	3050	
12688	tyrosine kinase	tyrosine kinase	1	0.987403161140781	11364	12689	11364	
1165	therapy of staphylococcal infections	therapy of staphylococcal infection	1	0.987403161140781	464	1167	464	
7669	negative plant pathogen Xanthomonas campestris pv	negative plant pathogen Xanthomonas campestris pv	1	0.987403161140781	7671	238	2007	
5231	different carbon sources	different carbon source	1	0.987403161140781	5233	816	5235	
6418	endonuclease digestion analysis	endonuclease digestion analysis	1	0.987403161140781	6420	5180	203	
6959	persistent colonization	persistent colonization	1	0.987403161140781	2703	6960	2703	
6014	different intestinal inflammatory pathologies	different intestinal inflammatory pathology	1	0.987403161140781	6016	816	6020	
668	oxacillin screening agar	oxacillin screening agar	1	0.987403161140781	670	669	672	
4434	significance of clonal strains	significance of clonal strain	1	0.987403161140781	4435	1787	4435	
12623	subterranean brine	subterranean brine	1	0.987403161140781	12625	2305	12625	
15046	different geographical areas	different geographical area	1	0.987403161140781	15048	816	4719	
15737	variability of antibiogram patterns	variability of antibiogram pattern	1	0.987403161140781	2276	15739	2276	
12608	antistaphylococcal agents	antistaphylococcal agent	1	0.987403161140781	1834	12609	1834	
9915	library screening	library screening	1	0.987403161140781	671	6628	671	
9285	diffraction method	diffraction method	1	0.987403161140781	596	9286	596	
14620	transcriptional fusion	transcriptional fusion	1	0.987403161140781	8418	2780	8418	
3231	mean cell residence time of the system	mean cell residence time of the system	1	0.987403161140781	3233	3232	1403	
8586	plasmid vector	plasmid vector	1	0.987403161140781	2218	3040	2218	
15462	identification of pathogens	identification of pathogen	1	0.987403161140781	644	186	644	
6231	Escherichia coli heat	Escherichia coli heat	1	0.987403161140781	6233	1840	1986	
15138	cases of M	case of M	1	0.987403161140781	2770	1921	2770	
9834	model of genital tract chlamydia infection	model of genital tract chlamydia infection	1	0.987403161140781	361	9836	361	
10288	evolution of traits	evolution of trait	1	0.987403161140781	2009	4796	2009	
7063	expression of the target genes	expression of the target gene	1	0.987403161140781	373	7065	373	
16139	histological diagnosis	histological diagnosis	1	0.987403161140781	5010	16140	5010	
11071	leprae invasion	leprae invasion	1	0.987403161140781	1178	11072	1178	
2051	resistance to ampicillin	resistance to ampicillin	1	0.987403161140781	1830	2053	1830	
9949	lower correlation	low correlation	1	0.987403161140781	1523	1390	1523	
13113	CTL effector function	CTL effector function	1	0.987403161140781	13115	13114	778	
12483	florid lymphoid hyperplasia	florid lymphoid hyperplasia	1	0.987403161140781	12485	12484	12487	
13623	N-acyl homoserine lactone	N-acyl homoserine lactone	1	0.987403161140781	13625	13624	13627	
9880	maturation of mutant enzymes	maturation of mutant enzyme	1	0.987403161140781	9881	9882	9881	
2588	% TID group	% TID group	1	0.987403161140781	2590	1209	351	
3560	SOS boxes	SOS box	1	0.987403161140781	3562	3561	3562	
706	Acinetobacter spp	Acinetobacter spp	1	0.987403161140781	708	707	708	
14557	expression analysis of phytoplasma genes	expression analysis of phytoplasma gene	1	0.987403161140781	14559	373	203	
6981	nonvaccinated hamsters	nonvaccinated hamster	1	0.987403161140781	6983	6982	6983	
15115	bacteria infection	bacteria infection	1	0.987403161140781	274	1999	274	
14160	Paraffin section IHC	Paraffin section IHC	1	0.987403161140781	14164	14161	14164	
4547	correlation analysis of all strains	correlation analysis of all strain	1	0.987403161140781	4549	1523	203	
51	CD8+ gamma delta T lymphocytes	CD8+ gamma delta T lymphocyte	1	0.987403161140781	53	52	59	
8087	successful combination	successful combination	1	0.987403161140781	1027	5435	1027	
13693	PMN phagocytosis of the W135 meningococci	PMN phagocytosis of the W135 meningococci	1	0.987403161140781	13695	278	8836	
8050	interpretation of clonality	interpretation of clonality	1	0.987403161140781	3537	8052	3537	
13017	incidence of central nervous system	incidence of central nervous system	1	0.987403161140781	3432	13019	3432	
11222	results of a 16S rRNA sequence analysis	result of a 16S rRNA sequence analysis	1	0.987403161140781	2870	11224	2870	
7857	patterns of methicillin	pattern of methicillin	1	0.987403161140781	2366	1650	2366	
7143	treatment adherence	treatment adherence	1	0.987403161140781	3685	61	3685	
3108	N-terminal amino acids	N-terminal amino acid	1	0.987403161140781	3110	1267	3060	
1071	Quantitative reverse transcription	Quantitative reverse transcription	1	0.987403161140781	1073	1072	1075	
14492	recent past	recent past	1	0.987403161140781	14494	1540	14494	
8327	ocular infections	ocular infection	1	0.987403161140781	736	8328	736	
6207	base residues	base residue	1	0.987403161140781	50	5487	50	
8266	Swelling of the hind paws	Swelling of the hind paw	1	0.987403161140781	8267	8268	8267	
16136	immunocompromised patient	immunocompromised patient	1	0.987403161140781	3504	16137	3504	
13085	cystic fibrosis units	cystic fibrosis unit	1	0.987403161140781	1085	13086	1085	
11757	resistance acquisition	resistance acquisition	1	0.987403161140781	4048	1830	4048	
792	healthy cows	healthy cow	1	0.987403161140781	794	133	794	
10729	patterns of amino acid requirements	pattern of amino acid requirement	1	0.987403161140781	2366	10731	2366	
12263	bacterial effector proteins	bacterial effector protein	1	0.987403161140781	4556	185	27	
407	'fast variant'	'fast variant'	1	0.987403161140781	409	408	409	
9882	mutant enzymes	mutant enzyme	1	0.987403161140781	8183	7616	8183	
8487	ability of 1E4	ability of 1E4	1	0.987403161140781	939	2702	939	
1672	diseased farms	diseased farm	1	0.987403161140781	587	1673	587	
12407	protective effect	protective effect	1	0.987403161140781	2937	4387	2937	
4137	dependent translation	dependent translation	1	0.987403161140781	3708	807	3708	
8778	H850 cells	H850 cell	1	0.987403161140781	113	8779	113	
300	excitonic disorder	excitonic disorder	1	0.987403161140781	291	301	291	
13249	medium size aliphatic chain	medium size aliphatic chain	1	0.987403161140781	13251	1926	320	
2744	pyruvate to the culture medium	pyruvate to the culture medium	1	0.987403161140781	2745	2746	2745	
4888	rapid test systems	rapid test system	1	0.987403161140781	4890	4185	4029	
11920	number of tandem repeats	number of tandem repeat	1	0.987403161140781	1034	105	1034	
6427	in vitro model	in_vitro model	1	0.987403161140781	361	6428	361	
10138	percent of the cases	percent of the case	1	0.987403161140781	7188	2770	7188	
8105	effector role	effector role	1	0.987403161140781	233	4557	233	
14544	evaluation of selective broths	evaluation of selective broth	1	0.987403161140781	6516	14546	6516	
5647	environmental constraints	environmental constraint	1	0.987403161140781	5649	1810	5649	
1150	lack of fresh water supply	lack of fresh water supply	1	0.987403161140781	1151	1152	1151	
9070	effector repertoire	effector repertoire	1	0.987403161140781	9072	4557	9072	
3695	safer GMOs	safe GMO	1	0.987403161140781	3697	3696	3697	
170	pump inhibitor	pump inhibitor	1	0.987403161140781	172	171	172	
5001	control groups	control group	1	0.987403161140781	4420	5002	4420	
3585	MRSA isolates	MRSA isolate	1	0.987403161140781	334	369	334	
12910	persistence of infection	persistence of infection	1	0.987403161140781	12911	274	12911	
1033	number of positive samples	number of positive sample	1	0.987403161140781	1034	1035	1034	
8518	distance of the C5 hydroxyl group	distance of the C5 hydroxyl group	1	0.987403161140781	8519	8520	8519	
4038	human pathogen	human pathogen	1	0.987403161140781	1905	834	1905	
13928	pressure monitor prophylaxis	pressure monitor prophylaxis	1	0.987403161140781	13930	8058	22	
9608	obligate intracellular pathogen	obligate intracellular pathogen	1	0.987403161140781	9610	3322	1905	
3448	rod protein	rod protein	1	0.987403161140781	406	3449	406	
13521	ascites cultures	ascite culture	1	0.987403161140781	4706	5380	4706	
9583	free systems	free system	1	0.987403161140781	4029	112	4029	
9281	multiple anomalous diffraction method	multiple anomalous diffraction method	1	0.987403161140781	9283	6040	596	
16101	acidic pH optimum	acidic pH optimum	1	0.987403161140781	16103	16102	16105	
1053	destabilization effects	destabilization effect	1	0.987403161140781	1055	1054	1055	
5214	majority of the label	majority of the label	1	0.987403161140781	5215	4999	5215	
6969	fragment of the C	fragment of the C	1	0.987403161140781	1268	243	1268	
14853	reactive oxygen species	reactive oxygen specie	1	0.987403161140781	14855	14854	73	
12069	epinastic growth	epinastic growth	1	0.987403161140781	217	12070	217	
14225	gene deletions	gene deletion	1	0.987403161140781	12260	18	12260	
11928	food categories	food category	1	0.987403161140781	11930	43	11930	
2674	irregular mantle zone	irregular mantle zone	1	0.987403161140781	2676	2675	2678	
833	human filarial nematode parasites	human filarial nematode parasite	1	0.987403161140781	835	834	104	
14810	polymorphism analysis	polymorphism analysis	1	0.987403161140781	203	5185	203	
8537	mitochondrial damage	mitochondrial damage	1	0.987403161140781	7418	8538	7418	
14157	selection scheme	selection scheme	1	0.987403161140781	4110	1647	4110	
9810	deoxyribonucleic acid sequencing of regions of the katG	deoxyribonucleic acid sequencing of region of the katG	1	0.987403161140781	9812	9811	1583	
10187	concentration breakpoints	concentration breakpoint	1	0.987403161140781	10189	2012	10189	
15608	pdh gene expression	pdh gene expression	1	0.987403161140781	3395	15609	373	
2091	culture plates	culture plate	1	0.987403161140781	2093	2092	2093	
1556	school age children	school age child	1	0.987403161140781	1558	1557	1560	
10108	cholera transmission	cholera transmission	1	0.987403161140781	1849	10109	1849	
13314	member of the phylum Bacteroidetes	member of the phylum Bacteroidete	1	0.987403161140781	4621	13316	4621	
8903	site residues	site residue	1	0.987403161140781	50	3	50	
6054	secondary effluent samples	secondary effluent sample	1	0.987403161140781	6056	68	225	
2134	mass spectrometry method	mass spectrometry method	1	0.987403161140781	2136	1193	596	
5485	stem base	stem base	1	0.987403161140781	5487	4482	5487	
9082	molecular level organization of BChl's	molecular level organization of BChl'	1	0.987403161140781	9084	376	2416	
11039	profound impact	profound impact	1	0.987403161140781	11041	11040	11041	
6182	deficient Y	deficient Y	1	0.987403161140781	4774	1064	4774	
7838	related strains	related strain	1	0.987403161140781	551	7839	551	
4865	throat samples	throat sample	1	0.987403161140781	225	4866	225	
15653	attractive therapeutic approaches	attractive therapeutic approach	1	0.987403161140781	15655	1940	15636	
15841	start codon	start codon	1	0.987403161140781	15843	7112	15843	
10929	commercial set	commercial set	1	0.987403161140781	417	1454	417	
648	invasive procedure	invasive procedure	1	0.987403161140781	650	649	650	
16521	open reading frame	open reading frame	1	0.987403161140781	16523	6575	16525	
14231	higher percent of necropsied calves	high percent of necropsied calf	1	0.987403161140781	14233	151	7188	
5697	lysozyme treatment of cells of Pseudomonas aeruginosa	lysozyme treatment of cell of Pseudomonas aeruginosa	1	0.987403161140781	5699	136	61	
13152	healthy Gambian children	healthy Gambian child	1	0.987403161140781	12838	133	1560	
5208	major problem	major problem	1	0.987403161140781	5210	71	5210	
1917	wall of the chicks	wall of the chick	1	0.987403161140781	1918	1919	1918	
7579	resistance to chloramphenicol	resistance to chloramphenicol	1	0.987403161140781	1830	463	1830	
15040	end of the triple therapy	end of the triple therapy	1	0.987403161140781	4425	3975	4425	
13215	protein extract	protein extract	1	0.987403161140781	3075	406	3075	
10915	CDI treatment	CDI treatment	1	0.987403161140781	61	979	61	
11238	clinical reports	clinical report	1	0.987403161140781	4876	323	4876	
11650	resistance of vancomycin	resistance of vancomycin	1	0.987403161140781	1830	11371	1830	
10291	human gastrointestinal pathogen	human gastrointestinal pathogen	1	0.987403161140781	10293	834	1905	
16689	endogenous IL	endogenous IL	1	0.987403161140781	8589	6292	8589	
9118	recent article	recent article	1	0.987403161140781	9120	1540	9120	
2814	optical microscopy	optical microscopy	1	0.987403161140781	2816	2815	2816	
14623	polyclonal rabbit serum	polyclonal rabbit serum	1	0.987403161140781	2526	8998	1798	
11973	signaling pathway of neuregulin	signaling pathway of neuregulin	1	0.987403161140781	11974	9965	661	
9154	probiotic activities	probiotic activity	1	0.987403161140781	1316	1093	1316	
8548	active state of IBD	active state of IBD	1	0.987403161140781	8550	1	788	
10653	coli O157 strains	coli O157 strain	1	0.987403161140781	10304	1842	551	
6778	bacterial periplasm	bacterial periplasm	1	0.987403161140781	2231	185	2231	
10558	trimeric enzyme	trimeric enzyme	1	0.987403161140781	4250	5063	4250	
12399	purification procedure	purification procedure	1	0.987403161140781	650	1173	650	
9865	enterocystoplasty infection stone model	enterocystoplasty infection stone model	1	0.987403161140781	9867	9866	361	
10296	commercial apple juice	commercial apple juice	1	0.987403161140781	10298	1454	10300	
803	small genomes	small genome	1	0.987403161140781	805	566	805	
15064	unique toxicity spectrum	unique toxicity spectrum	1	0.987403161140781	1693	3347	1695	
7777	Interactions of alkaline phosphatase	Interaction of alkaline phosphatase	1	0.987403161140781	7778	1288	7778	
4380	human tularemia	human tularemia	1	0.987403161140781	4382	834	4382	
11991	proteic inhibitor CI2	proteic inhibitor CI2	1	0.987403161140781	11993	11992	11995	
14834	class A scavenger receptors	class A scavenger receptor	1	0.987403161140781	14836	2435	546	
96	thermotolerance of the nitrogen	thermotolerance of the nitrogen	1	0.987403161140781	97	98	97	
3999	rates of inactivation	rate of inactivation	1	0.987403161140781	450	522	450	
14030	rickettsial infection	rickettsial infection	1	0.987403161140781	274	812	274	
11906	freundii reference strain	freundii reference strain	1	0.987403161140781	11908	3663	76	
427	two-dimensional aggregate of BChl molecules	two-dimensional aggregate of BChl molecule	1	0.987403161140781	429	428	430	
10166	mechanistic insights	mechanistic insight	1	0.987403161140781	1541	867	1541	
12312	Severity Score	Severity Score	1	0.987403161140781	3737	12313	3737	
15272	complications of basic disease	complication of basic disease	1	0.987403161140781	844	15274	844	
16258	rise to a hierarchy	rise to a hierarchy	1	0.987403161140781	590	16260	590	
5986	current cost	current cost	1	0.987403161140781	1638	5987	1638	
3829	closed communities	closed community	1	0.987403161140781	990	3830	990	
303	non-pulmonary disease	non-pulmonary disease	1	0.987403161140781	268	304	268	
6775	gene library	gene library	1	0.987403161140781	6628	18	6628	
12892	calcium acetate	calcium acetate	1	0.987403161140781	6084	5005	6084	
11575	injections of thalidomide	injection of thalidomide	1	0.987403161140781	11576	5057	11576	
13785	simple peptide	simple peptide	1	0.987403161140781	4638	1148	4638	
16779	nosocomial infections	nosocomial infection	1	0.987403161140781	736	11842	736	
9376	Reactions of libraries	Reaction of library	1	0.987403161140781	9377	9378	9377	
15102	part of bacteria	part of bacteria	1	0.987403161140781	1050	1999	1050	
1517	nasal specimens	nasal specimen	1	0.987403161140781	1519	1518	1519	
8384	iron uptake systems	iron uptake system	1	0.987403161140781	4029	6373	4029	
11807	lipoamide dehydrogenase	lipoamide dehydrogenase	1	0.987403161140781	2622	11808	2622	
7149	tissue cage infection	tissue cage infection	1	0.987403161140781	7151	569	274	
5769	humanized 1E4	humanized 1E4	1	0.987403161140781	2702	5770	2702	
594	usual method	usual method	1	0.987403161140781	596	595	596	
13791	engulfment ligands	engulfment ligand	1	0.987403161140781	7417	1992	7417	
224	samples of these patients	sample of these patient	1	0.987403161140781	225	226	225	
3620	Participation of C3	Participation of C3	1	0.987403161140781	3621	528	3621	
462	chloramphenicol therapy	chloramphenicol therapy	1	0.987403161140781	464	463	464	
2113	bacterial densities	bacterial density	1	0.987403161140781	2115	185	2115	
13180	cultivars CT6919	cultivar CT6919	1	0.987403161140781	9293	13181	9293	
2515	understanding of bacteria	understanding of bacteria	1	0.987403161140781	729	1999	729	
6277	urinary tract device usage	urinary tract device usage	1	0.987403161140781	6279	6278	6283	
12826	mapping of the 9-kb plasmid	mapping of the 9-kb plasmid	1	0.987403161140781	12827	12828	12827	
3943	Cut-off points	Cut-off point	1	0.987403161140781	3945	3944	3945	
1001	key adaptor	key adaptor	1	0.987403161140781	1003	1002	1003	
11694	rectal LGV	rectal LGV	1	0.987403161140781	2054	11695	2054	
9707	Combination Ceftriaxone	Combination Ceftriaxone	1	0.987403161140781	9709	9708	9709	
6890	nature of the siderophores	nature of the siderophore	1	0.987403161140781	3765	6892	3765	
10122	rational approach to the development of new treatments	rational approach to the development of new treatment	1	0.987403161140781	10124	10123	10125	
439	CA psCA3	CA psCA3	1	0.987403161140781	441	440	441	
14075	carotenoid gene cluster	carotenoid gene cluster	1	0.987403161140781	14077	514	14079	
12299	polyclonal areas	polyclonal area	1	0.987403161140781	4719	8998	4719	
3600	better efficiency of transformation	good efficiency of transformation	1	0.987403161140781	3602	3415	481	
3615	variability of gene expression	variability of gene expression	1	0.987403161140781	2276	3395	2276	
3348	photophysical properties	photophysical property	1	0.987403161140781	3103	3349	3103	
9325	complement receptors	complement receptor	1	0.987403161140781	546	2759	546	
13816	LCCD persons	LCCD person	1	0.987403161140781	5061	357	5061	
2032	carbon starvation	carbon starvation	1	0.987403161140781	2034	2033	2034	
15582	striking antigenic difference	striking antigenic difference	1	0.987403161140781	15584	15583	9632	
14804	restriction fragment length polymorphism analysis	restriction fragment length polymorphism analysis	1	0.987403161140781	14806	5178	203	
13744	high total counts of LAB	high total count of LAB	1	0.987403161140781	13746	264	2262	
4186	desensitization of chemokine	desensitization of chemokine	1	0.987403161140781	4187	545	4187	
16550	incoming water	incoming water	1	0.987403161140781	920	16551	920	
11780	negative bacterial infections	negative bacterial infection	1	0.987403161140781	8435	238	736	
5945	cleavable repressors	cleavable repressor	1	0.987403161140781	5947	5946	5947	
11047	different clinical spectra	different clinical spectrum	1	0.987403161140781	11049	816	10533	
2785	nirS regions	nirS region	1	0.987403161140781	2787	2786	2787	
5424	isolates of P	isolate of P	1	0.987403161140781	334	160	334	
10417	paraffin section	paraffin section	1	0.987403161140781	10419	10418	10419	
4197	storage trial	storage trial	1	0.987403161140781	4199	4054	4199	
5412	type bacterium Chlorobaculum tepidum	type bacterium Chlorobaculum tepidum	1	0.987403161140781	5414	1698	4783	
9394	invasive swine pathogen	invasive swine pathogen	1	0.987403161140781	9396	649	1905	
6988	addition of histidine to the medium	addition of histidine to the medium	1	0.987403161140781	2743	6990	2743	
4961	Multivariate analysis	Multivariate analysis	1	0.987403161140781	203	4962	203	
3533	oviduct pathology	oviduct pathology	1	0.987403161140781	3535	3534	3535	
4451	detection limit of the concentration	detection limit of the concentration	1	0.987403161140781	2617	2012	2619	
5479	Administration of the drug	Administration of the drug	1	0.987403161140781	5480	162	5480	
7894	expression of cytotoxic proteins	expression of cytotoxic protein	1	0.987403161140781	373	7896	373	
16764	strains of MRSA	strain of MRSA	1	0.987403161140781	551	369	551	
12156	potential use of a humanized MAb	potential use of a humanized MAb	1	0.987403161140781	12158	2154	32	
16767	SecA of Bacillus subtilis	SecA of Bacillus subtilis	1	0.987403161140781	2245	16769	2245	
4432	clinical significance of clonal strains	clinical significance of clonal strain	1	0.987403161140781	4434	323	4435	
10758	acid sequences	acid sequence	1	0.987403161140781	534	4	534	
4163	northern Spain	northern Spain	1	0.987403161140781	4165	4164	4165	
1432	independent experiments	independent experiment	1	0.987403161140781	1434	1433	1434	
14289	antibiotic selection	antibiotic selection	1	0.987403161140781	1647	31	1647	
2710	homozygous donors	homozygous donor	1	0.987403161140781	555	2711	555	
14580	clonal expansion of resistant lineages	clonal expansion of resistant lineage	1	0.987403161140781	14582	1788	7695	
1827	antibiotic resistance genes	antibiotic resistance gene	1	0.987403161140781	444	1828	444	
6393	ROC of PGI	ROC of PGI	1	0.987403161140781	6394	5677	6394	
3287	individual populations	individual population	1	0.987403161140781	1428	3288	1428	
1334	large yellow croaker defense	large yellow croaker defense	1	0.987403161140781	1340	1335	1340	
42	food flavor	food flavor	1	0.987403161140781	44	43	44	
13892	weight losses	weight loss	1	0.987403161140781	13894	681	13894	
3028	Japanese flounder infection model	Japanese flounder infection model	1	0.987403161140781	3032	294	361	
16235	external cell wall layers	external cell wall layer	1	0.987403161140781	16237	16236	16241	
13007	incubation temperature	incubation temperature	1	0.987403161140781	249	4801	249	
3428	soft stool	soft stool	1	0.987403161140781	1259	2545	1259	
1280	Flow cytometric measurement of neutrophil alkaline phosphatase	Flow cytometric measurement of neutrophil alkaline phosphatase	1	0.987403161140781	1282	1281	1285	
3120	cellular fatty acid compositions	cellular fatty acid composition	1	0.987403161140781	3122	3121	3126	
9037	product Rv3168	product Rv3168	1	0.987403161140781	9039	19	9039	
1935	mutants of C	mutant of C	1	0.987403161140781	1936	243	1936	
5385	Multiple signaling pathways	Multiple signaling pathway	1	0.987403161140781	5387	5386	5389	
15247	subsequent axonal damage	subsequent axonal damage	1	0.987403161140781	15249	841	7418	
11437	biophysical strategies	biophysical strategy	1	0.987403161140781	5392	11438	5392	
12577	short contact time	short contact time	1	0.987403161140781	12579	4956	1403	
377	regulation of Staphylococcus aureus virulence	regulation of Staphylococcus aureus virulence	1	0.987403161140781	378	379	378	
1603	neutral protease	neutral protease	1	0.987403161140781	1184	1604	1184	
5530	percentage of penicillin	percentage of penicillin	1	0.987403161140781	3374	5532	3374	
16582	structures of the agarases	structure of the agaras	1	0.987403161140781	11010	14572	11010	
3841	genotypic analysis	genotypic analysis	1	0.987403161140781	203	2569	203	
9061	natural biofertilizers	natural biofertilizer	1	0.987403161140781	9063	1029	9063	
15151	zone size	zone size	1	0.987403161140781	2659	2678	2659	
3088	methylotrophic yeast	methylotrophic yeast	1	0.987403161140781	3090	3089	3090	
15099	untranslated region	untranslated region	1	0.987403161140781	3464	11952	3464	
15626	bacterial elimination	bacterial elimination	1	0.987403161140781	10302	185	10302	
7237	carbon material	carbon material	1	0.987403161140781	7239	2033	7239	
15615	base composition of the type strain	base composition of the type strain	1	0.987403161140781	15617	5487	10137	
2427	part of a defense system	part of a defense system	1	0.987403161140781	1050	2429	1050	
565	small intestinal tissue	small intestinal tissue	1	0.987403161140781	567	566	569	
14648	cytotoxicity data	cytotoxicity datum	1	0.987403161140781	609	6827	609	
8108	tuberculosis families	tuberculosis family	1	0.987403161140781	8110	491	8110	
12869	effect of interferon	effect of interferon	1	0.987403161140781	2937	7986	2937	
11527	free ligand	free ligand	1	0.987403161140781	1993	112	1993	
14323	Nonspecific positive reactions	Nonspecific positive reaction	1	0.987403161140781	14325	14324	14327	
5681	synthesis of this nonfimbrial adhesive factor	synthesis of this nonfimbrial adhesive factor	1	0.987403161140781	515	5683	515	
15706	phototrophic microorganism	phototrophic microorganism	1	0.987403161140781	15708	15707	15708	
8644	effect of divalent metal ions	effect of divalent metal ion	1	0.987403161140781	2937	8646	2937	
2493	peptides species	peptide specie	1	0.987403161140781	73	1010	73	
14595	strain C321	strain C321	1	0.987403161140781	14597	76	14597	
13516	translocation genes	translocation gene	1	0.987403161140781	444	1768	444	
2352	human innate immune response	human innate immune response	1	0.987403161140781	2354	834	286	
6011	5-fold increase	5-fold increase	1	0.987403161140781	1465	6012	1465	
4081	diverse group of organisms	diverse group of organism	1	0.987403161140781	4083	4082	351	
784	paper carton	paper carton	1	0.987403161140781	786	785	786	
12737	response of turbot	response of turbot	1	0.987403161140781	286	10401	286	
0	active site acid	active site acid	1	0.987403161140781	2	1	4	
8375	significant pleiotropic changes	significant pleiotropic change	1	0.987403161140781	8377	24	1846	
15553	entire mer operon	entire mer operon	1	0.987403161140781	15555	4925	14352	
2048	high prevalence	high prevalence	1	0.987403161140781	1786	264	1786	
703	comparison of the structure	comparison of the structure	1	0.987403161140781	626	201	626	
1269	amino acid replacements	amino acid replacement	1	0.987403161140781	1273	1270	1273	
2	site acid	site acid	1	0.987403161140781	4	3	4	
13736	Southern blot analysis	Southern blot analysis	1	0.987403161140781	12946	13737	203	
8065	burnetii infection of macrophages	burnetii infection of macrophage	1	0.987403161140781	2518	394	274	
6836	potential acid	potential acid	1	0.987403161140781	4	2154	4	
14021	bobtail squid	bobtail squid	1	0.987403161140781	14023	14022	14023	
3655	PA airway infection	PA airway infection	1	0.987403161140781	3657	3422	274	
9165	result of recrudescence	result of recrudescence	1	0.987403161140781	4412	9167	4412	
846	typical mutations	typical mutation	1	0.987403161140781	773	847	773	
16751	active subtilisin	active subtilisin	1	0.987403161140781	2175	1	2175	
11515	cell debris	cell debris	1	0.987403161140781	11517	235	11517	
12017	Salmonella sp	Salmonella sp	1	0.987403161140781	3950	3520	3950	
15394	principal pathogens	principal pathogen	1	0.987403161140781	186	15395	186	
4895	comparative design	comparative design	1	0.987403161140781	3342	1579	3342	
3580	dietary concentrations	dietary concentration	1	0.987403161140781	163	3581	163	
6201	Stimulation of J774 cells	Stimulation of J774 cell	1	0.987403161140781	6202	6203	6202	
8878	acquisition of the TEM	acquisition of the TEM	1	0.987403161140781	4048	8880	4048	
13269	infection F	infection F	1	0.987403161140781	48	274	48	
3875	bacterial endocarditis case	bacterial endocarditis case	1	0.987403161140781	3877	185	618	
1750	strong antimicrobial agent	strong antimicrobial agent	1	0.987403161140781	1752	1751	1357	
15020	cellular fatty acids	cellular fatty acid	1	0.987403161140781	9003	3121	3060	
14697	detectable levels	detectable level	1	0.987403161140781	495	2936	495	
629	barrier to entry of penicillins	barrier to entry of penicillin	1	0.987403161140781	630	631	630	
1968	negative bacterial pathogens	negative bacterial pathogen	1	0.987403161140781	184	238	186	
6336	acyl chains	acyl chain	1	0.987403161140781	6338	6337	6338	
3383	multiresistant organisms	multiresistant organism	1	0.987403161140781	3385	3384	3385	
7834	pathogenic F	pathogenic F	1	0.987403161140781	48	2418	48	
7203	dependent signaling	dependent signaling	1	0.987403161140781	731	807	731	
6903	cellular invasion	cellular invasion	1	0.987403161140781	1178	3121	1178	
11788	intracellular pathogens	intracellular pathogen	1	0.987403161140781	186	859	186	
14958	PMN caspase activation	PMN caspase activation	1	0.987403161140781	14960	278	2118	
3085	regulatory pathway	regulatory pathway	1	0.987403161140781	661	3086	661	
12253	use of ozone	use of ozone	1	0.987403161140781	32	1630	32	
4803	Aminoglycoside antibiotics	Aminoglycoside antibiotic	1	0.987403161140781	3547	4804	3547	
11242	chromatographic analyses of free lipids	chromatographic analysis of free lipid	1	0.987403161140781	11244	11243	8104	
2987	LVS EF	LVS EF	1	0.987403161140781	1019	1202	1019	
11688	proof of principle	proof of principle	1	0.987403161140781	6798	11690	6798	
11735	28-mer analog K4K20S4	28-mer analog K4K20S4	1	0.987403161140781	11737	11736	11739	
10858	number of bifidobacteria	number of bifidobacteria	1	0.987403161140781	1034	7443	1034	
14513	butyric acid	butyric acid	1	0.987403161140781	4	14514	4	
919	water fishes	water fish	1	0.987403161140781	921	920	921	
10131	cellular fatty acid composition	cellular fatty acid composition	1	0.987403161140781	10133	3121	10137	
7522	quantities of IFN	quantity of IFN	1	0.987403161140781	1964	7524	1964	
5723	screening of plant probiotic traits of bacteria	screening of plant probiotic trait of bacteria	1	0.987403161140781	671	5725	671	
10411	single outpatient clinic	single outpatient clinic	1	0.987403161140781	10413	1933	5334	
2809	intestinal C	intestinal C	1	0.987403161140781	243	129	243	
12681	DNA G+C content	DNA G+C content	1	0.987403161140781	12683	468	4526	
4747	nonlabile ether bond	nonlabile ether bond	1	0.987403161140781	4749	4748	4751	
3176	colonic mucin	colonic mucin	1	0.987403161140781	677	3177	677	
9807	mga gene	mga gene	1	0.987403161140781	18	9808	18	
7011	strain typing results	strain typing result	1	0.987403161140781	2870	7012	2870	
9641	pump inhibitors	pump inhibitor	1	0.987403161140781	3272	171	3272	
16036	selective targeting to professional phagocytes	selective targeting to professional phagocyte	1	0.987403161140781	16038	5410	16039	
9340	expression systems	expression system	1	0.987403161140781	4029	373	4029	
13206	staphylococcal resistance	staphylococcal resistance	1	0.987403161140781	1830	823	1830	
8380	siderophore based iron uptake systems	siderophore based iron uptake system	1	0.987403161140781	8382	2812	4029	
1158	promoterless carotenoid transposons	promoterless carotenoid transposon	1	0.987403161140781	1160	1159	1162	
7002	primary determinant of spontaneous gastric hypoacidity	primary determinant of spontaneous gastric hypoacidity	1	0.987403161140781	7004	4073	7005	
14782	surface determinant	surface determinant	1	0.987403161140781	7005	339	7005	
1659	pig jejunal tissue	pig jejunal tissue	1	0.987403161140781	759	1660	569	
12560	partial deep vein occlusion of the left ileofemoral vein	partial deep vein occlusion of the left ileofemoral vein	1	0.987403161140781	12562	8623	12567	
15972	typical LPS patterns	typical LPS pattern	1	0.987403161140781	15974	847	2366	
8512	different oligosaccharides	different oligosaccharide	1	0.987403161140781	8514	816	8514	
4348	broad antibacterial spectrum	broad antibacterial spectrum	1	0.987403161140781	4350	796	1695	
16862	mechanism of tolerance	mechanism of tolerance	1	0.987403161140781	525	1278	525	
14609	fresh A	fresh A	1	0.987403161140781	1379	1153	1379	
15739	antibiogram patterns	antibiogram pattern	1	0.987403161140781	2366	3799	2366	
11075	Yersinia spp	Yersinia spp	1	0.987403161140781	708	11076	708	
14871	murine macrophage	murine macrophage	1	0.987403161140781	1087	1511	1087	
4988	atomic level	atomic level	1	0.987403161140781	1113	4989	1113	
10353	chlorosome long axis	chlorosome long axis	1	0.987403161140781	10355	419	10357	
6860	BCG granuloma	BCG granuloma	1	0.987403161140781	6862	853	6862	
3978	early passage levels	early passage level	1	0.987403161140781	3980	1097	495	
371	Recombinant expression	Recombinant expression	1	0.987403161140781	373	372	373	
13969	low level of education	low level of education	1	0.987403161140781	13971	1109	1113	
16956	S4 derivatives	S4 derivative	1	0.987403161140781	3424	4641	3424	
14789	Mycobacterium tuberculosis biodiversity	Mycobacterium tuberculosis biodiversity	1	0.987403161140781	14793	3626	14793	
16506	immunological properties	immunological property	1	0.987403161140781	3103	16507	3103	
14990	individual cells of H	individual cell of H	1	0.987403161140781	14991	764	113	
9846	GEN q24h	GEN q24h	1	0.987403161140781	9848	849	9848	
11468	antibody response to Salmonella antigens	antibody response to Salmonella antigen	1	0.987403161140781	1489	11472	286	
11537	important issue	important issue	1	0.987403161140781	11539	118	11539	
2623	negative subjects	negative subject	1	0.987403161140781	2625	238	2625	
4701	bacterium's advantage	bacterium' advantage	1	0.987403161140781	4703	4702	4703	
5545	Mycoplasma agassizii	Mycoplasma agassizii	1	0.987403161140781	2467	4341	2467	
11291	absence of exogenous carbon	absence of exogenous carbon	1	0.987403161140781	5502	11293	5502	
12088	fidaxomicin strategy	fidaxomicin strategy	1	0.987403161140781	6916	1070	6916	
6672	result of the use of antibiotics	result of the use of antibiotic	1	0.987403161140781	4412	6674	4412	
7572	unique strains	unique strain	1	0.987403161140781	551	3347	551	
15476	status of this gas	status of this gas	1	0.987403161140781	4668	6558	4668	
4860	pattern of Helicobacter pullorum	pattern of Helicobacter pullorum	1	0.987403161140781	4145	2913	4145	
2203	elevation of the white blood cell count	elevation of the white blood cell count	1	0.987403161140781	2204	2205	2204	
13490	disease outbreaks	disease outbreak	1	0.987403161140781	3550	268	3550	
14867	gastric mucin	gastric mucin	1	0.987403161140781	677	190	677	
12470	metabolite concentration	metabolite concentration	1	0.987403161140781	2012	12471	2012	
15940	absorption linear dichroism	absorption linear dichroism	1	0.987403161140781	12860	15941	12862	
4584	Mycoplasma otitis cases	Mycoplasma otitis case	1	0.987403161140781	2770	4585	2770	
3681	presence of this protease	presence of this protease	1	0.987403161140781	139	1184	139	
1446	reference Rickettsia conorii isolates	reference Rickettsia conorii isolate	1	0.987403161140781	1448	1447	334	
9430	individual chlorosomes	individual chlorosome	1	0.987403161140781	4776	3288	4776	
6390	serological results	serological result	1	0.987403161140781	2870	4667	2870	
1526	third day	third day	1	0.987403161140781	1528	1527	1528	
5585	h of heat stress	h of heat stress	1	0.987403161140781	4754	5587	4754	
99	right TR	right TR	1	0.987403161140781	101	100	101	
9736	helix motifs	helix motif	1	0.987403161140781	9738	5640	9738	
12929	recent reports of clonal strains of Pseudomonas aeruginosa	recent report of clonal strain of Pseudomonas aeruginosa	1	0.987403161140781	12931	1540	4876	
11459	survival advantage	survival advantage	1	0.987403161140781	4703	1950	4703	
8509	untreated group	untreated group	1	0.987403161140781	351	8510	351	
5140	additional strains	additional strain	1	0.987403161140781	551	5141	551	
1929	copies of MBD	copy of MBD	1	0.987403161140781	1930	1931	1930	
11178	valine to medium	valine to medium	1	0.987403161140781	11179	1926	11179	
5758	similar affinities	similar affinity	1	0.987403161140781	5760	1190	5760	
6051	Green exclusion	Green exclusion	1	0.987403161140781	3639	6052	3639	
4326	family income	family income	1	0.987403161140781	4328	2170	4328	
1893	dose response	dose response	1	0.987403161140781	286	1894	286	
7593	n-hexane extract of A	n-hexane extract of A	1	0.987403161140781	7594	1379	3075	
10912	Northern blotting	Northern blotting	1	0.987403161140781	10914	10913	10914	
2631	phospholipase C	phospholipase C	1	0.987403161140781	243	2632	243	
8608	response to chemokines CCL	response to chemokine CCL	1	0.987403161140781	286	8610	286	
7762	basic characteristics of probiotic bacteria	basic characteristic of probiotic bacteria	1	0.987403161140781	7764	7733	3758	
1095	early stages of the infection	early stage of the infection	1	0.987403161140781	1096	274	1098	
11433	bacterial advantage	bacterial advantage	1	0.987403161140781	4703	185	4703	
8884	properties of screening compounds	property of screening compound	1	0.987403161140781	3103	8886	3103	
245	antral mucosa	antral mucosa	1	0.987403161140781	247	246	247	
8648	metal ions	metal ion	1	0.987403161140781	8650	506	8650	
1291	outbreak of emergent MDRP	outbreak of emergent MDRP	1	0.987403161140781	986	1293	986	
6438	biochemical properties of MBD	biochemical property of MBD	1	0.987403161140781	6440	2869	3103	
16430	predictor of hypoacidity	predictor of hypoacidity	1	0.987403161140781	188	1460	188	
3946	O-linked C12	O-linked C12	1	0.987403161140781	2692	3486	2692	
11949	5' untranslated regions	5' untranslated region	1	0.987403161140781	11951	11950	2787	
15186	history of injection drug use	history of injection drug use	1	0.987403161140781	3162	15188	3162	
7562	antimicrobial surveillance	antimicrobial surveillance	1	0.987403161140781	3820	1753	3820	
16811	network of laboratories	network of laboratory	1	0.987403161140781	401	16813	401	
173	catabolic flux	catabolic flux	1	0.987403161140781	175	174	175	
6307	substantial regression	substantial regression	1	0.987403161140781	6309	6308	6309	
11713	excitonic dipole moment	excitonic dipole moment	1	0.987403161140781	11715	301	11717	
14111	primary goal of this study	primary goal of this study	1	0.987403161140781	14113	4073	9593	
4311	diagnostic gastroscopy	diagnostic gastroscopy	1	0.987403161140781	269	4312	269	
5699	treatment of cells of Pseudomonas aeruginosa	treatment of cell of Pseudomonas aeruginosa	1	0.987403161140781	61	5701	61	
8622	partial SecA protein	partial SecA protein	1	0.987403161140781	8624	8623	406	
2373	outer proteins	outer protein	1	0.987403161140781	27	2374	27	
5396	unique MIRU	unique MIRU	1	0.987403161140781	5398	3347	5398	
15874	piscicola isolates	piscicola isolate	1	0.987403161140781	334	6346	334	
16892	C(40) carotenoids canthaxanthin	C(40) carotenoid canthaxanthin	1	0.987403161140781	16894	16893	16896	
9113	anthrax lethal toxin	anthrax lethal toxin	1	0.987403161140781	9115	2492	1598	
4008	excellent correlation	excellent correlation	1	0.987403161140781	1523	4009	1523	
5725	plant probiotic traits of bacteria	plant probiotic trait of bacteria	1	0.987403161140781	5727	5726	4796	
6677	early administration of antibiotics	early administration of antibiotic	1	0.987403161140781	6679	1097	3007	
11839	cause of nosocomial infection	cause of nosocomial infection	1	0.987403161140781	8326	11841	8326	
8917	quantitative information	quantitative information	1	0.987403161140781	5490	8918	5490	
2089	tissue culture plates	tissue culture plate	1	0.987403161140781	2091	569	2093	
5284	list of unique metabolic traits	list of unique metabolic trait	1	0.987403161140781	5285	5286	5285	
14420	biochemical use	biochemical use	1	0.987403161140781	32	2869	32	
6941	set of modifications	set of modification	1	0.987403161140781	417	6943	417	
6566	virulence of the organism	virulence of the organism	1	0.987403161140781	383	308	383	
5982	plant morphogenesis	plant morphogenesis	1	0.987403161140781	5984	5726	5984	
11899	majority of the S	majority of the S	1	0.987403161140781	5215	1898	5215	
15157	unintended proliferation of GMOs	unintended proliferation of GMO	1	0.987403161140781	15159	15158	7985	
631	entry of penicillins	entry of penicillin	1	0.987403161140781	526	633	526	
14441	total infections	total infection	1	0.987403161140781	736	1402	736	
2793	third experiment	third experiment	1	0.987403161140781	2795	1527	2795	
4704	positive cultures	positive culture	1	0.987403161140781	4706	953	4706	
1664	bacteremic episodes	bacteremic episode	1	0.987403161140781	1666	1665	1666	
4562	specific cells	specific cell	1	0.987403161140781	113	504	113	
11866	aging of proteins	aging of protein	1	0.987403161140781	8086	27	8086	
6506	amino acid change	amino acid change	1	0.987403161140781	3734	1270	3734	
13147	family motif CX5R	family motif CX5R	1	0.987403161140781	13149	2170	13151	
5599	microbiology laboratory	microbiology laboratory	1	0.987403161140781	5601	5600	5601	
12969	urinary concentrations	urinary concentration	1	0.987403161140781	163	6278	163	
4875	reports of ciprofloxacin	report of ciprofloxacin	1	0.987403161140781	4876	1989	4876	
12389	deficient Yersinia	deficient Yersinia	1	0.987403161140781	11076	1064	11076	
13799	HTS format	HTS format	1	0.987403161140781	8787	5694	8787	
14715	pylori status	pylori status	1	0.987403161140781	4668	501	4668	
11875	Biopsy specimens	Biopsy specimen	1	0.987403161140781	1519	11876	1519	
6754	fatty acid compositions of these cells	fatty acid composition of these cell	1	0.987403161140781	3122	113	3126	
627	little barrier to entry of penicillins	little barrier to entry of penicillin	1	0.987403161140781	629	628	630	
16894	carotenoids canthaxanthin	carotenoid canthaxanthin	1	0.987403161140781	16896	16895	16896	
9843	reorganization energy	reorganization energy	1	0.987403161140781	1624	9844	1624	
10651	Escherichia coli O157 strains	Escherichia coli O157 strain	1	0.987403161140781	10653	1840	551	
9743	HCE cell surface	HCE cell surface	1	0.987403161140781	2505	1825	339	
5421	buffer solution	buffer solution	1	0.987403161140781	5423	5422	5423	
13298	design of antimicrobials	design of antimicrobial	1	0.987403161140781	3342	1279	3342	
2819	preconcentration of the urine	preconcentration of the urine	1	0.987403161140781	2820	892	2820	
3744	term H	term H	1	0.987403161140781	764	2270	764	
15922	inactivation of vvhA	inactivation of vvhA	1	0.987403161140781	522	2778	522	
12357	portion of the label	portion of the label	1	0.987403161140781	9160	4999	9160	
7920	presentations of LGV	presentation of LGV	1	0.987403161140781	7921	2054	7921	
5062	trimeric protein	trimeric protein	1	0.987403161140781	406	5063	406	
13975	extent of inhibition	extent of inhibition	1	0.987403161140781	3698	2510	3698	
9639	proton pump inhibitors	proton pump inhibitor	1	0.987403161140781	9641	169	3272	
8475	chest AIS	chest AIS	1	0.987403161140781	5526	8476	5526	
743	violations of intestinal microbiocenosis	violation of intestinal microbiocenosis	1	0.987403161140781	744	745	744	
5462	LexA repressor	LexA repressor	1	0.987403161140781	5464	5463	5464	
14284	phosphatidic acid	phosphatidic acid	1	0.987403161140781	4	14285	4	
14877	term PPI	term PPI	1	0.987403161140781	2872	2270	2872	
3558	Ec-like SOS boxes	Ec-like SOS box	1	0.987403161140781	3560	3559	3562	
9097	photophysical properties of BChl molecules	photophysical property of BChl molecule	1	0.987403161140781	9099	3349	3103	
4104	suitability of the Japanese typing scheme	suitability of the Japanese typing scheme	1	0.987403161140781	4105	4106	4105	
7544	recent consumption of marine bivalves	recent consumption of marine bivalve	1	0.987403161140781	7546	1540	7547	
15688	flea species	flea specie	1	0.987403161140781	73	15689	73	
11724	dose chloramphenicol treatment	dose chloramphenicol treatment	1	0.987403161140781	11726	1894	61	
5780	Blood culture	Blood culture	1	0.987403161140781	2092	5781	2092	
12128	anthrax toxin	anthrax toxin	1	0.987403161140781	1598	2492	1598	
651	impaired Mtb antigen	impaired Mtb antigen	1	0.987403161140781	653	652	655	
55	delta T lymphocytes	delta T lymphocyte	1	0.987403161140781	57	56	59	
12307	unique abilities	unique ability	1	0.987403161140781	2850	3347	2850	
13329	reliability of PCR	reliability of PCR	1	0.987403161140781	13330	2264	13330	
10247	Clinical cure	Clinical cure	1	0.987403161140781	10249	9510	10249	
9525	multiplication of LVS	multiplication of LVS	1	0.987403161140781	4113	1202	4113	
7474	prevalent REA DNA types	prevalent REA DNA type	1	0.987403161140781	7476	6956	769	
5635	level expression of genes	level expression of gene	1	0.987403161140781	5637	1113	373	
1990	engulfment ligand annexin1	engulfment ligand annexin1	1	0.987403161140781	1994	1991	1994	
1185	shock proteins of similar molecular mass	shock protein of similar molecular mass	1	0.987403161140781	1186	1189	27	
6955	prevalent patterns	prevalent pattern	1	0.987403161140781	2366	6956	2366	
7286	autolytic enzyme activity	autolytic enzyme activity	1	0.987403161140781	7288	7287	393	
2320	difficult optimizations	difficult optimization	1	0.987403161140781	2322	2321	2322	
6253	ELISA assays of serum pepsinogen	ELISA assay of serum pepsinogen	1	0.987403161140781	6255	2511	3106	
1191	molecular mass	molecular mass	1	0.987403161140781	1193	376	1193	
5029	antiquorum antiquorum	antiquorum antiquorum	1	0.987403161140781	5030	5030	5030	
344	receptor polymorphisms	receptor polymorphism	1	0.987403161140781	346	345	346	
7196	homologues of the genes	homologue of the gene	1	0.987403161140781	7197	444	7197	
9050	incorporation of chlamydia nucleic acid amplification tests	incorporation of chlamydia nucleic acid amplification test	1	0.987403161140781	9051	9052	9051	
15190	drug use	drug use	1	0.987403161140781	32	162	32	
12320	translational glycosylation	translational glycosylation	1	0.987403161140781	1430	12321	1430	
15691	negative E	negative E	1	0.987403161140781	79	238	79	
13559	lack of siderophore production	lack of siderophore production	1	0.987403161140781	1151	13561	1151	
4998	label study	label study	1	0.987403161140781	1514	4999	1514	
14370	live TFM	live TFM	1	0.987403161140781	3056	10562	3056	
866	mechanistic model	mechanistic model	1	0.987403161140781	361	867	361	
7394	injection to the peritoneal cavity	injection to the peritoneal cavity	1	0.987403161140781	3505	7396	3505	
14217	free M17 medium	free M17 medium	1	0.987403161140781	14219	112	1926	
10154	key enzyme	key enzyme	1	0.987403161140781	4250	1002	4250	
8754	Granzyme B	Granzyme B	1	0.987403161140781	977	8755	977	
1952	iron metabolism scavenging heme	iron metabolism scavenging heme	1	0.987403161140781	1954	1953	1958	
16185	conventional methods	conventional method	1	0.987403161140781	2371	11355	2371	
9267	visceral organs	visceral organ	1	0.987403161140781	9269	9268	9269	
4632	peripheral nervous system	peripheral nervous system	1	0.987403161140781	4634	1686	1501	
1770	severity of inflammation	severity of inflammation	1	0.987403161140781	436	1772	436	
4520	bacterial resistance	bacterial resistance	1	0.987403161140781	1830	185	1830	
5821	cells of sp	cell of sp	1	0.987403161140781	113	3950	113	
8053	Routine intracranial pressure monitor	Routine intracranial pressure monitor	1	0.987403161140781	8055	8054	7157	
547	K untypable strains	K untypable strain	1	0.987403161140781	549	548	551	
6329	inoculation of ~10¹² PFU	inoculation of ~10¹² PFU	1	0.987403161140781	6330	6331	6330	
4291	systematic review	systematic review	1	0.987403161140781	4293	3053	4293	
13454	chronic atrophic gastritis	chronic atrophic gastritis	1	0.987403161140781	8640	363	4245	
1723	Structural biology	Structural biology	1	0.987403161140781	1725	1724	1725	
7171	acid bacterial strains	acid bacterial strain	1	0.987403161140781	5966	4	551	
11097	bactericidal activity	bactericidal activity	1	0.987403161140781	393	9620	393	
12201	polyphasic approach	polyphasic approach	1	0.987403161140781	10125	12202	10125	
5011	early gastric mucosa	early gastric mucosa	1	0.987403161140781	5013	1097	247	
11357	calcium chloride	calcium chloride	1	0.987403161140781	9565	5005	9565	
7374	crystal volume	crystal volume	1	0.987403161140781	7376	4195	7376	
5275	series of synthetic derivatives	series of synthetic derivative	1	0.987403161140781	5276	5277	5276	
4232	potential virulence factor	potential virulence factor	1	0.987403161140781	4234	2154	72	
13629	skin manifestation	skin manifestation	1	0.987403161140781	13631	12437	13631	
8967	optimalization of antibiotic treatment	optimalization of antibiotic treatment	1	0.987403161140781	8968	8969	8968	
14242	formation of pathologic microbiocenosis	formation of pathologic microbiocenosis	1	0.987403161140781	4488	14244	4488	
16796	number of macrophages	number of macrophage	1	0.987403161140781	1034	394	1034	
2639	clinical symptoms	clinical symptom	1	0.987403161140781	2641	323	2641	
16119	differentiation factor	differentiation factor	1	0.987403161140781	72	884	72	
8057	pressure monitor	pressure monitor	1	0.987403161140781	7157	8058	7157	
15379	transport of ferrous iron	transport of ferrous iron	1	0.987403161140781	6263	15381	6263	
13647	numbers of penicillin	number of penicillin	1	0.987403161140781	46	5532	46	
8493	clinical disease	clinical disease	1	0.987403161140781	268	323	268	
15135	biocontrol agent	biocontrol agent	1	0.987403161140781	1357	2564	1357	
7360	response differences	response difference	1	0.987403161140781	1671	286	1671	
12257	Infection of mice	Infection of mouse	1	0.987403161140781	7964	1065	7964	
10376	MRSA prevention	MRSA prevention	1	0.987403161140781	7162	369	7162	
12776	female birds	female bird	1	0.987403161140781	4368	9831	4368	
3091	pathogenicity islands	pathogenicity island	1	0.987403161140781	3093	3092	3093	
10111	activities of antimicrobial agents	activity of antimicrobial agent	1	0.987403161140781	1316	1832	1316	
3748	useful way	useful way	1	0.987403161140781	3750	3426	3750	
14986	level of resistance of individual cells of H	level of resistance of individual cell of H	1	0.987403161140781	1113	14988	1113	
6076	Modulation of fibronectin adhesins	Modulation of fibronectin adhesin	1	0.987403161140781	6077	6078	6077	
16712	values of the transition dipole moment orientations	value of the transition dipole moment orientation	1	0.987403161140781	7423	16714	7423	
260	Mycobacterium abscessus	Mycobacterium abscessus	1	0.987403161140781	262	261	262	
5959	solid surfaces	solid surface	1	0.987403161140781	1811	1925	1811	
14394	like activator UreR	like activator UreR	1	0.987403161140781	14396	829	90	
12270	like receptor pathway	like receptor pathway	1	0.987403161140781	661	12271	661	
13471	genera Ectothiorhodospira	genera Ectothiorhodospira	1	0.987403161140781	13473	6164	13473	
12848	Few available studies	Few available study	1	0.987403161140781	12850	12849	2918	
10336	diseased Japanese flounder	diseased Japanese flounder	1	0.987403161140781	294	1673	296	
9176	eae genotypes	eae genotype	1	0.987403161140781	2389	9177	2389	
4229	like receptors	like receptor	1	0.987403161140781	546	829	546	
16065	biochemical data	biochemical datum	1	0.987403161140781	609	2869	609	
2916	Comparative studies	Comparative study	1	0.987403161140781	2918	2917	2918	
445	NaCl concentrations	NaCl concentration	1	0.987403161140781	163	446	163	
12901	Protection of Salmonella	Protection of Salmonella	1	0.987403161140781	12902	3520	12902	
2839	reduction of fever	reduction of fever	1	0.987403161140781	276	2841	276	
448	clearance rates	clearance rate	1	0.987403161140781	450	449	450	
13593	modeling studies of two-dimensional electronic spectra	modeling study of two-dimensional electronic spectrum	1	0.987403161140781	13595	13594	2918	
952	positive predictive value	positive predictive value	1	0.987403161140781	954	953	211	
179	secondary recurrent aborter	secondary recurrent aborter	1	0.987403161140781	181	68	183	
12592	carton fibres	carton fibre	1	0.987403161140781	12594	786	12594	
12983	phenotype of an Escherichia coli fur mutant	phenotype of an Escherichia coli fur mutant	1	0.987403161140781	5168	12985	5168	
2391	likely location	likely location	1	0.987403161140781	1670	2392	1670	
683	importance of FcgammaRIIa allotypes	importance of FcgammaRIIa allotype	1	0.987403161140781	684	685	684	
16792	ligand EF	ligand EF	1	0.987403161140781	1019	1993	1019	
11365	coli cells	coli cell	1	0.987403161140781	113	696	113	
5454	ssp tularensis	ssp tularensis	1	0.987403161140781	5453	5455	5453	
9677	extracellular enzyme	extracellular enzyme	1	0.987403161140781	4250	6	4250	
1372	secondary effluent drawn	secondary effluent drawn	1	0.987403161140781	1374	68	1376	
13166	like outbreak	like outbreak	1	0.987403161140781	986	829	986	
3233	cell residence time of the system	cell residence time of the system	1	0.987403161140781	3235	235	1403	
14203	pretreatment of enterocytes	pretreatment of enterocyte	1	0.987403161140781	14204	7871	14204	
16423	inversion gel electrophoresis	inversion gel electrophoresis	1	0.987403161140781	2363	16424	2365	
2346	number of SNPs	number of SNP	1	0.987403161140781	1034	2348	1034	
15223	absence of an overt outbreak	absence of an overt outbreak	1	0.987403161140781	5502	15225	5502	
15663	cell toxicity readout	cell toxicity readout	1	0.987403161140781	14728	234	14728	
2796	immune challenges	immune challenge	1	0.987403161140781	2798	2357	2798	
2214	transcription regulator	transcription regulator	1	0.987403161140781	756	1075	756	
12898	open environments	open environment	1	0.987403161140781	752	6575	752	
591	dynamics of group	dynamic of group	1	0.987403161140781	592	351	592	
4525	content of the stools	content of the stool	1	0.987403161140781	4526	2546	4526	
8315	terminal UTR of 621bp	terminal UTR of 621bp	1	0.987403161140781	8317	8316	8318	
3577	diphenyl ester	diphenyl ester	1	0.987403161140781	3579	3578	3579	
6847	healthy persons	healthy person	1	0.987403161140781	5061	133	5061	
8631	clinical studies of flomoxef	clinical study of flomoxef	1	0.987403161140781	8633	323	2918	
8393	progression of the lung granulomatous response	progression of the lung granulomatous response	1	0.987403161140781	2491	8395	2491	
12005	lung pathology	lung pathology	1	0.987403161140781	3535	936	3535	
12711	direct comparison	direct comparison	1	0.987403161140781	626	2188	626	
11011	screening of ABG	screening of ABG	1	0.987403161140781	671	6830	671	
16043	exchange columns	exchange column	1	0.987403161140781	16045	9212	16045	
16596	strain MIT9313	strain MIT9313	1	0.987403161140781	1951	76	1951	
11476	proteinase K digestion method	proteinase K digestion method	1	0.987403161140781	11478	6725	596	
1578	comparative genome sequencing [CGS]	comparative genome sequencing [CGS]	1	0.987403161140781	1580	1579	1584	
3468	ability of synthesis of thermolabile enterotoxin	ability of synthesis of thermolabile enterotoxin	1	0.987403161140781	939	3470	939	
4697	cell biology to the bacterium's advantage	cell biology to the bacterium' advantage	1	0.987403161140781	4699	235	1725	
15814	carriers of Campylobacter spp	carrier of Campylobacter spp	1	0.987403161140781	8170	15816	8170	
2207	blood cell count	blood cell count	1	0.987403161140781	2209	2208	2211	
8600	positive men	positive man	1	0.987403161140781	8602	953	8602	
15852	large number of ampicillin	large number of ampicillin	1	0.987403161140781	15854	288	1034	
1610	cell structure	cell structure	1	0.987403161140781	201	235	201	
14387	stable teicoplanin	stable teicoplanin	1	0.987403161140781	2327	1614	2327	
7901	history of MRSA	history of MRSA	1	0.987403161140781	3162	369	3162	
3401	interaction of human PMNs	interaction of human PMN	1	0.987403161140781	1709	3403	1709	
15925	future conservation efforts	future conservation effort	1	0.987403161140781	15927	15926	15929	
7022	poultry - a major source of human infection	poultry_-_a major source of human infection	1	0.987403161140781	7024	7023	3893	
1863	Elp component	Elp component	1	0.987403161140781	918	1864	918	
4151	gamma subclass	gamma subclass	1	0.987403161140781	4153	54	4153	
10571	proteolysis of the products	proteolysis of the product	1	0.987403161140781	10572	1031	10572	
155	structural features	structural feature	1	0.987403161140781	157	156	157	
14685	aerosol infection	aerosol infection	1	0.987403161140781	274	12520	274	
4659	ErbB3 activation	ErbB3 activation	1	0.987403161140781	2118	4660	2118	
7766	probiotic bacteria	probiotic bacteria	1	0.987403161140781	1999	1093	1999	
2593	unexpected transcriptome diversity	unexpected transcriptome diversity	1	0.987403161140781	2595	2594	2099	
12933	clonal strains of Pseudomonas aeruginosa	clonal strain of Pseudomonas aeruginosa	1	0.987403161140781	1787	2317	551	
14587	host cell viability	host cell viability	1	0.987403161140781	4309	12664	4309	
9065	chromosomal integration system	chromosomal integration system	1	0.987403161140781	9067	9066	1501	
2060	involvement of the cardiovascular system	involvement of the cardiovascular system	1	0.987403161140781	2061	2062	2061	
16086	family of effector proteins	family of effector protein	1	0.987403161140781	2170	4556	2170	
12350	departure of the lactyl ether	departure of the lactyl ether	1	0.987403161140781	12351	12352	12351	
5189	Hg(II) exposure	Hg(II) exposure	1	0.987403161140781	5191	5190	5191	
2425	integral part of a defense system	integral part of a defense system	1	0.987403161140781	2427	2426	1050	
1439	vacuum packages	vacuum package	1	0.987403161140781	1441	248	1441	
1483	mammalian tissues	mammalian tissue	1	0.987403161140781	1485	411	1485	
10257	reservoirs of viable methicillin	reservoir of viable methicillin	1	0.987403161140781	10258	10259	10258	
8835	phagocytosis assays	phagocytosis assay	1	0.987403161140781	3106	8836	3106	
3932	human disease control	human disease control	1	0.987403161140781	575	3933	575	
10535	causative agent of tularemia	causative agent of tularemia	1	0.987403161140781	3710	4382	1357	
9208	simple two-site exchange	simple two-site exchange	1	0.987403161140781	9210	1148	9212	
7798	lytic activity	lytic activity	1	0.987403161140781	393	7799	393	
2011	concentration of lactobacilli	concentration of lactobacilli	1	0.987403161140781	2012	2013	2012	
1129	gold standard	gold standard	1	0.987403161140781	1131	1130	1131	
11396	growth factor	growth factor	1	0.987403161140781	72	217	72	
15315	beta -1	beta -1	1	0.987403161140781	145	15316	145	
4642	disease development	disease development	1	0.987403161140781	1679	268	1679	
2655	average burst size	average burst size	1	0.987403161140781	2657	2656	2659	
15839	distance to the start codon	distance to the start codon	1	0.987403161140781	8519	15841	8519	
16622	Chlamydia infection	Chlamydia infection	1	0.987403161140781	274	4117	274	
10511	Vibrio parahaemolyticus	Vibrio parahaemolyticus	1	0.987403161140781	9315	1907	9315	
4497	bacterial density	bacterial density	1	0.987403161140781	4499	185	4499	
9455	human diseases	human disease	1	0.987403161140781	9457	834	9457	
9170	hemoglobin capture	hemoglobin capture	1	0.987403161140781	5620	4628	5620	
817	degrees of severity	degree of severity	1	0.987403161140781	818	436	818	
16871	absence of lysozyme	absence of lysozyme	1	0.987403161140781	5502	136	5502	
9222	active duodenal ulcer disease	active duodenal ulcer disease	1	0.987403161140781	9224	1	268	
12832	swarming motility	swarming motility	1	0.987403161140781	12834	8091	12834	
10649	nontoxinogenic Escherichia coli O157 strains	nontoxinogenic Escherichia coli O157 strain	1	0.987403161140781	10651	1015	551	
8405	causative organisms	causative organism	1	0.987403161140781	3385	229	3385	
1021	red bile glucose	red bile glucose	1	0.987403161140781	1023	1022	607	
999	universal key adaptor	universal key adaptor	1	0.987403161140781	1001	1000	1003	
5419	phosphate buffer solution	phosphate buffer solution	1	0.987403161140781	5421	350	5423	
10	opsonized meningococci W135	opsonized meningococci W135	1	0.987403161140781	12	11	14	
9970	limited studies	limited study	1	0.987403161140781	2918	3018	2918	
5093	brush border of human intestinal epithelial cells	brush border of human intestinal epithelial cell	1	0.987403161140781	5095	5094	5096	
4613	leukocyte count SUP15 × 10(9)	leukocyte count SUP15 × 10(9)	1	0.987403161140781	4615	4614	4617	
4662	Helicobacter pylori serological status	Helicobacter pylori serological status	1	0.987403161140781	4666	499	4668	
947	chain alkanes	chain alkane	1	0.987403161140781	949	320	949	
10315	H pylori eradication rates	H pylori eradication rate	1	0.987403161140781	10317	764	450	
973	occurrence of a mosquitocidal B	occurrence of a mosquitocidal B	1	0.987403161140781	871	975	871	
11036	inclusion proteins	inclusion protein	1	0.987403161140781	27	1762	27	
2055	T cell populations	T cell population	1	0.987403161140781	1428	2056	1428	
6824	follow-up cytotoxicity screening	follow-up cytotoxicity screening	1	0.987403161140781	6826	3407	671	
13583	mosquitocidal strains	mosquitocidal strain	1	0.987403161140781	551	9976	551	
12062	physiological functions	physiological function	1	0.987403161140781	12064	4031	12064	
1077	loci mycobacterial interspersed repetitive units	locus mycobacterial interspersed repetitive unit	1	0.987403161140781	1079	1078	1085	
13527	combinations of variables	combination of variable	1	0.987403161140781	13528	2413	13528	
6850	symbiotic S	symbiotic S	1	0.987403161140781	1898	3920	1898	
4148	syringae pv	syringae pv	1	0.987403161140781	2007	4149	2007	
808	urease expression	urease expression	1	0.987403161140781	373	809	373	
1589	presence of monoclonal B cells	presence of monoclonal B cell	1	0.987403161140781	139	1591	139	
9052	chlamydia nucleic acid amplification tests	chlamydia nucleic acid amplification test	1	0.987403161140781	9054	9053	2025	
410	mammalian hemopexin	mammalian hemopexin	1	0.987403161140781	412	411	412	
12238	risk of gastric cancer development	risk of gastric cancer development	1	0.987403161140781	3378	12240	3378	
2898	Subsequent characterisation of Φ st1	Subsequent characterisation of Φ st1	1	0.987403161140781	2900	2899	2901	
4761	different media	different medium	1	0.987403161140781	4763	816	4763	
20	de facto prophylaxis	de_facto prophylaxis	1	0.987403161140781	22	21	22	
12500	glycolytic pathway	glycolytic pathway	1	0.987403161140781	661	12501	661	
4035	rice plants	rice plant	1	0.987403161140781	688	34	688	
5641	gene pool to specific environmental constraints	gene pool to specific environmental constraint	1	0.987403161140781	5643	18	5469	
8886	screening compounds	screening compound	1	0.987403161140781	2878	671	2878	
3891	carbon source	carbon source	1	0.987403161140781	3893	2033	3893	
9520	mass spectrometer	mass spectrometer	1	0.987403161140781	9522	1193	9522	
8220	perfringens Type A	perfringen Type A	1	0.987403161140781	8222	7634	1379	
10784	presence of a 22-fold molar excess of Zn(II)	presence of a 22-fold molar excess of Zn(II)	1	0.987403161140781	139	10786	139	
5077	B-dependent asp23 mRNA levels	B-dependent asp23 mRNA level	1	0.987403161140781	5079	5078	495	
14806	fragment length polymorphism analysis	fragment length polymorphism analysis	1	0.987403161140781	14808	1268	203	
7324	mercury resistance	mercury resistance	1	0.987403161140781	1830	7325	1830	
15758	ulcerans disease	ulceran disease	1	0.987403161140781	268	15759	268	
14831	NOESY spectra	NOESY spectrum	1	0.987403161140781	10533	396	10533	
8627	NA2 allotypes	NA2 allotype	1	0.987403161140781	687	7887	687	
2275	variability of REA DNA type	variability of REA DNA type	1	0.987403161140781	2276	2277	2276	
5615	structure of a Hb capture complex	structure of a Hb capture complex	1	0.987403161140781	201	5617	201	
12958	broad substrate specificity	broad substrate specificity	1	0.987403161140781	8704	796	3352	
1632	positive animals	positive animal	1	0.987403161140781	1634	953	1634	
8582	homogeneous preparation	homogeneous preparation	1	0.987403161140781	8584	8583	8584	
3522	major polar lipid	major polar lipid	1	0.987403161140781	3524	71	3526	
5130	Scanning electron microscopy	Scanning electron microscopy	1	0.987403161140781	5132	5131	2816	
4890	test systems	test system	1	0.987403161140781	4029	85	4029	
8732	presence of gamma delta T cells	presence of gamma delta T cell	1	0.987403161140781	139	2855	139	
4154	Heidelberg capsule	Heidelberg capsule	1	0.987403161140781	4156	4155	4156	
15631	Group A rotavirus	Group A rotavirus	1	0.987403161140781	8474	6929	8474	
15141	Prospective screening culture surveillance	Prospective screening culture surveillance	1	0.987403161140781	15143	15142	3820	
14150	control of primary infection	control of primary infection	1	0.987403161140781	575	14152	575	
4995	systemic infection	systemic infection	1	0.987403161140781	274	4996	274	
1924	solid medium	solid medium	1	0.987403161140781	1926	1925	1926	
2802	line treatment	line treatment	1	0.987403161140781	61	1090	61	
14473	Escherichia coli exploit type	Escherichia coli exploit type	1	0.987403161140781	14475	1840	1698	
8176	endonuclease analysis	endonuclease analysis	1	0.987403161140781	203	5180	203	
15795	group members	group member	1	0.987403161140781	2171	351	2171	
9595	filarial parasite	filarial parasite	1	0.987403161140781	9597	103	9597	
15074	action of bactericidal agents	action of bactericidal agent	1	0.987403161140781	8607	15076	8607	
6610	electrophoresis silver	electrophoresis silver	1	0.987403161140781	6612	2365	6612	
8563	demographic features of the disease	demographic feature of the disease	1	0.987403161140781	8565	5298	157	
5470	MAIS complex	MAIS complex	1	0.987403161140781	1524	5471	1524	
150	higher eradication rate	high eradication rate	1	0.987403161140781	152	151	154	
480	efficiency of the oocysts	efficiency of the oocyst	1	0.987403161140781	481	482	481	
5217	lower cost	low cost	1	0.987403161140781	1638	1390	1638	
9256	mirabilis strains	mirabilis strain	1	0.987403161140781	551	7654	551	
16155	inflammatory function	inflammatory function	1	0.987403161140781	778	2643	778	
11087	bacteriophage M	bacteriophage M	1	0.987403161140781	1921	8561	1921	
15613	DNA base composition of the type strain	DNA base composition of the type strain	1	0.987403161140781	15615	468	10137	
1473	bitter off-flavours	bitter off-flavour	1	0.987403161140781	1475	1474	1475	
2905	degree of oocysts	degree of oocyst	1	0.987403161140781	2084	482	2084	
16283	variety of substrates	variety of substrate	1	0.987403161140781	1261	2372	1261	
11675	pncA genes	pncA gene	1	0.987403161140781	444	11676	444	
1873	growth ability	growth ability	1	0.987403161140781	939	217	939	
16541	biological repetitions	biological repetition	1	0.987403161140781	16543	14825	16543	
3184	pig erythrocytes	pig erythrocyte	1	0.987403161140781	3186	1660	3186	
16695	pooled sera	pooled serum	1	0.987403161140781	3345	3539	3345	
10636	industrialized countries	industrialized country	1	0.987403161140781	1091	10637	1091	
4246	obligate nature	obligate nature	1	0.987403161140781	3765	3322	3765	
8	IgG2 opsonized meningococci W135	IgG2 opsonized meningococci W135	1	0.987403161140781	10	9	14	
6536	acetate electrophoresis	acetate electrophoresis	1	0.987403161140781	2365	6084	2365	
12093	ureter cell line	ureter cell line	1	0.987403161140781	1088	12094	1090	
1727	thuringiensis strain	thuringiensis strain	1	0.987403161140781	76	1321	76	
13625	homoserine lactone	homoserine lactone	1	0.987403161140781	13627	13626	13627	
335	adhesion to the biotic surface	adhesion to the biotic surface	1	0.987403161140781	336	337	336	
11704	respiratory disease	respiratory disease	1	0.987403161140781	268	735	268	
1944	modification of proteins	modification of protein	1	0.987403161140781	1945	27	1945	
15196	current understanding of A	current understanding of A	1	0.987403161140781	15198	5987	729	
8325	cause of ocular infections	cause of ocular infection	1	0.987403161140781	8326	8327	8326	
13280	anomalous dispersion method	anomalous dispersion method	1	0.987403161140781	13282	9284	596	
10811	various clinical isolates	various clinical isolate	1	0.987403161140781	8007	3269	334	
1688	integration sites	integration site	1	0.987403161140781	1139	1689	1139	
16287	fish isolate of R	fish isolate of R	1	0.987403161140781	16289	1903	4397	
7235	endogenous carbon material	endogenous carbon material	1	0.987403161140781	7237	6292	7239	
3834	aromatic MAGs	aromatic MAG	1	0.987403161140781	3836	3835	3836	
16451	O antisera	O antiserum	1	0.987403161140781	16453	6480	16453	
5375	large clinical trial	large clinical trial	1	0.987403161140781	5377	288	4199	
2942	aforementioned bacteremia	aforementioned bacteremia	1	0.987403161140781	2944	2943	2944	
11980	mammalian partner protein to the native state	mammalian partner protein to the native state	1	0.987403161140781	11981	11986	406	
9766	small protein	small protein	1	0.987403161140781	406	566	406	
15555	mer operon	mer operon	1	0.987403161140781	14352	5175	14352	
12519	aerosol tuberculosis infection	aerosol tuberculosis infection	1	0.987403161140781	5631	12520	274	
9814	sequencing of regions of the katG	sequencing of region of the katG	1	0.987403161140781	1583	9816	1583	
1241	protein array technique	protein array technique	1	0.987403161140781	1245	900	1245	
263	high frequency	high frequency	1	0.987403161140781	265	264	265	
1927	surface copies of MBD	surface copy of MBD	1	0.987403161140781	1929	339	1930	
13934	enterotoxigenic B	enterotoxigenic B	1	0.987403161140781	977	5573	977	
4549	analysis of all strains	analysis of all strain	1	0.987403161140781	203	551	203	
16628	prochlorosin genes	prochlorosin gene	1	0.987403161140781	444	16629	444	
11328	cases of Mycoplasma otitis	case of Mycoplasma otitis	1	0.987403161140781	2770	4585	2770	
7752	genomic tools	genomic tool	1	0.987403161140781	7754	3065	7754	
9000	synthesis of molecules	synthesis of molecule	1	0.987403161140781	515	433	515	
3725	precise mechanisms	precise mechanism	1	0.987403161140781	519	3726	519	
610	Peruvian patients	Peruvian patient	1	0.987403161140781	226	611	226	
16718	moment orientations	moment orientation	1	0.987403161140781	16720	11717	16720	
8478	term complications	term complication	1	0.987403161140781	844	2270	844	
15143	screening culture surveillance	screening culture surveillance	1	0.987403161140781	15145	671	3820	
2241	phagocytic interaction	phagocytic interaction	1	0.987403161140781	1709	2242	1709	
2842	abdominal pain	abdominal pain	1	0.987403161140781	2844	2843	2844	
5097	human intestinal epithelial cells	human intestinal epithelial cell	1	0.987403161140781	5099	834	113	
6491	MW of 11 kDa	MW of 11_kDa	1	0.987403161140781	6492	6493	6492	
10762	proteomic studies	proteomic study	1	0.987403161140781	2918	10763	2918	
6362	unique model system	unique model system	1	0.987403161140781	6364	3347	1501	
1147	simple method	simple method	1	0.987403161140781	596	1148	596	
4882	activity of Haemophilus parasuis	activity of Haemophilus parasuis	1	0.987403161140781	393	4884	393	
1889	clonal spread	clonal spread	1	0.987403161140781	1891	1788	1891	
6246	warm temperature acclimation protein	warm temperature acclimation protein	1	0.987403161140781	6248	6247	406	
6716	host defences	host defence	1	0.987403161140781	6718	271	6718	
11447	immune responses	immune response	1	0.987403161140781	2627	2357	2627	
10590	unsaturated fatty acids	unsaturated fatty acid	1	0.987403161140781	9003	10591	3060	
8262	vast phage	vast phage	1	0.987403161140781	2407	8258	2407	
7281	spontaneous mutagenesis	spontaneous mutagenesis	1	0.987403161140781	5829	5906	5829	
14307	hydrophobic interactions	hydrophobic interaction	1	0.987403161140781	10246	3871	10246	
3513	resistance to penicillins	resistance to penicillin	1	0.987403161140781	1830	633	1830	
2700	transfer of 1E4	transfer of 1E4	1	0.987403161140781	1913	2702	1913	
14304	molecule expression	molecule expression	1	0.987403161140781	373	6034	373	
1498	nervous system infections	nervous system infection	1	0.987403161140781	1500	1499	736	
6105	Natural history of colonization	Natural history of colonization	1	0.987403161140781	3161	6106	3162	
16199	parietal cell	parietal cell	1	0.987403161140781	235	16200	235	
7181	thin sections	thin section	1	0.987403161140781	7183	7182	7183	
6385	immediate vicinity of pdhA	immediate vicinity of pdhA	1	0.987403161140781	6387	6386	6388	
5693	HTS assays	HTS assay	1	0.987403161140781	3106	5694	3106	
9534	model systems	model system	1	0.987403161140781	4029	361	4029	
7499	formation of inactive heterodimers	formation of inactive heterodimer	1	0.987403161140781	4488	7501	4488	
4566	spoilage of vacuum	spoilage of vacuum	1	0.987403161140781	458	248	458	
9623	cell harvest	cell harvest	1	0.987403161140781	9625	235	9625	
7923	selective agars	selective agar	1	0.987403161140781	5201	5410	5201	
6281	device usage	device usage	1	0.987403161140781	6283	6282	6283	
9804	original isolation	original isolation	1	0.987403161140781	326	494	326	
3800	rickettsial outer membrane protein A	rickettsial outer membrane protein A	1	0.987403161140781	3802	812	1379	
10924	capsule types	capsule type	1	0.987403161140781	769	4156	769	
3594	organ failure	organ failure	1	0.987403161140781	3596	1240	3596	
9416	mucosal presence	mucosal presence	1	0.987403161140781	139	9417	139	
4101	mRNA expression	mRNA expression	1	0.987403161140781	373	1570	373	
15381	ferrous iron	ferrous iron	1	0.987403161140781	1953	15382	1953	
563	pigs' small intestinal tissue	pigs' small intestinal tissue	1	0.987403161140781	565	564	569	
4758	genetic scars	genetic scar	1	0.987403161140781	4760	880	4760	
7928	Bacteroides fragilis	Bacteroide fragili	1	0.987403161140781	7930	7929	7930	
3951	Erythromycin resistance	Erythromycin resistance	1	0.987403161140781	1830	3952	1830	
1154	water supply	water supply	1	0.987403161140781	1156	920	1156	
12951	CC chemokine receptors CCR1	CC chemokine receptor CCR1	1	0.987403161140781	194	542	194	
6781	Molecular epidemiology	Molecular epidemiology	1	0.987403161140781	5717	3742	5717	
3815	phylogenetic data	phylogenetic datum	1	0.987403161140781	609	3816	609	
9024	solubility of fusion proteins	solubility of fusion protein	1	0.987403161140781	9025	9026	9025	
14818	m MgCl(2)	m MgCl(2)	1	0.987403161140781	14820	7200	14820	
3166	gram positive bacteria	gram positive bacteria	1	0.987403161140781	3168	3167	1999	
4343	passive transfer of antibodies	passive transfer of antibody	1	0.987403161140781	4345	2699	1913	
3409	second massive immigration	second massive immigration	1	0.987403161140781	3411	3410	3413	
15502	agropine type	agropine type	1	0.987403161140781	1698	15503	1698	
13512	Phytoplasma protein translocation genes	Phytoplasma protein translocation gene	1	0.987403161140781	13514	13513	444	
12294	adhesion to a biotic surface	adhesion to a biotic surface	1	0.987403161140781	336	337	336	
15745	intrinsic resistance	intrinsic resistance	1	0.987403161140781	1830	15746	1830	
16615	+ C16	+ C16	1	0.987403161140781	5253	6911	5253	
737	raw seafood	raw seafood	1	0.987403161140781	739	738	739	
7598	week's duration	week' duration	1	0.987403161140781	3208	7599	3208	
13272	capacity of S	capacity of S	1	0.987403161140781	4984	1898	4984	
1623	energy disorder	energy disorder	1	0.987403161140781	291	1624	291	
2350	evasion of the human innate immune response	evasion of the human innate immune response	1	0.987403161140781	2351	2352	2351	
10243	colitis gravis	colitis gravis	1	0.987403161140781	10245	4287	10245	
11068	fd phage	fd phage	1	0.987403161140781	2407	11069	2407	
518	mechanisms of microbial inactivation	mechanism of microbial inactivation	1	0.987403161140781	519	520	519	
813	disease of different degrees of severity	disease of different degree of severity	1	0.987403161140781	268	815	268	
6939	unusual set of modifications	unusual set of modification	1	0.987403161140781	6941	1692	417	
12015	isolations of Salmonella sp	isolation of Salmonella sp	1	0.987403161140781	12016	12017	12016	
2408	Different lines of evidence	Different line of evidence	1	0.987403161140781	2410	2409	2411	
15424	Gambian communities	Gambian community	1	0.987403161140781	990	12839	990	
15479	treatment of CDI	treatment of CDI	1	0.987403161140781	61	979	61	
4275	study of the safety	study of the safety	1	0.987403161140781	1514	675	1514	
5167	phenotype of T-lymphocytes	phenotype of T-lymphocyte	1	0.987403161140781	5168	5169	5168	
4175	muridarum respiratory infections	muridarum respiratory infection	1	0.987403161140781	734	4176	736	
4775	chlorosomes of a triple mutant of Chlorobaculum tepidum	chlorosome of a triple mutant of Chlorobaculum tepidum	1	0.987403161140781	4776	4777	4776	
13714	elimination of Helicobacter pylori	elimination of Helicobacter pylori	1	0.987403161140781	10302	499	10302	
14691	logistic regression models	logistic regression model	1	0.987403161140781	12639	14692	7459	
4070	grade primary gastric lymphoma	grade primary gastric lymphoma	1	0.987403161140781	4072	4071	259	
10864	mediation of attachment to HCE cells	mediation of attachment to HCE cell	1	0.987403161140781	10865	10866	10865	
1691	unusual toxicity spectrum	unusual toxicity spectrum	1	0.987403161140781	1693	1692	1695	
7399	log₁₀ FU	log₁₀ FU	1	0.987403161140781	7401	2480	7401	
2556	utilization of a variety of exogenous ones	utilization of a variety of exogenous one	1	0.987403161140781	2300	2558	2300	
13788	fur gene	fur gene	1	0.987403161140781	18	12990	18	
8448	CCL5 treatment	CCL5 treatment	1	0.987403161140781	61	8449	61	
15295	members of the family	member of the family	1	0.987403161140781	2171	2170	2171	
8532	spoilage potential of C	spoilage potential of C	1	0.987403161140781	8534	458	6353	
3542	time to clearance	time to clearance	1	0.987403161140781	1403	449	1403	
8638	development of atrophic gastritis	development of atrophic gastritis	1	0.987403161140781	1679	8640	1679	
13226	months of surveillance	month of surveillance	1	0.987403161140781	4496	3820	4496	
14688	chronic gastritis	chronic gastritis	1	0.987403161140781	4245	363	4245	
12455	organic substances	organic substance	1	0.987403161140781	12457	8308	12457	
835	filarial nematode parasites	filarial nematode parasite	1	0.987403161140781	837	103	104	
13918	null mutant	null mutant	1	0.987403161140781	4780	13919	4780	
4753	h of inoculum age	h of inoculum age	1	0.987403161140781	4754	4755	4754	
14753	free excretors	free excretor	1	0.987403161140781	14755	112	14755	
11753	pattern of antimicrobial resistance acquisition	pattern of antimicrobial resistance acquisition	1	0.987403161140781	4145	11755	4145	
2582	conformational changes	conformational change	1	0.987403161140781	1846	2583	1846	
9067	integration system	integration system	1	0.987403161140781	1501	1689	1501	
16103	pH optimum	pH optimum	1	0.987403161140781	16105	191	16105	
13599	electronic spectra	electronic spectrum	1	0.987403161140781	10533	13600	10533	
1123	specific recognition complexes	specific recognition complex	1	0.987403161140781	1125	504	1127	
11191	rate of S	rate of S	1	0.987403161140781	154	1898	154	
5690	nitrogen fixation	nitrogen fixation	1	0.987403161140781	5692	98	5692	
16495	summer months	summer month	1	0.987403161140781	4496	16496	4496	
11008	dimensional structures	dimensional structure	1	0.987403161140781	11010	1979	11010	
15762	time reverse transcription PCR	time reverse transcription PCR	1	0.987403161140781	15764	1403	2264	
1529	keratin stains	keratin stain	1	0.987403161140781	1531	1530	1531	
11356	calcium chloride method	calcium chloride method	1	0.987403161140781	596	11357	596	
11386	Bacillus lentus	Bacillus lentus	1	0.987403161140781	11388	3924	11388	
14598	drastic attenuation	drastic attenuation	1	0.987403161140781	14600	14599	14600	
6150	beacon probes	beacon probe	1	0.987403161140781	6152	6151	6152	
4589	weeks of therapy	week of therapy	1	0.987403161140781	4053	464	4053	
14455	Elucidation of molecular mechanisms of virulence factors	Elucidation of molecular mechanism of virulence factor	1	0.987403161140781	14456	14457	14456	
15850	survival of a large number of ampicillin	survival of a large number of ampicillin	1	0.987403161140781	1950	15852	1950	
638	reaction of agglutination	reaction of agglutination	1	0.987403161140781	561	640	561	
198	X-ray structure analysis of riboflavin synthase	X-ray structure analysis of riboflavin synthase	1	0.987403161140781	200	199	203	
14427	detailed molecular epidemiology survey	detailed molecular epidemiology survey	1	0.987403161140781	14429	14428	2706	
207	flow cytometer	flow cytometer	1	0.987403161140781	209	208	209	
15089	secretion of IL	secretion of IL	1	0.987403161140781	2586	8589	2586	
10838	dependent mechanisms	dependent mechanism	1	0.987403161140781	519	807	519	
8794	clinical factors	clinical factor	1	0.987403161140781	2924	323	2924	
1680	transcription of lacZ	transcription of lacZ	1	0.987403161140781	1075	1682	1075	
16269	potent antibacterial activity	potent antibacterial activity	1	0.987403161140781	1574	16270	393	
7419	free form	free form	1	0.987403161140781	4440	112	4440	
11374	lethal infection	lethal infection	1	0.987403161140781	274	9116	274	
16393	bi-selenite ion	bi-selenite ion	1	0.987403161140781	16395	16394	16395	
14043	Epidemiological factors	Epidemiological factor	1	0.987403161140781	2924	14044	2924	
14001	Rhipicephalus sanguineus	Rhipicephalus sanguineus	1	0.987403161140781	14003	14002	14003	
3340	protein design	protein design	1	0.987403161140781	3342	406	3342	
14729	eukaryotic cell toxicity	eukaryotic cell toxicity	1	0.987403161140781	234	4696	236	
8192	FMO samples	FMO sample	1	0.987403161140781	225	5258	225	
8825	epidemiological studies	epidemiological study	1	0.987403161140781	2918	8826	2918	
10077	patterns of carriage	pattern of carriage	1	0.987403161140781	2366	7310	2366	
8462	genetic characterization	genetic characterization	1	0.987403161140781	416	880	416	
950	high positive predictive value	high positive predictive value	1	0.987403161140781	952	264	211	
10918	antibiogram pattern	antibiogram pattern	1	0.987403161140781	4145	3799	4145	
2708	R131 homozygous donors	R131 homozygous donor	1	0.987403161140781	2710	2709	555	
13685	Mtb-infected human blood monocyte	Mtb-infected human blood monocyte	1	0.987403161140781	13687	13686	1204	
11453	Helicobactor pylori infection	Helicobactor pylori infection	1	0.987403161140781	8215	11454	274	
16562	virulent R	virulent R	1	0.987403161140781	1492	3625	1492	
15877	indistinguishable profiles	indistinguishable profile	1	0.987403161140781	3564	15878	3564	
9138	plant pathogenic bacterium	plant pathogenic bacterium	1	0.987403161140781	9140	5726	1136	
10458	integration vector	integration vector	1	0.987403161140781	2218	1689	2218	
7187	percent of isoniazid	percent of isoniazid	1	0.987403161140781	7188	7189	7188	
5838	N-terminal domain	N-terminal domain	1	0.987403161140781	253	1267	253	
7367	decision analytic simulation model	decision analytic simulation model	1	0.987403161140781	7369	7368	361	
8111	plant phloem tissues	plant phloem tissue	1	0.987403161140781	8113	5726	1485	
10528	conditional sterility	conditional sterility	1	0.987403161140781	10530	10529	10530	
16853	efficacy rate	efficacy rate	1	0.987403161140781	154	12123	154	
7875	day care center	day care center	1	0.987403161140781	7877	1528	4790	
11983	partner protein	partner protein	1	0.987403161140781	406	11286	406	
5948	RFLP patterns of Israeli isolates	RFLP pattern of Israeli isolate	1	0.987403161140781	5950	5949	2366	
4356	dependent translocation	dependent translocation	1	0.987403161140781	1768	807	1768	
7165	oligomerization motif	oligomerization motif	1	0.987403161140781	1438	7166	1438	
13233	functional factors	functional factor	1	0.987403161140781	2924	3355	2924	
4731	recent publications	recent publication	1	0.987403161140781	4733	1540	4733	
16758	phagocytosis of apoptotic cells	phagocytosis of apoptotic cell	1	0.987403161140781	8836	1562	8836	
16010	maximum of the Youden's index	maximum of the Youden' index	1	0.987403161140781	11551	16012	11551	
740	HCl pH	HCl pH	1	0.987403161140781	191	741	191	
310	bacterial loads	bacterial load	1	0.987403161140781	312	185	312	
15777	tryptophan to the medium	tryptophan to the medium	1	0.987403161140781	1118	1926	1118	
4607	difficile infection	difficile infection	1	0.987403161140781	274	4608	274	
13161	intracellular metabolite pool	intracellular metabolite pool	1	0.987403161140781	13163	859	5469	
10990	exogenous sialic acid	exogenous sialic acid	1	0.987403161140781	3670	2302	4	
3707	translation initiation	translation initiation	1	0.987403161140781	3709	3708	3709	
7507	number of host cells	number of host cell	1	0.987403161140781	1034	2143	1034	
15824	barrier to ampicillin	barrier to ampicillin	1	0.987403161140781	630	2053	630	
4653	right elbow abscess	right elbow abscess	1	0.987403161140781	4655	100	4657	
16004	Immunostaining of sIg	Immunostaining of sIg	1	0.987403161140781	16005	16006	16005	
11947	short 5' untranslated regions	short 5' untranslated region	1	0.987403161140781	11949	4956	2787	
1847	vehicle of transmission	vehicle of transmission	1	0.987403161140781	1848	1849	1848	
1381	parallel searches	parallel search	1	0.987403161140781	1102	1382	1102	
10277	resistance to cotrimoxazole	resistance to cotrimoxazole	1	0.987403161140781	1830	10279	1830	
7031	intranasal route	intranasal route	1	0.987403161140781	5164	7032	5164	
1939	attractive alternative	attractive alternative	1	0.987403161140781	1941	1940	1941	
9750	polyclonal murine antibody	polyclonal murine antibody	1	0.987403161140781	9752	8998	1299	
585	dairy farms	dairy farm	1	0.987403161140781	587	586	587	
2935	detectable effect	detectable effect	1	0.987403161140781	2937	2936	2937	
11233	P1 protein	P1 protein	1	0.987403161140781	406	11234	406	
16018	study period	study period	1	0.987403161140781	2478	1514	2478	
9832	mouse model of genital tract chlamydia infection	mouse model of genital tract chlamydia infection	1	0.987403161140781	9834	9833	361	
6727	homolog protein	homolog protein	1	0.987403161140781	406	6728	406	
1081	interspersed repetitive units	interspersed repetitive unit	1	0.987403161140781	1083	1082	1085	
2299	utilization of exogenous ones	utilization of exogenous one	1	0.987403161140781	2300	2301	2300	
6334	primary acyl chains	primary acyl chain	1	0.987403161140781	6336	4073	6338	
3114	myelin breakdown	myelin breakdown	1	0.987403161140781	1520	3115	1520	
16403	human population	human population	1	0.987403161140781	1248	834	1248	
1542	major ecotypes	major ecotype	1	0.987403161140781	1544	71	1544	
710	food surface	food surface	1	0.987403161140781	339	43	339	
10801	SOS gene expression	SOS gene expression	1	0.987403161140781	3395	3561	373	
12326	negative bacilli	negative bacilli	1	0.987403161140781	12328	238	12328	
7604	seed germination	seed germination	1	0.987403161140781	7606	5478	7606	
9481	opening of the micro fibrils	opening of the micro fibril	1	0.987403161140781	9482	9483	9482	
9518	resolution mass spectrometer	resolution mass spectrometer	1	0.987403161140781	9520	1852	9522	
9194	evidence of gene transfer	evidence of gene transfer	1	0.987403161140781	2412	1911	2412	
4143	identical pattern	identical pattern	1	0.987403161140781	4145	4144	4145	
4792	'public goods' traits	'public goods' trait	1	0.987403161140781	4794	4793	4796	
15320	higher lung cytokine levels	high lung cytokine level	1	0.987403161140781	15322	151	495	
12443	red alga Chondrus crispus	red alga Chondrus crispus	1	0.987403161140781	12445	1022	12449	
10550	Reproducible results	Reproducible result	1	0.987403161140781	2870	10551	2870	
10498	function of these proteins	function of these protein	1	0.987403161140781	778	27	778	
10898	areas of the world	area of the world	1	0.987403161140781	4719	10900	4719	
181	recurrent aborter	recurrent aborter	1	0.987403161140781	183	182	183	
7389	sputum samples	sputum sample	1	0.987403161140781	225	7390	225	
2083	degree of attachment to hydrophilic tissue culture plates	degree of attachment to hydrophilic tissue culture plate	1	0.987403161140781	2084	2085	2084	
10946	induction of infection	induction of infection	1	0.987403161140781	5850	274	5850	
8525	course of necrotic enteritis	course of necrotic enteritis	1	0.987403161140781	2939	1546	2939	
425	surface of the two-dimensional aggregate of BChl molecules	surface of the two-dimensional aggregate of BChl molecule	1	0.987403161140781	339	427	339	
11281	rice varieties	rice variety	1	0.987403161140781	11283	34	11283	
6344	Carnobacterium piscicola	Carnobacterium piscicola	1	0.987403161140781	6346	6345	6346	
7568	basis of age	basis of age	1	0.987403161140781	6748	912	6748	
11645	n=4 populations	n=4 population	1	0.987403161140781	1428	11646	1428	
12488	ex vivo conditions	ex_vivo condition	1	0.987403161140781	2285	2359	2285	
3784	week treatment	week treatment	1	0.987403161140781	61	3785	61	
713	nontypeable Haemophilus influenzae	nontypeable Haemophilus influenzae	1	0.987403161140781	715	714	717	
16831	drug targets	drug target	1	0.987403161140781	16833	162	16833	
11740	jail environmental surfaces	jail environmental surface	1	0.987403161140781	1809	4257	1811	
8156	EmbB alterations	EmbB alteration	1	0.987403161140781	8158	8157	8158	
9159	portion of the molecule	portion of the molecule	1	0.987403161140781	9160	6034	9160	
14276	parvum oocyst concentration	parvum oocyst concentration	1	0.987403161140781	2012	14277	2012	
13810	crucial components of the medium	crucial component of the medium	1	0.987403161140781	13812	13811	13813	
6088	cell walls	cell wall	1	0.987403161140781	6090	235	6090	
1132	bioluminescent marine bacterium	bioluminescent marine bacterium	1	0.987403161140781	1134	1133	1136	
3331	certain viruses	certain virus	1	0.987403161140781	3249	3332	3249	
7216	binding to the N-terminal region of ActA	binding to the N-terminal region of ActA	1	0.987403161140781	159	7218	159	
1246	proportion of the population	proportion of the population	1	0.987403161140781	1247	1248	1247	
6669	return of fever	return of fever	1	0.987403161140781	6670	2841	6670	
12843	one-step cloning system	one-step cloning system	1	0.987403161140781	12845	12844	1501	
5457	rickettsia antigens	rickettsia antigen	1	0.987403161140781	4100	5458	4100	
14949	pronounced apoptosis	pronounced apoptosis	1	0.987403161140781	4126	14950	4126	
16125	Phage display	Phage display	1	0.987403161140781	602	16126	602	
8195	galactose residues	galactose residue	1	0.987403161140781	50	8196	50	
9634	propionic acid	propionic acid	1	0.987403161140781	4	9635	4	
6236	N-terminal 14-mer sequence	N-terminal 14-mer sequence	1	0.987403161140781	6238	1267	1657	
10190	edema factor	edema factor	1	0.987403161140781	72	10191	72	
6255	assays of serum pepsinogen	assay of serum pepsinogen	1	0.987403161140781	3106	4092	3106	
6990	histidine to the medium	histidine to the medium	1	0.987403161140781	2449	1926	2449	
13835	significant fraction of the energy of maintenance	significant fraction of the energy of maintenance	1	0.987403161140781	13837	24	1018	
2595	transcriptome diversity	transcriptome diversity	1	0.987403161140781	2099	1326	2099	
8022	spontaneous decomposition to a nontoxic product	spontaneous decomposition to a nontoxic product	1	0.987403161140781	8024	5906	8025	
13257	tularensis internalization	tularensis internalization	1	0.987403161140781	4043	5453	4043	
5554	leucocytes migration	leucocyte migration	1	0.987403161140781	3154	5555	3154	
16193	blocker of the proton pump of the parietal cell	blocker of the proton pump of the parietal cell	1	0.987403161140781	16194	16195	16194	
8073	caecal content of chickens	caecal content of chicken	1	0.987403161140781	8075	1916	4526	
7860	important diversity of seed	important diversity of seed	1	0.987403161140781	7862	118	2099	
2590	TID group	TID group	1	0.987403161140781	351	2591	351	
1179	perianal ulceration	perianal ulceration	1	0.987403161140781	1181	1180	1181	
7402	intraleukocytic staphylococci	intraleukocytic staphylococci	1	0.987403161140781	7404	7403	7404	
6926	infected cells	infected cell	1	0.987403161140781	113	1838	113	
14683	burnetii aerosol infection	burnetii aerosol infection	1	0.987403161140781	14685	2519	274	
3250	length UreR	length UreR	1	0.987403161140781	90	2539	90	
86	acid residues of UreR	acid residue of UreR	1	0.987403161140781	88	4	50	
16684	H . influenzae	H . influenzae	1	0.987403161140781	16686	764	717	
11042	cell surface hydrophobicity	cell surface hydrophobicity	1	0.987403161140781	11044	235	3063	
9921	plasma membrane of human blood	plasma membrane of human blood	1	0.987403161140781	9923	9922	3723	
12985	Escherichia coli fur mutant	Escherichia coli fur mutant	1	0.987403161140781	12987	1840	4780	
10669	severe disease	severe disease	1	0.987403161140781	268	2773	268	
366	body MRSA infection	body MRSA infection	1	0.987403161140781	368	367	274	
7706	plant Artemisia annua	plant Artemisia annua	1	0.987403161140781	5401	5726	5403	
15029	isolates of MRSA	isolate of MRSA	1	0.987403161140781	334	369	334	
6511	diarrheagenic E	diarrheagenic E	1	0.987403161140781	79	6512	79	
13362	retrospective study of Mycoplasma otitis	retrospective study of Mycoplasma otitis	1	0.987403161140781	13364	13363	1514	
10731	amino acid requirements	amino acid requirement	1	0.987403161140781	658	1270	658	
685	FcgammaRIIa allotypes	FcgammaRIIa allotype	1	0.987403161140781	687	686	687	
16814	improved survival	improved survival	1	0.987403161140781	1950	16815	1950	
13988	known concentration of oocysts	known concentration of oocyst	1	0.987403161140781	13990	8439	2012	
3741	Molecular characterisation	Molecular characterisation	1	0.987403161140781	2901	3742	2901	
15429	culture conditions	culture condition	1	0.987403161140781	2285	2092	2285	
10701	Membrane mucin expression	Membrane mucin expression	1	0.987403161140781	10703	10702	373	
15834	antibiotic administration	antibiotic administration	1	0.987403161140781	3007	31	3007	
5311	secretion systems	secretion system	1	0.987403161140781	4029	2586	4029	
14669	deadly infectious disease	deadly infectious disease	1	0.987403161140781	14671	14670	268	
1866	bacteria reduction	bacteria reduction	1	0.987403161140781	276	1867	276	
5084	preinfection NAP levels	preinfection NAP level	1	0.987403161140781	5086	5085	495	
14071	specific integration of the carotenoid gene cluster	specific integration of the carotenoid gene cluster	1	0.987403161140781	14073	504	1689	
2249	nonbacterial pathogen	nonbacterial pathogen	1	0.987403161140781	1905	2250	1905	
12668	One-week triple therapy	One-week triple therapy	1	0.987403161140781	3975	12669	464	
12341	liquid chromatography	liquid chromatography	1	0.987403161140781	2312	12342	2312	
4623	antibiotic sensitivity data	antibiotic sensitivity datum	1	0.987403161140781	609	4624	609	
6056	effluent samples	effluent sample	1	0.987403161140781	225	1375	225	
6449	resolution mass spectrometry	resolution mass spectrometry	1	0.987403161140781	6451	1852	2137	
11755	antimicrobial resistance acquisition	antimicrobial resistance acquisition	1	0.987403161140781	11757	1753	4048	
13748	counts of LAB	count of LAB	1	0.987403161140781	2262	2422	2262	
14077	gene cluster	gene cluster	1	0.987403161140781	14079	18	14079	
16317	Patient age	Patient age	1	0.987403161140781	912	16318	912	
13159	variations of intracellular metabolite pool	variation of intracellular metabolite pool	1	0.987403161140781	13160	13161	13160	
11429	signaling network to the bacterial advantage	signaling network to the bacterial advantage	1	0.987403161140781	11431	731	401	
6463	treatment strategies	treatment strategy	1	0.987403161140781	5392	61	5392	
429	aggregate of BChl molecules	aggregate of BChl molecule	1	0.987403161140781	430	431	430	
8944	gastric mucosal	gastric mucosal	1	0.987403161140781	8946	190	8946	
5756	sites of similar affinities	site of similar affinity	1	0.987403161140781	1139	5758	1139	
5024	pyogenes strains	pyogene strain	1	0.987403161140781	551	2921	551	
9144	cell sorting	cell sorting	1	0.987403161140781	9146	235	9146	
806	dependent urease expression	dependent urease expression	1	0.987403161140781	808	807	373	
14009	mosquitocidal Cry protein	mosquitocidal Cry protein	1	0.987403161140781	14011	9976	406	
5942	LTQ Orbitrap	LTQ Orbitrap	1	0.987403161140781	5944	5943	5944	
7061	optimal expression of the target genes	optimal expression of the target gene	1	0.987403161140781	7063	7062	373	
15579	dietary concentration	dietary concentration	1	0.987403161140781	2012	3581	2012	
1350	intestinal microflora	intestinal microflora	1	0.987403161140781	960	129	960	
14841	1g of stool	1g of stool	1	0.987403161140781	14842	1259	14842	
4666	serological status	serological status	1	0.987403161140781	4668	4667	4668	
929	fluorescence actin staining test	fluorescence actin staining test	1	0.987403161140781	931	930	85	
3057	LCCD patients	LCCD patient	1	0.987403161140781	226	357	226	
10405	human bacterial pathogens	human bacterial pathogen	1	0.987403161140781	184	834	186	
15988	pathologic changes	pathologic change	1	0.987403161140781	1846	646	1846	
15092	untreated pulp	untreated pulp	1	0.987403161140781	4843	8510	4843	
3591	farm heterogeneity	farm heterogeneity	1	0.987403161140781	3593	3592	3593	
2695	binding of E	binding of E	1	0.987403161140781	159	79	159	
9550	susceptibility of patients	susceptibility of patient	1	0.987403161140781	273	226	273	
9271	number of exposures	number of exposure	1	0.987403161140781	1034	9273	1034	
4237	annexin1 expression	annexin1 expression	1	0.987403161140781	373	1994	373	
10037	immune evasion	immune evasion	1	0.987403161140781	2351	2357	2351	
5162	respiratory route	respiratory route	1	0.987403161140781	5164	735	5164	
13221	hyperimmune mouse sera	hyperimmune mouse serum	1	0.987403161140781	13223	13222	3345	
14195	active CD	active CD	1	0.987403161140781	14197	1	14197	
2851	NH antigen	NH antigen	1	0.987403161140781	655	2852	655	
5790	understanding of the causes of WARI	understanding of the cause of WARI	1	0.987403161140781	729	5792	729	
1331	pylori infections	pylori infection	1	0.987403161140781	736	501	736	
15854	number of ampicillin	number of ampicillin	1	0.987403161140781	1034	2053	1034	
9283	anomalous diffraction method	anomalous diffraction method	1	0.987403161140781	9285	9284	596	
10438	taxonomic study	taxonomic study	1	0.987403161140781	1514	2895	1514	
15443	pelvic dead space	pelvic dead space	1	0.987403161140781	15445	15444	3294	
6525	higher level	high level	1	0.987403161140781	1113	151	1113	
10895	susceptible individuals	susceptible individual	1	0.987403161140781	134	2970	134	
15262	active site channel	active site channel	1	0.987403161140781	15264	1	15266	
14874	Yop translocation	Yop translocation	1	0.987403161140781	1768	14875	1768	
11501	antibiotics treatment	antibiotic treatment	1	0.987403161140781	61	3547	61	
5353	insoluble states	insoluble state	1	0.987403161140781	1909	5354	1909	
4020	rDNA sequence analysis	rDNA sequence analysis	1	0.987403161140781	3066	4021	203	
5404	Antibacterial properties of the frog	Antibacterial property of the frog	1	0.987403161140781	5406	5405	3103	
14918	strain of P	strain of P	1	0.987403161140781	76	160	76	
2739	Japanese people	Japanese people	1	0.987403161140781	1812	295	1812	
15056	uptake regulator	uptake regulator	1	0.987403161140781	756	4481	756	
15451	operating curves	operating curve	1	0.987403161140781	15453	2284	15453	
9157	N-terminal portion of the molecule	N-terminal portion of the molecule	1	0.987403161140781	9159	1267	9160	
15188	injection drug use	injection drug use	1	0.987403161140781	15190	3505	32	
3431	incidence of this disease	incidence of this disease	1	0.987403161140781	3432	268	3432	
6765	decontamination of product surface	decontamination of product surface	1	0.987403161140781	6766	6767	6766	
10461	human isolates	human isolate	1	0.987403161140781	334	834	334	
14026	non-coding transcripts	non-coding transcript	1	0.987403161140781	10616	14027	10616	
3530	interpretative criteria	interpretative criterion	1	0.987403161140781	3532	3531	3532	
10819	Serial dilutions	Serial dilution	1	0.987403161140781	10821	10820	10821	
10597	8th months	8th month	1	0.987403161140781	4496	10598	4496	
5058	anorectal manifestations	anorectal manifestation	1	0.987403161140781	5060	5059	5060	
7501	inactive heterodimers	inactive heterodimer	1	0.987403161140781	7503	7502	7503	
9702	individual cells of H	individual cell of H	1	0.987403161140781	9704	3288	113	
9362	untreated cells	untreated cell	1	0.987403161140781	113	8510	113	
9987	weight gain	weight gain	1	0.987403161140781	9989	681	9989	
3717	CSF to PCR analysis	CSF to PCR analysis	1	0.987403161140781	3718	3719	3718	
7983	cell proliferation	cell proliferation	1	0.987403161140781	7985	235	7985	
12788	development of soft texture	development of soft texture	1	0.987403161140781	1679	12790	1679	
14336	lineages indicative of widespread acquisition	lineage indicative of widespread acquisition	1	0.987403161140781	14337	14338	14337	
13266	course of chemotherapy	course of chemotherapy	1	0.987403161140781	2939	4717	2939	
11854	biotic surfaces	biotic surface	1	0.987403161140781	1811	338	1811	
16265	sensory rejection	sensory rejection	1	0.987403161140781	16267	6515	16267	
4724	further education	further education	1	0.987403161140781	4726	2629	4726	
14965	Mycobacterium tuberculosis Erdman	Mycobacterium tuberculosis Erdman	1	0.987403161140781	14969	3626	14969	
7230	negative analysis	negative analysis	1	0.987403161140781	203	238	203	
3792	acid extracts	acid extract	1	0.987403161140781	3189	4	3189	
5656	Different strains of P	Different strain of P	1	0.987403161140781	5658	2409	551	
13332	antibiotic therapy	antibiotic therapy	1	0.987403161140781	464	31	464	
10382	determination of the number of subsites	determination of the number of subsite	1	0.987403161140781	7968	10384	7968	
8520	C5 hydroxyl group	C5 hydroxyl group	1	0.987403161140781	8522	8521	351	
3290	middle ear space	middle ear space	1	0.987403161140781	3292	3291	3294	
13556	colonization pattern	colonization pattern	1	0.987403161140781	4145	2703	4145	
13595	studies of two-dimensional electronic spectra	study of two-dimensional electronic spectrum	1	0.987403161140781	2918	13597	2918	
1200	LVS binding to monocyte	LVS binding to monocyte	1	0.987403161140781	1201	1204	159	
15331	dry foods	dry food	1	0.987403161140781	15333	15332	15333	
14988	resistance of individual cells of H	resistance of individual cell of H	1	0.987403161140781	1830	14990	1830	
1582	sequencing [CGS]	sequencing [CGS]	1	0.987403161140781	1584	1583	1584	
7811	chemotherapy to antibiotics	chemotherapy to antibiotic	1	0.987403161140781	4717	3547	4717	
11692	prevalence of rectal LGV	prevalence of rectal LGV	1	0.987403161140781	1786	11694	1786	
12420	concentration of PGI	concentration of PGI	1	0.987403161140781	2012	5677	2012	
3017	limited reactivity	limited reactivity	1	0.987403161140781	3019	3018	3019	
9305	excellent effect	excellent effect	1	0.987403161140781	2937	4009	2937	
11578	type ureR allele	type ureR allele	1	0.987403161140781	11580	1698	11582	
12890	M calcium acetate	M calcium acetate	1	0.987403161140781	12892	1921	6084	
8766	Severe swelling of the hind paws	Severe swelling of the hind paw	1	0.987403161140781	8768	8767	7448	
1205	per-protocol analysis	per-protocol analysis	1	0.987403161140781	203	1206	203	
23	significant homology to proteins	significant homology to protein	1	0.987403161140781	25	24	26	
7141	Mean treatment adherence	Mean treatment adherence	1	0.987403161140781	7143	7142	3685	
16912	RAPD profile	RAPD profile	1	0.987403161140781	7587	12492	7587	
1374	effluent drawn	effluent drawn	1	0.987403161140781	1376	1375	1376	
3992	Analysis of global regulatory activities	Analysis of global regulatory activity	1	0.987403161140781	3993	3994	3993	
13433	immune defence	immune defence	1	0.987403161140781	2019	2357	2019	
3909	alfalfa symbiont	alfalfa symbiont	1	0.987403161140781	3911	3910	3911	
4251	Sequence analysis of ompB	Sequence analysis of ompB	1	0.987403161140781	4252	4255	203	
11513	removal of the cell debris	removal of the cell debris	1	0.987403161140781	11514	11515	11514	
11958	glial cells of the PNS	glial cell of the PNS	1	0.987403161140781	11960	11959	113	
2462	Value of protein array	Value of protein array	1	0.987403161140781	2463	900	2463	
5016	respiratory activity	respiratory activity	1	0.987403161140781	393	735	393	
11648	Emergence of resistance of vancomycin	Emergence of resistance of vancomycin	1	0.987403161140781	11380	11650	11380	
11993	inhibitor CI2	inhibitor CI2	1	0.987403161140781	11995	172	11995	
14845	cell extracts	cell extract	1	0.987403161140781	3189	235	3189	
5955	adherence of bacteria to solid surfaces	adherence of bacteria to solid surface	1	0.987403161140781	5956	5959	3685	
11211	teleost species	teleost specie	1	0.987403161140781	73	11212	73	
2205	white blood cell count	white blood cell count	1	0.987403161140781	2207	2206	2211	
3156	number of strains	number of strain	1	0.987403161140781	1034	551	1034	
11480	digestion method	digestion method	1	0.987403161140781	596	6421	596	
13468	distinct mutations	distinct mutation	1	0.987403161140781	773	2607	773	
13264	clinical course of chemotherapy	clinical course of chemotherapy	1	0.987403161140781	13266	323	2939	
11466	strong antibody response to Salmonella antigens	strong antibody response to Salmonella antigen	1	0.987403161140781	11468	1751	286	
1558	age children	age child	1	0.987403161140781	1560	912	1560	
2146	Leu+ transformants	Leu+ transformant	1	0.987403161140781	2148	2147	2148	
822	staphylococcal strains	staphylococcal strain	1	0.987403161140781	551	823	551	
10117	clinical signs of URTD	clinical sign of URTD	1	0.987403161140781	10118	1862	7841	
4114	range of Chlamydia trachomatis	range of Chlamydia trachomatis	1	0.987403161140781	928	4116	928	
255	low-grade MALT lymphoma	low-grade MALT lymphoma	1	0.987403161140781	257	256	259	
2601	central caseous necrosis	central caseous necrosis	1	0.987403161140781	2603	863	422	
15225	overt outbreak	overt outbreak	1	0.987403161140781	986	15226	986	
5819	Anabaena cells of sp	Anabaena cell of sp	1	0.987403161140781	5821	5820	113	
4074	gastric lymphoma	gastric lymphoma	1	0.987403161140781	259	190	259	
11664	5-year follow-up study	5-year follow-up study	1	0.987403161140781	11666	11665	1514	
13837	fraction of the energy of maintenance	fraction of the energy of maintenance	1	0.987403161140781	1018	2667	1018	
451	significant attention	significant attention	1	0.987403161140781	453	24	453	
8997	polyclonal MIRU	polyclonal MIRU	1	0.987403161140781	5398	8998	5398	
16959	cirrhotic patients	cirrhotic patient	1	0.987403161140781	226	16960	226	
1521	weak correlation	weak correlation	1	0.987403161140781	1523	1522	1523	
11066	filamentous fd phage	filamentous fd phage	1	0.987403161140781	11068	11067	2407	
3292	ear space	ear space	1	0.987403161140781	3294	3293	3294	
10841	significant role	significant role	1	0.987403161140781	233	24	233	
1802	type of chemotaxonomic marker	type of chemotaxonomic marker	1	0.987403161140781	1698	1804	1698	
3472	thermolabile enterotoxin	thermolabile enterotoxin	1	0.987403161140781	3474	3473	3474	
9982	serovar sotto	serovar sotto	1	0.987403161140781	9984	5901	9984	
14482	Hb binding	Hb binding	1	0.987403161140781	159	5618	159	
16108	biological processes	biological process	1	0.987403161140781	3489	14825	3489	
642	strain identification	strain identification	1	0.987403161140781	644	76	644	
1515	inmates' nasal specimens	inmates' nasal specimen	1	0.987403161140781	1517	1516	1519	
12926	use of rifampin	use of rifampin	1	0.987403161140781	32	421	32	
15696	rate of H	rate of H	1	0.987403161140781	154	764	154	
1870	carboxylic function	carboxylic function	1	0.987403161140781	778	1871	778	
15352	buffer saline	buffer saline	1	0.987403161140781	1923	5422	1923	
12590	paper carton fibres	paper carton fibre	1	0.987403161140781	12592	785	12594	
3371	increase of percentage neutrophils	increase of percentage neutrophil	1	0.987403161140781	1465	3373	1465	
2737	young Japanese people	young Japanese people	1	0.987403161140781	2739	2738	1812	
4360	lymphoid tissue	lymphoid tissue	1	0.987403161140781	569	4361	569	
14480	inhibitors of Hb binding	inhibitor of Hb binding	1	0.987403161140781	3272	14482	3272	
5406	properties of the frog	property of the frog	1	0.987403161140781	3103	5408	3103	
16084	YopJ family of effector proteins	YopJ family of effector protein	1	0.987403161140781	16086	4142	2170	
15411	crystallographic structural studies	crystallographic structural study	1	0.987403161140781	10264	1104	2918	
9816	regions of the katG	region of the katG	1	0.987403161140781	2787	9818	2787	
10921	close link	close link	1	0.987403161140781	10923	10922	10923	
15167	classical neuregulin	classical neuregulin	1	0.987403161140781	9965	15168	9965	
4106	Japanese typing scheme	Japanese typing scheme	1	0.987403161140781	4108	295	4110	
3923	Bacillus species	Bacillus specie	1	0.987403161140781	73	3924	73	
7496	Ara+ soil	Ara+ soil	1	0.987403161140781	7498	38	7498	
4518	widespread bacterial resistance	widespread bacterial resistance	1	0.987403161140781	4520	4519	1830	
10046	courses of AZLI	course of AZLI	1	0.987403161140781	2160	8720	2160	
8293	polar flagellum	polar flagellum	1	0.987403161140781	8295	3525	8295	
8969	antibiotic treatment	antibiotic treatment	1	0.987403161140781	61	31	61	
8522	hydroxyl group	hydroxyl group	1	0.987403161140781	351	8523	351	
7618	widespread acquisition of antimicrobial resistance	widespread acquisition of antimicrobial resistance	1	0.987403161140781	4047	4519	4048	
12078	variety of environmental surfaces	variety of environmental surface	1	0.987403161140781	1261	1809	1261	
1134	marine bacterium	marine bacterium	1	0.987403161140781	1136	1135	1136	
905	traumatic brain injury	traumatic brain injury	1	0.987403161140781	907	906	909	
13640	selective inhibition	selective inhibition	1	0.987403161140781	2510	5410	2510	
16277	gastric atrophy	gastric atrophy	1	0.987403161140781	1396	190	1396	
8467	energy landscape	energy landscape	1	0.987403161140781	8469	1624	8469	
8808	nonfimbrial adhesive factor of an enterotoxigenic Escherichia coli strain	nonfimbrial adhesive factor of an enterotoxigenic Escherichia coli strain	1	0.987403161140781	8810	5684	72	
4337	1st quarter	1st quarter	1	0.987403161140781	4339	4338	4339	
7639	FcgammaRIIIb allotypes	FcgammaRIIIb allotype	1	0.987403161140781	687	7640	687	
715	Haemophilus influenzae	Haemophilus influenzae	1	0.987403161140781	717	716	717	
15772	allergenic mold	allergenic mold	1	0.987403161140781	15774	15773	15774	
15816	Campylobacter spp	Campylobacter spp	1	0.987403161140781	708	889	708	
6998	glycoprotein biosynthesis	glycoprotein biosynthesis	1	0.987403161140781	7000	140	7000	
11027	N-terminal amino acid sequences	N-terminal amino acid sequence	1	0.987403161140781	534	11028	534	
2189	physical contact	physical contact	1	0.987403161140781	2191	2190	2191	
12445	alga Chondrus crispus	alga Chondrus crispus	1	0.987403161140781	12447	12388	12449	
3662	freundii Gentamicin	freundii Gentamicin	1	0.987403161140781	3664	3663	3664	
16716	dipole moment orientations	dipole moment orientation	1	0.987403161140781	16718	11716	16720	
5815	Nitrogenase activity of Anabaena cells of sp	Nitrogenase activity of Anabaena cell of sp	1	0.987403161140781	5817	5816	393	
4320	intake of probiotics	intake of probiotic	1	0.987403161140781	2477	4322	2477	
5963	serum PG	serum PG	1	0.987403161140781	5965	1798	5965	
2104	lactic acid bacteria drug resistance	lactic acid bacteria drug resistance	1	0.987403161140781	2110	2105	1830	
8144	different host systems	different host system	1	0.987403161140781	4029	8145	4029	
8579	domain of ActA	domain of ActA	1	0.987403161140781	253	1265	253	
13578	high index of suspicion	high index of suspicion	1	0.987403161140781	13580	264	1233	
13914	TSS fur null mutant	TSS fur null mutant	1	0.987403161140781	13916	5603	4780	
13842	continuous infusion	continuous infusion	1	0.987403161140781	13844	4067	13844	
2578	×  10(9) CFU)	× _10(9)_CFU)	1	0.987403161140781	2580	2579	2580	
6944	milk packs	milk pack	1	0.987403161140781	3529	6945	3529	
12648	single strains	single strain	1	0.987403161140781	551	1933	551	
12715	guinea pig model of infection	guinea pig model of infection	1	0.987403161140781	12717	3183	361	
2029	copiotrophic bacteria	copiotrophic bacteria	1	0.987403161140781	1999	2030	1999	
15210	strain E	strain E	1	0.987403161140781	79	76	79	
10901	wide genetic diversity	wide genetic diversity	1	0.987403161140781	2097	2070	2099	
7273	intestinal cells	intestinal cell	1	0.987403161140781	113	129	113	
493	original levels	original level	1	0.987403161140781	495	494	495	
5727	probiotic traits of bacteria	probiotic trait of bacteria	1	0.987403161140781	5729	1093	4796	
1822	number of pTRA1	number of pTRA1	1	0.987403161140781	1034	1824	1034	
10055	x-ray crystal structure of Hb	x-ray crystal structure of Hb	1	0.987403161140781	10057	10056	201	
14356	damaging effects	damaging effect	1	0.987403161140781	1055	14357	1055	
3101	pharmacokinetic properties	pharmacokinetic property	1	0.987403161140781	3103	3102	3103	
15309	diversity of M	diversity of M	1	0.987403161140781	2099	1921	2099	
8679	stress period	stress period	1	0.987403161140781	2478	780	2478	
7969	cup method	cup method	1	0.987403161140781	596	7970	596	
5989	measures of the aggregate excitonic properties	measure of the aggregate excitonic property	1	0.987403161140781	489	5991	489	
10180	burnetii exposure	burnetii exposure	1	0.987403161140781	5191	2519	5191	
8356	animal challenge models	animal challenge model	1	0.987403161140781	8358	4461	7459	
8125	induction of apoptosis	induction of apoptosis	1	0.987403161140781	5850	4126	5850	
9838	tract chlamydia infection	tract chlamydia infection	1	0.987403161140781	274	9839	274	
820	tolerant staphylococcal strains	tolerant staphylococcal strain	1	0.987403161140781	822	821	551	
6694	dissociation constant	dissociation constant	1	0.987403161140781	6696	6695	6696	
1355	causal agent	causal agent	1	0.987403161140781	1357	1356	1357	
40	deterioration of food flavor	deterioration of food flavor	1	0.987403161140781	41	42	41	
4226	scanning microscopy	scanning microscopy	1	0.987403161140781	2816	4227	2816	
4288	non-pulmonary sites	non-pulmonary site	1	0.987403161140781	1139	304	1139	
9975	mosquitocidal Bacillus thuringiensis serovar sotto strain	mosquitocidal Bacillus thuringiensis serovar sotto strain	1	0.987403161140781	9977	9976	76	
14998	tularensis adhesion	tularensis adhesion	1	0.987403161140781	336	5453	336	
15716	obligate intracellular bacterial pathogen	obligate intracellular bacterial pathogen	1	0.987403161140781	15718	3322	1905	
5877	cardiovascular cells	cardiovascular cell	1	0.987403161140781	113	2063	113	
11408	cells of the adult PNS	cell of the adult PNS	1	0.987403161140781	113	11410	113	
7714	chlorosomes of green photosynthetic bacteria	chlorosome of green photosynthetic bacteria	1	0.987403161140781	4776	7716	4776	
12564	vein occlusion of the left ileofemoral vein	vein occlusion of the left ileofemoral vein	1	0.987403161140781	12566	12565	12567	
4794	goods' traits	goods' trait	1	0.987403161140781	4796	4795	4796	
6214	state levels of fnbA	state level of fnbA	1	0.987403161140781	6216	788	495	
13937	organic acid levels	organic acid level	1	0.987403161140781	495	13938	495	
16986	beta fragment	beta fragment	1	0.987403161140781	1268	15316	1268	
16416	resistant Staphylococcus aureus strains	resistant Staphylococcus aureus strain	1	0.987403161140781	16418	123	551	
16556	surface exposure of phosphatidylserine	surface exposure of phosphatidylserine	1	0.987403161140781	16558	339	5191	
13243	cardiovascular collapse	cardiovascular collapse	1	0.987403161140781	13245	2063	13245	
12009	decisive role	decisive role	1	0.987403161140781	233	12010	233	
5075	sigma B-dependent asp23 mRNA levels	sigma B-dependent asp23 mRNA level	1	0.987403161140781	5077	5076	495	
2369	commercial methods	commercial method	1	0.987403161140781	2371	1454	2371	
13061	different growth media	different growth medium	1	0.987403161140781	13063	816	4763	
3678	adulticidal activity	adulticidal activity	1	0.987403161140781	393	3679	393	
9966	exception of a few limited studies	exception of a few limited study	1	0.987403161140781	331	9968	331	
12397	new purification procedure	new purification procedure	1	0.987403161140781	12399	1171	650	
7265	carbonic anhydrases	carbonic anhydras	1	0.987403161140781	7267	7266	7267	
13985	cloning vector	cloning vector	1	0.987403161140781	2218	8928	2218	
158	binding of P	binding of P	1	0.987403161140781	159	160	159	
5543	exposure to Mycoplasma agassizii	exposure to Mycoplasma agassizii	1	0.987403161140781	5191	5545	5191	
3506	Gram positive bacteria	Gram positive bacteria	1	0.987403161140781	3168	615	1999	
6599	enterotoxigenic E	enterotoxigenic E	1	0.987403161140781	79	5573	79	
4027	regulatory systems	regulatory system	1	0.987403161140781	4029	3086	4029	
6305	remainder substantial regression	remainder substantial regression	1	0.987403161140781	6307	6306	6309	
2487	neuroregeneration process	neuroregeneration process	1	0.987403161140781	2489	2488	2489	
1236	squid's light organ	squid' light organ	1	0.987403161140781	1238	1237	1240	
3061	cell hydrophobicity	cell hydrophobicity	1	0.987403161140781	3063	235	3063	
2568	genotypic methods	genotypic method	1	0.987403161140781	2371	2569	2371	
11310	lack of resources	lack of resource	1	0.987403161140781	1151	11312	1151	
4345	transfer of antibodies	transfer of antibody	1	0.987403161140781	1913	517	1913	
4411	result of xylan hydrolysis	result of xylan hydrolysis	1	0.987403161140781	4412	4413	4412	
9501	Serological analysis of O	Serological analysis of O	1	0.987403161140781	9503	9502	203	
10889	indicative test	indicative test	1	0.987403161140781	85	10890	85	
12692	second half of the catalytic cycle	second half of the catalytic cycle	1	0.987403161140781	12694	3410	12695	
14429	molecular epidemiology survey	molecular epidemiology survey	1	0.987403161140781	2706	12904	2706	
940	human T cells	human T cell	1	0.987403161140781	942	834	113	
13204	modes of staphylococcal resistance	mode of staphylococcal resistance	1	0.987403161140781	13205	13206	13205	
4787	day-care center attendees	day-care center attendee	1	0.987403161140781	4791	4788	4791	
529	receptor CR3	receptor CR3	1	0.987403161140781	531	345	531	
9693	anhydrase psCA3	anhydrase psCA3	1	0.987403161140781	441	9694	441	
5663	protein S1	protein S1	1	0.987403161140781	5665	406	5665	
13098	protein weight (V(M))	protein weight (V(M))	1	0.987403161140781	13100	406	13102	
4443	LD observables	LD observable	1	0.987403161140781	4445	1980	4445	
14680	purification protocols	purification protocol	1	0.987403161140781	13666	1173	13666	
16931	enzymatic modification of the antibiotics	enzymatic modification of the antibiotic	1	0.987403161140781	16933	3863	1945	
8939	DNA damage	DNA damage	1	0.987403161140781	7418	468	7418	
13111	distinct CTL effector function	distinct CTL effector function	1	0.987403161140781	13113	2607	778	
1346	representatives of normal intestinal microflora	representative of normal intestinal microflora	1	0.987403161140781	1347	1348	1347	
4710	evolution of pathogenicity	evolution of pathogenicity	1	0.987403161140781	2009	3092	2009	
7240	alternative mechanisms	alternative mechanism	1	0.987403161140781	519	6472	519	
2682	P3 promoter	P3 promoter	1	0.987403161140781	2298	2683	2298	
1172	purification method	purification method	1	0.987403161140781	596	1173	596	
6137	blood culture isolates of non-O1 V	blood culture isolate of non-O1 V	1	0.987403161140781	6139	2208	334	
6947	cellular adhesion	cellular adhesion	1	0.987403161140781	336	3121	336	
5254	fluorescent dyes	fluorescent dye	1	0.987403161140781	5256	5255	5256	
12779	Symbiotic induction of pyruvate dehydrogenase genes	Symbiotic induction of pyruvate dehydrogenase gene	1	0.987403161140781	12781	12780	5850	
6634	Association of mutation patterns	Association of mutation pattern	1	0.987403161140781	3884	6636	3884	
5317	resistant screening agar	resistant screening agar	1	0.987403161140781	670	123	672	
6049	SYTOX Green exclusion	SYTOX Green exclusion	1	0.987403161140781	6051	6050	3639	
5460	Ah LexA repressor	Ah LexA repressor	1	0.987403161140781	5462	5461	5464	
16900	cDNA of MyD88	cDNA of MyD88	1	0.987403161140781	6626	3773	6626	
5099	intestinal epithelial cells	intestinal epithelial cell	1	0.987403161140781	5101	129	113	
8472	A rotavirus	A rotavirus	1	0.987403161140781	8474	1379	8474	
13201	gene of the TL	gene of the TL	1	0.987403161140781	18	700	18	
8382	based iron uptake systems	based iron uptake system	1	0.987403161140781	8384	8383	4029	
14984	low level of resistance of individual cells of H	low level of resistance of individual cell of H	1	0.987403161140781	14986	1109	1113	
7435	coli helix	coli helix	1	0.987403161140781	5640	696	5640	
6826	cytotoxicity screening	cytotoxicity screening	1	0.987403161140781	671	6827	671	
3917	exclusive symbiotic relationship	exclusive symbiotic relationship	1	0.987403161140781	3919	3918	2156	
10103	high carriage rate	high carriage rate	1	0.987403161140781	7309	264	154	
7408	cloacal swabs	cloacal swab	1	0.987403161140781	3050	7409	3050	
14228	n=7 populations	n=7 population	1	0.987403161140781	1428	14229	1428	
13316	phylum Bacteroidetes	phylum Bacteroidete	1	0.987403161140781	13318	13317	13318	
12211	specific virulence determinant	specific virulence determinant	1	0.987403161140781	12213	504	7005	
6805	protease of Bacillus polymyxa	protease of Bacillus polymyxa	1	0.987403161140781	1184	6807	1184	
6185	VRE studies	VRE study	1	0.987403161140781	2918	3192	2918	
1677	normal development	normal development	1	0.987403161140781	1679	1349	1679	
177	year-old secondary recurrent aborter	year-old secondary recurrent aborter	1	0.987403161140781	179	178	183	
12783	pyruvate dehydrogenase genes	pyruvate dehydrogenase gene	1	0.987403161140781	12785	2745	444	
10213	strains of Pseudomonas aeruginosa	strain of Pseudomonas aeruginosa	1	0.987403161140781	551	2317	551	
2769	cases of CDI	case of CDI	1	0.987403161140781	2770	979	2770	
9185	balanced salt solution	balanced salt solution	1	0.987403161140781	9187	9186	5423	
352	Zollinger Ellison's syndrome	Zollinger Ellison' syndrome	1	0.987403161140781	354	353	356	
10057	crystal structure of Hb	crystal structure of Hb	1	0.987403161140781	10058	5618	201	
3300	effectiveness ratio	effectiveness ratio	1	0.987403161140781	3302	3301	3302	
9995	multocida isolates	multocida isolate	1	0.987403161140781	334	9996	334	
10997	large numbers of gamma delta T cells	large number of gamma delta T cell	1	0.987403161140781	10999	288	46	
11786	response to intracellular pathogens	response to intracellular pathogen	1	0.987403161140781	286	11788	286	
3588	sensitive phosphorylation	sensitive phosphorylation	1	0.987403161140781	3590	3589	3590	
7043	surface methodology	surface methodology	1	0.987403161140781	7045	339	7045	
5286	unique metabolic traits	unique metabolic trait	1	0.987403161140781	5288	3347	4796	
4741	durans HZ28	duran HZ28	1	0.987403161140781	4743	4742	4743	
3223	ozone demand	ozone demand	1	0.987403161140781	3225	1630	3225	
6550	sequence types	sequence type	1	0.987403161140781	769	1657	769	
15484	infection clinics	infection clinic	1	0.987403161140781	15486	274	15486	
3480	high affinity to heme	high affinity to heme	1	0.987403161140781	3481	1958	2311	
9140	pathogenic bacterium	pathogenic bacterium	1	0.987403161140781	1136	2418	1136	
362	chronic foreign body MRSA infection	chronic foreign body MRSA infection	1	0.987403161140781	364	363	274	
4899	P4 site	P4 site	1	0.987403161140781	3	4900	3	
6003	major therapeutic challenge	major therapeutic challenge	1	0.987403161140781	6005	71	2836	
13058	3-day incubation	3-day incubation	1	0.987403161140781	4801	13059	4801	
6803	neutral protease of Bacillus polymyxa	neutral protease of Bacillus polymyxa	1	0.987403161140781	6805	1604	1184	
903	non-operative traumatic brain injury	non-operative traumatic brain injury	1	0.987403161140781	905	904	909	
8776	eutropha H850 cells	eutropha H850 cell	1	0.987403161140781	8778	8777	113	
4426	survey populations	survey population	1	0.987403161140781	1428	2706	1428	
5382	working resolution	working resolution	1	0.987403161140781	1852	5383	1852	
913	CLSI M100	CLSI M100	1	0.987403161140781	915	914	915	
5135	culture methods	culture method	1	0.987403161140781	2371	2092	2371	
3073	burnetii extract	burnetii extract	1	0.987403161140781	3075	2519	3075	
14238	ARS activity	ARS activity	1	0.987403161140781	393	328	393	
508	oral routes	oral route	1	0.987403161140781	510	509	510	
15546	influenzae subspecies	influenzae subspecy	1	0.987403161140781	1119	3781	1119	
4181	pipiens molestus	pipien molestus	1	0.987403161140781	4183	4182	4183	
4265	hematological ward	hematological ward	1	0.987403161140781	4267	4266	4267	
9367	placebo group	placebo group	1	0.987403161140781	351	2390	351	
12213	virulence determinant	virulence determinant	1	0.987403161140781	7005	383	7005	
16523	reading frame	reading frame	1	0.987403161140781	16525	16524	16525	
15149	Kirby zone size	Kirby zone size	1	0.987403161140781	15151	15150	2659	
8658	organism' development of a biofilm	organism' development of a biofilm	1	0.987403161140781	8660	8659	1679	
14107	fructose medium	fructose medium	1	0.987403161140781	1926	624	1926	
12804	Symptom relief	Symptom relief	1	0.987403161140781	12806	12805	12806	
2452	kingae infection	kingae infection	1	0.987403161140781	274	1052	274	
14889	molecular pathways	molecular pathway	1	0.987403161140781	5389	376	5389	
15374	novels ligands	novel ligand	1	0.987403161140781	7417	15375	7417	
9370	sarA mRNA levels	sarA mRNA level	1	0.987403161140781	1569	2681	495	
6801	Bacterial neutral protease of Bacillus polymyxa	Bacterial neutral protease of Bacillus polymyxa	1	0.987403161140781	6803	1177	1184	
2230	periplasm of sucrose	periplasm of sucrose	1	0.987403161140781	2231	2232	2231	
12163	fibrotic changes	fibrotic change	1	0.987403161140781	1846	12164	1846	
9107	important mechanism	important mechanism	1	0.987403161140781	525	118	525	
3174	human colonic mucin	human colonic mucin	1	0.987403161140781	3176	834	677	
6514	sensory evaluation	sensory evaluation	1	0.987403161140781	6516	6515	6516	
16938	species of a new genus	specie of a new genus	1	0.987403161140781	73	15932	73	
15343	mammalian aspartic proteinases pepsinogen	mammalian aspartic proteinas pepsinogen	1	0.987403161140781	15345	411	4094	
11968	stages of processing	stage of processing	1	0.987403161140781	1098	8763	1098	
13238	EHEC strain EDL	EHEC strain EDL	1	0.987403161140781	13240	10421	13242	
6119	asymptomatic subjects	asymptomatic subject	1	0.987403161140781	2625	6120	2625	
1197	smaller granulomata	small granuloma	1	0.987403161140781	1199	1198	1199	
4273	18-month study of the safety	18-month study of the safety	1	0.987403161140781	4275	4274	1514	
6016	intestinal inflammatory pathologies	intestinal inflammatory pathology	1	0.987403161140781	6018	129	6020	
3077	subsequent detection of salmonellae	subsequent detection of salmonellae	1	0.987403161140781	3079	841	2459	
1028	natural products chemistry	natural product chemistry	1	0.987403161140781	1030	1029	1032	
7131	pathogenic infection	pathogenic infection	1	0.987403161140781	274	2418	274	
664	pneumonia infection	pneumonia infection	1	0.987403161140781	274	665	274	
12329	influence of different factors	influence of different factor	1	0.987403161140781	3119	12331	3119	
13275	severity of infection	severity of infection	1	0.987403161140781	436	274	436	
1408	septic tank	septic tank	1	0.987403161140781	1410	1409	1410	
12418	serum concentration of PGI	serum concentration of PGI	1	0.987403161140781	12420	1798	2012	
2410	lines of evidence	line of evidence	1	0.987403161140781	2411	2412	2411	
4127	changes of pathogens	change of pathogen	1	0.987403161140781	1846	186	1846	
322	clinical features	clinical feature	1	0.987403161140781	157	323	157	
2932	infected monocytes	infected monocyte	1	0.987403161140781	2934	1838	2934	
4220	monodisperse suspension	monodisperse suspension	1	0.987403161140781	4222	4221	4222	
15786	membrane of R	membrane of R	1	0.987403161140781	3723	1492	3723	
1367	scope of microbial work	scope of microbial work	1	0.987403161140781	1368	1369	1368	
11960	cells of the PNS	cell of the PNS	1	0.987403161140781	113	11412	113	
14566	source of significant morbidity	source of significant morbidity	1	0.987403161140781	3893	14568	3893	
4419	groups antibody detection	group antibody detection	1	0.987403161140781	4421	4420	2459	
14772	tryptophan fluorescence experiments	tryptophan fluorescence experiment	1	0.987403161140781	14774	1118	1434	
4541	invasive K	invasive K	1	0.987403161140781	548	649	548	
11584	industrial production	industrial production	1	0.987403161140781	93	11585	93	
5498	specific requirement	specific requirement	1	0.987403161140781	5274	504	5274	
3215	lymph node infections	lymph node infection	1	0.987403161140781	3217	3216	736	
1421	MRSA Arbekacin	MRSA Arbekacin	1	0.987403161140781	1423	369	1423	
10185	inhibitory concentration breakpoints	inhibitory concentration breakpoint	1	0.987403161140781	10187	3014	10189	
6548	unique sequence types	unique sequence type	1	0.987403161140781	6550	3347	769	
13350	strong antibacterial activities	strong antibacterial activity	1	0.987403161140781	13352	1751	1316	
7041	Response surface methodology	Response surface methodology	1	0.987403161140781	7043	7042	7045	
442	ParC genes	ParC gene	1	0.987403161140781	444	443	444	
12735	inflammatory response of turbot	inflammatory response of turbot	1	0.987403161140781	12737	2643	286	
7690	further C-UBT	further C-UBT	1	0.987403161140781	476	2629	476	
14520	intracellular signaling pathways	intracellular signaling pathway	1	0.987403161140781	5387	859	5389	
15391	Bax system	Bax system	1	0.987403161140781	1501	4510	1501	
11730	presence of professional phagocytes	presence of professional phagocyte	1	0.987403161140781	139	5156	139	
10736	strain relatedness	strain relatedness	1	0.987403161140781	10738	76	10738	
16152	resistance to amikacin	resistance to amikacin	1	0.987403161140781	1830	3691	1830	
7392	zymosan injection to the peritoneal cavity	zymosan injection to the peritoneal cavity	1	0.987403161140781	7394	7393	3505	
1915	caecal wall of the chicks	caecal wall of the chick	1	0.987403161140781	1917	1916	1918	
16428	significant predictor of hypoacidity	significant predictor of hypoacidity	1	0.987403161140781	16430	24	188	
6541	soluble proteins	soluble protein	1	0.987403161140781	27	6542	27	
11702	lower respiratory disease	low respiratory disease	1	0.987403161140781	11704	1390	268	
885	Thalidomide immunomodulation	Thalidomide immunomodulation	1	0.987403161140781	887	886	887	
8665	health information	health information	1	0.987403161140781	5490	6744	5490	
12717	pig model of infection	pig model of infection	1	0.987403161140781	12719	1660	361	
10358	bacterial endosymbiont	bacterial endosymbiont	1	0.987403161140781	827	185	827	
14088	important mediator	important mediator	1	0.987403161140781	14090	118	14090	
7999	rickettsial antigens	rickettsial antigen	1	0.987403161140781	4100	812	4100	
16749	Display of active subtilisin	Display of active subtilisin	1	0.987403161140781	16750	16751	16750	
5637	expression of genes	expression of gene	1	0.987403161140781	373	444	373	
3810	specific cell types	specific cell type	1	0.987403161140781	769	3811	769	
12570	ileofemoral vein	ileofemoral vein	1	0.987403161140781	12565	12571	12565	
1703	lateral roots	lateral root	1	0.987403161140781	1705	1704	1705	
16111	HTS process	HTS process	1	0.987403161140781	2489	5694	2489	
9763	Molecular determinants	Molecular determinant	1	0.987403161140781	1717	3742	1717	
4844	essential oils	essential oil	1	0.987403161140781	4846	1607	4846	
5668	attachment of E	attachment of E	1	0.987403161140781	938	79	938	
2553	intestinal microbiota	intestinal microbiota	1	0.987403161140781	2555	129	2555	
9483	micro fibrils	micro fibril	1	0.987403161140781	9485	2951	9485	
10201	large excess of ligand	large excess of ligand	1	0.987403161140781	10203	288	10204	
4207	microheterogeneous mixture	microheterogeneous mixture	1	0.987403161140781	2124	4208	2124	
7933	Bacteroides fragilis	Bacteroide fragilis	1	0.987403161140781	7935	7929	7935	
14795	small G protein	small G protein	1	0.987403161140781	14797	566	406	
2541	MDRP emergence	MDRP emergence	1	0.987403161140781	1702	541	1702	
11908	reference strain	reference strain	1	0.987403161140781	76	1447	76	
8950	specific CD8+ T cell response	specific CD8+ T cell response	1	0.987403161140781	286	8951	286	
3425	useful adjunct	useful adjunct	1	0.987403161140781	3427	3426	3427	
5261	capping activity	capping activity	1	0.987403161140781	393	5262	393	
3728	periplasmic alkaline phosphatase	periplasmic alkaline phosphatase	1	0.987403161140781	1288	3729	1290	
13004	children ages	child age	1	0.987403161140781	13006	1560	13006	
2873	costs of fidaxomicin	cost of fidaxomicin	1	0.987403161140781	2874	1070	2874	
11420	significant advantage	significant advantage	1	0.987403161140781	4703	24	4703	
11832	Demographic characteristics	Demographic characteristic	1	0.987403161140781	3758	11833	3758	
10448	vaccinia virus	vaccinia virus	1	0.987403161140781	768	10449	768	
10041	intermittent 28-day courses of AZLI treatment	intermittent 28-day course of AZLI treatment	1	0.987403161140781	10043	10042	61	
5524	head AIS	head AIS	1	0.987403161140781	5526	5525	5526	
9836	genital tract chlamydia infection	genital tract chlamydia infection	1	0.987403161140781	9838	6167	274	
15935	inclusion body formation	inclusion body formation	1	0.987403161140781	4488	15936	4488	
4429	respect to age	respect to age	1	0.987403161140781	424	912	424	
4243	Chronic gastritis	Chronic gastritis	1	0.987403161140781	4245	4244	4245	
9940	barbed ends	barbed end	1	0.987403161140781	9942	9941	9942	
1443	susceptibility test	susceptibility test	1	0.987403161140781	85	273	85	
12540	resistant lactococci	resistant lactococci	1	0.987403161140781	6322	123	6322	
16790	bacterial ligand EF	bacterial ligand EF	1	0.987403161140781	16792	185	1019	
13944	negative predictive value	negative predictive value	1	0.987403161140781	954	238	211	
2376	large numbers of self	large number of self	1	0.987403161140781	2378	288	46	
5650	refinement of the selenomethionine structure	refinement of the selenomethionine structure	1	0.987403161140781	5651	5652	5651	
4552	E2p component	E2p component	1	0.987403161140781	918	4553	918	
4810	discriminatory index of antibiograms	discriminatory index of antibiogram	1	0.987403161140781	1231	1551	1233	
7038	specific antibodies	specific antibody	1	0.987403161140781	517	504	517	
7803	pathogen of young children	pathogen of young child	1	0.987403161140781	1905	7805	1905	
16706	base excess	base excess	1	0.987403161140781	10204	5487	10204	
10208	yeast extract	yeast extract	1	0.987403161140781	3075	3090	3075	
7949	specific ligand binding	specific ligand binding	1	0.987403161140781	7951	504	159	
3398	course of infection	course of infection	1	0.987403161140781	2939	274	2939	
8810	adhesive factor of an enterotoxigenic Escherichia coli strain	adhesive factor of an enterotoxigenic Escherichia coli strain	1	0.987403161140781	5685	5572	72	
6553	response to virulence plasmid	response to virulence plasmid	1	0.987403161140781	286	5441	286	
325	isolation of an ARS site	isolation of an ARS site	1	0.987403161140781	326	327	326	
4467	Trial of H . pylori	Trial of H . pylori	1	0.987403161140781	4468	4469	4468	
15496	Agrobacterium rhizogenes strains of the agropine type	Agrobacterium rhizogene strain of the agropine type	1	0.987403161140781	15498	15497	551	
12807	octadecadienoic acid	octadecadienoic acid	1	0.987403161140781	4	12808	4	
7520	larger quantities of IFN	large quantity of IFN	1	0.987403161140781	7522	7521	1964	
850	periphery of the BCG granulomas	periphery of the BCG granuloma	1	0.987403161140781	851	852	851	
13063	growth media	growth medium	1	0.987403161140781	4763	217	4763	
13658	alvei strain	alvei strain	1	0.987403161140781	76	801	76	
7250	bacterial reductions	bacterial reduction	1	0.987403161140781	7252	185	7252	
6587	susceptibility to antibiotics	susceptibility to antibiotic	1	0.987403161140781	273	3547	273	
3434	UreR mutants	UreR mutant	1	0.987403161140781	1936	90	1936	
10561	live vaccine	live vaccine	1	0.987403161140781	9215	10562	9215	
3500	thermal injury patient	thermal injury patient	1	0.987403161140781	3504	3501	3504	
13942	high negative predictive value	high negative predictive value	1	0.987403161140781	13944	264	211	
9464	group P21212	group P21212	1	0.987403161140781	9466	351	9466	
12866	increase of intensity	increase of intensity	1	0.987403161140781	1465	4874	1465	
4224	laser scanning microscopy	laser scanning microscopy	1	0.987403161140781	4226	4225	2816	
767	virus types	virus type	1	0.987403161140781	769	768	769	
12818	important factor	important factor	1	0.987403161140781	72	118	72	
4095	year-old patient	year-old patient	1	0.987403161140781	3504	178	3504	
14019	Hawaiian bobtail squid	Hawaiian bobtail squid	1	0.987403161140781	14021	14020	14023	
14011	Cry protein	Cry protein	1	0.987403161140781	406	14012	406	
9610	intracellular pathogen	intracellular pathogen	1	0.987403161140781	1905	859	1905	
15867	melitensis 16M native hapten	melitensis 16M native hapten	1	0.987403161140781	15869	15868	15873	
287	large amount of disorder	large amount of disorder	1	0.987403161140781	289	288	290	
6279	tract device usage	tract device usage	1	0.987403161140781	6281	3496	6283	
8257	vast majority of the cases	vast majority of the case	1	0.987403161140781	8259	8258	5215	
11971	downstream signaling pathway of neuregulin	downstream signaling pathway of neuregulin	1	0.987403161140781	11973	11972	661	
6468	single light	single light	1	0.987403161140781	6470	1933	6470	
645	pathologic findings	pathologic finding	1	0.987403161140781	647	646	647	
1820	copy number of pTRA1	copy number of pTRA1	1	0.987403161140781	1822	1821	1034	
2573	15% NaCl	15% NaCl	1	0.987403161140781	446	2574	446	
7745	human autologous dendritic cells	human autologous dendritic cell	1	0.987403161140781	7747	834	113	
10097	predictor of recurrence	predictor of recurrence	1	0.987403161140781	188	2751	188	
9902	high levels of protection	high level of protection	1	0.987403161140781	9729	1310	495	
1696	novel type	novel type	1	0.987403161140781	1698	82	1698	
7111	start sites	start site	1	0.987403161140781	1139	7112	1139	
9030	reagent addition steps	reagent addition step	1	0.987403161140781	9032	9031	9034	
1755	IS6110 typing	IS6110 typing	1	0.987403161140781	1658	1398	1658	
12524	prevalence of H . pylori	prevalence of H . pylori	1	0.987403161140781	1786	4469	1786	
16347	transcript levels	transcript level	1	0.987403161140781	495	16348	495	
8660	development of a biofilm	development of a biofilm	1	0.987403161140781	1679	8662	1679	
7109	transcriptional start sites	transcriptional start site	1	0.987403161140781	7111	2780	1139	
332	of4 isolates	of4 isolate	1	0.987403161140781	334	333	334	
9977	Bacillus thuringiensis serovar sotto strain	Bacillus thuringiensis serovar sotto strain	1	0.987403161140781	9979	3924	76	
15445	dead space	dead space	1	0.987403161140781	3294	15446	3294	
14015	crystal structures	crystal structure	1	0.987403161140781	11010	4195	11010	
5797	high level of NTHi diversity	high level of NTHi diversity	1	0.987403161140781	5798	5801	1113	
11889	axenic rice seedlings	axenic rice seedling	1	0.987403161140781	8162	11890	8164	
6133	Tu antibodies	Tu antibody	1	0.987403161140781	517	3221	517	
10999	numbers of gamma delta T cells	number of gamma delta T cell	1	0.987403161140781	46	2855	46	
5746	presence of epithelial cells	presence of epithelial cell	1	0.987403161140781	139	5101	139	
3787	phosphate isomerase	phosphate isomerase	1	0.987403161140781	3789	350	3789	
14126	bacterial surface protein	bacterial surface protein	1	0.987403161140781	2341	185	406	
9776	baumannii pathogenesis	baumannii pathogenesis	1	0.987403161140781	3055	3200	3055	
13115	effector function	effector function	1	0.987403161140781	778	4557	778	
14615	inoculation of approx	inoculation of approx	1	0.987403161140781	6330	14617	6330	
4523	water content of the stools	water content of the stool	1	0.987403161140781	4525	920	4526	
2252	importance of adhesion	importance of adhesion	1	0.987403161140781	684	336	684	
8024	decomposition to a nontoxic product	decomposition to a nontoxic product	1	0.987403161140781	8025	8026	8025	
5604	strain MRGR3	strain MRGR3	1	0.987403161140781	5606	76	5606	
15007	type chlorosomes	type chlorosome	1	0.987403161140781	4776	1698	4776	
395	NOESY analysis of the kinetic network	NOESY analysis of the kinetic network	1	0.987403161140781	397	396	203	
9973	Characterization of a mosquitocidal Bacillus thuringiensis serovar sotto strain	Characterization of a mosquitocidal Bacillus thuringiensis serovar sotto strain	1	0.987403161140781	2897	9975	2897	
13129	Hg(II) challenge	Hg(II) challenge	1	0.987403161140781	2836	5190	2836	
4850	heterosexual transmission of HIV	heterosexual transmission of HIV	1	0.987403161140781	4852	4851	1849	
2767	inpatient cases of CDI	inpatient case of CDI	1	0.987403161140781	2769	2768	2770	
13073	Diagnosis of atrophic body gastritis	Diagnosis of atrophic body gastritis	1	0.987403161140781	13074	13075	13074	
13770	High reactivity	High reactivity	1	0.987403161140781	3019	5844	3019	
16281	wide variety of substrates	wide variety of substrate	1	0.987403161140781	16283	2070	1261	
3719	PCR analysis	PCR analysis	1	0.987403161140781	203	2264	203	
12345	complementary strand	complementary strand	1	0.987403161140781	12347	12346	12347	
6996	exploitation of glycoprotein biosynthesis	exploitation of glycoprotein biosynthesis	1	0.987403161140781	6997	6998	6997	
9541	transcriptional output	transcriptional output	1	0.987403161140781	9543	2780	9543	
3926	Results of serotyping of strains	Result of serotyping of strain	1	0.987403161140781	3927	3928	3927	
13884	alvei isolates	alvei isolate	1	0.987403161140781	334	801	334	
138	presence of glycoprotein	presence of glycoprotein	1	0.987403161140781	139	140	139	
11463	circulatory shock	circulatory shock	1	0.987403161140781	1187	11464	1187	
10045	courses of AZLI treatment	course of AZLI treatment	1	0.987403161140781	61	10046	61	
2805	avirulent R	avirulent R	1	0.987403161140781	1492	2806	1492	
14909	complementary strands	complementary strand	1	0.987403161140781	14911	12346	14911	
7805	young children	young child	1	0.987403161140781	1560	2738	1560	
1596	like toxin	like toxin	1	0.987403161140781	1598	829	1598	
7533	novel route	novel route	1	0.987403161140781	5164	82	5164	
2973	whole cells	whole cell	1	0.987403161140781	113	2974	113	
5172	Cryptosporidium parvum	Cryptosporidium parvum	1	0.987403161140781	5174	5173	5174	
6352	potential of F	potential of F	1	0.987403161140781	6353	48	6353	
5233	carbon sources	carbon source	1	0.987403161140781	5235	2033	5235	
6037	value of multiple Helicobacter pylori	value of multiple Helicobacter pylori	1	0.987403161140781	211	6039	211	
2155	relationship to phylogeny	relationship to phylogeny	1	0.987403161140781	2156	2157	2156	
4676	multiplex polymerase chain reaction	multiplex polymerase chain reaction	1	0.987403161140781	557	4677	561	
6993	ng of antigen	ng of antigen	1	0.987403161140781	6994	655	6994	
6457	harsh hospital environments	harsh hospital environment	1	0.987403161140781	6459	6458	752	
872	Enterobacter cloacae IPM	Enterobacter cloaca IPM	1	0.987403161140781	874	873	876	
8210	detection rate of H	detection rate of H	1	0.987403161140781	6719	764	154	
4979	larvicidal activity	larvicidal activity	1	0.987403161140781	393	4980	393	
8132	protein patterns	protein pattern	1	0.987403161140781	2366	406	2366	
9769	significant competition	significant competition	1	0.987403161140781	9771	24	9771	
2606	distinct lineage	distinct lineage	1	0.987403161140781	2442	2607	2442	
9686	aminoglycoside phosphotransferase	aminoglycoside phosphotransferase	1	0.987403161140781	9688	9687	9688	
12917	Bacteremic episodes	Bacteremic episode	1	0.987403161140781	1666	12918	1666	
6679	administration of antibiotics	administration of antibiotic	1	0.987403161140781	3007	3547	3007	
6655	intestinal lesions	intestinal lesion	1	0.987403161140781	2399	129	2399	
14268	response rate	response rate	1	0.987403161140781	154	286	154	
1837	infected Escherichia coli cells	infected Escherichia coli cell	1	0.987403161140781	1839	1838	113	
8138	clinical materials	clinical material	1	0.987403161140781	8140	323	8140	
9321	activities of cephems	activity of cephem	1	0.987403161140781	1316	8425	1316	
16682	strains of H . influenzae	strain of H . influenzae	1	0.987403161140781	551	16684	551	
9232	carriage rate of H	carriage rate of H	1	0.987403161140781	7309	764	154	
2877	compounds (R(2)SUP	compound (R(2)SUP	1	0.987403161140781	2879	2878	2879	
16210	metabolic engineering of the obligate methanotroph Methylomonas sp	metabolic engineering of the obligate methanotroph Methylomonas sp	1	0.987403161140781	2120	12626	2122	
1572	Evaluation of antibacterial activity	Evaluation of antibacterial activity	1	0.987403161140781	1573	1574	1573	
3351	specificity of 76%	specificity of 76%	1	0.987403161140781	3352	3353	3352	
3885	MerR metal	MerR metal	1	0.987403161140781	506	3420	506	
11064	surface of filamentous fd phage	surface of filamentous fd phage	1	0.987403161140781	339	11066	339	
1991	engulfment ligand	engulfment ligand	1	0.987403161140781	1993	1992	1993	
4639	dermaseptin S4	dermaseptin S4	1	0.987403161140781	4641	4640	4641	
16370	consistent definition of clearance	consistent definition of clearance	1	0.987403161140781	16372	16371	16373	
730	signaling mechanisms	signaling mechanism	1	0.987403161140781	519	731	519	
10494	presence of additives	presence of additive	1	0.987403161140781	139	10496	139	
8081	clustering of resistance phenotypes	clustering of resistance phenotype	1	0.987403161140781	8082	8083	8082	
10790	excess of Zn(II)	excess of Zn(II)	1	0.987403161140781	10204	10792	10204	
13449	RGG domain of nucleolin	RGG domain of nucleolin	1	0.987403161140781	13450	254	253	
16340	seasonal distribution	seasonal distribution	1	0.987403161140781	895	16341	895	
2094	wide genetic diversity of M	wide genetic diversity of M	1	0.987403161140781	2096	2070	2099	
9698	marine cyanobacteria	marine cyanobacteria	1	0.987403161140781	9700	1135	9700	
2490	progression of anthrax	progression of anthrax	1	0.987403161140781	2491	2492	2491	
11822	important role of hemopexin	important role of hemopexin	1	0.987403161140781	4834	412	233	
8962	susceptibility to E	susceptibility to E	1	0.987403161140781	273	79	273	
5019	Atrophic body gastritis	Atrophic body gastritis	1	0.987403161140781	5021	5020	4245	
8867	rRNA gene sequences	rRNA gene sequence	1	0.987403161140781	8869	8868	534	
9351	diagnosis of bacterial meningitis	diagnosis of bacterial meningitis	1	0.987403161140781	5010	7742	5010	
16538	jelly roll	jelly roll	1	0.987403161140781	16540	16539	16540	
10075	intermittent patterns of carriage	intermittent pattern of carriage	1	0.987403161140781	10077	10042	2366	
7218	N-terminal region of ActA	N-terminal region of ActA	1	0.987403161140781	7220	1267	3464	
1956	scavenging heme	scavenging heme	1	0.987403161140781	1958	1957	1958	
815	different degrees of severity	different degree of severity	1	0.987403161140781	817	816	818	
7801	invasive pathogen of young children	invasive pathogen of young child	1	0.987403161140781	7803	649	1905	
12166	unknown mechanism	unknown mechanism	1	0.987403161140781	525	12167	525	
3881	bacterial challenge	bacterial challenge	1	0.987403161140781	2836	185	2836	
7134	unrelated bacterium Deinococcus radiodurans	unrelated bacterium Deinococcus radioduran	1	0.987403161140781	7136	7135	7140	
7206	cyanogen bromide cleavage	cyanogen bromide cleavage	1	0.987403161140781	7208	7207	4898	
12887	SCID mice	SCID mouse	1	0.987403161140781	1065	12888	1065	
14477	exploit type	exploit type	1	0.987403161140781	1698	14478	1698	
289	amount of disorder	amount of disorder	1	0.987403161140781	290	291	290	
15844	bile resistances	bile resistance	1	0.987403161140781	15846	1024	15846	
4582	proportion of Mycoplasma otitis cases	proportion of Mycoplasma otitis case	1	0.987403161140781	1247	4584	1247	
15954	preventive measures	preventive measure	1	0.987403161140781	489	15955	489	
5146	omission of individual amino acids	omission of individual amino acid	1	0.987403161140781	5147	5148	5147	
9796	cardiac failure markers	cardiac failure marker	1	0.987403161140781	9798	2829	9800	
11377	reduction of annexin1	reduction of annexin1	1	0.987403161140781	276	1994	276	
967	cyanide production	cyanide production	1	0.987403161140781	93	968	93	
16509	predictions of gastric pH	prediction of gastric pH	1	0.987403161140781	16510	189	16510	
5004	calcium responses	calcium response	1	0.987403161140781	2627	5005	2627	
9229	grade of atrophy	grade of atrophy	1	0.987403161140781	4071	1396	4071	
8577	functional domain of ActA	functional domain of ActA	1	0.987403161140781	8579	3355	253	
16129	duration of carriage	duration of carriage	1	0.987403161140781	3208	7310	3208	
1476	high salt concentrations	high salt concentration	1	0.987403161140781	1478	264	163	
6130	states of acylation	state of acylation	1	0.987403161140781	1909	69	1909	
3487	glycosylation processes	glycosylation process	1	0.987403161140781	3489	1430	3489	
4025	different regulatory systems	different regulatory system	1	0.987403161140781	4027	816	4029	
13497	isolates of atypical mycobacteria	isolate of atypical mycobacterium	1	0.987403161140781	334	13499	334	
3127	significant decrease	significant decrease	1	0.987403161140781	3129	24	3129	
16875	Latin American country	Latin American country	1	0.987403161140781	16877	16876	16879	
1954	metabolism scavenging heme	metabolism scavenging heme	1	0.987403161140781	1956	1955	1958	
10883	ring opening	ring opening	1	0.987403161140781	9482	5195	9482	
13422	translocation assays	translocation assay	1	0.987403161140781	3106	1768	3106	
7975	novel bacteria	novel bacteria	1	0.987403161140781	1999	82	1999	
14277	parvum oocyst	parvum oocyst	1	0.987403161140781	14279	5174	14279	
14361	cell cultures	cell culture	1	0.987403161140781	4706	235	4706	
3373	percentage neutrophils	percentage neutrophil	1	0.987403161140781	2439	3374	2439	
14785	human CTLs	human CTL	1	0.987403161140781	13011	834	13011	
11123	common cause of Gram	common cause of Gram	1	0.987403161140781	11125	870	8326	
10611	food venue	food venue	1	0.987403161140781	10613	43	10613	
9295	complete inhibition of activity	complete inhibition of activity	1	0.987403161140781	9297	4306	2510	
10578	synthetic metabolites	synthetic metabolite	1	0.987403161140781	864	3339	864	
5270	Maintenance energy requirement	Maintenance energy requirement	1	0.987403161140781	5272	5271	5274	
14916	dominant strain of P	dominant strain of P	1	0.987403161140781	14918	1533	76	
11628	numerous research groups	numerous research group	1	0.987403161140781	11630	10645	4420	
8947	evaluation of cytotoxicity	evaluation of cytotoxicity	1	0.987403161140781	6516	6827	6516	
6866	picture of diarrhea	picture of diarrhea	1	0.987403161140781	6867	982	6867	
5399	effect of Artemisia annua	effect of Artemisia annua	1	0.987403161140781	2937	5401	2937	
9335	Identification of a novel glycoprotein	Identification of a novel glycoprotein	1	0.987403161140781	8807	9337	8807	
12751	derivative of methicillin	derivative of methicillin	1	0.987403161140781	9722	1650	9722	
16149	restriction+modification+strain of S	restriction+modification+strain of S	1	0.987403161140781	16150	1898	16150	
15639	bactericidal properties	bactericidal property	1	0.987403161140781	3103	9620	3103	
14396	activator UreR	activator UreR	1	0.987403161140781	90	14397	90	
10942	Subtle differences	Subtle difference	1	0.987403161140781	1671	10943	1671	
3217	node infections	node infection	1	0.987403161140781	736	3218	736	
616	example of a case	example of a case	1	0.987403161140781	617	618	617	
16498	daily recording of any side	daily recording of any side	1	0.987403161140781	16500	11572	16501	
9413	critical adhesin	critical adhesin	1	0.987403161140781	3583	8801	3583	
8980	chlorosome level	chlorosome level	1	0.987403161140781	1113	419	1113	
13996	significant increase	significant increase	1	0.987403161140781	1465	24	1465	
4077	ecological niche of this diverse group of organisms	ecological niche of this diverse group of organism	1	0.987403161140781	4079	4078	307	
3152	cell migration	cell migration	1	0.987403161140781	3154	235	3154	
15012	medical communities	medical community	1	0.987403161140781	990	13093	990	
6820	fluorescens infection	fluorescen infection	1	0.987403161140781	274	6821	274	
114	TLR2 crosstalk	TLR2 crosstalk	1	0.987403161140781	116	115	116	
5364	interaction of riboflavin synthase	interaction of riboflavin synthase	1	0.987403161140781	1709	204	1709	
9798	failure markers	failure marker	1	0.987403161140781	9800	3596	9800	
3457	novel marine bacterium of the family	novel marine bacterium of the family	1	0.987403161140781	3459	82	1136	
14423	specific assay	specific assay	1	0.987403161140781	562	504	562	
3607	specific pseudopeptide HB	specific pseudopeptide HB	1	0.987403161140781	3609	504	3611	
9332	iron source	iron source	1	0.987403161140781	3893	1953	3893	
2790	Concordant findings	Concordant finding	1	0.987403161140781	647	2791	647	
570	vascular permeability	vascular permeability	1	0.987403161140781	572	571	572	
9741	biotic HCE cell surface	biotic HCE cell surface	1	0.987403161140781	9743	338	339	
14184	length of study follow-up	length of study follow-up	1	0.987403161140781	2539	14186	2539	
15162	development of gastric cancer	development of gastric cancer	1	0.987403161140781	1679	385	1679	
12547	prevalence of pharyngeal carriage	prevalence of pharyngeal carriage	1	0.987403161140781	1786	12549	1786	
2620	phosphate dehydrogenase	phosphate dehydrogenase	1	0.987403161140781	2622	350	2622	
1284	measurement of neutrophil alkaline phosphatase	measurement of neutrophil alkaline phosphatase	1	0.987403161140781	1285	1286	1285	
7089	greater final density	great final density	1	0.987403161140781	7091	4501	4499	
14081	recurrent disease	recurrent disease	1	0.987403161140781	268	182	268	
12677	murine macrophages	murine macrophage	1	0.987403161140781	394	1511	394	
4121	Mycobacterium tuberculosis isolates	Mycobacterium tuberculosis isolate	1	0.987403161140781	490	261	334	
10748	invasion of host tissues	invasion of host tissue	1	0.987403161140781	1178	10750	1178	
9619	bactericidal antibodies	bactericidal antibody	1	0.987403161140781	517	9620	517	
13870	field of possible virulence factors	field of possible virulence factor	1	0.987403161140781	2362	13872	2362	
13851	bacterial viability	bacterial viability	1	0.987403161140781	4309	185	4309	
12363	capacity of the DC antigen	capacity of the DC antigen	1	0.987403161140781	4984	12365	4984	
10927	use of commercial set	use of commercial set	1	0.987403161140781	32	10929	32	
11214	outbreak investigation	outbreak investigation	1	0.987403161140781	3051	11215	3051	
8331	type of sample	type of sample	1	0.987403161140781	1698	2222	1698	
10767	sulfur bacterium Chlorobaculum tepidum	sulfur bacterium Chlorobaculum tepidum	1	0.987403161140781	5414	6703	4783	
7415	contributions of these ligands	contribution of these ligand	1	0.987403161140781	7416	7417	7416	
5643	pool to specific environmental constraints	pool to specific environmental constraint	1	0.987403161140781	5469	5645	5469	
8910	fusion to BCL	fusion to BCL	1	0.987403161140781	8418	8912	8418	
13188	metabolic engineering of microorganisms	metabolic engineering of microorganism	1	0.987403161140781	2120	1629	2122	
15500	strains of the agropine type	strain of the agropine type	1	0.987403161140781	551	15502	551	
8788	PS antigen	PS antigen	1	0.987403161140781	655	8789	655	
11859	normal flora of children	normal flora of child	1	0.987403161140781	11861	1349	1413	
7332	reservoir production fluid	reservoir production fluid	1	0.987403161140781	7334	7333	5371	
2612	signals of the different forms	signal of the different form	1	0.987403161140781	2587	2614	2587	
10029	Culture of purulent material	Culture of purulent material	1	0.987403161140781	10030	10031	10030	
16377	free enzyme	free enzyme	1	0.987403161140781	4250	112	4250	
12281	differentiation of a bacterium	differentiation of a bacterium	1	0.987403161140781	884	1136	884	
7489	monoclonal antibodies of Chlamydia trachomatis	monoclonal antibody of Chlamydia trachomatis	1	0.987403161140781	7490	4116	517	
15178	conventional culturing	conventional culturing	1	0.987403161140781	15180	11355	15180	
579	aminododecanoic acid to P14	aminododecanoic acid to P14	1	0.987403161140781	581	580	4	
16668	Hb sequence	Hb sequence	1	0.987403161140781	1657	5618	1657	
16289	isolate of R	isolate of R	1	0.987403161140781	4397	1492	4397	
4777	triple mutant of Chlorobaculum tepidum	triple mutant of Chlorobaculum tepidum	1	0.987403161140781	4779	3976	4780	
9720	3.5-kb derivative	3.5-kb derivative	1	0.987403161140781	9722	9721	9722	
12180	Positive PCR	Positive PCR	1	0.987403161140781	2264	12181	2264	
16097	neutral locations	neutral location	1	0.987403161140781	11155	1604	11155	
5897	LGV associated serovar	LGV associated serovar	1	0.987403161140781	5899	2054	5901	
11658	Clostridium perfringens infection	Clostridium perfringen infection	1	0.987403161140781	274	11659	274	
9469	strong immunoprotection	strong immunoprotection	1	0.987403161140781	9471	1751	9471	
3411	massive immigration	massive immigration	1	0.987403161140781	3413	3412	3413	
7298	tetrazolium bromide	tetrazolium bromide	1	0.987403161140781	7209	7299	7209	
7268	predominance of CD20	predominance of CD20	1	0.987403161140781	7269	5921	7269	
15454	Severe destructive arthritis	Severe destructive arthritis	1	0.987403161140781	2774	8767	2776	
14390	primary role	primary role	1	0.987403161140781	233	4073	233	
6123	C40 carotenoid synthesis	C40 carotenoid synthesis	1	0.987403161140781	513	6124	515	
11052	purpose of this study	purpose of this study	1	0.987403161140781	11053	1514	11053	
6033	molecule CD252	molecule CD252	1	0.987403161140781	6035	6034	6035	
14575	ulcer healing rate	ulcer healing rate	1	0.987403161140781	14577	6180	154	
2585	secretion signals	secretion signal	1	0.987403161140781	2587	2586	2587	
4513	tracts of healthy fish	tract of healthy fish	1	0.987403161140781	1795	4515	1795	
9944	Brucella soluble antigens	Brucella soluble antigen	1	0.987403161140781	9946	9945	4100	
14260	influx of neutrophils	influx of neutrophil	1	0.987403161140781	14261	2439	14261	
14881	numerous potential applications	numerous potential application	1	0.987403161140781	14883	10645	2931	
7315	infection period	infection period	1	0.987403161140781	2478	274	2478	
6005	therapeutic challenge	therapeutic challenge	1	0.987403161140781	2836	2756	2836	
5661	ribosomal protein S1	ribosomal protein S1	1	0.987403161140781	5663	5662	5665	
14065	% BID group	% BID group	1	0.987403161140781	14067	1209	351	
1987	susceptibility to ciprofloxacin	susceptibility to ciprofloxacin	1	0.987403161140781	273	1989	273	
1599	use of bacterial neutral protease	use of bacterial neutral protease	1	0.987403161140781	32	1601	32	
28	unrestricted antibiotic use	unrestricted antibiotic use	1	0.987403161140781	30	29	32	
1615	toxin genes	toxin gene	1	0.987403161140781	444	1598	444	
6248	temperature acclimation protein	temperature acclimation protein	1	0.987403161140781	6250	249	406	
2065	serum glycoprotein	serum glycoprotein	1	0.987403161140781	140	1798	140	
11416	Clinical benefits	Clinical benefit	1	0.987403161140781	11418	9510	11418	
1348	normal intestinal microflora	normal intestinal microflora	1	0.987403161140781	1350	1349	960	
7693	recent expansion	recent expansion	1	0.987403161140781	7695	1540	7695	
12663	host cell factors	host cell factor	1	0.987403161140781	2924	12664	2924	
10387	Infected cells	Infected cell	1	0.987403161140781	113	10388	113	
6937	presence of an unusual set of modifications	presence of an unusual set of modification	1	0.987403161140781	139	6939	139	
7880	outer membrane protein OmpX	outer membrane protein OmpX	1	0.987403161140781	7886	3803	7886	
14469	pathogenic strains of Escherichia coli exploit type	pathogenic strain of Escherichia coli exploit type	1	0.987403161140781	14471	2418	551	
5538	A la-l	A la-l	1	0.987403161140781	5540	1379	5540	
11254	activation of nuclear factor	activation of nuclear factor	1	0.987403161140781	2118	11256	2118	
6327	intracloacal inoculation of ~10¹² PFU	intracloacal inoculation of ~10¹² PFU	1	0.987403161140781	6329	6328	6330	
6856	limited pathogenicity	limited pathogenicity	1	0.987403161140781	3092	3018	3092	
877	major genetic group designation	major genetic group designation	1	0.987403161140781	879	71	883	
6063	significant effect of TeCB	significant effect of TeCB	1	0.987403161140781	6065	24	2937	
15969	Marked differences	Marked difference	1	0.987403161140781	1671	15970	1671	
11017	orders of magnitude	order of magnitude	1	0.987403161140781	11018	11019	11018	
577	conjugation of aminododecanoic acid to P14	conjugation of aminododecanoic acid to P14	1	0.987403161140781	578	579	578	
12708	rickettsial DNA	rickettsial DNA	1	0.987403161140781	468	812	468	
3266	presence of various protease inhibitors	presence of various protease inhibitor	1	0.987403161140781	139	3268	139	
11986	native state	native state	1	0.987403161140781	788	7848	788	
10329	game birds	game bird	1	0.987403161140781	4368	10330	4368	
7343	fibrin clot	fibrin clot	1	0.987403161140781	7345	126	7345	
5812	new therapy	new therapy	1	0.987403161140781	464	1171	464	
5806	management factors	management factor	1	0.987403161140781	2924	5807	2924	
15363	LAB isolates	LAB isolate	1	0.987403161140781	334	2422	334	
4278	gel filtration	gel filtration	1	0.987403161140781	4280	2364	4280	
2848	superior abilities	superior ability	1	0.987403161140781	2850	2849	2850	
15550	addition of E	addition of E	1	0.987403161140781	2743	79	2743	
7004	determinant of spontaneous gastric hypoacidity	determinant of spontaneous gastric hypoacidity	1	0.987403161140781	7005	7006	7005	
2957	Sardinian province	Sardinian province	1	0.987403161140781	2959	2958	2959	
9825	overall bacterial virulence	overall bacterial virulence	1	0.987403161140781	9827	5154	383	
9601	oxacillin resistance	oxacillin resistance	1	0.987403161140781	1830	669	1830	
15847	different hosts	different host	1	0.987403161140781	774	816	774	
16166	LAB microflora	LAB microflora	1	0.987403161140781	960	2422	960	
9399	TB strains	TB strain	1	0.987403161140781	551	9400	551	
15892	Methylocella silvestris	Methylocella silvestris	1	0.987403161140781	15894	726	15894	
14319	outbreak of cholera	outbreak of cholera	1	0.987403161140781	986	10109	986	
7582	similar immunoblot profiles	similar immunoblot profile	1	0.987403161140781	7584	1190	3564	
4386	protective MAb	protective MAb	1	0.987403161140781	2567	4387	2567	
14179	day-care centres	day-care centre	1	0.987403161140781	14181	4789	14181	
15869	16M native hapten	16M native hapten	1	0.987403161140781	15871	15870	15873	
1417	biosynthetic precursors	biosynthetic precursor	1	0.987403161140781	1419	1418	1419	
2474	4-week intake period	4-week intake period	1	0.987403161140781	2476	2475	2478	
399	kinetic network	kinetic network	1	0.987403161140781	401	400	401	
5713	farm level epidemiology	farm level epidemiology	1	0.987403161140781	5717	5714	5717	
6091	constitutive expression interfere	constitutive expression interfere	1	0.987403161140781	6095	6092	6095	
16769	Bacillus subtilis	Bacillus subtilis	1	0.987403161140781	9943	3924	9943	
4184	rapid desensitization of chemokine	rapid desensitization of chemokine	1	0.987403161140781	4186	4185	4187	
2755	therapeutic experiences	therapeutic experience	1	0.987403161140781	2757	2756	2757	
15307	genetic diversity of M	genetic diversity of M	1	0.987403161140781	15309	880	2099	
10692	ARS site(s)	ARS site(s)	1	0.987403161140781	10694	328	10694	
12031	halotolerent bacteria	halotolerent bacteria	1	0.987403161140781	1999	12032	1999	
6697	treatment of various infections	treatment of various infection	1	0.987403161140781	61	6699	61	
3838	phenolic glycolipid	phenolic glycolipid	1	0.987403161140781	3840	3839	3840	
12533	current conditions	current condition	1	0.987403161140781	2285	5987	2285	
12468	terms of metabolite concentration	term of metabolite concentration	1	0.987403161140781	10145	12470	10145	
6139	culture isolates of non-O1 V	culture isolate of non-O1 V	1	0.987403161140781	6141	2092	334	
6674	use of antibiotics	use of antibiotic	1	0.987403161140781	32	3547	32	
9739	attachment to the biotic HCE cell surface	attachment to the biotic HCE cell surface	1	0.987403161140781	938	9741	938	
4486	root formation	root formation	1	0.987403161140781	4488	4487	4488	
7312	bullae formation	bullae formation	1	0.987403161140781	4488	7313	4488	
16979	Double membranes	Double membrane	1	0.987403161140781	1899	16980	1899	
782	bio-bleaching of paper carton	bio-bleaching of paper carton	1	0.987403161140781	783	784	783	
10793	Recurrent pregnancy loss	Recurrent pregnancy loss	1	0.987403161140781	7647	10794	4308	
1213	serotypes of E	serotype of E	1	0.987403161140781	1214	79	1214	
5181	fragment length polymorphism	fragment length polymorphism	1	0.987403161140781	5183	1268	5185	
12557	residue of the region	residue of the region	1	0.987403161140781	2217	3464	2217	
14364	KMM 3909(T)	KMM 3909(T)	1	0.987403161140781	14366	14365	14366	
15337	substrate binding	substrate binding	1	0.987403161140781	159	3652	159	
4532	diglucosamine disaccharides	diglucosamine disaccharide	1	0.987403161140781	4534	4533	4534	
1317	common structure	common structure	1	0.987403161140781	201	870	201	
1461	infection increase of NAP activity	infection increase of NAP activity	1	0.987403161140781	1463	274	393	
11496	Helicobacter pylori infection	Helicobacter pylori infection	1	0.987403161140781	8215	500	274	
16385	clonal band	clonal band	1	0.987403161140781	1934	1788	1934	
15277	above bacterial isolates	above bacterial isolate	1	0.987403161140781	15279	15278	334	
1006	expression of amyloidogenic peptides	expression of amyloidogenic peptide	1	0.987403161140781	373	1008	373	
749	Concurrent pneumonia	Concurrent pneumonia	1	0.987403161140781	665	750	665	
9441	clonal strain	clonal strain	1	0.987403161140781	76	1788	76	
2291	adhesion to tissue	adhesion to tissue	1	0.987403161140781	336	569	336	
6242	positive culture	positive culture	1	0.987403161140781	2092	953	2092	
965	Hydrogen cyanide production	Hydrogen cyanide production	1	0.987403161140781	967	966	93	
14266	high response rate	high response rate	1	0.987403161140781	14268	264	154	
532	access to sequences	access to sequence	1	0.987403161140781	533	534	533	
7176	epidemiologic factors	epidemiologic factor	1	0.987403161140781	2924	7177	2924	
7822	NAP intensity increase	NAP intensity increase	1	0.987403161140781	1465	6174	1465	
14206	mechanistic implications of peptides' hydrophobicity	mechanistic implication of peptides' hydrophobicity	1	0.987403161140781	14208	867	1783	
3104	displacement assays	displacement assay	1	0.987403161140781	3106	298	3106	
11746	ability of Lactobacillus	ability of Lactobacillus	1	0.987403161140781	939	6761	939	
5673	crystallographic studies	crystallographic study	1	0.987403161140781	2918	1104	2918	
8791	aggressive monitoring	aggressive monitoring	1	0.987403161140781	2523	8792	2523	
11895	longitudinal study	longitudinal study	1	0.987403161140781	1514	11896	1514	
6713	lambdoid prophages	lambdoid prophage	1	0.987403161140781	6715	6714	6715	
4815	levels of fibronectin	level of fibronectin	1	0.987403161140781	495	603	495	
13911	mutational analyses	mutational analysis	1	0.987403161140781	8104	13912	8104	
10203	excess of ligand	excess of ligand	1	0.987403161140781	10204	1993	10204	
5372	smooth LPSs	smooth LPS	1	0.987403161140781	39	5373	39	
6189	placebo groups	placebo group	1	0.987403161140781	4420	2390	4420	
13533	pediatric inflammatory bowel disease	pediatric inflammatory bowel disease	1	0.987403161140781	2642	9873	268	
16755	novel isolate	novel isolate	1	0.987403161140781	4397	82	4397	
13100	weight (V(M))	weight (V(M))	1	0.987403161140781	13102	681	13102	
15347	proteinases pepsinogen	proteinas pepsinogen	1	0.987403161140781	4094	15348	4094	
9544	penicillinase production	penicillinase production	1	0.987403161140781	93	9545	93	
9147	resistant marker	resistant marker	1	0.987403161140781	1806	123	1806	
7872	absence of treatment	absence of treatment	1	0.987403161140781	5502	61	5502	
15591	intracellular growth of Legionella pneumophila	intracellular growth of Legionella pneumophila	1	0.987403161140781	15593	859	217	
13805	water treatment	water treatment	1	0.987403161140781	61	920	61	
14098	significant differences	significant difference	1	0.987403161140781	1671	24	1671	
8481	wide antisense transcription	wide antisense transcription	1	0.987403161140781	8483	2070	1075	
14676	contacts of the patients	contact of the patient	1	0.987403161140781	14677	226	14677	
8231	various preparations	various preparation	1	0.987403161140781	137	3269	137	
14255	bacterial adhesion	bacterial adhesion	1	0.987403161140781	336	185	336	
6293	metabolism of Escherichia coli cells	metabolism of Escherichia coli cell	1	0.987403161140781	1955	1839	1955	
15647	dodecyl sulfate	dodecyl sulfate	1	0.987403161140781	15649	15648	15649	
2044	g quantity	g quantity	1	0.987403161140781	2046	2045	2046	
3566	accuracy of the detection	accuracy of the detection	1	0.987403161140781	3567	2459	3567	
8440	environmental compounds	environmental compound	1	0.987403161140781	2878	1810	2878	
2833	analysis of site	analysis of site	1	0.987403161140781	203	3	203	
8184	mechanism of resistance	mechanism of resistance	1	0.987403161140781	525	1830	525	
10523	polypeptide chain	polypeptide chain	1	0.987403161140781	320	1854	320	
16610	lethal drug concentrations	lethal drug concentration	1	0.987403161140781	161	9116	163	
13687	human blood monocyte	human blood monocyte	1	0.987403161140781	13689	834	1204	
8026	nontoxic product	nontoxic product	1	0.987403161140781	19	8027	19	
16692	gastroenteritis patients	gastroenteritis patient	1	0.987403161140781	226	16693	226	
14509	antigenic scheme	antigenic scheme	1	0.987403161140781	4110	14510	4110	
8687	probe vectors	probe vector	1	0.987403161140781	6087	1947	6087	
4838	different genotypes	different genotype	1	0.987403161140781	2389	816	2389	
5494	glycoside hydrolases	glycoside hydrolas	1	0.987403161140781	5496	5495	5496	
11603	specific activity	specific activity	1	0.987403161140781	393	504	393	
4669	promising step	promising step	1	0.987403161140781	4671	4670	4671	
11607	hematology ward	hematology ward	1	0.987403161140781	4267	11608	4267	
375	molecular regulation of Staphylococcus aureus virulence	molecular regulation of Staphylococcus aureus virulence	1	0.987403161140781	377	376	378	
15076	bactericidal agents	bactericidal agent	1	0.987403161140781	1834	9620	1834	
4610	available compounds	available compound	1	0.987403161140781	2878	3319	2878	
62	established mature biofilms	established mature biofilm	1	0.987403161140781	64	63	66	
15595	Legionella pneumophila	Legionella pneumophila	1	0.987403161140781	15597	15596	15597	
8229	examinations of various preparations	examination of various preparation	1	0.987403161140781	8230	8231	8230	
16952	properties of dermaseptin S4 derivatives	property of dermaseptin S4 derivative	1	0.987403161140781	3103	16954	3103	
16898	length cDNA of MyD88	length cDNA of MyD88	1	0.987403161140781	16900	2539	6626	
12151	protein glycosylation systems	protein glycosylation system	1	0.987403161140781	12153	406	4029	
13364	study of Mycoplasma otitis	study of Mycoplasma otitis	1	0.987403161140781	1514	4585	1514	
5607	free fish farm	free fish farm	1	0.987403161140781	5609	112	3592	
7771	resistant S	resistant S	1	0.987403161140781	1898	123	1898	
9875	cell lines	cell line	1	0.987403161140781	2411	235	2411	
4852	transmission of HIV	transmission of HIV	1	0.987403161140781	1849	4854	1849	
4806	common strain	common strain	1	0.987403161140781	76	870	76	
4066	continuous surveillance	continuous surveillance	1	0.987403161140781	3820	4067	3820	
4646	pneumococcal surface protein A	pneumococcal surface protein A	1	0.987403161140781	4648	4647	1379	
14447	unusual nature	unusual nature	1	0.987403161140781	3765	1692	3765	
3083	main regulatory pathway	main regulatory pathway	1	0.987403161140781	3085	232	661	
7476	REA DNA types	REA DNA type	1	0.987403161140781	7478	2278	769	
15230	addition of n-hexane extract	addition of n-hexane extract	1	0.987403161140781	2743	7594	2743	
825	pandemic endosymbiont	pandemic endosymbiont	1	0.987403161140781	827	826	827	
5449	samples of water	sample of water	1	0.987403161140781	225	920	225	
14657	wide variety of marine environments	wide variety of marine environment	1	0.987403161140781	14659	2070	1261	
1539	recent insights	recent insight	1	0.987403161140781	1541	1540	1541	
8284	Various process parameters	Various process parameter	1	0.987403161140781	8286	8285	8288	
10307	insufficient phagocytosis	insufficient phagocytosis	1	0.987403161140781	8836	5752	8836	
3826	HpaJ secretion	HpaJ secretion	1	0.987403161140781	2586	3827	2586	
3823	catalytic machinery	catalytic machinery	1	0.987403161140781	3825	1315	3825	
5710	antibiotic susceptibility	antibiotic susceptibility	1	0.987403161140781	273	31	273	
15220	fecal microbiota	fecal microbiota	1	0.987403161140781	2226	15221	2226	
11580	ureR allele	ureR allele	1	0.987403161140781	11582	11581	11582	
14527	PMN apoptosis	PMN apoptosis	1	0.987403161140781	4126	278	4126	
14373	antibacterial effectiveness	antibacterial effectiveness	1	0.987403161140781	3301	1575	3301	
12140	Salmonella survival	Salmonella survival	1	0.987403161140781	1950	3520	1950	
81	novel noninvasive test	novel noninvasive test	1	0.987403161140781	83	82	85	
2524	application of rabbit serum	application of rabbit serum	1	0.987403161140781	1507	2526	1507	
6483	homologs of effectors	homolog of effector	1	0.987403161140781	6484	454	6484	
6381	phenotypic changes	phenotypic change	1	0.987403161140781	1846	6382	1846	
4002	heat shock protein	heat shock protein	1	0.987403161140781	4004	1986	406	
4595	number of bacterial species	number of bacterial specie	1	0.987403161140781	1034	3193	1034	
11791	wound closure	wound closure	1	0.987403161140781	11793	11792	11793	
5558	Amino acid requirements of strains of Chlamydia trachomatis	Amino acid requirement of strain of Chlamydia trachomatis	1	0.987403161140781	5560	5559	658	
8972	toxin A	toxin A	1	0.987403161140781	1379	1598	1379	
7891	FcgammaR allotypes	FcgammaR allotype	1	0.987403161140781	687	7892	687	
7755	LVS bacterial membrane proteins	LVS bacterial membrane protein	1	0.987403161140781	7757	1202	27	
16296	secondary acylation site of the 3-position	secondary acylation site of the 3-position	1	0.987403161140781	16300	67	3	
7486	broad specificity	broad specificity	1	0.987403161140781	3352	796	3352	
16462	chicken faecal material	chicken faecal material	1	0.987403161140781	16464	8759	7239	
8286	process parameters	process parameter	1	0.987403161140781	8288	2489	8288	
8096	secA gene	secA gene	1	0.987403161140781	18	8097	18	
15523	colocalization of P	colocalization of P	1	0.987403161140781	678	160	678	
6797	proof of monoclonality	proof of monoclonality	1	0.987403161140781	6798	4336	6798	
4508	Efficiency of Bax	Efficiency of Bax	1	0.987403161140781	4509	4510	4509	
3254	potential determinants of virulence	potential determinant of virulence	1	0.987403161140781	3256	2154	1717	
11117	use of prophylactic antibiotics	use of prophylactic antibiotic	1	0.987403161140781	32	3545	32	
9080	different molecular level organization of BChl's	different molecular level organization of BChl'	1	0.987403161140781	9082	816	2416	
11810	region of RpoB	region of RpoB	1	0.987403161140781	3464	11812	3464	
14244	pathologic microbiocenosis	pathologic microbiocenosis	1	0.987403161140781	747	646	747	
6029	expression of the costimulatory molecule CD252	expression of the costimulatory molecule CD252	1	0.987403161140781	373	6031	373	
9244	emergence of glycopeptide resistance	emergence of glycopeptide resistance	1	0.987403161140781	1702	9246	1702	
14603	HOX polypeptide	HOX polypeptide	1	0.987403161140781	1854	11300	1854	
15133	potential biocontrol agent	potential biocontrol agent	1	0.987403161140781	15135	2154	1357	
601	display of fibronectin	display of fibronectin	1	0.987403161140781	602	603	602	
7680	PMN controls	PMN control	1	0.987403161140781	7682	278	7682	
11630	research groups	research group	1	0.987403161140781	4420	11082	4420	
2179	30-kg child	30-kg child	1	0.987403161140781	2181	2180	2181	
4884	Haemophilus parasuis	Haemophilus parasuis	1	0.987403161140781	4886	716	4886	
13916	fur null mutant	fur null mutant	1	0.987403161140781	13918	12990	4780	
13105	OVID Medline	OVID Medline	1	0.987403161140781	13107	13106	13107	
10632	presence of serum	presence of serum	1	0.987403161140781	139	1798	139	
11338	Standardized methods	Standardized method	1	0.987403161140781	2371	11339	2371	
11817	Genetic biocontainment strategies	Genetic biocontainment strategy	1	0.987403161140781	11819	11818	5392	
14189	percent of rifampin	percent of rifampin	1	0.987403161140781	7188	421	7188	
6115	ErbB3 heterodimerization	ErbB3 heterodimerization	1	0.987403161140781	6117	4660	6117	
16473	slight swelling	slight swelling	1	0.987403161140781	7448	16474	7448	
12940	studies of S	study of S	1	0.987403161140781	2918	1898	2918	
14094	locations-the fliCS	locations-the fliCS	1	0.987403161140781	14096	14095	14096	
8719	AZLI TID	AZLI TID	1	0.987403161140781	2591	8720	2591	
11369	Efficacies of vancomycin	Efficacy of vancomycin	1	0.987403161140781	11370	11371	11370	
12473	specificity of 83%	specificity of 83%	1	0.987403161140781	3352	12475	3352	
14417	base residue	base residue	1	0.987403161140781	2217	5487	2217	
5514	membrane integrity	membrane integrity	1	0.987403161140781	5516	3723	5516	
13108	Ah cells	Ah cell	1	0.987403161140781	113	5461	113	
200	structure analysis of riboflavin synthase	structure analysis of riboflavin synthase	1	0.987403161140781	202	201	203	
7107	maps of transcriptional start sites	map of transcriptional start site	1	0.987403161140781	7108	7109	7108	
11108	importance of the C-terminal domain of P28	importance of the C-terminal domain of P28	1	0.987403161140781	684	11110	684	
2212	global transcription regulator	global transcription regulator	1	0.987403161140781	2214	2213	756	
1767	translocation of tortoises	translocation of tortoise	1	0.987403161140781	1768	1769	1768	
15792	case study	case study	1	0.987403161140781	1514	618	1514	
2116	bacterial activation	bacterial activation	1	0.987403161140781	2118	185	2118	
6265	LPSs of the different B	LPS of the different B	1	0.987403161140781	39	6267	39	
4042	internalization of CCR5	internalization of CCR5	1	0.987403161140781	4043	4044	4043	
16163	acetic acid	acetic acid	1	0.987403161140781	4	16164	4	
701	comprehensive comparison of the structure	comprehensive comparison of the structure	1	0.987403161140781	703	702	626	
3159	natural history of colonization	natural history of colonization	1	0.987403161140781	3161	1029	3162	
9856	growth inhibition	growth inhibition	1	0.987403161140781	2510	217	2510	
4893	group comparative design	group comparative design	1	0.987403161140781	4895	351	3342	
14532	Recent findings	Recent finding	1	0.987403161140781	647	14533	647	
7357	majority of farms	majority of farm	1	0.987403161140781	5215	587	5215	
1508	Experimental murine tuberculosis	Experimental murine tuberculosis	1	0.987403161140781	1510	1509	491	
6583	structural properties	structural property	1	0.987403161140781	3103	156	3103	
3452	serine protease subtilisin	serine protease subtilisin	1	0.987403161140781	3454	3453	2175	
2468	species identification	specie identification	1	0.987403161140781	644	73	644	
16844	high degree of complexity	high degree of complexity	1	0.987403161140781	16846	264	2084	
9896	patient compliance	patient compliance	1	0.987403161140781	8920	3504	8920	
9696	important marine cyanobacteria	important marine cyanobacteria	1	0.987403161140781	9698	118	9700	
11989	presence of the proteic inhibitor CI2	presence of the proteic inhibitor CI2	1	0.987403161140781	139	11991	139	
933	staining test	staining test	1	0.987403161140781	85	934	85	
8699	characterization of a minor allergen	characterization of a minor allergen	1	0.987403161140781	416	8701	416	
5032	transcriptional architecture	transcriptional architecture	1	0.987403161140781	5034	2780	5034	
16558	exposure of phosphatidylserine	exposure of phosphatidylserine	1	0.987403161140781	5191	16560	5191	
14952	certain degree	certain degree	1	0.987403161140781	2084	3332	2084	
15584	antigenic difference	antigenic difference	1	0.987403161140781	9632	14510	9632	
10174	significant preference	significant preference	1	0.987403161140781	10176	24	10176	
15404	anionic detergent LAS	anionic detergent LAS	1	0.987403161140781	15406	15405	15408	
7136	bacterium Deinococcus radiodurans	bacterium Deinococcus radioduran	1	0.987403161140781	7138	1136	7140	
11944	biopsy specimens	biopsy specimen	1	0.987403161140781	1519	11945	1519	
1079	mycobacterial interspersed repetitive units	mycobacterial interspersed repetitive unit	1	0.987403161140781	1081	1080	1085	
1363	Construction of a host	Construction of a host	1	0.987403161140781	1364	271	1364	
3393	urease gene expression	urease gene expression	1	0.987403161140781	3395	809	373	
13519	positive ascites cultures	positive ascite culture	1	0.987403161140781	13521	953	4706	
6807	Bacillus polymyxa	Bacillus polymyxa	1	0.987403161140781	6809	3924	6809	
4841	egg pulp	egg pulp	1	0.987403161140781	4843	4842	4843	
2476	intake period	intake period	1	0.987403161140781	2478	2477	2478	
4240	Transformation of C	Transformation of C	1	0.987403161140781	4241	243	4241	
1453	commercial use of this agent	commercial use of this agent	1	0.987403161140781	1455	1454	32	
6859	BCG granuloma formation	BCG granuloma formation	1	0.987403161140781	4488	6860	4488	
1651	free system	free system	1	0.987403161140781	1501	112	1501	
5683	nonfimbrial adhesive factor	nonfimbrial adhesive factor	1	0.987403161140781	5685	5684	72	
4943	clinical application of this combination	clinical application of this combination	1	0.987403161140781	4945	323	1507	
10091	host species	host specie	1	0.987403161140781	73	271	73	
11361	In60 integron	In60 integron	1	0.987403161140781	11363	11362	11363	
11236	recent clinical reports	recent clinical report	1	0.987403161140781	11238	1540	4876	
5903	Concurrent spontaneous bacterial peritonitis	Concurrent spontaneous bacterial peritonitis	1	0.987403161140781	5905	750	5909	
6772	AutoMR wizard	AutoMR wizard	1	0.987403161140781	6774	6773	6774	
10507	negative bacterium Vibrio parahaemolyticus	negative bacterium Vibrio parahaemolyticus	1	0.987403161140781	10511	10508	9315	
15434	K antigens	K antigen	1	0.987403161140781	4100	548	4100	
5303	gene A protein	gene A protein	1	0.987403161140781	5305	18	406	
6250	acclimation protein	acclimation protein	1	0.987403161140781	406	6251	406	
10367	primer set	primer set	1	0.987403161140781	417	4457	417	
16933	modification of the antibiotics	modification of the antibiotic	1	0.987403161140781	1945	3547	1945	
9605	peak shifts	peak shift	1	0.987403161140781	4709	1743	4709	
8149	Nucleotide sequence	Nucleotide sequence	1	0.987403161140781	1657	8150	1657	
12989	fur mutant	fur mutant	1	0.987403161140781	4780	12990	4780	
1608	polymeric cell structure	polymeric cell structure	1	0.987403161140781	1610	1609	201	
8395	lung granulomatous response	lung granulomatous response	1	0.987403161140781	284	936	286	
5527	2nd month	2nd month	1	0.987403161140781	5529	5528	5529	
869	common occurrence	common occurrence	1	0.987403161140781	871	870	871	
10160	exposure to quinupristin	exposure to quinupristin	1	0.987403161140781	5191	10162	5191	
2512	new perspectives	new perspective	1	0.987403161140781	2514	1171	2514	
15469	various tissues	various tissue	1	0.987403161140781	1485	3269	1485	
6921	molecular genetics of MDR	molecular genetic of MDR	1	0.987403161140781	6923	376	6924	
12248	group P212121	group P212121	1	0.987403161140781	12250	351	12250	
13486	response to respiratory disease outbreaks	response to respiratory disease outbreak	1	0.987403161140781	286	13488	286	
13751	fever group rickettsiae	fever group rickettsiae	1	0.987403161140781	13755	6560	13755	
1138	sites of mycobacterial infection	site of mycobacterial infection	1	0.987403161140781	1139	1140	1139	
15911	additional members of the Map	additional member of the Map	1	0.987403161140781	15913	5141	2171	
15751	fatty acid compositions of the bile	fatty acid composition of the bile	1	0.987403161140781	3122	1024	3126	
342	Fcgamma receptor polymorphisms	Fcgamma receptor polymorphism	1	0.987403161140781	344	343	346	
7006	spontaneous gastric hypoacidity	spontaneous gastric hypoacidity	1	0.987403161140781	2164	5906	1460	
16195	proton pump of the parietal cell	proton pump of the parietal cell	1	0.987403161140781	16197	169	171	
14340	widespread acquisition	widespread acquisition	1	0.987403161140781	4048	4519	4048	
13083	adult cystic fibrosis units	adult cystic fibrosis unit	1	0.987403161140781	13085	2946	1085	
728	understanding of signaling mechanisms	understanding of signaling mechanism	1	0.987403161140781	729	730	729	
9784	single QS	single QS	1	0.987403161140781	3493	1933	3493	
16836	12089(T)=CCUG 47092(T))	12089(T)=CCUG 47092(T))	1	0.987403161140781	16838	16837	16838	
3346	unique photophysical properties	unique photophysical property	1	0.987403161140781	3348	3347	3103	
9092	secondary infection	secondary infection	1	0.987403161140781	274	68	274	
5112	farmed chickens	farmed chicken	1	0.987403161140781	5114	5113	5114	
7068	major changes	major change	1	0.987403161140781	1846	71	1846	
13906	seawater exposure	seawater exposure	1	0.987403161140781	5191	13907	5191	
12719	model of infection	model of infection	1	0.987403161140781	361	274	361	
1900	Presence of the fish pathogen Vibrio salmonicida	Presence of the fish pathogen Vibrio salmonicida	1	0.987403161140781	1901	1902	1901	
16081	dye fluorescence	dye fluorescence	1	0.987403161140781	930	16082	930	
4765	growth recovery	growth recovery	1	0.987403161140781	479	217	479	
15015	potential pathogen	potential pathogen	1	0.987403161140781	1905	2154	1905	
13756	RFLP analysis	RFLP analysis	1	0.987403161140781	203	5949	203	
698	left TL	left TL	1	0.987403161140781	700	699	700	
10219	opportunistic pathogen	opportunistic pathogen	1	0.987403161140781	1905	10220	1905	
1056	non-vaccinated cattle	non-vaccinated cattle	1	0.987403161140781	1058	1057	1058	
7723	bromodeoxyuridine triphosphate	bromodeoxyuridine triphosphate	1	0.987403161140781	7725	7724	7725	
11801	Bacillus intermedius S	Bacillus intermedius S	1	0.987403161140781	1898	6155	1898	
2558	variety of exogenous ones	variety of exogenous one	1	0.987403161140781	1261	2301	1261	
13118	variety of molecules	variety of molecule	1	0.987403161140781	1261	433	1261	
16664	methods aid	method aid	1	0.987403161140781	16666	2371	16666	
4376	causative agent of human tularemia	causative agent of human tularemia	1	0.987403161140781	3710	4380	1357	
2397	granulomatous lesions	granulomatous lesion	1	0.987403161140781	2399	285	2399	
5046	effect of growth	effect of growth	1	0.987403161140781	2937	217	2937	
5409	selective advantage	selective advantage	1	0.987403161140781	4703	5410	4703	
1645	dependent selection	dependent selection	1	0.987403161140781	1647	807	1647	
2999	effect of Wap65 protein	effect of Wap65 protein	1	0.987403161140781	2937	3001	2937	
7817	hyaluronate lyase	hyaluronate lyase	1	0.987403161140781	7819	7818	7819	
10564	Stimulation of J774 cell line	Stimulation of J774 cell line	1	0.987403161140781	6202	10566	6202	
11139	unidentified receptor	unidentified receptor	1	0.987403161140781	345	11140	345	
2603	caseous necrosis	caseous necrosis	1	0.987403161140781	422	2604	422	
11682	hexose oxidase production	hexose oxidase production	1	0.987403161140781	11684	11683	93	
8438	known environmental compounds	known environmental compound	1	0.987403161140781	8440	8439	2878	
9379	sludge facilities	sludge facility	1	0.987403161140781	9381	9380	9381	
3048	nasal swabs	nasal swab	1	0.987403161140781	3050	1518	3050	
8619	adhesion drugs	adhesion drug	1	0.987403161140781	8621	336	8621	
1565	lung cytokine mRNA levels	lung cytokine mRNA level	1	0.987403161140781	1567	936	495	
13832	episodes of stools	episode of stool	1	0.987403161140781	1666	2546	1666	
3857	major side	major side	1	0.987403161140781	3859	71	3859	
3968	party payer perspective	party payer perspective	1	0.987403161140781	3970	3969	3972	
3465	mechanisms of 1E4	mechanism of 1E4	1	0.987403161140781	519	2702	519	
10126	development of new treatments	development of new treatment	1	0.987403161140781	1679	10128	1679	
11918	variable number of tandem repeats	variable number of tandem repeat	1	0.987403161140781	11920	6069	1034	
13339	relative antibiotic resistance	relative antibiotic resistance	1	0.987403161140781	1828	6285	1830	
12447	Chondrus crispus	Chondrus crispus	1	0.987403161140781	12449	12448	12449	
4648	surface protein A	surface protein A	1	0.987403161140781	1379	2341	1379	
8926	Molecular cloning	Molecular cloning	1	0.987403161140781	8928	3742	8928	
11244	analyses of free lipids	analysis of free lipid	1	0.987403161140781	8104	11246	8104	
8271	cases of human enteritis	case of human enteritis	1	0.987403161140781	2770	8273	2770	
15173	interaction liquid chromatography	interaction liquid chromatography	1	0.987403161140781	12338	1709	2312	
8865	16S rRNA gene sequences	16S rRNA gene sequence	1	0.987403161140781	8867	4019	534	
2663	species identification	species identification	1	0.987403161140781	644	2664	644	
1221	residual bulbitis	residual bulbitis	1	0.987403161140781	1223	1222	1223	
7284	deficiency of autolytic enzyme activity	deficiency of autolytic enzyme activity	1	0.987403161140781	5340	7286	5340	
215	maintenance of the growth	maintenance of the growth	1	0.987403161140781	216	217	216	
9297	inhibition of activity	inhibition of activity	1	0.987403161140781	2510	393	2510	
3648	new vaccines	new vaccine	1	0.987403161140781	3650	1171	3650	
15	rolBTR gene product	rolBTR gene product	1	0.987403161140781	17	16	19	
15986	significant pathologic changes	significant pathologic change	1	0.987403161140781	15988	24	1846	
6787	young Japanese gastric cancer patients	young Japanese gastric cancer patient	1	0.987403161140781	6789	2738	226	
3928	serotyping of strains	serotyping of strain	1	0.987403161140781	3929	551	3929	
1580	genome sequencing [CGS]	genome sequencing [CGS]	1	0.987403161140781	1582	1581	1584	
5390	general strategies	general strategy	1	0.987403161140781	5392	5391	5392	
13143	phosphatase super family motif CX5R	phosphatase super family motif CX5R	1	0.987403161140781	13145	1290	13151	
13722	accuracy of the system	accuracy of the system	1	0.987403161140781	3567	1501	3567	
9981	serovar sotto strain	serovar sotto strain	1	0.987403161140781	76	9982	76	
3490	Cell invasion	Cell invasion	1	0.987403161140781	1178	3491	1178	
13450	RGG domain	RGG domain	1	0.987403161140781	253	251	253	
11870	Comparative transcriptomics	Comparative transcriptomic	1	0.987403161140781	11872	2917	11872	
2716	opsonin receptors	opsonin receptor	1	0.987403161140781	546	2717	546	
12028	distinctive requirement	distinctive requirement	1	0.987403161140781	5274	12029	5274	
12439	kg diet	kg diet	1	0.987403161140781	12441	11745	12441	
8353	ethylenediaminetetraacetic acid	ethylenediaminetetraacetic acid	1	0.987403161140781	4	8354	4	
1182	ml of this protease	ml of this protease	1	0.987403161140781	1183	1184	1183	
16950	Antibacterial properties of dermaseptin S4 derivatives	Antibacterial property of dermaseptin S4 derivative	1	0.987403161140781	16952	5405	3103	
11325	meningitis cases	meningitis case	1	0.987403161140781	2770	1362	2770	
3387	positive transcriptional regulator of urease gene expression	positive transcriptional regulator of urease gene expression	1	0.987403161140781	3389	953	756	
16106	diverse biological processes	diverse biological process	1	0.987403161140781	16108	4082	3489	
4365	multiplicity of infection	multiplicity of infection	1	0.987403161140781	4366	274	4366	
5914	aeruginosa bacteria	aeruginosa bacteria	1	0.987403161140781	1999	2319	1999	
3597	kappa coefficient	kappa coefficient	1	0.987403161140781	3599	3598	3599	
317	Open chain product	Open chain product	1	0.987403161140781	319	318	19	
7972	monocyte migration	monocyte migration	1	0.987403161140781	3154	1204	3154	
5153	overall trend	overall trend	1	0.987403161140781	5155	5154	5155	
4949	entry to the study	entry to the study	1	0.987403161140781	526	1514	526	
16363	diverse range of environments	diverse range of environment	1	0.987403161140781	16365	4082	928	
2047	high prevalence of resistance to ampicillin	high prevalence of resistance to ampicillin	1	0.987403161140781	2048	2051	1786	
13587	polysaccharide hydrolases	polysaccharide hydrolas	1	0.987403161140781	5496	5138	5496	
5801	NTHi diversity	NTHi diversity	1	0.987403161140781	2099	5802	2099	
12453	oxidizable organic substances	oxidizable organic substance	1	0.987403161140781	12455	12454	12457	
15242	Australian transmissible strain	Australian transmissible strain	1	0.987403161140781	15244	15243	76	
6751	gene of the locus	gene of the locus	1	0.987403161140781	18	6571	18	
535	infective centre	infective centre	1	0.987403161140781	537	536	537	
6163	genera Enterococcus	genera Enterococcus	1	0.987403161140781	4300	6164	4300	
2799	clinical presentation	clinical presentation	1	0.987403161140781	2801	323	2801	
11951	untranslated regions	untranslated region	1	0.987403161140781	2787	11952	2787	
12872	fever response	fever response	1	0.987403161140781	286	2841	286	
14411	repertoire of type	repertoire of type	1	0.987403161140781	9072	1698	9072	
14379	components of the pyruvate dehydrogenase	component of the pyruvate dehydrogenase	1	0.987403161140781	13813	14381	13813	
11293	exogenous carbon	exogenous carbon	1	0.987403161140781	2033	2302	2033	
1567	cytokine mRNA levels	cytokine mRNA level	1	0.987403161140781	1569	1568	495	
13278	wavelength anomalous dispersion method	wavelength anomalous dispersion method	1	0.987403161140781	13280	3961	596	
14960	caspase activation	caspase activation	1	0.987403161140781	2118	14704	2118	
2304	subterranean environment	subterranean environment	1	0.987403161140781	131	2305	131	
7460	Susceptibility distribution	Susceptibility distribution	1	0.987403161140781	895	1628	895	
2159	courses of aztreonam	course of aztreonam	1	0.987403161140781	2160	2161	2160	
3356	homologue of the rolB protein	homologue of the rolB protein	1	0.987403161140781	3357	3358	3357	
4305	complete loss of viability	complete loss of viability	1	0.987403161140781	4307	4306	4308	
473	delta C-UBT value	delta C-UBT value	1	0.987403161140781	475	56	211	
1740	varied peak positions	varied peak position	1	0.987403161140781	1742	1741	1744	
3440	clinical trials	clinical trial	1	0.987403161140781	3442	323	3442	
3713	year-old male	year-old male	1	0.987403161140781	3715	178	3715	
1463	increase of NAP activity	increase of NAP activity	1	0.987403161140781	393	1464	393	
9319	antimicrobial activities of cephems	antimicrobial activity of cephem	1	0.987403161140781	9321	1753	1316	
272	susceptibility to infection	susceptibility to infection	1	0.987403161140781	273	274	273	
7575	nitrocellulose paper	nitrocellulose paper	1	0.987403161140781	785	7576	785	
7463	clinical response	clinical response	1	0.987403161140781	286	323	286	
6169	eradication of H pylori	eradication of H pylori	1	0.987403161140781	153	4062	153	
8499	normal mucosa	normal mucosa	1	0.987403161140781	247	1349	247	
12584	spectrum of bronchiolitis	spectrum of bronchiolitis	1	0.987403161140781	1695	12586	1695	
1796	high serum	high serum	1	0.987403161140781	1798	264	1798	
16245	early gastric MALT lymphoma	early gastric MALT lymphoma	1	0.987403161140781	8363	1097	259	
10477	body surface area burns	body surface area burn	1	0.987403161140781	10481	10478	10483	
9152	plant probiotic activities	plant probiotic activity	1	0.987403161140781	9154	5726	1316	
1701	emergence of the lateral roots	emergence of the lateral root	1	0.987403161140781	1702	1703	1702	
10855	Defecation frequency	Defecation frequency	1	0.987403161140781	265	10856	265	
12025	toxinogenic E	toxinogenic E	1	0.987403161140781	79	12026	79	
13963	use of a radiotelemetry device	use of a radiotelemetry device	1	0.987403161140781	32	13965	32	
1342	smilacinae gen	smilacinae gen	1	0.987403161140781	1344	1343	1344	
6976	typical death domain	typical death domain	1	0.987403161140781	6978	847	253	
9179	cases of MDRP	case of MDRP	1	0.987403161140781	2770	541	2770	
8291	single polar flagellum	single polar flagellum	1	0.987403161140781	8293	1933	8295	
2437	Percentage of neutrophils	Percentage of neutrophil	1	0.987403161140781	2438	2439	2438	
12987	coli fur mutant	coli fur mutant	1	0.987403161140781	12989	1842	4780	
12949	inflammatory CC chemokine receptors CCR1	inflammatory CC chemokine receptor CCR1	1	0.987403161140781	12951	2643	194	
9452	soluble MBP	soluble MBP	1	0.987403161140781	9454	6542	9454	
12352	lactyl ether	lactyl ether	1	0.987403161140781	4750	12353	4750	
15249	axonal damage	axonal damage	1	0.987403161140781	7418	15250	7418	
9923	membrane of human blood	membrane of human blood	1	0.987403161140781	3723	8859	3723	
6705	populations of gopher tortoises	population of gopher tortoise	1	0.987403161140781	1428	4505	1428	
15120	CF patients	CF patient	1	0.987403161140781	226	2948	226	
16274	Child C	Child C	1	0.987403161140781	243	3311	243	
12605	Evaluation of Probiotics	Evaluation of Probiotic	1	0.987403161140781	1573	12607	1573	
3334	production of ammonia	production of ammonia	1	0.987403161140781	93	1577	93	
14034	time polymerase chain reaction analysis	time polymerase chain reaction analysis	1	0.987403161140781	203	8672	203	
4847	therapeutic advantage	therapeutic advantage	1	0.987403161140781	4703	2756	4703	
13163	metabolite pool	metabolite pool	1	0.987403161140781	5469	12471	5469	
11591	early stages of infection	early stage of infection	1	0.987403161140781	1096	274	1098	
2069	wide regulon of putative virulence genes	wide regulon of putative virulence gene	1	0.987403161140781	2071	2070	2072	
13401	HCE cell biotic surface	HCE cell biotic surface	1	0.987403161140781	13403	1825	339	
13655	Preparation of spheroplasts	Preparation of spheroplast	1	0.987403161140781	13656	3937	13656	
5783	H . pylori infection	H . pylori infection	1	0.987403161140781	274	4469	274	
779	stress response	stress response	1	0.987403161140781	286	780	286	
2279	DNA type	DNA type	1	0.987403161140781	1698	468	1698	
349	phosphate group	phosphate group	1	0.987403161140781	351	350	351	
14718	X-ray crystallographic analysis of Rv3168	X-ray crystallographic analysis of Rv3168	1	0.987403161140781	14720	199	203	
9912	Caribbean countries	Caribbean country	1	0.987403161140781	1091	9913	1091	
1965	viable disinfectant	viable disinfectant	1	0.987403161140781	1967	1966	1967	
12998	farm homogeneity	farm homogeneity	1	0.987403161140781	13000	3592	13000	
3240	non-standard amino acids	non-standard amino acid	1	0.987403161140781	3242	3241	3060	
5035	wastewater plants	wastewater plant	1	0.987403161140781	688	5036	688	
13903	Changes of pathogens	Change of pathogen	1	0.987403161140781	13904	186	13904	
16038	targeting to professional phagocytes	targeting to professional phagocyte	1	0.987403161140781	16039	5156	16039	
13866	review of literature	review of literature	1	0.987403161140781	4293	13868	4293	
13863	low yields	low yield	1	0.987403161140781	13865	1109	13865	
2197	two-carbon spacer	two-carbon spacer	1	0.987403161140781	2199	2198	2199	
10628	body surfaces	body surface	1	0.987403161140781	1811	367	1811	
14192	major pathogen	major pathogen	1	0.987403161140781	1905	71	1905	
9110	second method	second method	1	0.987403161140781	596	3410	596	
15198	understanding of A	understanding of A	1	0.987403161140781	729	1379	729	
12544	cut-off point	cut-off point	1	0.987403161140781	457	12545	457	
9515	pathophysiology of anthrax	pathophysiology of anthrax	1	0.987403161140781	9516	2492	9516	
7378	respiratory symptoms	respiratory symptom	1	0.987403161140781	2641	735	2641	
2647	significant human pathogens	significant human pathogen	1	0.987403161140781	2649	24	186	
12814	neighbourhood controls	neighbourhood control	1	0.987403161140781	7682	12815	7682	
12232	coli O157	coli O157	1	0.987403161140781	5537	696	5537	
9509	Clinical factors	Clinical factor	1	0.987403161140781	2924	9510	2924	
13169	endophytic spreading	endophytic spreading	1	0.987403161140781	13171	4619	13171	
3756	study characteristics	study characteristic	1	0.987403161140781	3758	1514	3758	
3117	marked influence	marked influence	1	0.987403161140781	3119	3118	3119	
15416	X-ray diffraction data	X-ray diffraction datum	1	0.987403161140781	15418	199	609	
6018	inflammatory pathologies	inflammatory pathology	1	0.987403161140781	6020	2643	6020	
13644	Vancomycin resistance	Vancomycin resistance	1	0.987403161140781	1830	13645	1830	
11772	necropsied cattle	necropsied cattle	1	0.987403161140781	1058	11773	1058	
2610	NMR signals of the different forms	NMR signal of the different form	1	0.987403161140781	2612	2611	2587	
13887	sudden resistance to quinupristin	sudden resistance to quinupristin	1	0.987403161140781	13889	13888	1830	
12098	Quantitative metabolome analysis	Quantitative metabolome analysis	1	0.987403161140781	12100	1072	203	
16029	degree of virulence	degree of virulence	1	0.987403161140781	2084	383	2084	
13301	presence of 20% sucrose	presence of 20% sucrose	1	0.987403161140781	139	5624	139	
6000	factor sequences	factor sequence	1	0.987403161140781	534	72	534	
8590	isolation challenges	isolation challenge	1	0.987403161140781	2798	326	2798	
9058	amplification tests	amplification test	1	0.987403161140781	2025	9059	2025	
7034	IgG class specific antibodies	IgG class specific antibody	1	0.987403161140781	7036	3705	517	
47	F praunsitzii	F praunsitzii	1	0.987403161140781	49	48	49	
2000	chelonei complex	chelonei complex	1	0.987403161140781	1524	2001	1524	
7184	MDRP isolates	MDRP isolate	1	0.987403161140781	334	541	334	
3751	biocontainment mechanisms	biocontainment mechanism	1	0.987403161140781	519	3752	519	
11666	follow-up study	follow-up study	1	0.987403161140781	1514	3407	1514	
5359	mixtures of pure compounds	mixture of pure compound	1	0.987403161140781	5360	5361	5360	
1004	bacterial expression of amyloidogenic peptides	bacterial expression of amyloidogenic peptide	1	0.987403161140781	1006	185	373	
11769	inner ear	inner ear	1	0.987403161140781	11771	1711	11771	
11173	distribution of FcgammaRIIa	distribution of FcgammaRIIa	1	0.987403161140781	895	686	895	
2136	spectrometry method	spectrometry method	1	0.987403161140781	596	2137	596	
3956	bound forms	bound form	1	0.987403161140781	2616	3957	2616	
9652	asymptomatic poultry	asymptomatic poultry	1	0.987403161140781	9654	6120	9654	
6645	LexA repressor of Ec	LexA repressor of Ec	1	0.987403161140781	6647	5463	5464	
7259	intensity of NAP activity	intensity of NAP activity	1	0.987403161140781	4874	7261	4874	
16074	kg n-hexane extract	kg n-hexane extract	1	0.987403161140781	8238	11745	3075	
5950	patterns of Israeli isolates	pattern of Israeli isolate	1	0.987403161140781	2366	5952	2366	
13411	tularensis LVS strain	tularensis LVS strain	1	0.987403161140781	13413	5453	76	
6409	differential modulation	differential modulation	1	0.987403161140781	193	5008	193	
16568	aberrant production of outer membrane proteins	aberrant production of outer membrane protein	1	0.987403161140781	16570	16569	93	
1685	peripheral nerves	peripheral nerve	1	0.987403161140781	1687	1686	1687	
13700	Unveiling molecular mechanisms of bacterial surface proteins	Unveiling molecular mechanism of bacterial surface protein	1	0.987403161140781	13702	13701	519	
12134	spectral parameters	spectral parameter	1	0.987403161140781	8288	4708	8288	
15685	incremental cost	incremental cost	1	0.987403161140781	1638	15686	1638	
5998	adherence factor sequences	adherence factor sequence	1	0.987403161140781	6000	3685	534	
14384	Hg(II) sequestration	Hg(II) sequestration	1	0.987403161140781	14386	5190	14386	
4902	faecium blood culture	faecium blood culture	1	0.987403161140781	4904	1675	2092	
5520	different environments	different environment	1	0.987403161140781	752	816	752	
14720	crystallographic analysis of Rv3168	crystallographic analysis of Rv3168	1	0.987403161140781	14722	1104	203	
1978	dimensional LD	dimensional LD	1	0.987403161140781	1980	1979	1980	
15036	accumulation of heat	accumulation of heat	1	0.987403161140781	15037	1986	15037	
961	thermal treatments	thermal treatment	1	0.987403161140781	963	962	963	
11540	parC of topoisomerase	parC of topoisomerase	1	0.987403161140781	1586	11542	1586	
11348	A broth	A broth	1	0.987403161140781	1622	1379	1622	
13502	different sources	different source	1	0.987403161140781	5235	816	5235	
3519	Salmonella infection	Salmonella infection	1	0.987403161140781	274	3520	274	
15204	healthy adults	healthy adult	1	0.987403161140781	7978	133	7978	
5267	surface charge	surface charge	1	0.987403161140781	4993	339	4993	
6238	14-mer sequence	14-mer sequence	1	0.987403161140781	1657	6239	1657	
15558	positive cocci	positive coccus	1	0.987403161140781	15560	953	15560	
13608	diphenyleneiodonium chloride	diphenyleneiodonium chloride	1	0.987403161140781	9565	13609	9565	
6402	types of hybrid DNA molecules	type of hybrid DNA molecule	1	0.987403161140781	769	3633	769	
12981	defective phenotype of an Escherichia coli fur mutant	defective phenotype of an Escherichia coli fur mutant	1	0.987403161140781	12983	12982	5168	
11737	analog K4K20S4	analog K4K20S4	1	0.987403161140781	11739	11738	11739	
108	healthcare institutions	healthcare institution	1	0.987403161140781	110	109	110	
6886	plant development	plant development	1	0.987403161140781	1679	5726	1679	
9755	Virulence determinants	Virulence determinant	1	0.987403161140781	1717	9756	1717	
10366	primer set VH	primer set VH	1	0.987403161140781	10370	10367	10370	
12683	G+C content	G+C content	1	0.987403161140781	4526	4824	4526	
1023	bile glucose	bile glucose	1	0.987403161140781	607	1024	607	
6563	fragment of 1E4	fragment of 1E4	1	0.987403161140781	1268	2702	1268	
16242	field of obstetrics	field of obstetric	1	0.987403161140781	2362	16244	2362	
10603	precursors of gastric cancer	precursor of gastric cancer	1	0.987403161140781	1419	385	1419	
4401	risk factors of gastric cancer	risk factor of gastric cancer	1	0.987403161140781	3377	385	2924	
12251	Excessive use of ozone	Excessive use of ozone	1	0.987403161140781	12253	12252	32	
3735	Injury Score	Injury Score	1	0.987403161140781	3737	3736	3737	
9664	bacterial tropism	bacterial tropism	1	0.987403161140781	5237	185	5237	
16676	proctitis symptoms	proctitis symptom	1	0.987403161140781	2641	16677	2641	
9592	goal of filarial parasite drug discovery	goal of filarial parasite drug discovery	1	0.987403161140781	9593	9594	9593	
12656	quality control of antimicrobial susceptibility	quality control of antimicrobial susceptibility	1	0.987403161140781	12658	10457	575	
12858	Absorption linear dichroism	Absorption linear dichroism	1	0.987403161140781	12860	12859	12862	
13183	Large inocula of either species	Large inocula of either species	1	0.987403161140781	13185	13184	13186	
8259	majority of the cases	majority of the case	1	0.987403161140781	5215	2770	5215	
14944	Expression of Ah lexA	Expression of Ah lexA	1	0.987403161140781	14945	7565	14945	
13671	Mycobacterium leprae antigen	Mycobacterium leprae antigen	1	0.987403161140781	655	1799	655	
3438	further clinical trials	further clinical trial	1	0.987403161140781	3440	2629	3442	
2192	extensive bony involvement	extensive bony involvement	1	0.987403161140781	2194	2193	2061	
5504	re-adaptation to a change	re-adaptation to a change	1	0.987403161140781	5505	3734	5505	
4699	biology to the bacterium's advantage	biology to the bacterium' advantage	1	0.987403161140781	1725	4701	1725	
7296	blue tetrazolium bromide	blue tetrazolium bromide	1	0.987403161140781	7298	7297	7209	
4072	primary gastric lymphoma	primary gastric lymphoma	1	0.987403161140781	4074	4073	259	
13775	phase synthesis	phase synthesis	1	0.987403161140781	515	1218	515	
2246	rabbit antibody	rabbit antibody	1	0.987403161140781	1299	2247	1299	
6274	LEU2 gene	LEU2 gene	1	0.987403161140781	18	6275	18	
14252	coefficient of contingency	coefficient of contingency	1	0.987403161140781	3599	14254	3599	
2123	mixture of lactic acid bacteria	mixture of lactic acid bacteria	1	0.987403161140781	2124	2105	2124	
6416	restriction endonuclease digestion analysis	restriction endonuclease digestion analysis	1	0.987403161140781	6418	5178	203	
3079	detection of salmonellae	detection of salmonellae	1	0.987403161140781	2459	3081	2459	
5186	free extracts	free extract	1	0.987403161140781	3189	112	3189	
14708	properties of extracellular alkaline phosphatase	property of extracellular alkaline phosphatase	1	0.987403161140781	3103	14710	3103	
789	levels of RNAIII	level of RNAIII	1	0.987403161140781	495	791	495	
2130	year-old female	year-old female	1	0.987403161140781	2132	178	2132	
14829	analysis of the NOESY spectra	analysis of the NOESY spectrum	1	0.987403161140781	203	14831	203	
2499	immunosorbent assay	immunosorbent assay	1	0.987403161140781	562	2500	562	
10050	fever group isolates	fever group isolate	1	0.987403161140781	334	6560	334	
13193	MALT lymphomas	MALT lymphoma	1	0.987403161140781	13195	258	13195	
12785	dehydrogenase genes	dehydrogenase gene	1	0.987403161140781	444	2622	444	
2227	bacterial invasion	bacterial invasion	1	0.987403161140781	1178	185	1178	
25	homology to proteins	homology to protein	1	0.987403161140781	26	27	26	
4398	eradication of bismuth	eradication of bismuth	1	0.987403161140781	153	4400	153	
11625	transfer of this drug	transfer of this drug	1	0.987403161140781	1913	162	1913	
12762	function of gamma delta T cells	function of gamma delta T cell	1	0.987403161140781	778	2855	778	
931	actin staining test	actin staining test	1	0.987403161140781	933	932	85	
2434	class of Gammaproteobacteria	class of Gammaproteobacteria	1	0.987403161140781	2435	2436	2435	
10043	28-day courses of AZLI treatment	28-day course of AZLI treatment	1	0.987403161140781	10045	10044	61	
13731	chronic duodenal ulcers	chronic duodenal ulcer	1	0.987403161140781	1305	363	1307	
2990	specific features of this drug	specific feature of this drug	1	0.987403161140781	2992	504	157	
13808	individual crucial components of the medium	individual crucial component of the medium	1	0.987403161140781	13810	3288	13813	
8452	Virchow isolates	Virchow isolate	1	0.987403161140781	334	8453	334	
1817	sensitivity of 67%	sensitivity of 67%	1	0.987403161140781	1818	1819	1818	
3421	PA susceptibility	PA susceptibility	1	0.987403161140781	273	3422	273	
14777	120-kDa polypeptide gene	120-kDa polypeptide gene	1	0.987403161140781	12978	14778	18	
7364	% of the phage	% of the phage	1	0.987403161140781	1209	2407	1209	
7471	host survival	host survival	1	0.987403161140781	1950	271	1950	
1776	immunity to Mtb infection	immunity to Mtb infection	1	0.987403161140781	1777	1778	1777	
7307	low carriage rate	low carriage rate	1	0.987403161140781	7309	1109	154	
192	modulation of CCR1	modulation of CCR1	1	0.987403161140781	193	194	193	
2017	meningococcal defence	meningococcal defence	1	0.987403161140781	2019	267	2019	
8707	time to defervescence	time to defervescence	1	0.987403161140781	1403	8709	1403	
9675	mg extracellular enzyme	mg extracellular enzyme	1	0.987403161140781	9677	1420	4250	
811	rickettsial disease of different degrees of severity	rickettsial disease of different degree of severity	1	0.987403161140781	813	812	268	
8351	m ethylenediaminetetraacetic acid	m ethylenediaminetetraacetic acid	1	0.987403161140781	8353	7200	4	
3701	up-regulation of perforin	up-regulation of perforin	1	0.987403161140781	3702	3703	3702	
13092	medical center	medical center	1	0.987403161140781	4790	13093	4790	
6630	initial injury	initial injury	1	0.987403161140781	909	2838	909	
4353	serogroups W135	serogroup W135	1	0.987403161140781	14	4354	14	
9216	length of stay	length of stay	1	0.987403161140781	2539	9218	2539	
2102	probiotic lactic acid bacteria drug resistance	probiotic lactic acid bacteria drug resistance	1	0.987403161140781	2104	1093	1830	
392	activity of macrophages	activity of macrophage	1	0.987403161140781	393	394	393	
8002	local farm	local farm	1	0.987403161140781	3592	8003	3592	
12219	fluid suspension culture	fluid suspension culture	1	0.987403161140781	12221	5371	2092	
340	role of Fcgamma receptor polymorphisms	role of Fcgamma receptor polymorphism	1	0.987403161140781	233	342	233	
14749	case isolates	case isolate	1	0.987403161140781	334	618	334	
9047	enzyme ApaI	enzyme ApaI	1	0.987403161140781	9049	4250	9049	
7248	equivalent bacterial reductions	equivalent bacterial reduction	1	0.987403161140781	7250	7249	7252	
3904	skilled nursing facility	skilled nursing facility	1	0.987403161140781	3906	3905	3908	
656	Treatment requirements	Treatment requirement	1	0.987403161140781	658	657	658	
16027	high degree of virulence	high degree of virulence	1	0.987403161140781	16029	264	2084	
4260	compensate to a certain extent	compensate to a certain extent	1	0.987403161140781	4261	4262	4261	
14561	phytoplasma genes	phytoplasma gene	1	0.987403161140781	444	2282	444	
354	Ellison's syndrome	Ellison' syndrome	1	0.987403161140781	356	355	356	
9726	test P	test P	1	0.987403161140781	160	85	160	
15260	deep active site channel	deep active site channel	1	0.987403161140781	15262	12563	15266	
12224	Maximum production	Maximum production	1	0.987403161140781	93	12225	93	
15927	conservation efforts	conservation effort	1	0.987403161140781	15929	7990	15929	
4683	trachomatis strains	trachomatis strain	1	0.987403161140781	551	4118	551	
1450	conorii isolates	conorii isolate	1	0.987403161140781	334	1451	334	
5086	NAP levels	NAP level	1	0.987403161140781	495	1466	495	
11684	oxidase production	oxidase production	1	0.987403161140781	93	1330	93	
13561	siderophore production	siderophore production	1	0.987403161140781	93	2812	93	
413	molecular characterization of a set	molecular characterization of a set	1	0.987403161140781	415	376	416	
5314	majority of microorganisms	majority of microorganism	1	0.987403161140781	5215	1629	5215	
7607	azithromycin combination	azithromycin combination	1	0.987403161140781	1027	7608	1027	
12841	specific one-step cloning system	specific one-step cloning system	1	0.987403161140781	12843	504	1501	
13096	unit protein weight (V(M))	unit protein weight (V(M))	1	0.987403161140781	13098	1107	13102	
7371	simulation model	simulation model	1	0.987403161140781	361	7372	361	
10786	22-fold molar excess of Zn(II)	22-fold molar excess of Zn(II)	1	0.987403161140781	10788	10787	10204	
7020	retail poultry - a major source of human infection	retail poultry_-_a major source of human infection	1	0.987403161140781	7022	7021	3893	
9528	individual metabolites	individual metabolite	1	0.987403161140781	864	3288	864	
13475	Strains of R	Strain of R	1	0.987403161140781	149	1492	149	
14768	chart abstraction	chart abstraction	1	0.987403161140781	14770	14769	14770	
10470	current state of knowledge	current state of knowledge	1	0.987403161140781	10472	5987	788	
15694	Recurrence rate of H	Recurrence rate of H	1	0.987403161140781	15696	497	154	
16851	clinical efficacy rate	clinical efficacy rate	1	0.987403161140781	16853	323	154	
1613	stable toxin genes	stable toxin gene	1	0.987403161140781	1615	1614	444	
5772	food handler samples	food handler sample	1	0.987403161140781	225	5773	225	
12595	direct dot-blot assay	direct dot-blot assay	1	0.987403161140781	12597	2188	562	
3759	Application of ozone	Application of ozone	1	0.987403161140781	3760	1630	3760	
5039	time point	time point	1	0.987403161140781	457	1403	457	
8502	nt ORF	nt ORF	1	0.987403161140781	8504	5121	8504	
8361	diagnosis of gastric MALT lymphoma	diagnosis of gastric MALT lymphoma	1	0.987403161140781	5010	8363	5010	
1804	chemotaxonomic marker	chemotaxonomic marker	1	0.987403161140781	1806	1805	1806	
6475	factor sigma B	factor sigma B	1	0.987403161140781	6477	72	977	
7190	independent cleavage	independent cleavage	1	0.987403161140781	4898	1433	4898	
7125	minimum gastric pH	minimum gastric pH	1	0.987403161140781	189	7126	191	
7024	major source of human infection	major source of human infection	1	0.987403161140781	7026	71	3893	
15957	persistence of the fish pathogen Vibrio salmonicida	persistence of the fish pathogen Vibrio salmonicida	1	0.987403161140781	12911	1902	12911	
15887	experimental approaches	experimental approach	1	0.987403161140781	15636	7451	15636	
9594	filarial parasite drug discovery	filarial parasite drug discovery	1	0.987403161140781	9598	9595	9600	
8179	Antibiotic therapy	Antibiotic therapy	1	0.987403161140781	464	8180	464	
12875	reduction of populations	reduction of population	1	0.987403161140781	276	1428	276	
7369	analytic simulation model	analytic simulation model	1	0.987403161140781	7371	7370	361	
5444	Production of a cellulase	Production of a cellulase	1	0.987403161140781	5445	5446	5445	
9199	drop vapour	drop vapour	1	0.987403161140781	9201	9200	9201	
3877	endocarditis case	endocarditis case	1	0.987403161140781	618	3878	618	
5297	demographic change	demographic change	1	0.987403161140781	3734	5298	3734	
3569	control of the promoter	control of the promoter	1	0.987403161140781	575	2298	575	
13251	size aliphatic chain	size aliphatic chain	1	0.987403161140781	13253	2659	320	
16842	unrecognized high degree of complexity	unrecognized high degree of complexity	1	0.987403161140781	16844	16843	2084	
12035	associate Gram	associate Gram	1	0.987403161140781	615	12036	615	
16372	definition of clearance	definition of clearance	1	0.987403161140781	16373	449	16373	
5701	cells of Pseudomonas aeruginosa	cell of Pseudomonas aeruginosa	1	0.987403161140781	113	2317	113	
14646	robust cytotoxicity data	robust cytotoxicity datum	1	0.987403161140781	14648	13286	609	
15449	receiver operating curves	receiver operating curve	1	0.987403161140781	15451	15450	15453	
4921	infection of monocyte	infection of monocyte	1	0.987403161140781	274	1204	274	
1041	higher numbers	high number	1	0.987403161140781	46	151	46	
6420	digestion analysis	digestion analysis	1	0.987403161140781	203	6421	203	
837	nematode parasites	nematode parasite	1	0.987403161140781	104	838	104	
14824	biological roles	biological role	1	0.987403161140781	8900	14825	8900	
13447	terminal RGG domain of nucleolin	terminal RGG domain of nucleolin	1	0.987403161140781	13449	8316	253	
5895	DNA of an LGV associated serovar	DNA of an LGV associated serovar	1	0.987403161140781	468	5897	468	
14085	expression vector	expression vector	1	0.987403161140781	2218	373	2218	
5125	atrophy of gastric mucosa	atrophy of gastric mucosa	1	0.987403161140781	1396	5013	1396	
16360	aerosol M	aerosol M	1	0.987403161140781	1921	12520	1921	
13199	rolB gene of the TL	rolB gene of the TL	1	0.987403161140781	13201	3359	18	
11346	selenite A broth	selenite A broth	1	0.987403161140781	11348	1621	1622	
16700	numbers of E	number of E	1	0.987403161140781	46	79	46	
9644	strong correlation	strong correlation	1	0.987403161140781	1523	1751	1523	
14582	expansion of resistant lineages	expansion of resistant lineage	1	0.987403161140781	7695	14584	7695	
5104	Preliminary X-ray crystallographic analysis	Preliminary X-ray crystallographic analysis	1	0.987403161140781	5106	5105	203	
581	acid to P14	acid to P14	1	0.987403161140781	4	583	4	
91	ESBL production	ESBL production	1	0.987403161140781	93	92	93	
15377	direct transport of ferrous iron	direct transport of ferrous iron	1	0.987403161140781	15379	2188	6263	
2781	reporter assay	reporter assay	1	0.987403161140781	562	2782	562	
12144	representative of each farm	representative of each farm	1	0.987403161140781	12145	3592	12145	
4171	virulence of Chlamydia muridarum respiratory infections	virulence of Chlamydia muridarum respiratory infection	1	0.987403161140781	383	4173	383	
7729	morphogenic activity	morphogenic activity	1	0.987403161140781	393	7730	393	
524	mechanism of entry	mechanism of entry	1	0.987403161140781	525	526	525	
14409	extensive repertoire of type	extensive repertoire of type	1	0.987403161140781	14411	2193	9072	
4004	shock protein	shock protein	1	0.987403161140781	406	1187	406	
5205	6-diphenyl -1	6-diphenyl -1	1	0.987403161140781	145	5206	145	
13311	genome size	genome size	1	0.987403161140781	2659	1581	2659	
8334	Gel filtration	Gel filtration	1	0.987403161140781	4280	8335	4280	
1083	repetitive units	repetitive unit	1	0.987403161140781	1085	1084	1085	
15837	median distance to the start codon	median distance to the start codon	1	0.987403161140781	15839	911	8519	
15300	free lipid A of V	free lipid A of V	1	0.987403161140781	15302	112	1379	
15974	LPS patterns	LPS pattern	1	0.987403161140781	2366	7060	2366	
3865	tube dilution method	tube dilution method	1	0.987403161140781	3867	2634	596	
5804	role of management factors	role of management factor	1	0.987403161140781	233	5806	233	
14053	total follow-up	total follow-up	1	0.987403161140781	3209	1402	3209	
2894	taxonomic position	taxonomic position	1	0.987403161140781	621	2895	621	
13352	antibacterial activities	antibacterial activity	1	0.987403161140781	1316	1575	1316	
10362	Bacillus anthracis	Bacillus anthracis	1	0.987403161140781	7001	3924	7001	
3954	different bound forms	different bound form	1	0.987403161140781	3956	816	2616	
12498	enzymes of the glycolytic pathway	enzyme of the glycolytic pathway	1	0.987403161140781	8183	12500	8183	
15302	lipid A of V	lipid A of V	1	0.987403161140781	4939	2022	1379	
13464	inactivation of luxS	inactivation of luxS	1	0.987403161140781	522	13466	522	
1262	presence of the ActA N-terminal fragment	presence of the ActA N-terminal fragment	1	0.987403161140781	139	1264	139	
14497	ill patients	ill patient	1	0.987403161140781	226	14498	226	
14073	integration of the carotenoid gene cluster	integration of the carotenoid gene cluster	1	0.987403161140781	1689	14075	1689	
8901	active site residues	active site residue	1	0.987403161140781	8903	1	50	
1066	economic value of fidaxomicin	economic value of fidaxomicin	1	0.987403161140781	1068	1067	211	
3989	economic concern	economic concern	1	0.987403161140781	3991	1067	3991	
7228	Dominant negative analysis	Dominant negative analysis	1	0.987403161140781	7230	7229	203	
14629	body weight	body weight	1	0.987403161140781	681	367	681	
14381	pyruvate dehydrogenase	pyruvate dehydrogenase	1	0.987403161140781	2622	2745	2622	
4929	israeli travelers	israeli traveler	1	0.987403161140781	3076	4930	3076	
11571	daily subcutaneous injections of thalidomide	daily subcutaneous injection of thalidomide	1	0.987403161140781	11573	11572	11576	
12153	glycosylation systems	glycosylation system	1	0.987403161140781	4029	1430	4029	
10317	pylori eradication rates	pylori eradication rate	1	0.987403161140781	10319	501	450	
1140	mycobacterial infection	mycobacterial infection	1	0.987403161140781	274	1080	274	
16553	related genotype	related genotype	1	0.987403161140781	16555	7839	16555	
9539	component of the transcriptional output	component of the transcriptional output	1	0.987403161140781	918	9541	918	
6044	multiple strains of P	multiple strain of P	1	0.987403161140781	5658	6040	551	
16300	site of the 3-position	site of the 3-position	1	0.987403161140781	3	16302	3	
3994	global regulatory activities	global regulatory activity	1	0.987403161140781	3996	2213	1316	
4570	outer protein	outer protein	1	0.987403161140781	406	2374	406	
8298	treat analysis	treat analysis	1	0.987403161140781	203	8299	203	
2534	response to infection	response to infection	1	0.987403161140781	286	274	286	
10676	part of the S4 pocket	part of the S4 pocket	1	0.987403161140781	1050	10678	1050	
5272	energy requirement	energy requirement	1	0.987403161140781	5274	1624	5274	
11125	cause of Gram	cause of Gram	1	0.987403161140781	8326	615	8326	
5798	high level	high level	1	0.987403161140781	1113	264	1113	
15459	further studies	further study	1	0.987403161140781	2918	2629	2918	
6518	PAGE profiles	PAGE profile	1	0.987403161140781	3564	6519	3564	
1308	significant protection	significant protection	1	0.987403161140781	1310	24	1310	
11680	optimization of hexose oxidase production	optimization of hexose oxidase production	1	0.987403161140781	11681	11682	11681	
11020	Listeria innocua	Listeria innocua	1	0.987403161140781	11022	6659	11022	
11775	widespread pneumococcal vaccination	widespread pneumococcal vaccination	1	0.987403161140781	11777	4519	11779	
8428	tissue culture medium	tissue culture medium	1	0.987403161140781	2746	569	1926	
7065	target genes	target gene	1	0.987403161140781	444	6812	444	
8250	reporter nucleus	reporter nucleus	1	0.987403161140781	8252	2782	8252	
8019	antibacterial agents	antibacterial agent	1	0.987403161140781	1834	1575	1834	
9136	unculturable plant pathogenic bacterium	unculturable plant pathogenic bacterium	1	0.987403161140781	9138	9137	1136	
37	Ara+ LPSs	Ara+ LPS	1	0.987403161140781	39	38	39	
2722	divalent cations	divalent cation	1	0.987403161140781	2724	2723	2724	
12245	% of children	% of child	1	0.987403161140781	1209	1560	1209	
3035	exceptional ability	exceptional ability	1	0.987403161140781	939	3036	939	
10394	384-well screening plates	384-well screening plate	1	0.987403161140781	10396	10395	2093	
7094	contribution of YopJ	contribution of YopJ	1	0.987403161140781	95	4142	95	
4502	permeability of the H	permeability of the H	1	0.987403161140781	572	764	572	
3338	synthetic protein design	synthetic protein design	1	0.987403161140781	3340	3339	3342	
7546	consumption of marine bivalves	consumption of marine bivalve	1	0.987403161140781	7547	7548	7547	
858	intracellular concentrations of central metabolites	intracellular concentration of central metabolite	1	0.987403161140781	860	859	163	
16606	Pathogenicity of the gram	Pathogenicity of the gram	1	0.987403161140781	16607	3167	16607	
12000	Lymphoepithelial lesions	Lymphoepithelial lesion	1	0.987403161140781	2399	12001	2399	
15645	sodium dodecyl sulfate	sodium dodecyl sulfate	1	0.987403161140781	15647	15646	15649	
511	Total carotenoid synthesis	Total carotenoid synthesis	1	0.987403161140781	513	512	515	
5628	secY gene	secY gene	1	0.987403161140781	18	5629	18	
2221	sample matrices	sample matrix	1	0.987403161140781	2223	2222	2223	
13460	result of the deletional inactivation of luxS	result of the deletional inactivation of luxS	1	0.987403161140781	4412	13462	4412	
5597	clinical microbiology laboratory	clinical microbiology laboratory	1	0.987403161140781	5599	323	5601	
10384	number of subsites	number of subsite	1	0.987403161140781	1034	10386	1034	
8371	Gingivomandibular infection	Gingivomandibular infection	1	0.987403161140781	274	8372	274	
14813	proliferation of resistant lineages	proliferation of resistant lineage	1	0.987403161140781	7985	14584	7985	
2420	level of LAB	level of LAB	1	0.987403161140781	1113	2422	1113	
9253	control birds	control bird	1	0.987403161140781	4368	575	4368	
7337	optimal growth	optimal growth	1	0.987403161140781	217	7062	217	
11878	different mucosal surfaces	different mucosal surface	1	0.987403161140781	11880	816	1811	
3052	systematic reviews	systematic review	1	0.987403161140781	3054	3053	3054	
9718	construction of a 3.5-kb derivative	construction of a 3.5-kb derivative	1	0.987403161140781	9719	9720	9719	
9559	standard treatment	standard treatment	1	0.987403161140781	61	8654	61	
13408	facial fractures	facial fracture	1	0.987403161140781	13410	13409	13410	
8693	treatment center	treatment center	1	0.987403161140781	4790	61	4790	
13827	sustained decreases	sustained decrease	1	0.987403161140781	13829	13828	13829	
14851	PMN reactive oxygen species	PMN reactive oxygen specie	1	0.987403161140781	14853	278	73	
4637	peptide dermaseptin S4	peptide dermaseptin S4	1	0.987403161140781	4639	4638	4641	
13554	root colonization pattern	root colonization pattern	1	0.987403161140781	13556	4487	4145	
14848	combination of FcgammaRIIa	combination of FcgammaRIIa	1	0.987403161140781	1027	686	1027	
4982	unique capacity	unique capacity	1	0.987403161140781	4984	3347	4984	
3973	low-dose triple therapy	low-dose triple therapy	1	0.987403161140781	3975	3974	464	
15402	addition of the anionic detergent LAS	addition of the anionic detergent LAS	1	0.987403161140781	2743	15404	2743	
15568	Effect of cytokine modulation	Effect of cytokine modulation	1	0.987403161140781	15569	3940	15569	
11797	resistant strain of Bacillus intermedius S	resistant strain of Bacillus intermedius S	1	0.987403161140781	8896	11801	76	
12460	genetic backgrounds	genetic background	1	0.987403161140781	12462	880	12462	
10390	absence of complement	absence of complement	1	0.987403161140781	5502	2759	5502	
11270	similarity to transglycosylases	similarity to transglycosylas	1	0.987403161140781	7908	11272	7908	
1773	nerve degeneration	nerve degeneration	1	0.987403161140781	1775	1774	1775	
13821	V protein	V protein	1	0.987403161140781	406	2022	406	
15054	Ferric uptake regulator	Ferric uptake regulator	1	0.987403161140781	15056	15055	756	
10206	4% yeast extract	4% yeast extract	1	0.987403161140781	10208	10207	3075	
4108	typing scheme	typing scheme	1	0.987403161140781	4110	1658	4110	
3819	surveillance of CAUTI	surveillance of CAUTI	1	0.987403161140781	3820	391	3820	
5882	rod-shaped bacterium	rod-shaped bacterium	1	0.987403161140781	1136	5883	1136	
2445	streptococcal strains	streptococcal strain	1	0.987403161140781	551	2446	551	
8011	elevated gastric pH	elevated gastric pH	1	0.987403161140781	189	8012	191	
12374	NleG family	NleG family	1	0.987403161140781	2170	12375	2170	
5609	fish farm	fish farm	1	0.987403161140781	3592	1903	3592	
13676	rapid bactericidal kinetics	rapid bactericidal kinetic	1	0.987403161140781	13678	4185	13680	
14208	implications of peptides' hydrophobicity	implication of peptides' hydrophobicity	1	0.987403161140781	1783	14210	1783	
13223	mouse sera	mouse serum	1	0.987403161140781	3345	9833	3345	
5079	asp23 mRNA levels	asp23 mRNA level	1	0.987403161140781	1569	5080	495	
8389	putative function	putative function	1	0.987403161140781	778	2074	778	
11320	major virulence genes	major virulence gene	1	0.987403161140781	2075	71	444	
14927	creation of random combinatorial libraries of mutants	creation of random combinatorial library of mutant	1	0.987403161140781	14928	14929	14928	
3098	Staphylococcus growth	Staphylococcus growth	1	0.987403161140781	217	3099	217	
10526	form of conditional sterility	form of conditional sterility	1	0.987403161140781	4440	10528	4440	
8768	swelling of the hind paws	swelling of the hind paw	1	0.987403161140781	7448	8268	7448	
15130	transposable elements	transposable element	1	0.987403161140781	15132	15131	15132	
3790	nucleic acid extracts	nucleic acid extract	1	0.987403161140781	3792	3791	3189	
10465	CNS infection rate	CNS infection rate	1	0.987403161140781	154	10466	154	
10232	rapid methods	rapid method	1	0.987403161140781	2371	4185	2371	
860	concentrations of central metabolites	concentration of central metabolite	1	0.987403161140781	163	862	163	
538	nursing home	nursing home	1	0.987403161140781	540	539	540	
10955	infectivity of the malaria	infectivity of the malaria	1	0.987403161140781	10956	10957	10956	
4909	domain structure	domain structure	1	0.987403161140781	201	253	201	
8951	specific CD8+ T cell	specific CD8+ T cell	1	0.987403161140781	8953	504	235	
14746	medical devices	medical device	1	0.987403161140781	14748	13093	14748	
4200	upper respiratory tract disease	upper respiratory tract disease	1	0.987403161140781	4202	4201	268	
3403	human PMNs	human PMN	1	0.987403161140781	3405	834	3405	
3179	different pull	different pull	1	0.987403161140781	3181	816	3181	
7685	endocellular bacteria	endocellular bacteria	1	0.987403161140781	1999	7686	1999	
7529	regulatory cascade	regulatory cascade	1	0.987403161140781	7531	3086	7531	
3321	obligate parasitism	obligate parasitism	1	0.987403161140781	3323	3322	3323	
1737	control monkeys	control monkey	1	0.987403161140781	1739	575	1739	
125	fibrin clots	fibrin clot	1	0.987403161140781	127	126	127	
7429	isozyme bands	isozyme band	1	0.987403161140781	7431	7430	7431	
496	Recurrence of Helicobacter pylori infection	Recurrence of Helicobacter pylori infection	1	0.987403161140781	497	498	497	
270	host susceptibility to infection	host susceptibility to infection	1	0.987403161140781	272	271	273	
9328	concentric cylinders	concentric cylinder	1	0.987403161140781	9330	9329	9330	
14855	oxygen species	oxygen specie	1	0.987403161140781	73	5696	73	
14475	coli exploit type	coli exploit type	1	0.987403161140781	14477	1842	1698	
13971	level of education	level of education	1	0.987403161140781	1113	4726	1113	
8989	time of ICP monitor insertion	time of ICP monitor insertion	1	0.987403161140781	1403	8991	1403	
6539	coli soluble proteins	coli soluble protein	1	0.987403161140781	6541	6540	27	
9990	T cell activation	T cell activation	1	0.987403161140781	2118	2056	2118	
10816	nature cells	nature cell	1	0.987403161140781	113	3765	113	
14922	Higher concentrations	High concentration	1	0.987403161140781	163	14923	163	
11925	protein level	protein level	1	0.987403161140781	1113	406	1113	
10868	HCE cells	HCE cell	1	0.987403161140781	113	1825	113	
5617	Hb capture complex	Hb capture complex	1	0.987403161140781	5619	5618	1524	
4018	16S rDNA sequence analysis	16S rDNA sequence analysis	1	0.987403161140781	4020	4019	203	
4439	form of distributions of LD observables	form of distribution of LD observable	1	0.987403161140781	4440	4441	4440	
16527	Klebsiella pneumonia infections	Klebsiella pneumonia infection	1	0.987403161140781	16529	663	736	
6440	properties of MBD	property of MBD	1	0.987403161140781	3103	1931	3103	
15668	invasion stages	invasion stage	1	0.987403161140781	1098	1178	1098	
6206	base residues Glu	base residue Glu	1	0.987403161140781	4970	6207	4970	
11265	eae of enteropathogenic E	eae of enteropathogenic E	1	0.987403161140781	11266	6596	11266	
15274	basic disease	basic disease	1	0.987403161140781	268	7733	268	
15072	lethal action of bactericidal agents	lethal action of bactericidal agent	1	0.987403161140781	15074	9116	8607	
4620	member of the family	member of the family	1	0.987403161140781	4621	2170	4621	
2087	hydrophilic tissue culture plates	hydrophilic tissue culture plate	1	0.987403161140781	2089	2088	2093	
16458	independent manner	independent manner	1	0.987403161140781	2721	1433	2721	
9586	tetradecanoic acid	tetradecanoic acid	1	0.987403161140781	4	9587	4	
9313	Vibro parahaemolyticus	Vibro parahaemolyticus	1	0.987403161140781	9315	9314	9315	
14161	Paraffin section	Paraffin section	1	0.987403161140781	10419	11815	10419	
7611	serotypes A	serotype A	1	0.987403161140781	1379	1214	1379	
797	understanding of the causes	understanding of the cause	1	0.987403161140781	729	799	729	
6978	death domain	death domain	1	0.987403161140781	253	281	253	
2256	white blood cell counts	white blood cell count	1	0.987403161140781	2258	2206	2262	
5341	severe destructive Lyme arthritis	severe destructive Lyme arthritis	1	0.987403161140781	5343	2773	2776	
15498	rhizogenes strains of the agropine type	rhizogene strain of the agropine type	1	0.987403161140781	15500	15499	551	
6662	ActA protein	ActA protein	1	0.987403161140781	406	1265	406	
13900	combination of interferon	combination of interferon	1	0.987403161140781	1027	7986	1027	
5824	cholerae bacteremia	cholerae bacteremia	1	0.987403161140781	2944	5825	2944	
2401	Evaluation of impermeant	Evaluation of impermeant	1	0.987403161140781	1573	2403	1573	
11157	phylogenetic tree	phylogenetic tree	1	0.987403161140781	11159	3816	11159	
5905	spontaneous bacterial peritonitis	spontaneous bacterial peritonitis	1	0.987403161140781	5907	5906	5909	
13039	induction of inflammation	induction of inflammation	1	0.987403161140781	5850	1772	5850	
2041	sensitivity tests	sensitivity test	1	0.987403161140781	2025	1818	2025	
1699	site of emergence of the lateral roots	site of emergence of the lateral root	1	0.987403161140781	3	1701	3	
1500	system infections	system infection	1	0.987403161140781	736	1501	736	
6602	deficient serum	deficient serum	1	0.987403161140781	1798	1064	1798	
11162	selection of subtilisin variants	selection of subtilisin variant	1	0.987403161140781	1647	2174	1647	
10031	purulent material	purulent material	1	0.987403161140781	7239	10032	7239	
6233	coli heat	coli heat	1	0.987403161140781	1986	1842	1986	
9011	complex of Chlorobaculum tepidum	complex of Chlorobaculum tepidum	1	0.987403161140781	1524	4781	1524	
5866	agent susceptibility testing	agent susceptibility testing	1	0.987403161140781	5868	1357	5870	
10978	Structure of MurNAc 6-phosphate hydrolase	Structure of MurNAc 6-phosphate hydrolase	1	0.987403161140781	10979	8568	10979	
1296	monoclonal antibody to TCR delta	monoclonal antibody to TCR delta	1	0.987403161140781	1297	1300	1299	
2969	susceptible revertant	susceptible revertant	1	0.987403161140781	2971	2970	2971	
4015	large granulomata	large granuloma	1	0.987403161140781	1199	288	1199	
15812	potential carriers of Campylobacter spp	potential carrier of Campylobacter spp	1	0.987403161140781	15814	2154	8170	
1997	eradication of bacteria	eradication of bacteria	1	0.987403161140781	153	1999	153	
13637	oculogenital origin	oculogenital origin	1	0.987403161140781	13639	13638	13639	
8222	Type A	Type A	1	0.987403161140781	1379	7668	1379	
14444	cremoris strains	cremoris strain	1	0.987403161140781	551	14445	551	
7551	vero cytotoxin genes	vero cytotoxin gene	1	0.987403161140781	7553	7552	444	
15655	therapeutic approaches	therapeutic approach	1	0.987403161140781	15636	2756	15636	
3032	infection model	infection model	1	0.987403161140781	361	274	361	
11700	control of lower respiratory disease	control of low respiratory disease	1	0.987403161140781	575	11702	575	
2992	features of this drug	feature of this drug	1	0.987403161140781	157	162	157	
7721	presence of bromodeoxyuridine triphosphate	presence of bromodeoxyuridine triphosphate	1	0.987403161140781	139	7723	139	
14152	primary infection	primary infection	1	0.987403161140781	274	4073	274	
2652	multivariable model	multivariable model	1	0.987403161140781	361	2653	361	
15366	maculicola protein	maculicola protein	1	0.987403161140781	406	15367	406	
13282	dispersion method	dispersion method	1	0.987403161140781	596	7434	596	
12810	plasmid DNA	plasmid DNA	1	0.987403161140781	468	3040	468	
10283	electrokinetic properties of cells	electrokinetic property of cell	1	0.987403161140781	10285	10284	3103	
5507	disk diffusion method	disk diffusion method	1	0.987403161140781	5509	5508	596	
10193	evaluation of the bacteriological effect	evaluation of the bacteriological effect	1	0.987403161140781	6516	10195	6516	
15720	bacterial pathogen	bacterial pathogen	1	0.987403161140781	1905	185	1905	
60	treatment of established mature biofilms	treatment of established mature biofilm	1	0.987403161140781	61	62	61	
6008	aztreonam lysine	aztreonam lysine	1	0.987403161140781	4528	2161	4528	
10866	attachment to HCE cells	attachment to HCE cell	1	0.987403161140781	938	10868	938	
8083	resistance phenotypes	resistance phenotype	1	0.987403161140781	6668	1830	6668	
6432	liquid of the streptomycin	liquid of the streptomycin	1	0.987403161140781	6433	6434	6433	
12206	variable fragments of an LPS	variable fragment of an LPS	1	0.987403161140781	6068	7060	6070	
16829	antimicrobial drug targets	antimicrobial drug target	1	0.987403161140781	16831	1753	16833	
4917	phosphodiesterase activities	phosphodiesterase activity	1	0.987403161140781	1316	4918	1316	
7539	type analysis	type analysis	1	0.987403161140781	203	1698	203	
1320	thuringiensis strains	thuringiensis strain	1	0.987403161140781	551	1321	551	
16197	pump of the parietal cell	pump of the parietal cell	1	0.987403161140781	171	16199	171	
6814	sensitivity of 89%	sensitivity of 89%	1	0.987403161140781	1818	5627	1818	
13697	W135 meningococci	W135 meningococci	1	0.987403161140781	13	14	13	
15082	Profile E4	Profile E4	1	0.987403161140781	15084	15083	15084	
8317	UTR of 621bp	UTR of 621bp	1	0.987403161140781	8318	8319	8318	
12100	metabolome analysis	metabolome analysis	1	0.987403161140781	203	484	203	
6065	effect of TeCB	effect of TeCB	1	0.987403161140781	2937	6067	2937	
13508	expression analysis of Phytoplasma protein translocation genes	expression analysis of Phytoplasma protein translocation gene	1	0.987403161140781	13510	373	203	
5810	effective new therapy	effective new therapy	1	0.987403161140781	5812	5811	464	
3540	estimates of time to clearance	estimate of time to clearance	1	0.987403161140781	3541	3542	3541	
7098	trauma intensive care unit	trauma intensive care unit	1	0.987403161140781	3022	7099	1107	
15822	permeability barrier to ampicillin	permeability barrier to ampicillin	1	0.987403161140781	15824	572	630	
14507	Japanese antigenic scheme	Japanese antigenic scheme	1	0.987403161140781	14509	295	4110	
5305	A protein	A protein	1	0.987403161140781	406	1379	406	
7548	marine bivalves	marine bivalve	1	0.987403161140781	2432	1135	2432	
12863	step of an iron	step of an iron	1	0.987403161140781	4671	1953	4671	
306	niche of the organism	niche of the organism	1	0.987403161140781	307	308	307	
4307	loss of viability	loss of viability	1	0.987403161140781	4308	4309	4308	
11504	numerous processes	numerous process	1	0.987403161140781	3489	10645	3489	
16441	eae genes	eae gene	1	0.987403161140781	444	9177	444	
3888	Gastric biopsies	Gastric biopsy	1	0.987403161140781	3370	1459	3370	
14235	necropsied calves	necropsied calf	1	0.987403161140781	2101	11773	2101	
6195	genotypic data	genotypic datum	1	0.987403161140781	609	2569	609	
16444	carriage rate of children	carriage rate of child	1	0.987403161140781	7309	1560	154	
7814	invasiveness of V	invasiveness of V	1	0.987403161140781	5483	2022	5483	
14592	CLO test	CLO test	1	0.987403161140781	85	14593	85	
10002	wide level of diversity	wide level of diversity	1	0.987403161140781	10004	2070	1113	
1606	essential polymeric cell structure	essential polymeric cell structure	1	0.987403161140781	1608	1607	201	
11333	key regulatory roles	key regulatory role	1	0.987403161140781	11335	1002	8900	
14883	potential applications	potential application	1	0.987403161140781	2931	2154	2931	
11507	novel receptor	novel receptor	1	0.987403161140781	345	82	345	
13855	Temperature upshift	Temperature upshift	1	0.987403161140781	13857	13856	13857	
3853	ratio E	ratio E	1	0.987403161140781	79	3302	79	
13378	intake period	intake period	1	0.987403161140781	2478	13379	2478	
5792	causes of WARI	cause of WARI	1	0.987403161140781	799	3155	799	
1293	emergent MDRP	emergent MDRP	1	0.987403161140781	541	1294	541	
6691	fungal pathogens	fungal pathogen	1	0.987403161140781	186	6692	186	
15563	Tryptone glucose extract	Tryptone glucose extract	1	0.987403161140781	15565	15564	3075	
4779	mutant of Chlorobaculum tepidum	mutant of Chlorobaculum tepidum	1	0.987403161140781	4780	4781	4780	
1759	bacterial inclusion bodies	bacterial inclusion body	1	0.987403161140781	1761	185	1763	
3970	payer perspective	payer perspective	1	0.987403161140781	3972	3971	3972	
8174	restriction endonuclease analysis	restriction endonuclease analysis	1	0.987403161140781	8176	5178	203	
7048	overview of the dynamics of the HCN production	overview of the dynamic of the HCN production	1	0.987403161140781	7049	7050	7049	
9670	adhesion to an abiotic surface	adhesion to an abiotic surface	1	0.987403161140781	336	4213	336	
12615	Diarrheagenic E	Diarrheagenic E	1	0.987403161140781	79	12616	79	
800	alvei strains	alvei strain	1	0.987403161140781	551	801	551	
1358	causative pathogens of meningitis	causative pathogen of meningitis	1	0.987403161140781	228	1362	186	
3906	nursing facility	nursing facility	1	0.987403161140781	3908	539	3908	
15861	inflammatory cytokines	inflammatory cytokine	1	0.987403161140781	13346	2643	13346	
11819	biocontainment strategies	biocontainment strategy	1	0.987403161140781	5392	3752	5392	
8783	piped water	piped water	1	0.987403161140781	920	8784	920	
16350	effect of structural disorder	effect of structural disorder	1	0.987403161140781	2937	1712	2937	
7590	addition of tobramycin	addition of tobramycin	1	0.987403161140781	2743	7592	2743	
2448	histidine tag	histidine tag	1	0.987403161140781	2450	2449	2450	
862	central metabolites	central metabolite	1	0.987403161140781	864	863	864	
6350	growth potential of F	growth potential of F	1	0.987403161140781	6352	217	6353	
15097	terminal untranslated region	terminal untranslated region	1	0.987403161140781	15099	8316	3464	
6934	membrane disks	membrane disk	1	0.987403161140781	6936	3723	6936	
8741	unique strain group	unique strain group	1	0.987403161140781	351	8742	351	
16730	acute lower respiratory illness	acute low respiratory illness	1	0.987403161140781	1389	6312	637	
7832	human pathogenic F	human pathogenic F	1	0.987403161140781	7834	834	48	
9537	major component of the transcriptional output	major component of the transcriptional output	1	0.987403161140781	9539	71	918	
14865	human gastric mucin	human gastric mucin	1	0.987403161140781	14867	834	677	
6878	food products	food product	1	0.987403161140781	1031	43	1031	
15254	positive correlations	positive correlation	1	0.987403161140781	239	953	239	
6494	type pigments	type pigment	1	0.987403161140781	6496	1698	6496	
3361	pairs of oligonucleotide primers	pair of oligonucleotide primer	1	0.987403161140781	3362	3363	3362	
4459	Testing animal	Testing animal	1	0.987403161140781	4461	4460	4461	
459	interesting organism	interesting organism	1	0.987403161140781	308	460	308	
2184	prevalence of B	prevalence of B	1	0.987403161140781	1786	977	1786	
985	outbreak of the disease	outbreak of the disease	1	0.987403161140781	986	268	986	
8797	surgical patients	surgical patient	1	0.987403161140781	226	8798	226	
1045	conservative Toll	conservative Toll	1	0.987403161140781	1047	1046	1047	
4692	concentrations of ozone	concentration of ozone	1	0.987403161140781	163	1630	163	
15538	dry season	dry season	1	0.987403161140781	15540	15332	15540	
9348	male gender	male gender	1	0.987403161140781	9350	9349	9350	
14758	structure of MurQ	structure of MurQ	1	0.987403161140781	201	1388	201	
9302	models of frequency	model of frequency	1	0.987403161140781	7459	265	7459	
8773	frequency of defecation	frequency of defecation	1	0.987403161140781	265	1719	265	
7931	enterotoxigenic Bacteroides fragilis	enterotoxigenic Bacteroide fragilis	1	0.987403161140781	7933	5573	7935	
5277	synthetic derivatives	synthetic derivative	1	0.987403161140781	3424	3339	3424	
4690	low concentrations of ozone	low concentration of ozone	1	0.987403161140781	4692	1109	163	
168	proton pump inhibitor	proton pump inhibitor	1	0.987403161140781	170	169	172	
5300	crystallization trials	crystallization trial	1	0.987403161140781	3442	5301	3442	
855	impaired infection	impaired infection	1	0.987403161140781	274	652	274	
3844	life of vacuum	life of vacuum	1	0.987403161140781	3227	248	3227	
5899	associated serovar	associated serovar	1	0.987403161140781	5901	5900	5901	
14338	indicative of widespread acquisition	indicative of widespread acquisition	1	0.987403161140781	10890	14340	10890	
3699	dependent up-regulation of perforin	dependent up-regulation of perforin	1	0.987403161140781	3701	807	3702	
16223	staphylococcal endocarditis	staphylococcal endocarditis	1	0.987403161140781	3878	823	3878	
9021	dietary addition	dietary addition	1	0.987403161140781	2743	3581	2743	
13711	abiotic surfaces	abiotic surface	1	0.987403161140781	1811	4214	1811	
635	serious illness	serious illness	1	0.987403161140781	637	636	637	
12724	contents of hexadecenoic acid	content of hexadecenoic acid	1	0.987403161140781	6287	7965	6287	
12279	swarming differentiation of a bacterium	swarming differentiation of a bacterium	1	0.987403161140781	12281	8091	884	
16413	PCB congener	PCB congener	1	0.987403161140781	16415	16414	16415	
7584	immunoblot profiles	immunoblot profile	1	0.987403161140781	3564	7585	3564	
12755	blood samples	blood sample	1	0.987403161140781	225	2208	225	
9249	xylanase activity	xylanase activity	1	0.987403161140781	393	7233	393	
11028	N-terminal amino acid	N-terminal amino acid	1	0.987403161140781	1270	1267	4	
13236	eae of EHEC strain EDL	eae of EHEC strain EDL	1	0.987403161140781	11266	13238	11266	
8800	critical assessment	critical assessment	1	0.987403161140781	8802	8801	8802	
15703	Exposure of E	Exposure of E	1	0.987403161140781	15704	79	15704	
7086	selection schemes	selection scheme	1	0.987403161140781	7088	1647	7088	
5560	acid requirements of strains of Chlamydia trachomatis	acid requirement of strain of Chlamydia trachomatis	1	0.987403161140781	5562	4	658	
6784	frequencies of isolation	frequency of isolation	1	0.987403161140781	6785	326	6785	
6528	functional activity	functional activity	1	0.987403161140781	393	3355	393	
7294	thiazolyl blue tetrazolium bromide	thiazolyl blue tetrazolium bromide	1	0.987403161140781	7296	7295	7209	
6471	alternative transcription factor sigma B	alternative transcription factor sigma B	1	0.987403161140781	6473	6472	977	
988	different communities	different community	1	0.987403161140781	990	816	990	
4112	multiplication of a range of Chlamydia trachomatis	multiplication of a range of Chlamydia trachomatis	1	0.987403161140781	4113	4114	4113	
1448	Rickettsia conorii isolates	Rickettsia conorii isolate	1	0.987403161140781	1450	1449	334	
14092	chromosomal locations-the fliCS	chromosomal locations-the fliCS	1	0.987403161140781	14094	9066	14096	
2670	presence of an enlarged irregular mantle zone	presence of an enlarged irregular mantle zone	1	0.987403161140781	139	2672	139	
7220	region of ActA	region of ActA	1	0.987403161140781	3464	1265	3464	
16846	degree of complexity	degree of complexity	1	0.987403161140781	2084	16848	2084	
10531	optical spectra	optical spectrum	1	0.987403161140781	10533	2815	10533	
15491	proteolytic cleavage	proteolytic cleavage	1	0.987403161140781	4898	15492	4898	
7383	expression of pdhA genes	expression of pdhA gene	1	0.987403161140781	373	7385	373	
15154	morphological changes	morphological change	1	0.987403161140781	1846	15155	1846	
9150	potential plant probiotic activities	potential plant probiotic activity	1	0.987403161140781	9152	2154	1316	
11226	rRNA sequence analysis	rRNA sequence analysis	1	0.987403161140781	3066	8868	203	
14606	membrane of cells	membrane of cell	1	0.987403161140781	3723	113	3723	
13001	secondary responses	secondary response	1	0.987403161140781	2627	68	2627	
2073	putative virulence genes	putative virulence gene	1	0.987403161140781	2075	2074	444	
2429	defense system	defense system	1	0.987403161140781	1501	1340	1501	
12972	polyclonal pattern	polyclonal pattern	1	0.987403161140781	4145	8998	4145	
15998	model organism	model organism	1	0.987403161140781	308	361	308	
5551	agricultural products	agricultural product	1	0.987403161140781	1031	5552	1031	
8338	fluorescence microscopy	fluorescence microscopy	1	0.987403161140781	2816	930	2816	
9032	addition steps	addition step	1	0.987403161140781	9034	2743	9034	
9589	agarase B	agarase B	1	0.987403161140781	977	9590	977	
14541	microbial world	microbial world	1	0.987403161140781	10900	521	10900	
15947	present study serum pepsinogen	present study serum pepsinogen	1	0.987403161140781	4092	8458	4094	
7788	human anthrax	human anthrax	1	0.987403161140781	2492	834	2492	
10124	approach to the development of new treatments	approach to the development of new treatment	1	0.987403161140781	10125	10126	10125	
11249	sensitive ones	sensitive one	1	0.987403161140781	2303	3589	2303	
13292	less C	less C	1	0.987403161140781	243	13293	243	
12853	common cause of WARI	common cause of WARI	1	0.987403161140781	12855	870	8326	
11204	hypertonic strontium chloride	hypertonic strontium chloride	1	0.987403161140781	11206	11205	9565	
13930	monitor prophylaxis	monitor prophylaxis	1	0.987403161140781	22	7157	22	
13543	C-urea breath test	C-urea breath test	1	0.987403161140781	10454	13544	85	
3475	fish samples	fish sample	1	0.987403161140781	225	1903	225	
5893	specific DNA of an LGV associated serovar	specific DNA of an LGV associated serovar	1	0.987403161140781	5895	504	468	
4630	development of peripheral nervous system	development of peripheral nervous system	1	0.987403161140781	1679	4632	1679	
11518	years of age living	year of age living	1	0.987403161140781	9423	11519	9423	
12749	resistant derivative of methicillin	resistant derivative of methicillin	1	0.987403161140781	12751	123	9722	
6021	alkaline phosphatases	alkaline phosphatas	1	0.987403161140781	6023	1289	6023	
15048	geographical areas	geographical area	1	0.987403161140781	4719	15049	4719	
5118	ongoing F	ongoing F	1	0.987403161140781	48	5119	48	
7046	broad overview of the dynamics of the HCN production	broad overview of the dynamic of the HCN production	1	0.987403161140781	7048	796	7049	
13383	gastroduodenal ulcers	gastroduodenal ulcer	1	0.987403161140781	1307	1794	1307	
12612	similar effect	similar effect	1	0.987403161140781	2937	1190	2937	
8099	patterns of occurrence	pattern of occurrence	1	0.987403161140781	2366	871	2366	
5288	metabolic traits	metabolic trait	1	0.987403161140781	4796	2121	4796	
6477	sigma B	sigma B	1	0.987403161140781	977	5076	977	
12450	Hp IgG	Hp IgG	1	0.987403161140781	3705	12451	3705	
1637	cost of Group C therapy	cost of Group C therapy	1	0.987403161140781	1638	1639	1638	
5228	treatment of AOM	treatment of AOM	1	0.987403161140781	61	1260	61	
14298	Regulation of cytotoxic effector molecule expression	Regulation of cytotoxic effector molecule expression	1	0.987403161140781	14299	14300	14299	
5645	specific environmental constraints	specific environmental constraint	1	0.987403161140781	5647	504	5649	
8633	studies of flomoxef	study of flomoxef	1	0.987403161140781	2918	8635	2918	
6340	Evaluation of the role of Carnobacterium piscicola	Evaluation of the role of Carnobacterium piscicola	1	0.987403161140781	1573	6342	1573	
11963	B cell	B cell	1	0.987403161140781	235	977	235	
5548	role of sialidase	role of sialidase	1	0.987403161140781	233	5550	233	
16982	isolation procedures	isolation procedure	1	0.987403161140781	4746	326	4746	
6451	mass spectrometry	mass spectrometry	1	0.987403161140781	2137	1193	2137	
8701	minor allergen	minor allergen	1	0.987403161140781	8703	8702	8703	
7396	peritoneal cavity	peritoneal cavity	1	0.987403161140781	7398	7397	7398	
16470	protein levels	protein level	1	0.987403161140781	495	406	495	
15977	identical sequences	identical sequence	1	0.987403161140781	534	4144	534	
10739	high efficiency	high efficiency	1	0.987403161140781	481	264	481	
3318	available antimicrobials	available antimicrobial	1	0.987403161140781	1279	3319	1279	
2263	PCR test	PCR test	1	0.987403161140781	85	2264	85	
1152	fresh water supply	fresh water supply	1	0.987403161140781	1154	1153	1156	
7334	production fluid	production fluid	1	0.987403161140781	5371	93	5371	
8722	equimolar Cd(II)	equimolar Cd(II)	1	0.987403161140781	8724	8723	8724	
10906	anthrax bacterium	anthrax bacterium	1	0.987403161140781	1136	2492	1136	
16631	overall health of tortoise populations	overall health of tortoise population	1	0.987403161140781	16633	5154	6744	
10374	component of MRSA prevention	component of MRSA prevention	1	0.987403161140781	918	10376	918	
10301	elimination of mycotoxins	elimination of mycotoxin	1	0.987403161140781	10302	10303	10302	
3235	residence time of the system	residence time of the system	1	0.987403161140781	3237	3236	1403	
15905	impaired bacterial clearance	impaired bacterial clearance	1	0.987403161140781	15907	652	449	
10443	Exogenous sialic acid	Exogenous sialic acid	1	0.987403161140781	3670	10444	4	
15487	Usage of signaling	Usage of signaling	1	0.987403161140781	15488	731	15488	
117	important insects	important insect	1	0.987403161140781	119	118	119	
11974	signaling pathway	signaling pathway	1	0.987403161140781	661	731	661	
5849	induction of Lyme arthritis	induction of Lyme arthritis	1	0.987403161140781	5850	5345	5850	
12503	Statistical analysis	Statistical analysis	1	0.987403161140781	203	12504	203	
12646	concentrations of single strains	concentration of single strain	1	0.987403161140781	163	12648	163	
7877	care center	care center	1	0.987403161140781	4790	3025	4790	
11318	regulation of some major virulence genes	regulation of some major virulence gene	1	0.987403161140781	378	11320	378	
5095	border of human intestinal epithelial cells	border of human intestinal epithelial cell	1	0.987403161140781	5096	5097	5096	
5817	activity of Anabaena cells of sp	activity of Anabaena cell of sp	1	0.987403161140781	393	5819	393	
6148	molecular beacon probes	molecular beacon probe	1	0.987403161140781	6150	376	6152	
13355	Blood samples	Blood sample	1	0.987403161140781	225	5781	225	
13149	motif CX5R	motif CX5R	1	0.987403161140781	13151	1438	13151	
11132	beneficial traits	beneficial trait	1	0.987403161140781	4796	11133	4796	
1793	gastroduodenal tracts	gastroduodenal tract	1	0.987403161140781	1795	1794	1795	
11485	growth of F	growth of F	1	0.987403161140781	217	48	217	
6102	synchrotron beamline	synchrotron beamline	1	0.987403161140781	6104	6103	6104	
7091	final density	final density	1	0.987403161140781	4499	7092	4499	
4413	xylan hydrolysis	xylan hydrolysis	1	0.987403161140781	4415	4414	4415	
10666	strain Y	strain Y	1	0.987403161140781	4774	76	4774	
14376	gopher tortoise	gopher tortoise	1	0.987403161140781	1427	4506	1427	
15510	evidence of CTX	evidence of CTX	1	0.987403161140781	2412	15512	2412	
11256	nuclear factor	nuclear factor	1	0.987403161140781	72	11257	72	
5833	Mutational analysis of the N-terminal domain of UreR	Mutational analysis of the N-terminal domain of UreR	1	0.987403161140781	5835	5834	203	
10514	term Helicobacter pylori infection	term Helicobacter pylori infection	1	0.987403161140781	498	2270	274	
3524	polar lipid	polar lipid	1	0.987403161140781	3526	3525	3526	
2911	Isolation of Helicobacter pullorum	Isolation of Helicobacter pullorum	1	0.987403161140781	2912	2913	2912	
11313	dextran administration	dextran administration	1	0.987403161140781	3007	11314	3007	
13157	significant variations of intracellular metabolite pool	significant variation of intracellular metabolite pool	1	0.987403161140781	13159	24	13160	
11451	diagnosis of Helicobactor pylori infection	diagnosis of Helicobactor pylori infection	1	0.987403161140781	5010	11453	5010	
13802	NOESY spectrum	NOESY spectrum	1	0.987403161140781	1695	396	1695	
15617	composition of the type strain	composition of the type strain	1	0.987403161140781	10137	9801	10137	
9822	production of a cellulase	production of a cellulase	1	0.987403161140781	93	5446	93	
219	canonical Erk	canonical Erk	1	0.987403161140781	221	220	221	
16380	Polymerase chain reaction	Polymerase chain reaction	1	0.987403161140781	559	16381	561	
6497	bacterial proteins	bacterial protein	1	0.987403161140781	27	185	27	
5350	infected animals	infected animal	1	0.987403161140781	1634	1838	1634	
13019	central nervous system	central nervous system	1	0.987403161140781	4634	863	1501	
8869	gene sequences	gene sequence	1	0.987403161140781	534	18	534	
11902	states exchange	state exchange	1	0.987403161140781	9212	1909	9212	
3873	subacute bacterial endocarditis case	subacute bacterial endocarditis case	1	0.987403161140781	3875	3874	618	
12781	induction of pyruvate dehydrogenase genes	induction of pyruvate dehydrogenase gene	1	0.987403161140781	5850	12783	5850	
2509	inhibition ELISA	inhibition ELISA	1	0.987403161140781	2511	2510	2511	
3651	substrate analogues	substrate analogue	1	0.987403161140781	3653	3652	3653	
3612	potential role	potential role	1	0.987403161140781	233	2154	233	
12573	Activation of this pathway	Activation of this pathway	1	0.987403161140781	12574	661	12574	
11220	basis of the results of a 16S rRNA sequence analysis	basis of the result of a 16S rRNA sequence analysis	1	0.987403161140781	6748	11222	6748	
111	free cells	free cell	1	0.987403161140781	113	112	113	
662	Klebsiella pneumonia infection	Klebsiella pneumonia infection	1	0.987403161140781	664	663	274	
2881	age-related prevalence of K	age-related prevalence of K	1	0.987403161140781	2883	2882	1786	
7764	characteristics of probiotic bacteria	characteristic of probiotic bacteria	1	0.987403161140781	3758	7766	3758	
2182	equal prevalence of B	equal prevalence of B	1	0.987403161140781	2184	2183	1786	
4673	heterogeneity of strains	heterogeneity of strain	1	0.987403161140781	3593	551	3593	
604	Hospitalization rates	Hospitalization rate	1	0.987403161140781	450	605	450	
368	MRSA infection	MRSA infection	1	0.987403161140781	274	369	274	
1257	Watery stool	Watery stool	1	0.987403161140781	1259	1258	1259	
5369	amniotic fluid	amniotic fluid	1	0.987403161140781	5371	5370	5371	
6650	bismuth subcitrate	bismuth subcitrate	1	0.987403161140781	6652	6651	6652	
2947	CF units	CF unit	1	0.987403161140781	1085	2948	1085	
653	Mtb antigen	Mtb antigen	1	0.987403161140781	655	654	655	
231	main role	main role	1	0.987403161140781	233	232	233	
13661	positive bacterial infection	positive bacterial infection	1	0.987403161140781	13663	953	274	
7303	antral gastritis	antral gastritis	1	0.987403161140781	4245	246	4245	
6893	world's oceans	world' ocean	1	0.987403161140781	6895	6894	6895	
13812	components of the medium	component of the medium	1	0.987403161140781	13813	1926	13813	
5619	capture complex	capture complex	1	0.987403161140781	1524	5620	1524	
6843	phase protein	phase protein	1	0.987403161140781	406	1218	406	
4500	greater permeability of the H	great permeability of the H	1	0.987403161140781	4502	4501	572	
6158	random sample	random sample	1	0.987403161140781	2222	6159	2222	
13381	treatment of gastroduodenal ulcers	treatment of gastroduodenal ulcer	1	0.987403161140781	61	13383	61	
471	excess delta C-UBT value	excess delta C-UBT value	1	0.987403161140781	473	472	211	
14991	individual cells	individual cell	1	0.987403161140781	113	3288	113	
4463	Japanese Intervention Trial of H . pylori	Japanese Intervention Trial of H . pylori	1	0.987403161140781	4465	295	4468	
9498	polymorphic DNA	polymorphic DNA	1	0.987403161140781	468	5939	468	
588	temperature rise	temperature rise	1	0.987403161140781	590	249	590	
11530	presence of toxin	presence of toxin	1	0.987403161140781	139	1598	139	
16877	American country	American country	1	0.987403161140781	16879	16878	16879	
2685	leu2- to LEU2+	leu2-_to LEU2+	1	0.987403161140781	2687	2686	2687	
13462	deletional inactivation of luxS	deletional inactivation of luxS	1	0.987403161140781	13464	13463	522	
3470	synthesis of thermolabile enterotoxin	synthesis of thermolabile enterotoxin	1	0.987403161140781	515	3472	515	
2286	production of virulence determinants	production of virulence determinant	1	0.987403161140781	93	2288	93	
10963	algal galactans	algal galactan	1	0.987403161140781	10965	10964	10965	
15384	atrophy of the gastric mucosa progresses	atrophy of the gastric mucosa progress	1	0.987403161140781	15390	7438	15390	
8165	mutant chlorosomes	mutant chlorosome	1	0.987403161140781	4776	7616	4776	
12284	tumor necrosis factor	tumor necrosis factor	1	0.987403161140781	12286	12285	72	
2038	emergency prophylaxis	emergency prophylaxis	1	0.987403161140781	22	2039	22	
12821	transcriptional level	transcriptional level	1	0.987403161140781	1113	2780	1113	
916	E3 component	E3 component	1	0.987403161140781	918	917	918	
15604	symbiotic activation of pdh gene expression	symbiotic activation of pdh gene expression	1	0.987403161140781	15606	3920	2118	
7405	gastric biopsies	gastric biopsy	1	0.987403161140781	3370	190	3370	
3962	transformation ability	transformation ability	1	0.987403161140781	939	3604	939	
5225	Alkaline phosphatase	Alkaline phosphatase	1	0.987403161140781	1290	5226	1290	
9477	great potential	great potential	1	0.987403161140781	6353	9478	6353	
16996	oxidation of some ingredients	oxidation of some ingredient	1	0.987403161140781	16997	16998	16997	
10966	bacterial surface adherence	bacterial surface adherence	1	0.987403161140781	3685	5115	3685	
11614	CD8+ T cells	CD8+ T cell	1	0.987403161140781	942	52	113	
16418	Staphylococcus aureus strains	Staphylococcus aureus strain	1	0.987403161140781	551	16419	551	
13725	low-light conditions	low-light condition	1	0.987403161140781	2285	13726	2285	
10706	likely pseudogenes	likely pseudogene	1	0.987403161140781	10708	2392	10708	
3366	bacterial cells	bacterial cell	1	0.987403161140781	113	185	113	
6660	monocytogenes ActA protein	monocytogene ActA protein	1	0.987403161140781	6662	121	406	
12335	kinetic parameters	kinetic parameter	1	0.987403161140781	8288	400	8288	
7732	basic conditions	basic condition	1	0.987403161140781	2285	7733	2285	
6224	mild side	mild side	1	0.987403161140781	3859	6225	3859	
14347	% magnesium sulphate	% magnesium sulphate	1	0.987403161140781	14349	1209	14351	
5179	endonuclease fragment length polymorphism	endonuclease fragment length polymorphism	1	0.987403161140781	5181	5180	5185	
12177	low compliance	low compliance	1	0.987403161140781	8920	1109	8920	
881	group designation	group designation	1	0.987403161140781	883	351	883	
11085	fo bacteriophage M	fo bacteriophage M	1	0.987403161140781	11087	11086	1921	
13611	occurrence of meningococcal disease	occurrence of meningococcal disease	1	0.987403161140781	871	266	871	
12122	efficacy of vancomycin	efficacy of vancomycin	1	0.987403161140781	12123	11371	12123	
15599	popular protease inhibitors	popular protease inhibitor	1	0.987403161140781	3270	15600	3272	
4727	Recurrence of Pelecypod	Recurrence of Pelecypod	1	0.987403161140781	497	4729	497	
3197	Acinetobacter baumannii pathogenicity	Acinetobacter baumannii pathogenicity	1	0.987403161140781	3092	3198	3092	
9968	few limited studies	few limited study	1	0.987403161140781	9970	9969	2918	
1478	salt concentrations	salt concentration	1	0.987403161140781	163	1479	163	
15369	continuous heat stress	continuous heat stress	1	0.987403161140781	5587	4067	780	
8892	SecY of B	SecY of B	1	0.987403161140781	8893	977	8893	
16188	fatality rate	fatality rate	1	0.987403161140781	154	16189	154	
11049	clinical spectra	clinical spectrum	1	0.987403161140781	10533	323	10533	
2521	ICP monitoring	ICP monitoring	1	0.987403161140781	2523	315	2523	
12412	molecular weight	molecular weight	1	0.987403161140781	681	376	681	
7422	values of the LD parameter distributions	value of the LD parameter distribution	1	0.987403161140781	7423	7424	7423	
8204	PCR assay	PCR assay	1	0.987403161140781	562	2264	562	
13050	Burkholderia pseudomallei isolates	Burkholderia pseudomallei isolate	1	0.987403161140781	10641	13051	334	
4324	low family income	low family income	1	0.987403161140781	4326	1109	4328	
14136	recovery of these agents	recovery of these agent	1	0.987403161140781	479	1834	479	
1959	sediment samples	sediment sample	1	0.987403161140781	225	1960	225	
3645	excitation energy	excitation energy	1	0.987403161140781	1624	3646	1624	
10222	cellular metabolism	cellular metabolism	1	0.987403161140781	1955	3121	1955	
33	rice seeds	rice seed	1	0.987403161140781	35	34	35	
1176	Bacterial invasion	Bacterial invasion	1	0.987403161140781	1178	1177	1178	
12003	concomitant lung pathology	concomitant lung pathology	1	0.987403161140781	12005	12004	3535	
3996	regulatory activities	regulatory activity	1	0.987403161140781	1316	3086	1316	
6531	control of gonorrhea	control of gonorrhea	1	0.987403161140781	575	6533	575	
2096	genetic diversity of M	genetic diversity of M	1	0.987403161140781	2097	1921	2099	
11305	sputum of patients	sputum of patient	1	0.987403161140781	7390	226	7390	
5292	species communities	species community	1	0.987403161140781	990	74	990	
16545	large quantities of material	large quantity of material	1	0.987403161140781	16547	288	1964	
5925	median time to clearance	median time to clearance	1	0.987403161140781	5926	449	1403	
4079	niche of this diverse group of organisms	niche of this diverse group of organism	1	0.987403161140781	307	4081	307	
13872	possible virulence factors	possible virulence factor	1	0.987403161140781	2922	13873	2924	
1896	growth of S	growth of S	1	0.987403161140781	217	1898	217	
15637	Potent bactericidal properties	Potent bactericidal property	1	0.987403161140781	15639	15638	3103	
4924	entire course of therapy	entire course of therapy	1	0.987403161140781	4926	4925	2939	
15244	transmissible strain	transmissible strain	1	0.987403161140781	76	15245	76	
2538	length of shelf	length of shelf	1	0.987403161140781	2539	2482	2539	
4331	indirect immunofluorescence assay	indirect immunofluorescence assay	1	0.987403161140781	4333	4332	562	
12568	left ileofemoral vein	left ileofemoral vein	1	0.987403161140781	12570	699	12565	
9084	level organization of BChl's	level organization of BChl'	1	0.987403161140781	2414	9088	2416	
12103	SecY proteins	SecY protein	1	0.987403161140781	27	8893	27	
16487	tobacco leaf discs	tobacco leaf disc	1	0.987403161140781	16489	10958	16491	
16857	components of the peptidoglycan layer	component of the peptidoglycan layer	1	0.987403161140781	13813	1706	13813	
9547	low cost	low cost	1	0.987403161140781	1638	1109	1638	
1715	molecular determinants	molecular determinant	1	0.987403161140781	1717	376	1717	
5729	traits of bacteria	trait of bacteria	1	0.987403161140781	4796	1999	4796	
5328	quorum sensing	quorum sensing	1	0.987403161140781	5330	2910	5330	
3147	serotypes D-I	serotype D-I	1	0.987403161140781	3149	1214	3149	
15593	growth of Legionella pneumophila	growth of Legionella pneumophila	1	0.987403161140781	217	15595	217	
5434	successful eradication	successful eradication	1	0.987403161140781	153	5435	153	
2384	survival of a species	survival of a species	1	0.987403161140781	1950	74	1950	
10169	sensitive atopic sera	sensitive atopic serum	1	0.987403161140781	10171	3589	3345	
6078	fibronectin adhesins	fibronectin adhesin	1	0.987403161140781	2508	603	2508	
5569	trend of increase	trend of increase	1	0.987403161140781	5155	1465	5155	
2698	passive transfer of 1E4	passive transfer of 1E4	1	0.987403161140781	2700	2699	1913	
6608	gel electrophoresis silver	gel electrophoresis silver	1	0.987403161140781	6610	2364	6612	
8691	burn treatment center	burn treatment center	1	0.987403161140781	8693	8692	4790	
9572	conorii reference strains	conorii reference strain	1	0.987403161140781	5885	1451	551	
1017	fraction of EF	fraction of EF	1	0.987403161140781	1018	1019	1018	
8594	animal species	animal specie	1	0.987403161140781	73	4461	73	
3802	outer membrane protein A	outer membrane protein A	1	0.987403161140781	1379	3803	1379	
12368	inactive Crohn's disease	inactive Crohn' disease	1	0.987403161140781	12370	7502	268	
3551	secondary mannitol salts	secondary mannitol salt	1	0.987403161140781	3553	68	3555	
11354	conventional calcium chloride method	conventional calcium chloride method	1	0.987403161140781	11356	11355	596	
6216	levels of fnbA	level of fnbA	1	0.987403161140781	495	6218	495	
6284	relative contents of hexadecanoic acid	relative content of hexadecanoic acid	1	0.987403161140781	6286	6285	6287	
11510	nerve regeneration	nerve regeneration	1	0.987403161140781	1684	1774	1684	
13121	narrow range of incubation conditions	narrow range of incubation condition	1	0.987403161140781	10433	13122	928	
6397	altered genetic code	altered genetic code	1	0.987403161140781	6399	6398	6401	
15108	role of the different groups	role of the different group	1	0.987403161140781	233	15110	233	
5843	High genetic diversity	High genetic diversity	1	0.987403161140781	2097	5844	2099	
13990	concentration of oocysts	concentration of oocyst	1	0.987403161140781	2012	482	2012	
9946	soluble antigens	soluble antigen	1	0.987403161140781	4100	6542	4100	
10688	human health	human health	1	0.987403161140781	6744	834	6744	
3704	IgG antibodies	IgG antibody	1	0.987403161140781	517	3705	517	
8122	hydrophila infections	hydrophila infection	1	0.987403161140781	736	4797	736	
15907	bacterial clearance	bacterial clearance	1	0.987403161140781	449	185	449	
9657	appropriate precautions	appropriate precaution	1	0.987403161140781	9659	9658	9659	
13510	analysis of Phytoplasma protein translocation genes	analysis of Phytoplasma protein translocation gene	1	0.987403161140781	203	13512	203	
4316	regular 4-week intake of probiotics	regular 4-week intake of probiotic	1	0.987403161140781	4318	4317	2477	
10267	non-native folding	non-native folding	1	0.987403161140781	10269	10268	10269	
13955	assay of tuberculin hypersensitivity	assay of tuberculin hypersensitivity	1	0.987403161140781	562	13957	562	
527	C3 receptor CR3	C3 receptor CR3	1	0.987403161140781	529	528	531	
2817	100-fold preconcentration of the urine	100-fold preconcentration of the urine	1	0.987403161140781	2819	2818	2820	
3406	follow-up period	follow-up period	1	0.987403161140781	2478	3407	2478	
5108	crystallographic analysis	crystallographic analysis	1	0.987403161140781	203	1104	203	
11308	result of lack of resources	result of lack of resource	1	0.987403161140781	4412	11310	4412	
9830	female mouse model of genital tract chlamydia infection	female mouse model of genital tract chlamydia infection	1	0.987403161140781	9832	9831	361	
7951	ligand binding	ligand binding	1	0.987403161140781	159	1993	159	
6590	infant pneumonia	infant pneumonia	1	0.987403161140781	665	6591	665	
15896	impact of glycopeptide resistance	impact of glycopeptide resistance	1	0.987403161140781	11041	9246	11041	
16579	interferon gamma	interferon gamma	1	0.987403161140781	54	7986	54	
14359	Primary cell cultures	Primary cell culture	1	0.987403161140781	14361	14360	4706	
13993	effective control	effective control	1	0.987403161140781	575	5811	575	
10574	Monolayer cultures	Monolayer culture	1	0.987403161140781	4706	10575	4706	
12370	Crohn's disease	Crohn' disease	1	0.987403161140781	268	12371	268	
907	brain injury	brain injury	1	0.987403161140781	909	908	909	
1144	number of E	number of E	1	0.987403161140781	1034	79	1034	
13399	adhesion to the HCE cell biotic surface	adhesion to the HCE cell biotic surface	1	0.987403161140781	336	13401	336	
2529	Chinese patients	Chinese patient	1	0.987403161140781	226	2530	226	
12132	Fluorescence spectral parameters	Fluorescence spectral parameter	1	0.987403161140781	12134	1736	8288	
4045	Widespread acquisition of antimicrobial resistance	Widespread acquisition of antimicrobial resistance	1	0.987403161140781	4047	4046	4048	
16054	association of the resistance	association of the resistance	1	0.987403161140781	7991	1830	7991	
14353	bacterial niche	bacterial niche	1	0.987403161140781	307	185	307	
13285	robust PMN ROS production	robust PMN ROS production	1	0.987403161140781	8243	13286	93	
388	value of 35 cm	value of 35 cm	1	0.987403161140781	211	390	211	
4083	group of organisms	group of organism	1	0.987403161140781	351	3385	351	
13591	various modeling studies of two-dimensional electronic spectra	various modeling study of two-dimensional electronic spectrum	1	0.987403161140781	13593	3269	2918	
7702	aerial parts of the plant Artemisia annua	aerial part of the plant Artemisia annua	1	0.987403161140781	7704	7703	7705	
16331	poorer lung function	poor lung function	1	0.987403161140781	14402	16332	778	
5338	component deficiency	component deficiency	1	0.987403161140781	5340	918	5340	
12049	virulence factors of the bacterium	virulence factor of the bacterium	1	0.987403161140781	2922	1136	2924	
3380	labile toxin	labile toxin	1	0.987403161140781	1598	3381	1598	
14955	last class	last class	1	0.987403161140781	2435	14318	2435	
15441	exudates of the pelvic dead space	exudate of the pelvic dead space	1	0.987403161140781	15442	15443	15442	
9781	lymphogranuloma venereum	lymphogranuloma venereum	1	0.987403161140781	9783	9782	9783	
13499	atypical mycobacteria	atypical mycobacterium	1	0.987403161140781	11100	10831	11100	
7704	parts of the plant Artemisia annua	part of the plant Artemisia annua	1	0.987403161140781	7705	7706	7705	
135	lysozyme preparations	lysozyme preparation	1	0.987403161140781	137	136	137	
9076	expression of V	expression of V	1	0.987403161140781	373	2022	373	
12127	anthrax toxin receptor	anthrax toxin receptor	1	0.987403161140781	345	12128	345	
8610	chemokines CCL	chemokine CCL	1	0.987403161140781	8612	8611	8612	
15118	airways of CF patients	airway of CF patient	1	0.987403161140781	15119	15120	15119	
14367	mortality rate	mortality rate	1	0.987403161140781	154	4920	154	
10541	specific molecule	specific molecule	1	0.987403161140781	6034	504	6034	
16464	faecal material	faecal material	1	0.987403161140781	7239	16465	7239	
5264	MIC90 of AMK	MIC90 of AMK	1	0.987403161140781	2925	5266	2925	
16726	11-year study of acute lower respiratory illness	11-year study of acute low respiratory illness	1	0.987403161140781	16728	16727	1514	
7169	lactic acid bacterial strains	lactic acid bacterial strain	1	0.987403161140781	7171	2106	551	
1683	regeneration of peripheral nerves	regeneration of peripheral nerve	1	0.987403161140781	1684	1685	1684	
2026	non-infected heifers	non-infected heifer	1	0.987403161140781	2028	2027	2028	
10823	pathophysiological deterioration	pathophysiological deterioration	1	0.987403161140781	41	10824	41	
6724	proteinase fusions	proteinase fusion	1	0.987403161140781	1815	6725	1815	
13176	seeds of the rice cultivars CT6919	seed of the rice cultivar CT6919	1	0.987403161140781	35	13178	35	
6647	repressor of Ec	repressor of Ec	1	0.987403161140781	5464	6649	5464	
16050	Chlamydophila pneumoniae	Chlamydophila pneumoniae	1	0.987403161140781	8121	16051	8121	
10709	QS system	QS system	1	0.987403161140781	1501	3493	1501	
8423	MIC50S of cephems	MIC50S of cephem	1	0.987403161140781	8424	8425	8424	
11596	spectrum penicillin	spectrum penicillin	1	0.987403161140781	5532	1695	5532	
12828	9-kb plasmid	9-kb plasmid	1	0.987403161140781	3040	12829	3040	
1784	higher prevalence	high prevalence	1	0.987403161140781	1786	151	1786	
15890	ability of Methylocella silvestris	ability of Methylocella silvestris	1	0.987403161140781	939	15892	939	
1394	corpus atrophy	corpus atrophy	1	0.987403161140781	1396	1395	1396	
11636	rate constants	rate constant	1	0.987403161140781	11638	154	11638	
4958	controlled fashion	controlled fashion	1	0.987403161140781	4960	4959	4960	
12221	suspension culture	suspension culture	1	0.987403161140781	2092	4222	2092	
13430	course of AZLI	course of AZLI	1	0.987403161140781	2939	8720	2939	
8534	potential of C	potential of C	1	0.987403161140781	6353	243	6353	
6910	+ C12	+ C12	1	0.987403161140781	2692	6911	2692	
15279	bacterial isolates	bacterial isolate	1	0.987403161140781	334	185	334	
9045	restriction enzyme ApaI	restriction enzyme ApaI	1	0.987403161140781	9047	5178	9049	
16068	P ro-Phe(P)	P ro-Phe(P)	1	0.987403161140781	16070	160	16070	
4087	H pylori therapy	H pylori therapy	1	0.987403161140781	4089	764	464	
2378	numbers of self	number of self	1	0.987403161140781	46	1277	46	
9016	extreme temperatures	extreme temperature	1	0.987403161140781	9018	4799	9018	
13443	catalytic properties	catalytic property	1	0.987403161140781	3103	1315	3103	
15710	cell components	cell component	1	0.987403161140781	13813	235	13813	
4373	mucous stool	mucous stool	1	0.987403161140781	1259	4374	1259	
4262	certain extent	certain extent	1	0.987403161140781	3698	3332	3698	
12331	different factors	different factor	1	0.987403161140781	2924	816	2924	
7785	Spoligotyping analysis	Spoligotyping analysis	1	0.987403161140781	203	7786	203	
13824	proportion of cases	proportion of case	1	0.987403161140781	1247	2770	1247	
10672	lower costs	low cost	1	0.987403161140781	2874	1390	2874	
6059	phosphoglycerol moiety	phosphoglycerol moiety	1	0.987403161140781	6061	6060	6061	
14756	cocrystal structure of MurQ	cocrystal structure of MurQ	1	0.987403161140781	14758	14757	201	
7354	ability of E	ability of E	1	0.987403161140781	939	79	939	
4784	inhibition experiments	inhibition experiment	1	0.987403161140781	1434	2510	1434	
10753	groups of cattle sera	group of cattle serum	1	0.987403161140781	4420	10755	4420	
12040	role of lambdoid phages	role of lambdoid phage	1	0.987403161140781	233	12042	233	
5050	none of the nasopharyngeal cultures	none of the nasopharyngeal culture	1	0.987403161140781	5051	5052	5051	
8128	chromosome of the host	chromosome of the host	1	0.987403161140781	8129	271	8129	
599	surface display of fibronectin	surface display of fibronectin	1	0.987403161140781	601	339	602	
5880	oval rod-shaped bacterium	oval rod-shaped bacterium	1	0.987403161140781	5882	5881	1136	
10298	apple juice	apple juice	1	0.987403161140781	10300	10299	10300	
5993	excitonic properties	excitonic property	1	0.987403161140781	3103	301	3103	
13766	Drug tolerance	Drug tolerance	1	0.987403161140781	1278	13767	1278	
222	Serum samples of these patients	Serum sample of these patient	1	0.987403161140781	224	223	225	
15535	rich medium	rich medium	1	0.987403161140781	1926	15536	1926	
10094	addition of the helix	addition of the helix	1	0.987403161140781	2743	5640	2743	
4515	healthy fish	healthy fish	1	0.987403161140781	2824	133	2824	
14700	FACS analysis of caspase	FACS analysis of caspase	1	0.987403161140781	14702	11252	203	
3343	horse sera	horse serum	1	0.987403161140781	3345	3344	3345	
275	reduction of PMN cell death	reduction of PMN cell death	1	0.987403161140781	276	277	276	
4055	xopC region	xopC region	1	0.987403161140781	3464	4056	3464	
12855	cause of WARI	cause of WARI	1	0.987403161140781	8326	3155	8326	
8921	early pregnancy loss	early pregnancy loss	1	0.987403161140781	7647	1097	4308	
7657	swab cultures	swab culture	1	0.987403161140781	4706	7658	4706	
8227	microscopic examinations of various preparations	microscopic examination of various preparation	1	0.987403161140781	8229	8228	8230	
4474	susceptible MRSA parent	susceptible MRSA parent	1	0.987403161140781	4476	2970	4478	
9878	efficiency of maturation of mutant enzymes	efficiency of maturation of mutant enzyme	1	0.987403161140781	481	9880	481	
16406	RecA protein of this bacterial species	RecA protein of this bacterial specie	1	0.987403161140781	16408	6572	406	
3268	various protease inhibitors	various protease inhibitor	1	0.987403161140781	3270	3269	3272	
15171	hydrophilic interaction liquid chromatography	hydrophilic interaction liquid chromatography	1	0.987403161140781	15173	2088	2312	
13530	urine sediments	urine sediment	1	0.987403161140781	7741	892	7741	
13669	specific Mycobacterium leprae antigen	specific Mycobacterium leprae antigen	1	0.987403161140781	13671	504	655	
922	correct conformation	correct conformation	1	0.987403161140781	924	923	924	
10416	paraffin section immunophenotyping	paraffin section immunophenotyping	1	0.987403161140781	5667	10417	5667	
2614	different forms	different form	1	0.987403161140781	2616	816	2616	
11246	free lipids	free lipid	1	0.987403161140781	11248	112	11248	
5165	TCR phenotype of T-lymphocytes	TCR phenotype of T-lymphocyte	1	0.987403161140781	5167	1301	5168	
15936	inclusion body	inclusion body	1	0.987403161140781	367	1762	367	
8060	actin polymerization experiments	actin polymerization experiment	1	0.987403161140781	1434	8061	1434	
16397	Burkholderia cepacia	Burkholderia cepacia	1	0.987403161140781	16399	13051	16399	
13440	combination treatment	combination treatment	1	0.987403161140781	61	1027	61	
7481	preferred testing grounds	preferred testing ground	1	0.987403161140781	7483	7482	7485	
5336	complement component deficiency	complement component deficiency	1	0.987403161140781	5338	2759	5340	
8953	CD8+ T cell	CD8+ T cell	1	0.987403161140781	2056	52	235	
6770	PHENIX AutoMR wizard	PHENIX AutoMR wizard	1	0.987403161140781	6772	6771	6774	
10163	restriction endonucleases	restriction endonucleas	1	0.987403161140781	10165	5178	10165	
4952	haemolytic activity	haemolytic activity	1	0.987403161140781	393	4953	393	
11372	high lethal infection	high lethal infection	1	0.987403161140781	11374	264	274	
7979	biocontainment methods	biocontainment method	1	0.987403161140781	2371	3752	2371	
9210	two-site exchange	two-site exchange	1	0.987403161140781	9212	9211	9212	
14797	G protein	G protein	1	0.987403161140781	406	384	406	
1844	significant changes	significant change	1	0.987403161140781	1846	24	1846	
2496	immunosorbent assay	immunosorbent assay	1	0.987403161140781	562	2497	562	
10974	arabinosylnucleoside triphosphates	arabinosylnucleoside triphosphate	1	0.987403161140781	10976	10975	10976	
5979	spectrometry (MS(n))	spectrometry (MS(n))	1	0.987403161140781	5981	2137	5981	
10396	screening plates	screening plate	1	0.987403161140781	2093	671	2093	
8889	addition of rifampin	addition of rifampin	1	0.987403161140781	2743	421	2743	
13413	LVS strain	LVS strain	1	0.987403161140781	76	1202	76	
7322	bacterial mercury resistance	bacterial mercury resistance	1	0.987403161140781	7324	185	1830	
8853	latent period	latent period	1	0.987403161140781	2478	8854	2478	
3164	ratios of gram positive bacteria	ratio of gram positive bacteria	1	0.987403161140781	3165	3166	3165	
6097	suppurative inflammatory response	suppurative inflammatory response	1	0.987403161140781	6099	6098	286	
6286	contents of hexadecanoic acid	content of hexadecanoic acid	1	0.987403161140781	6287	6288	6287	
10484	association of comorbid conditions	association of comorbid condition	1	0.987403161140781	7991	5356	7991	
11554	Staphylococcus epidermidis ABK	Staphylococcus epidermidis ABK	1	0.987403161140781	11558	10371	11558	
7340	Seafood ingestion	Seafood ingestion	1	0.987403161140781	7342	7341	7342	
5106	X-ray crystallographic analysis	X-ray crystallographic analysis	1	0.987403161140781	5108	199	203	
11656	course of a Clostridium perfringens infection	course of a Clostridium perfringen infection	1	0.987403161140781	2939	11658	2939	
7988	little conservation	little conservation	1	0.987403161140781	7990	628	7990	
15327	Older age	Old age	1	0.987403161140781	912	15328	912	
1458	Gastric hypoacidity	Gastric hypoacidity	1	0.987403161140781	1460	1459	1460	
14963	viable Mycobacterium tuberculosis Erdman	viable Mycobacterium tuberculosis Erdman	1	0.987403161140781	14965	1966	14969	
2920	pyogenes virulence factors	pyogene virulence factor	1	0.987403161140781	2922	2921	2924	
9275	efficient screening	efficient screening	1	0.987403161140781	671	9276	671	
4935	genetic environment	genetic environment	1	0.987403161140781	131	880	131	
11413	PA infection	PA infection	1	0.987403161140781	274	3422	274	
9869	stone model	stone model	1	0.987403161140781	361	7631	361	
7450	experimental work	experimental work	1	0.987403161140781	1371	7451	1371	
14710	extracellular alkaline phosphatase	extracellular alkaline phosphatase	1	0.987403161140781	1288	6	1290	
8505	190-kDa gene	190-kDa gene	1	0.987403161140781	18	8506	18	
9190	secretion effectors	secretion effector	1	0.987403161140781	454	2586	454	
4189	antimicrobial properties	antimicrobial property	1	0.987403161140781	3103	1753	3103	
15505	mechanistic studies	mechanistic study	1	0.987403161140781	2918	867	2918	
8408	range of angles	range of angle	1	0.987403161140781	928	8410	928	
12790	soft texture	soft texture	1	0.987403161140781	12792	2545	12792	
10625	location of TSS	location of TSS	1	0.987403161140781	1670	5603	1670	
15543	influenzae subspecies	influenzae subspecy	1	0.987403161140781	1119	3778	1119	
16827	novel antimicrobial drug targets	novel antimicrobial drug target	1	0.987403161140781	16829	82	16833	
6901	significance of cellular invasion	significance of cellular invasion	1	0.987403161140781	4435	6903	4435	
6027	surface expression of the costimulatory molecule CD252	surface expression of the costimulatory molecule CD252	1	0.987403161140781	6029	339	373	
11718	xylanase production	xylanase production	1	0.987403161140781	93	7233	93	
10871	intensity of enzyme activity	intensity of enzyme activity	1	0.987403161140781	4874	7288	4874	
8225	Electron microscopic examinations of various preparations	Electron microscopic examination of various preparation	1	0.987403161140781	8227	8226	8230	
5773	food handler	food handler	1	0.987403161140781	5775	43	5775	
6039	multiple Helicobacter pylori	multiple Helicobacter pylori	1	0.987403161140781	499	6040	501	
2929	Ozone applications	Ozone application	1	0.987403161140781	2931	2930	2931	
11083	replication fo bacteriophage M	replication fo bacteriophage M	1	0.987403161140781	11085	3665	1921	
11981	mammalian partner protein	mammalian partner protein	1	0.987403161140781	11983	411	406	
10618	Swarming differentiation of vibrio vulnificus	Swarming differentiation of vibrio vulnificus	1	0.987403161140781	10620	10619	884	
7909	respective N	respective N	1	0.987403161140781	148	7910	148	
12458	Ec genetic backgrounds	Ec genetic background	1	0.987403161140781	12460	6649	12462	
8323	major cause of ocular infections	major cause of ocular infection	1	0.987403161140781	8325	71	8326	
6203	J774 cells	J774 cell	1	0.987403161140781	113	2766	113	
15422	open Gambian communities	open Gambian community	1	0.987403161140781	15424	6575	990	
894	distribution of the disease melioidosis	distribution of the disease melioidosis	1	0.987403161140781	895	896	895	
8875	cases of HIV	case of HIV	1	0.987403161140781	2770	4854	2770	
5854	superficial abscesses	superficial abscess	1	0.987403161140781	5856	5855	5856	
6722	aspartic proteinase fusions	aspartic proteinase fusion	1	0.987403161140781	6724	6723	1815	
2167	AraC family members	AraC family member	1	0.987403161140781	2169	2168	2171	
2139	reduction rate of host cells	reduction rate of host cell	1	0.987403161140781	2141	276	154	
10062	trauma registry	trauma registry	1	0.987403161140781	10064	7099	10064	
9121	O-linked glycosylation pathway	O-linked glycosylation pathway	1	0.987403161140781	1429	3486	661	
13845	reservoir of iron	reservoir of iron	1	0.987403161140781	7333	1953	7333	
10010	Structural basis	Structural basis	1	0.987403161140781	6748	1724	6748	
102	filarial parasites	filarial parasite	1	0.987403161140781	104	103	104	
2981	dependent pathway	dependent pathway	1	0.987403161140781	661	807	661	
13386	genetic basis	genetic basis	1	0.987403161140781	6748	880	6748	
9598	drug discovery	drug discovery	1	0.987403161140781	9600	162	9600	
1276	self tolerance	self tolerance	1	0.987403161140781	1278	1277	1278	
5431	DNA synthesis	DNA synthesis	1	0.987403161140781	515	468	515	
9259	retail packs of minced meat	retail pack of minced meat	1	0.987403161140781	9131	7021	3529	
6198	human macrophages	human macrophage	1	0.987403161140781	394	834	394	
9962	severity of disease	severity of disease	1	0.987403161140781	436	268	436	
12478	phage titre	phage titre	1	0.987403161140781	12480	2407	12480	
10886	min of infection	min of infection	1	0.987403161140781	3265	274	3265	
15181	Incorporation of membrane	Incorporation of membrane	1	0.987403161140781	15182	3723	15182	
12699	metabolic dependence	metabolic dependence	1	0.987403161140781	12701	2121	12701	
13319	interleukin -1 receptor domain	interleukin -1 receptor domain	1	0.987403161140781	253	13320	253	
15323	lung cytokine	lung cytokine	1	0.987403161140781	1568	936	1568	
2244	SecA rabbit antibody	SecA rabbit antibody	1	0.987403161140781	2246	2245	1299	
10553	culture of strain L	culture of strain L	1	0.987403161140781	2092	1883	2092	
15682	regulator of S	regulator of S	1	0.987403161140781	756	1898	756	
13926	intracranial pressure monitor prophylaxis	intracranial pressure monitor prophylaxis	1	0.987403161140781	13928	8056	22	
14671	infectious disease	infectious disease	1	0.987403161140781	268	843	268	
7261	NAP activity	NAP activity	1	0.987403161140781	393	1466	393	
237	negative correlations	negative correlation	1	0.987403161140781	239	238	239	
6789	Japanese gastric cancer patients	Japanese gastric cancer patient	1	0.987403161140781	6791	295	226	
15742	Mycobacterium kansasii	Mycobacterium kansasii	1	0.987403161140781	15744	261	15744	
16337	K(is) values	K(is) value	1	0.987403161140781	7423	16338	7423	
8358	challenge models	challenge model	1	0.987403161140781	7459	2836	7459	
9839	tract chlamydia	tract chlamydia	1	0.987403161140781	9053	3496	9053	
2635	different seasons	different season	1	0.987403161140781	2637	816	2637	
5593	substrate urea	substrate urea	1	0.987403161140781	3833	3652	3833	
12566	occlusion of the left ileofemoral vein	occlusion of the left ileofemoral vein	1	0.987403161140781	12567	12568	12567	
13525	linear combinations of variables	linear combination of variable	1	0.987403161140781	13527	12861	13528	
11550	maximum resolution	maximum resolution	1	0.987403161140781	1852	11551	1852	
10177	probiotic group	probiotic group	1	0.987403161140781	351	1093	351	
11093	host serum bactericidal activity	host serum bactericidal activity	1	0.987403161140781	11095	271	393	
14618	lacZ transcriptional fusion	lacZ transcriptional fusion	1	0.987403161140781	14620	1682	8418	
4856	fatty acid pattern of Helicobacter pullorum	fatty acid pattern of Helicobacter pullorum	1	0.987403161140781	4860	3123	4145	
9503	analysis of O	analysis of O	1	0.987403161140781	203	6480	203	
10695	pulmonary function	pulmonary function	1	0.987403161140781	778	10696	778	
15679	morphogenetic activity	morphogenetic activity	1	0.987403161140781	393	15680	393	
14651	absence of an obvious Shine	absence of an obvious Shine	1	0.987403161140781	5502	14653	5502	
16439	complete eae genes	complete eae gene	1	0.987403161140781	16441	4306	444	
12795	biofilm development	biofilm development	1	0.987403161140781	1679	8662	1679	
7381	symbiotic expression of pdhA genes	symbiotic expression of pdhA gene	1	0.987403161140781	7383	3920	373	
2900	characterisation of Φ st1	characterisation of Φ st1	1	0.987403161140781	2901	2902	2901	
13741	hundreds of TSS	hundred of TSS	1	0.987403161140781	13742	5603	13742	
16679	Lymphogranuloma venereum	Lymphogranuloma venereum	1	0.987403161140781	9783	16680	9783	
13795	Cell counts	Cell count	1	0.987403161140781	2262	3491	2262	
7542	history of recent consumption of marine bivalves	history of recent consumption of marine bivalve	1	0.987403161140781	3162	7544	3162	
5257	FMO complexes	FMO complex	1	0.987403161140781	1127	5258	1127	
13196	degree of association	degree of association	1	0.987403161140781	2084	7991	2084	
5956	adherence of bacteria	adherence of bacteria	1	0.987403161140781	3685	1999	3685	
15606	activation of pdh gene expression	activation of pdh gene expression	1	0.987403161140781	2118	15608	2118	
13027	negative control	negative control	1	0.987403161140781	575	238	575	
11102	polymorphonuclear leukocytes	polymorphonuclear leukocyte	1	0.987403161140781	3851	10101	3851	
6791	gastric cancer patients	gastric cancer patient	1	0.987403161140781	226	385	226	
8190	different FMO samples	different FMO sample	1	0.987403161140781	8192	816	225	
12579	contact time	contact time	1	0.987403161140781	1403	2191	1403	
9779	outbreak of lymphogranuloma venereum	outbreak of lymphogranuloma venereum	1	0.987403161140781	986	9781	986	
1876	Scottish isolates	Scottish isolate	1	0.987403161140781	334	1877	334	
10088	absence of neutrophils	absence of neutrophil	1	0.987403161140781	5502	2439	5502	
10355	long axis	long axis	1	0.987403161140781	10357	10356	10357	
5590	protective effects	protective effect	1	0.987403161140781	1055	4387	1055	
11335	regulatory roles	regulatory role	1	0.987403161140781	8900	3086	8900	
5007	differential diagnosis of early gastric mucosa	differential diagnosis of early gastric mucosa	1	0.987403161140781	5009	5008	5010	
7058	ES114 LPS	ES114 LPS	1	0.987403161140781	7060	7059	7060	
15466	significant increases	significant increase	1	0.987403161140781	15468	24	15468	
13014	granulomatous lesion	granulomatous lesion	1	0.987403161140781	13016	285	13016	
14972	drug discovery initiatives	drug discovery initiative	1	0.987403161140781	14974	162	14976	
2014	lipoteichoic acid	lipoteichoic acid	1	0.987403161140781	4	2015	4	
9788	healthy infants	healthy infant	1	0.987403161140781	9790	133	9790	
9356	strong argument	strong argument	1	0.987403161140781	9358	1751	9358	
16809	GASP network of laboratories	GASP network of laboratory	1	0.987403161140781	16811	244	401	
2676	mantle zone	mantle zone	1	0.987403161140781	2678	2677	2678	
753	gene regulator Mga	gene regulator Mga	1	0.987403161140781	755	18	757	
3642	new method	new method	1	0.987403161140781	596	1171	596	
13172	cohorts of children	cohort of child	1	0.987403161140781	4561	1560	4561	
1790	positive clone	positive clone	1	0.987403161140781	1792	953	1792	
14334	distant lineages indicative of widespread acquisition	distant lineage indicative of widespread acquisition	1	0.987403161140781	14336	14335	14337	
3461	bacterium of the family	bacterium of the family	1	0.987403161140781	1136	2170	1136	
8465	protein energy landscape	protein energy landscape	1	0.987403161140781	8467	406	8469	
9035	gene product Rv3168	gene product Rv3168	1	0.987403161140781	9037	18	9039	
12966	psittaci strains	psittaci strain	1	0.987403161140781	551	10806	551	
5501	absence of these adhesins	absence of these adhesin	1	0.987403161140781	5502	2508	5502	
7119	Biophysical studies	Biophysical study	1	0.987403161140781	2918	7120	2918	
6853	chimeric proteins	chimeric protein	1	0.987403161140781	27	6854	27	
4268	attachment to the abiotic surface	attachment to the abiotic surface	1	0.987403161140781	938	4213	938	
8557	Evaluation of a lytic bacteriophage	Evaluation of a lytic bacteriophage	1	0.987403161140781	1573	8559	1573	
12651	colonial morphology	colonial morphology	1	0.987403161140781	5323	12652	5323	
1981	Lactococcus lactis strains	Lactococcus lactis strain	1	0.987403161140781	1983	1982	551	
15820	little permeability barrier to ampicillin	little permeability barrier to ampicillin	1	0.987403161140781	15822	628	630	
9099	properties of BChl molecules	property of BChl molecule	1	0.987403161140781	3103	431	3103	
11186	ultrafiltration procedure	ultrafiltration procedure	1	0.987403161140781	650	11187	650	
2153	potential relationship to phylogeny	potential relationship to phylogeny	1	0.987403161140781	2155	2154	2156	
2828	cardiac dysfunction	cardiac dysfunction	1	0.987403161140781	2830	2829	2830	
6331	~10¹² PFU	~10¹² PFU	1	0.987403161140781	2481	6332	2481	
1086	macrophage cell line	macrophage cell line	1	0.987403161140781	1088	1087	1090	
14113	goal of this study	goal of this study	1	0.987403161140781	9593	1514	9593	
9723	ceftriaxone monotherapy	ceftriaxone monotherapy	1	0.987403161140781	9725	9724	9725	
5	extracellular milieu	extracellular milieu	1	0.987403161140781	7	6	7	
1781	clinical implications	clinical implication	1	0.987403161140781	1783	323	1783	
15252	significant positive correlations	significant positive correlation	1	0.987403161140781	15254	24	239	
14995	halophilic bacterium	halophilic bacterium	1	0.987403161140781	1136	14996	1136	
3446	flagellar rod protein	flagellar rod protein	1	0.987403161140781	3448	3447	406	
2868	biochemical results	biochemical result	1	0.987403161140781	2870	2869	2870	
